data_2ndi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ndi _Structure_validation_residue.Date_analyzed 2017-06-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.796 0.332 . . . . 206.49 110.585 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.77 -42.81 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 336.78 110.947 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.07 53.64 1.61 Allowed Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.465 -0.654 . . . . 108.67 111.465 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.61 -46.53 87.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.83 0.348 . . . . 133.27 110.699 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.18 -42.08 99.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.289 0.566 . . . . 25.78 110.139 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.84 168.5 7.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.278 -0.874 . . . . 119.04 109.897 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.98 97.23 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.862 -0.335 . . . . 157.06 110.932 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.97 -32.15 27.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.429 -0.35 . . . . 258.73 111.023 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -75.1 166.98 22.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 339.06 110.938 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -130.9 143.89 51.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.01 -0.541 . . . . 50.72 110.629 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -135.58 138.53 43.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.3 -0.629 . . . . 39.11 109.3 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 9.9 p -148.3 118.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.56 -0.456 . . . . 261.82 110.402 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.61 118.93 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 135.42 111.094 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 26' ' ' THR . 16.2 p -97.53 160.57 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 156.21 109.344 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p 179.53 117.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.921 0.867 . . . . 137.43 109.252 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.626 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.42 -56.63 2.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.269 -1.332 . . . . 67.15 111.387 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -113.41 -174.5 2.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.188 0.518 . . . . 451.81 111.77 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.41 -9.62 57.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.352 -0.84 . . . . 214.64 111.911 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.11 -41.1 96.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.879 0.371 . . . . 328.18 110.85 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -163.01 169.42 19.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 386.81 110.866 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.78 143.13 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.554 . . . . 184.5 110.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 18' ' ' THR . 99.4 m -117.25 137.43 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.503 -0.771 . . . . 151.99 111.168 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -125.79 156.23 39.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.871 -0.604 . . . . 999.99 109.531 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -147.96 159.25 44.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.303 0.573 . . . . 242.47 111.253 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.6 t -175.14 137.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.41 -0.814 . . . . 15.64 109.194 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -110.67 134.74 52.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.948 0.404 . . . . 422.56 110.948 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -86.56 140.41 29.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.893 -0.594 . . . . 627.38 109.707 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -89.99 102.71 15.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.964 0.412 . . . . 220.71 110.659 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ASN . 21.5 m -138.04 126.51 23.39 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.495 0.664 . . . . 255.23 110.032 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.25 -71.11 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 CA-C-N 114.663 -1.153 . . . . 82.17 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 33' ' ' THR . 84.2 m-20 -111.98 142.21 44.68 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.789 -0.448 . . . . 405.39 109.789 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -70.92 143.86 50.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 183.25 110.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 p -147.02 117.05 7.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.134 -0.485 . . . . 196.98 110.209 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.42 161.61 23.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 537.65 110.978 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 7.5 p -64.05 150.19 92.4 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.855 -0.612 . . . . 34.91 110.143 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.01 137.56 21.85 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.069 1.846 . . . . 87.7 111.768 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.13 7.41 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.793 -0.923 . . . . 244.37 110.793 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.857 0.36 . . . . 909.71 110.617 -179.612 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.21 -0.293 . . . . 206.49 110.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.41 85.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.872 0.368 . . . . 336.78 110.185 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.99 65.24 0.52 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.622 -0.991 . . . . 108.67 110.622 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.06 -41.72 97.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 133.27 110.588 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.9 m -61.31 -41.17 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 25.78 110.173 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.61 166.46 14.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.778 . . . . 119.04 109.954 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.48 95.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 157.06 110.926 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.22 -29.61 24.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 258.73 111.055 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.469 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.0 mm-40 -76.14 159.97 30.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.414 . . . . 339.06 111.136 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 35.1 t -109.88 153.3 24.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.922 -0.581 . . . . 50.72 110.366 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.7 t -144.65 127.27 16.11 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.242 -0.651 . . . . 39.11 109.242 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.61 128.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 261.82 110.614 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -99.28 132.87 44.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 135.42 110.733 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 24.0 p -122.32 161.09 24.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.871 -0.604 . . . . 156.21 109.51 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 179.27 118.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.988 0.899 . . . . 137.43 109.2 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.13 -64.06 1.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.972 -1.467 . . . . 67.15 110.973 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.7 pt-20 -109.89 -173.06 2.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.122 0.487 . . . . 451.81 111.479 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.69 -11.62 56.64 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.574 -0.739 . . . . 214.64 111.858 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.25 -39.93 92.17 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.927 -0.309 . . . . 328.18 110.957 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ptm -159.11 167.23 29.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 386.81 111.001 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.3 t -123.17 143.37 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.859 -0.61 . . . . 184.5 110.571 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 84.1 m -118.26 135.68 54.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.51 -0.768 . . . . 151.99 110.988 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -142.47 155.3 45.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.082 -0.508 . . . . 999.99 110.032 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -140.94 149.2 41.54 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.015 0.436 . . . . 242.47 111.012 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -172.09 116.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 15.64 109.794 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -82.2 150.1 27.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 422.56 110.88 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -112.75 141.71 46.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.086 -0.506 . . . . 627.38 109.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.469 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 92.4 m -69.34 126.73 30.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 220.71 110.529 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 35' ' ' ASN . 27.3 p -151.03 89.44 1.53 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.417 0.627 . . . . 255.23 110.448 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.08 -47.93 1.34 Allowed Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 114.984 -1.007 . . . . 82.17 110.946 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.0 m120 -131.77 139.84 49.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.1 -0.333 . . . . 405.39 110.1 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -82.51 145.42 29.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 183.25 110.781 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.8 p -129.5 -145.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.132 -0.486 . . . . 196.98 109.892 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -161.16 154.35 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.062 -0.517 . . . . 537.65 110.836 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.4 p -66.91 149.7 98.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 34.91 110.054 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.89 136.33 20.5 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.141 1.894 . . . . 87.7 111.849 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.38 -39.99 98.39 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.987 -0.845 . . . . 244.37 110.987 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.858 0.361 . . . . 909.71 110.463 -179.831 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 110.252 -0.277 . . . . 206.49 110.252 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.16 -39.63 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 336.78 110.242 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.64 62.76 0.44 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.628 -0.989 . . . . 108.67 110.628 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.6 -46.55 89.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 133.27 110.766 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.5 m -63.1 -41.86 99.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 25.78 110.299 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.54 163.56 6.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.312 -0.858 . . . . 119.04 109.585 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.78 91.8 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.488 -0.485 . . . . 157.06 110.405 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.33 -38.69 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 258.73 110.48 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.26 156.52 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 339.06 110.515 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.623 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 1.8 p -108.12 171.22 7.53 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.197 -0.297 . . . . 50.72 110.197 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -156.17 127.71 7.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.312 -0.625 . . . . 39.11 109.312 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.95 129.13 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 261.82 110.38 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -94.9 120.26 34.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.017 -0.538 . . . . 135.42 110.948 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 26' ' ' THR . 15.5 p -104.4 164.86 11.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.034 -0.53 . . . . 156.21 109.653 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.04 119.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.833 0.825 . . . . 137.43 109.087 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.16 -65.94 0.93 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.336 -1.302 . . . . 67.15 111.013 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -108.66 -171.97 1.96 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.11 0.481 . . . . 451.81 111.567 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.35 -13.34 52.14 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.694 -0.685 . . . . 214.64 111.973 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -60.54 -41.58 94.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 328.18 110.722 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptp -160.87 161.71 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.922 -0.581 . . . . 386.81 110.495 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.14 160.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.907 -0.588 . . . . 184.5 110.956 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 18' ' ' THR . 78.0 m -129.75 138.55 51.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.734 -0.666 . . . . 151.99 111.232 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -128.13 154.51 45.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.578 . . . . 999.99 109.817 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -141.9 148.38 38.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.043 0.449 . . . . 242.47 110.822 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -171.92 101.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 15.64 109.339 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.623 ' CG ' ' H ' ' A' ' 14' ' ' CYS . 9.4 pt-20 -60.65 163.47 5.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.356 0.598 . . . . 422.56 111.375 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -136.35 143.27 43.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.833 -1.076 . . . . 627.38 110.07 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.1 m -112.06 122.8 48.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.909 0.385 . . . . 220.71 110.76 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.1 p -154.16 84.27 1.14 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.607 0.717 . . . . 255.23 110.321 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.88 -5.24 58.73 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.517 -1.22 . . . . 82.17 110.442 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.4 m-20 -154.77 149.37 26.4 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.936 -0.394 . . . . 405.39 109.936 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.88 143.21 32.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 183.25 110.935 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 10.2 t -155.46 124.53 6.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 196.98 110.107 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.6 mp0 -81.71 159.41 23.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.625 . . . . 537.65 110.808 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 160.23 0.22 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.466 -0.568 . . . . 34.91 109.466 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.09 133.04 15.99 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.06 1.84 . . . . 87.7 111.894 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.22 -40.36 98.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 244.37 111.212 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.833 0.349 . . . . 909.71 110.549 -179.703 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.716 0.293 . . . . 206.49 110.607 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.34 84.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.882 0.373 . . . . 336.78 110.192 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.2 75.13 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.633 -0.987 . . . . 108.67 110.633 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 133.27 110.624 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.1 m -62.49 -41.77 99.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 25.78 110.202 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.73 163.15 9.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 119.04 110.09 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.38 88.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 157.06 110.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -91.89 11.4 25.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.256 -0.429 . . . . 258.73 111.441 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.0 mm-40 -119.12 159.4 24.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.071 0.462 . . . . 339.06 111.051 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.4 t -104.35 155.17 19.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.769 -0.65 . . . . 50.72 110.656 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 41.9 t -146.13 127.73 15.14 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.455 -0.572 . . . . 39.11 109.455 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.57 130.54 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 261.82 110.336 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -106.89 123.32 47.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.183 -0.462 . . . . 135.42 111.078 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -110.12 161.99 15.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.787 -0.642 . . . . 156.21 109.546 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p -178.33 116.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 122.008 0.909 . . . . 137.43 109.636 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.81 -57.78 2.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.139 -1.391 . . . . 67.15 110.748 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -116.37 -176.78 3.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.296 0.569 . . . . 451.81 111.428 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.9 -12.27 56.81 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.197 -0.911 . . . . 214.64 111.048 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -61.69 -44.47 96.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.417 . . . . 328.18 111.211 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.9 ttp -154.28 145.0 22.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 386.81 110.924 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.03 143.28 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.002 -0.544 . . . . 184.5 110.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.3 m -115.28 132.61 56.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.589 -0.732 . . . . 151.99 111.083 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -132.65 155.36 48.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.983 -0.553 . . . . 999.99 109.939 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 t -144.47 146.22 32.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.946 0.403 . . . . 242.47 110.72 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.4 t -173.65 116.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 15.64 109.803 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 78.7 mm-40 -85.04 154.84 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 422.56 110.898 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.13 143.97 49.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.899 -0.591 . . . . 627.38 109.881 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.495 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 95.2 m -88.91 119.39 29.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.949 0.404 . . . . 220.71 110.751 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.2 p -153.01 82.68 1.21 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.559 0.695 . . . . 255.23 110.577 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 78.5 -4.46 59.76 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.501 -1.227 . . . . 82.17 110.935 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 34' ' ' GLY . 33.2 m120 -159.01 148.66 18.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 405.39 110.398 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.37 140.26 37.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.34 -0.391 . . . . 183.25 110.626 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.61 124.39 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.988 0.423 . . . . 196.98 110.444 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.4 mp0 -82.44 166.07 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 537.65 111.035 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 7.7 p -62.51 150.59 85.46 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.921 -0.582 . . . . 34.91 110.05 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.05 140.96 23.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.057 1.838 . . . . 87.7 111.964 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.72 -40.45 99.21 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 244.37 110.883 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.784 0.325 . . . . 909.71 110.213 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.719 0.295 . . . . 206.49 110.331 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.17 -39.56 86.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 336.78 110.217 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.3 64.89 0.5 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.605 -0.998 . . . . 108.67 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -60.86 -45.22 95.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.803 0.335 . . . . 133.27 110.656 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.4 m -62.51 -41.59 98.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.219 0.533 . . . . 25.78 110.167 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.18 165.8 7.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.388 -0.823 . . . . 119.04 109.899 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.35 95.74 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.828 -0.349 . . . . 157.06 110.821 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.59 -32.38 25.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 258.73 111.282 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 32' ' ' THR . 76.9 mm-40 -74.22 153.97 39.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 339.06 111.188 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.5 t -101.02 156.48 17.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.927 -0.578 . . . . 50.72 110.284 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -151.43 129.81 12.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.325 -0.62 . . . . 39.11 109.325 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 131.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 261.82 110.63 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -95.54 120.05 35.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.03 -0.532 . . . . 135.42 110.65 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 26' ' ' THR . 10.6 p -107.02 161.97 14.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.041 -0.527 . . . . 156.21 110.07 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.0 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.979 0.895 . . . . 137.43 108.981 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -93.61 -94.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.84 -1.527 . . . . 67.15 111.443 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -80.37 -18.65 48.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.202 -0.908 . . . . 451.81 111.239 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.19 -8.43 75.59 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.204 -0.758 . . . . 214.64 111.204 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.56 -42.12 91.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 328.18 109.388 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.404 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.6 ttp -142.57 104.59 4.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.312 -0.858 . . . . 386.81 109.284 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.27 146.9 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 184.5 110.96 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 18' ' ' THR . 73.2 m -125.37 134.66 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.354 -0.839 . . . . 151.99 110.944 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.74 146.23 51.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.006 -0.543 . . . . 999.99 109.903 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -134.09 145.38 49.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.87 0.367 . . . . 242.47 110.639 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -172.86 116.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 15.64 109.994 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -80.04 153.57 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 422.56 110.865 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.45 142.61 46.64 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.047 -0.524 . . . . 627.38 110.017 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.4 m -68.05 126.3 29.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.064 0.459 . . . . 220.71 110.374 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.8 p -151.31 88.85 1.46 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.827 -0.624 . . . . 255.23 110.539 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -47.65 1.22 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 114.875 -1.057 . . . . 82.17 110.979 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 33' ' ' THR . 81.7 m-20 -133.34 138.72 46.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.158 -0.312 . . . . 405.39 110.158 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.3 m-85 -83.18 146.41 28.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 183.25 110.573 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.445 ' HG1' ' N ' ' A' ' 38' ' ' GLU . 38.6 p -133.36 -144.84 0.23 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.253 -0.431 . . . . 196.98 110.118 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' N ' ' HG1' ' A' ' 37' ' ' THR . 24.3 pt-20 -158.21 159.14 35.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 537.65 110.739 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 p -57.33 152.04 34.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.091 -0.504 . . . . 34.91 109.993 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.31 135.39 20.43 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.313 2.009 . . . . 87.7 112.259 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.35 96.88 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.706 -0.958 . . . . 244.37 110.706 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.876 0.37 . . . . 909.71 110.302 -179.767 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.917 0.389 . . . . 206.49 110.791 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 336.78 110.418 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.38 58.34 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.452 -0.659 . . . . 108.67 111.452 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.29 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.808 -0.357 . . . . 133.27 110.514 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.3 m -62.55 -43.68 98.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 25.78 109.848 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.42 165.55 3.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.27 -0.877 . . . . 119.04 109.854 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.5 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.937 -0.305 . . . . 157.06 111.079 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.79 -31.18 26.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.441 -0.345 . . . . 258.73 111.379 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 32' ' ' THR . 77.7 mm-40 -75.0 156.54 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.913 0.387 . . . . 339.06 111.356 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 t -108.85 157.81 18.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.935 -0.575 . . . . 50.72 110.395 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 48.1 t -146.18 133.68 20.85 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.845 -0.428 . . . . 39.11 109.845 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.15 117.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.613 -0.435 . . . . 261.82 109.854 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 97.3 m-20 -95.25 118.64 32.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 135.42 111.158 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -103.62 163.56 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.735 -0.666 . . . . 156.21 109.553 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 p -179.05 117.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.881 0.848 . . . . 137.43 109.412 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -100.89 -63.85 1.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.26 -1.336 . . . . 67.15 111.09 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.5 pt-20 -107.38 -177.22 3.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.33 0.586 . . . . 451.81 111.846 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.96 -12.02 57.03 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 115.01 -0.996 . . . . 214.64 111.352 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -60.22 -42.85 96.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 328.18 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptp -156.43 166.61 32.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 386.81 110.77 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.15 140.28 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.099 -0.501 . . . . 184.5 110.698 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 m -110.85 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 151.99 111.124 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' NH2' ' OD2' ' A' ' 17' ' ' ASP . 77.3 mtp85 -132.4 147.19 52.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.047 -0.524 . . . . 999.99 109.995 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -137.36 146.81 44.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.989 0.423 . . . . 242.47 110.74 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -175.01 117.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.821 -0.627 . . . . 15.64 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -83.39 155.79 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 422.56 111.195 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -118.3 144.21 46.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.942 -0.572 . . . . 627.38 109.877 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 96.0 m -80.1 123.89 28.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 220.71 110.708 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.96 89.7 1.4 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.882 -0.599 . . . . 255.23 110.395 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.35 -41.69 0.79 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.012 -0.994 . . . . 82.17 110.792 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.3 m-20 -134.39 139.72 45.79 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.079 -0.341 . . . . 405.39 110.079 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.78 147.59 27.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 183.25 110.858 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 p -146.92 119.62 8.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.041 -0.527 . . . . 196.98 109.89 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -73.98 158.07 35.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.966 -0.561 . . . . 537.65 111.133 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.6 p -64.82 149.67 95.82 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.975 -0.557 . . . . 34.91 110.058 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.72 138.96 21.98 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.101 1.868 . . . . 87.7 112.052 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.07 98.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 244.37 110.741 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.833 0.349 . . . . 909.71 110.252 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.24 -0.281 . . . . 206.49 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -39.74 87.26 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.746 -0.382 . . . . 336.78 110.124 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.43 62.02 0.48 Allowed Glycine 0 N--CA 1.466 0.652 0 N-CA-C 110.395 -1.082 . . . . 108.67 110.395 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.47 -45.75 92.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.771 0.32 . . . . 133.27 110.82 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.44 -42.12 99.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 25.78 110.232 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.71 167.88 7.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.286 -0.87 . . . . 119.04 109.874 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.04 96.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.874 -0.331 . . . . 157.06 110.776 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.15 -34.99 28.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.367 -0.379 . . . . 258.73 111.088 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.41 152.28 42.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 339.06 110.883 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 25.9 t -104.85 154.17 20.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 50.72 109.856 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.437 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 t -147.32 130.32 16.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.671 -0.492 . . . . 39.11 109.671 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.4 p -148.26 131.88 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.352 . . . . 261.82 110.482 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -100.62 120.83 40.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.119 -0.491 . . . . 135.42 110.529 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 27.5 p -107.37 164.91 11.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.187 -0.461 . . . . 156.21 109.931 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 178.07 117.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.924 0.868 . . . . 137.43 109.397 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.07 -55.59 2.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.224 -1.353 . . . . 67.15 110.586 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -118.17 -177.02 3.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.286 0.565 . . . . 451.81 111.425 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.33 -12.3 57.45 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.313 -0.858 . . . . 214.64 111.129 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.78 -44.74 96.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 328.18 111.153 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.1 ttp -154.74 144.64 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 386.81 110.95 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.0 t -103.9 147.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.078 -0.51 . . . . 184.5 110.318 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 77.3 m -123.94 139.84 53.56 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 151.99 111.346 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -145.89 160.61 41.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.906 -0.588 . . . . 999.99 109.788 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.3 p -150.14 161.92 41.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.958 0.408 . . . . 242.47 110.829 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -169.95 127.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 15.64 109.963 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.423 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 77.3 mm-40 -75.83 151.82 37.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 422.56 111.155 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -128.01 138.89 52.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.744 -0.662 . . . . 627.38 109.925 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 34' ' ' GLY . 27.7 p -71.45 69.81 0.6 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 220.71 110.378 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -78.4 45.2 0.55 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.909 0.861 . . . . 255.23 110.163 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 32' ' ' THR . . . 82.58 -0.92 88.88 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.194 -1.366 . . . . 82.17 110.146 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 80.6 m-20 -149.44 142.61 25.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.747 -0.464 . . . . 405.39 109.747 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.86 136.96 33.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 183.25 110.632 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 21.2 p -133.98 -150.28 0.39 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.693 -0.484 . . . . 196.98 109.693 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' N ' ' HG1' ' A' ' 37' ' ' THR . 98.3 mt-10 -144.73 142.87 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.845 -0.616 . . . . 537.65 110.766 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 p -65.13 150.41 95.5 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 109.61 -0.515 . . . . 34.91 109.61 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.07 130.35 15.3 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.988 1.792 . . . . 87.7 112.039 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.37 95.65 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.978 -0.849 . . . . 244.37 110.978 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.883 0.373 . . . . 909.71 110.615 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 110.288 -0.264 . . . . 206.49 110.288 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.26 -39.6 87.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.351 . . . . 336.78 110.391 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.2 65.81 0.55 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.773 -0.931 . . . . 108.67 110.773 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.868 0.366 . . . . 133.27 110.601 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.0 m -61.14 -42.58 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 25.78 109.916 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.09 163.99 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.338 -0.846 . . . . 119.04 109.744 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.15 95.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.589 -0.278 . . . . 157.06 111.145 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -86.38 -29.51 22.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 258.73 111.418 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -74.21 159.17 32.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.716 0.293 . . . . 339.06 111.028 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.3 t -102.77 150.2 23.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.147 -0.478 . . . . 50.72 110.28 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.42 124.82 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.122 -0.696 . . . . 39.11 109.122 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.9 131.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.984 0.421 . . . . 261.82 110.412 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -95.58 120.98 36.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.936 -0.574 . . . . 135.42 110.752 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 26' ' ' THR . 36.2 p -104.81 165.32 11.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.942 -0.572 . . . . 156.21 109.947 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 176.18 118.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.772 0.796 . . . . 137.43 109.216 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.295 -1.321 . . . . 67.15 110.826 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -112.15 -173.05 2.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.076 0.465 . . . . 451.81 111.442 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.25 -11.98 56.72 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.662 -0.699 . . . . 214.64 111.918 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.32 -39.54 90.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.803 0.335 . . . . 328.18 111.041 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.4 ptp -157.78 167.99 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 386.81 111.057 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.3 t -124.04 146.62 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.986 -0.552 . . . . 184.5 110.475 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 18' ' ' THR . 83.7 m -125.28 142.11 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.731 -0.668 . . . . 151.99 111.219 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -137.36 154.74 49.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.053 -0.521 . . . . 999.99 110.218 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -134.18 150.4 51.08 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.024 0.44 . . . . 242.47 110.988 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -176.24 128.35 0.21 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.186 -0.672 . . . . 15.64 109.186 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 37' ' ' THR . 95.4 mt-10 -107.56 130.58 54.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.937 0.398 . . . . 422.56 111.326 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.0 150.07 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.574 . . . . 627.38 110.45 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -95.4 122.92 38.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 220.71 110.433 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -145.88 84.07 1.65 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.612 0.72 . . . . 255.23 110.875 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.54 -5.67 55.65 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.596 -1.184 . . . . 82.17 110.989 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.0 m-20 -155.93 148.98 24.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 405.39 110.253 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 137.72 37.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 183.25 110.525 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 56.6 p -151.23 119.24 6.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.263 -0.426 . . . . 196.98 110.438 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 99.7 mt-10 -75.06 161.69 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 537.65 110.392 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.45 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.2 p -52.03 157.5 2.13 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.475 -0.565 . . . . 34.91 109.475 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -55.63 163.1 5.64 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.594 1.53 . . . . 87.7 112.694 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.63 65.1 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.85 -1.068 . . . . 244.37 110.493 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 110.024 -0.361 . . . . 909.71 110.024 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.273 -0.269 . . . . 206.49 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.09 -39.48 86.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.994 -0.373 . . . . 336.78 109.994 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.65 62.2 0.48 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.687 -0.965 . . . . 108.67 110.687 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -60.72 -43.49 97.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.826 0.346 . . . . 133.27 110.515 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.3 m -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.261 0.553 . . . . 25.78 109.958 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.74 167.45 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.423 -0.808 . . . . 119.04 109.865 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.56 96.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.802 -0.359 . . . . 157.06 110.841 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.15 -32.66 24.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 258.73 111.05 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.82 158.52 35.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 339.06 110.901 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.9 t -111.51 146.81 36.63 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 50.72 110.169 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.8 t -140.97 129.04 22.02 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.046 -0.724 . . . . 39.11 109.046 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.9 p -148.48 131.48 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 261.82 110.422 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.92 121.35 38.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.997 -0.547 . . . . 135.42 110.939 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 p -103.51 166.31 10.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.927 -0.579 . . . . 156.21 109.84 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 178.09 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.993 0.901 . . . . 137.43 109.103 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.42 -95.01 0.17 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.913 -1.494 . . . . 67.15 111.269 -178.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.35 -28.08 59.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.954 -1.021 . . . . 451.81 111.084 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -13.73 58.82 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.274 -0.731 . . . . 214.64 111.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.79 -39.15 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 328.18 109.624 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.432 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 69.5 mtm -137.55 101.45 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.466 -0.788 . . . . 386.81 109.613 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.7 147.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.583 -0.447 . . . . 184.5 110.821 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.1 m -126.03 139.02 53.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.814 -0.63 . . . . 151.99 111.539 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.47 147.12 50.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 999.99 109.494 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -134.47 147.95 50.48 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.033 0.445 . . . . 242.47 111.224 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -175.42 130.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.219 -0.66 . . . . 15.64 109.219 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -108.12 167.09 10.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.942 0.401 . . . . 422.56 110.858 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.1 148.01 50.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.811 -0.631 . . . . 627.38 110.336 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.9 m -89.81 122.62 33.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 220.71 110.521 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -147.2 84.34 1.58 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.661 0.743 . . . . 255.23 110.768 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.57 -5.6 56.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.568 -1.196 . . . . 82.17 110.896 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -155.84 151.17 26.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.118 -0.327 . . . . 405.39 110.118 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.41 141.51 33.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.841 0.353 . . . . 183.25 110.992 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 t -161.48 130.7 4.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 196.98 109.837 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -86.39 169.6 12.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.833 -0.621 . . . . 537.65 111.032 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.3 p -58.71 152.13 48.9 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.939 -0.573 . . . . 34.91 109.968 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 134.9 16.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.101 1.867 . . . . 87.7 112.085 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.05 -39.75 97.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.909 -0.876 . . . . 244.37 110.909 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.965 0.412 . . . . 909.71 110.457 -179.723 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.735 0.302 . . . . 206.49 110.417 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.25 -40.35 93.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 336.78 111.054 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 49.82 0.9 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.978 -0.849 . . . . 108.67 110.978 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -61.21 -49.92 75.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 133.27 110.569 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.4 m -64.69 -41.61 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.315 0.579 . . . . 25.78 110.126 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.19 167.81 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 119.04 109.867 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.63 97.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.954 -0.298 . . . . 157.06 111.005 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.64 -30.98 24.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 258.73 111.243 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.55 158.58 33.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 339.06 110.994 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 38.6 t -112.91 144.19 42.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 50.72 110.602 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -137.89 128.3 26.35 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.194 -0.669 . . . . 39.11 109.194 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.5 p -143.11 133.18 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.878 0.37 . . . . 261.82 110.557 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.5 121.96 34.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 135.42 110.808 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 26' ' ' THR . 14.6 p -101.01 164.73 11.67 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 156.21 109.946 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 176.38 119.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.079 0.942 . . . . 137.43 108.91 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.24 -94.39 0.18 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.751 -1.568 . . . . 67.15 111.48 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -77.71 -21.31 52.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.165 -0.925 . . . . 451.81 111.189 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.57 71.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.298 -0.721 . . . . 214.64 111.298 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.54 -42.64 92.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.327 -0.62 . . . . 328.18 109.327 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.6 ttp -141.75 111.27 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.322 -0.854 . . . . 386.81 109.111 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.93 150.03 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.177 0.513 . . . . 184.5 111.082 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' ' OG1' ' A' ' 18' ' ' THR . 89.2 m -132.89 143.95 49.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.484 -0.78 . . . . 151.99 111.057 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -132.13 163.84 27.61 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.95 -0.568 . . . . 999.99 110.116 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 t -148.62 150.49 33.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.987 0.422 . . . . 242.47 111.087 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.3 t -170.6 134.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 15.64 109.305 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -112.59 135.71 52.99 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.982 0.42 . . . . 422.56 111.337 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.43 144.96 26.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.848 -0.615 . . . . 627.38 110.203 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.6 m -93.66 102.93 15.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 220.71 110.612 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.5 m -140.28 125.89 19.16 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.491 0.662 . . . . 255.23 110.111 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.67 -64.85 0.45 Allowed Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.652 -1.158 . . . . 82.17 110.827 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' THR . 83.2 m-20 -122.53 146.89 47.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.977 -0.379 . . . . 405.39 109.977 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -73.25 146.22 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.422 -0.354 . . . . 183.25 110.902 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.15 122.11 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 196.98 110.391 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.06 165.15 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.61 . . . . 537.65 110.896 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 7.7 p -63.65 150.11 91.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 34.91 109.94 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.15 138.61 22.9 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.01 1.807 . . . . 87.7 111.841 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.85 0.43 67.2 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.954 -0.858 . . . . 244.37 110.954 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.92 0.391 . . . . 909.71 110.503 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.628 0.251 . . . . 206.49 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -61.41 -40.6 94.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 336.78 111.122 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.31 47.76 1.12 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.953 -0.859 . . . . 108.67 110.953 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -61.24 -50.16 74.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.378 . . . . 133.27 110.638 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.61 -41.46 96.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.906 -0.588 . . . . 25.78 110.209 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -172.41 168.73 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.301 -0.863 . . . . 119.04 109.859 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.889 -0.324 . . . . 157.06 110.941 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.61 -31.35 24.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 258.73 111.11 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.82 156.29 36.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 339.06 111.014 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -112.95 144.46 42.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.132 -0.486 . . . . 50.72 110.515 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -136.73 127.17 26.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.832 -0.803 . . . . 39.11 108.832 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.64 130.37 42.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.04 0.448 . . . . 261.82 110.833 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.4 138.57 31.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.828 -0.624 . . . . 135.42 110.898 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 26' ' ' THR . 19.0 p -128.06 159.22 35.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.884 -0.598 . . . . 156.21 109.834 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 p 178.67 118.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.685 -0.857 . . . . 137.43 108.685 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.4 -92.07 0.26 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.97 -1.468 . . . . 67.15 112.172 -177.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.586 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 4.0 pt-20 -70.92 -33.83 70.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 451.81 110.863 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.42 46.42 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 115.573 -0.739 . . . . 214.64 111.89 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.586 ' H ' ' CG ' ' A' ' 21' ' ' GLU . 37.8 t70 -60.41 -42.59 96.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.467 -0.568 . . . . 328.18 109.467 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.1 ttp -138.44 116.42 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 386.81 109.312 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.29 149.66 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.269 0.557 . . . . 184.5 110.754 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 18' ' ' THR . 75.5 m -128.66 142.37 51.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.391 -0.822 . . . . 151.99 110.928 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -145.3 162.17 37.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.031 -0.531 . . . . 999.99 110.048 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 t -149.75 152.84 35.92 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 242.47 110.986 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.7 t -168.58 131.82 1.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.849 -0.614 . . . . 15.64 109.427 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -102.91 149.21 24.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.942 0.401 . . . . 422.56 111.34 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.79 146.2 32.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.791 -0.641 . . . . 627.38 110.315 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.8 m -96.09 122.03 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 220.71 110.634 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.9 p -150.19 84.9 1.39 Allowed 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.55 0.691 . . . . 255.23 110.606 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.517 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 78.38 -3.98 60.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.636 -1.165 . . . . 82.17 110.723 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 34' ' ' GLY . 31.6 m120 -158.17 149.53 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.104 -0.332 . . . . 405.39 110.104 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -98.01 139.3 34.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 183.25 110.788 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.7 p -146.93 118.15 7.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 196.98 110.082 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -76.23 160.25 29.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 537.65 110.877 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 p -59.98 150.68 68.55 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.065 -0.516 . . . . 34.91 110.002 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.06 134.23 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.217 1.944 . . . . 87.7 111.909 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.72 -40.03 98.11 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.847 -0.901 . . . . 244.37 110.847 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 120.847 0.356 . . . . 909.71 110.268 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.69 0.281 . . . . 206.49 110.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.27 -40.17 93.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 336.78 110.814 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.58 46.84 1.29 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.068 -0.813 . . . . 108.67 111.068 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -60.84 -50.25 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.893 0.378 . . . . 133.27 110.571 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.95 -41.99 95.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 25.78 109.865 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.95 166.9 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.334 -0.848 . . . . 119.04 110.0 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 157.06 111.186 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -92.44 13.76 18.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.376 -0.374 . . . . 258.73 111.429 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.31 158.58 29.24 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.597 -0.274 . . . . 339.06 110.354 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.8 t -112.44 144.36 42.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.492 -0.322 . . . . 50.72 110.679 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -139.07 129.15 25.2 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.507 -0.553 . . . . 39.11 109.507 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.83 132.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 261.82 110.532 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -92.4 123.36 35.66 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.191 -0.459 . . . . 135.42 110.948 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -100.96 158.58 15.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.014 -0.539 . . . . 156.21 109.669 178.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p 179.32 116.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.983 0.896 . . . . 137.43 109.581 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -73.77 -92.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.925 -1.488 . . . . 67.15 111.148 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -90.22 -65.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.68 -0.691 . . . . 451.81 110.953 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.81 -10.54 0.11 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.808 -0.71 . . . . 214.64 111.352 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.6 -41.88 91.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.555 -0.535 . . . . 328.18 109.555 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.536 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 65.6 ttp -146.7 140.16 25.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.317 -0.856 . . . . 386.81 109.421 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.78 158.29 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 184.5 111.015 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 18' ' ' THR . 88.3 m -136.65 145.64 45.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.603 -0.726 . . . . 151.99 110.795 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.09 160.58 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.147 -0.479 . . . . 999.99 110.122 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -148.56 150.73 33.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.939 0.4 . . . . 242.47 110.832 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -170.58 129.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 15.64 109.691 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -107.03 138.25 43.55 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.893 0.377 . . . . 422.56 110.828 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -95.66 167.55 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.989 -0.55 . . . . 627.38 110.725 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.2 m -113.21 124.23 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.619 -0.719 . . . . 220.71 110.348 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -151.43 85.08 1.31 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.614 0.721 . . . . 255.23 110.733 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.59 -6.11 54.36 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.718 -1.128 . . . . 82.17 110.661 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -156.19 149.48 24.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.895 -0.409 . . . . 405.39 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 137.19 36.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 183.25 110.837 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.0 p -146.05 117.15 7.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.089 -0.505 . . . . 196.98 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.5 162.57 26.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 537.65 110.889 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 p -60.35 150.6 72.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.014 -0.539 . . . . 34.91 109.953 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.77 133.53 17.09 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.104 1.87 . . . . 87.7 112.05 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.73 97.76 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.825 -0.91 . . . . 244.37 110.825 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 909.71 110.621 -179.795 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.597 0.237 . . . . 206.49 110.417 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.05 -39.87 87.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 336.78 110.302 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.27 65.6 0.52 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.543 -1.023 . . . . 108.67 110.543 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.57 -44.86 95.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.879 0.371 . . . . 133.27 110.802 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.5 m -61.94 -43.1 99.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.384 0.611 . . . . 25.78 109.68 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.85 162.28 7.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.99 -1.005 . . . . 119.04 109.384 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.51 93.0 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.412 -0.515 . . . . 157.06 110.608 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.91 -38.97 69.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 258.73 111.073 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -73.83 161.07 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 339.06 111.146 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.7 t -109.28 155.52 21.05 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.361 -0.381 . . . . 50.72 110.351 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.3 t -149.62 129.19 13.11 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.524 -0.546 . . . . 39.11 109.524 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.33 132.21 8.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.837 0.351 . . . . 261.82 110.492 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.73 119.24 38.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.097 -0.501 . . . . 135.42 110.483 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 22.4 p -105.56 163.69 12.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.057 -0.519 . . . . 156.21 109.926 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p 178.38 117.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.84 0.829 . . . . 137.43 109.14 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.97 -62.36 1.32 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.231 -1.35 . . . . 67.15 111.123 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.8 pt-20 -104.5 -178.74 3.74 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.367 0.603 . . . . 451.81 111.913 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.44 -10.28 59.46 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.052 -0.976 . . . . 214.64 111.372 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.2 t0 -60.59 -44.07 96.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 328.18 110.84 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -159.94 168.75 24.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.038 -0.528 . . . . 386.81 110.953 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.0 t -118.15 143.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.026 -0.534 . . . . 184.5 110.547 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.1 m -118.34 137.6 52.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.742 . . . . 151.99 111.111 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -146.61 161.41 40.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.228 -0.442 . . . . 999.99 110.125 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -151.93 162.83 40.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.875 0.369 . . . . 242.47 110.859 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.3 t -168.48 131.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 15.64 110.03 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 74.5 mm-40 -77.87 154.46 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 422.56 111.277 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -121.37 138.67 54.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.746 -0.661 . . . . 627.38 109.555 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.6 m -79.87 123.09 27.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.145 -0.479 . . . . 220.71 110.589 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -154.77 88.28 1.19 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.494 0.664 . . . . 255.23 110.536 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -50.49 1.46 Allowed Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 114.812 -1.086 . . . . 82.17 111.1 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.73 136.68 47.81 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.749 0.309 . . . . 405.39 110.385 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -83.76 150.53 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 183.25 110.493 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.502 ' HG1' ' N ' ' A' ' 38' ' ' GLU . 32.2 p -126.86 -145.71 0.32 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.957 0.408 . . . . 196.98 110.296 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.502 ' N ' ' HG1' ' A' ' 37' ' ' THR . 52.6 tp10 -151.6 139.21 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 537.65 110.318 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 p -56.77 150.92 34.56 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.107 -0.497 . . . . 34.91 110.158 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.25 157.79 41.54 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.449 2.099 . . . . 87.7 112.162 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.41 -93.07 1.64 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.682 -0.967 . . . . 244.37 110.682 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 909.71 110.216 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.715 0.293 . . . . 206.49 110.524 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.83 -39.4 84.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 336.78 110.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.37 74.11 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.651 -0.98 . . . . 108.67 110.651 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.26 -44.01 97.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.368 . . . . 133.27 110.597 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -62.63 -41.78 99.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 25.78 110.39 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.47 163.64 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.597 -0.729 . . . . 119.04 110.095 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.73 90.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 157.06 110.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -91.62 10.52 27.74 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.349 -0.387 . . . . 258.73 111.431 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.506 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.3 mm-40 -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 339.06 110.865 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 40.5 t -106.06 156.99 17.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.81 -0.632 . . . . 50.72 110.854 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.5 t -147.64 126.36 12.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.514 -0.551 . . . . 39.11 109.514 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 p -150.99 131.98 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.01 -0.367 . . . . 261.82 110.01 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -101.41 118.66 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 135.42 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' THR . 2.4 p -100.69 161.98 13.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.632 -0.713 . . . . 156.21 109.15 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p 178.41 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.815 0.817 . . . . 137.43 109.331 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -90.03 -62.57 1.44 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.25 -1.341 . . . . 67.15 110.184 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -117.91 -172.91 2.34 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.98 0.419 . . . . 451.81 110.736 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.01 -20.19 47.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.357 -0.697 . . . . 214.64 111.357 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.56 -40.13 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.595 0.236 . . . . 328.18 111.539 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mtp -137.0 153.44 50.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.123 0.487 . . . . 386.81 111.601 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.73 142.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.625 -0.716 . . . . 184.5 110.085 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.0 m -123.78 134.62 53.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.946 -0.57 . . . . 151.99 111.249 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -128.72 147.44 50.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.001 -0.545 . . . . 999.99 109.911 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -133.8 145.85 50.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.969 0.414 . . . . 242.47 110.715 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -173.41 115.25 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.837 -0.62 . . . . 15.64 109.745 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.5 mm-40 -84.78 155.01 22.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.954 0.407 . . . . 422.56 111.014 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -121.96 143.74 49.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.905 -0.588 . . . . 627.38 109.804 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.506 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 93.7 m -89.32 119.61 29.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.353 -0.385 . . . . 220.71 110.79 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.3 p -152.21 82.49 1.25 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.645 0.736 . . . . 255.23 110.468 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.66 -5.72 56.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.455 -1.248 . . . . 82.17 110.737 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.4 m-20 -156.58 149.04 23.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.704 0.287 . . . . 405.39 110.252 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.03 139.33 39.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.836 0.35 . . . . 183.25 110.717 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 123.97 4.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 196.98 110.384 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.455 ' OE2' ' N ' ' A' ' 38' ' ' GLU . 58.2 mp0 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 537.65 111.135 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.8 p -63.53 150.67 89.66 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.922 -0.581 . . . . 34.91 110.153 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.03 142.75 28.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.133 1.888 . . . . 87.7 111.841 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.77 0.82 74.03 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 244.37 110.924 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.943 0.402 . . . . 909.71 110.524 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.808 0.337 . . . . 206.49 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 336.78 110.137 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.27 81.74 0.32 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.493 -1.043 . . . . 108.67 110.493 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -61.2 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 133.27 110.597 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.2 m -62.34 -41.44 98.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.895 -0.593 . . . . 25.78 110.333 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.63 161.41 6.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.521 -0.763 . . . . 119.04 109.863 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -46.16 91.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.691 -0.403 . . . . 157.06 110.71 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.5 -38.33 74.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 258.73 110.525 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 32' ' ' THR . 69.2 mm-40 -75.72 167.88 21.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.702 -0.681 . . . . 339.06 111.018 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 16.2 p -112.57 171.1 7.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.218 -0.446 . . . . 50.72 110.324 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -152.48 126.92 9.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.453 -0.573 . . . . 39.11 109.453 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.86 129.67 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 261.82 110.512 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -115.05 133.94 55.61 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.071 -0.513 . . . . 135.42 110.77 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 26' ' ' THR . 20.3 p -126.91 162.02 26.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 156.21 109.687 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -178.77 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.997 0.903 . . . . 137.43 109.455 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.78 -53.26 3.47 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.938 -1.483 . . . . 67.15 110.684 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -120.37 -178.05 3.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.307 0.575 . . . . 451.81 111.419 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.61 -11.16 59.62 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.148 -0.933 . . . . 214.64 111.049 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.73 -44.38 96.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.806 0.336 . . . . 328.18 111.13 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.3 ttp -155.12 147.3 23.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 386.81 110.92 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.36 142.71 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 184.5 110.403 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 18' ' ' THR . 73.1 m -117.05 133.59 55.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 151.99 110.798 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -151.6 163.45 39.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.178 -0.465 . . . . 999.99 110.398 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -149.47 148.03 28.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.054 0.454 . . . . 242.47 110.813 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.9 t -169.36 114.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 15.64 109.388 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.6 159.77 20.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 422.56 111.331 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -124.57 142.94 50.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.053 -0.521 . . . . 627.38 110.176 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.505 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 99.8 m -84.87 121.55 27.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 220.71 110.371 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.8 p -153.57 90.06 1.38 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.373 0.606 . . . . 255.23 110.61 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 -40.35 0.82 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.926 -1.034 . . . . 82.17 110.957 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 33' ' ' THR . 81.4 m-20 -134.62 139.42 45.31 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.845 0.355 . . . . 405.39 110.212 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.11 150.49 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 183.25 110.975 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.63 122.36 5.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 196.98 110.131 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' CYS . 88.1 tt0 -81.5 148.7 29.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.832 -0.622 . . . . 537.65 111.332 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -41.08 164.4 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.857 -0.61 . . . . 34.91 110.159 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -75.89 142.77 25.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.398 2.065 . . . . 87.7 111.789 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.94 -39.88 98.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 244.37 110.865 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.816 0.341 . . . . 909.71 110.308 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.709 0.29 . . . . 206.49 110.614 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.69 -39.98 90.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.415 -0.357 . . . . 336.78 110.686 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.38 85.98 0.38 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.749 -0.94 . . . . 108.67 110.749 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -62.61 -43.38 98.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.705 0.288 . . . . 133.27 110.991 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.2 m -62.0 -43.11 99.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 25.78 110.281 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -166.66 166.04 16.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.391 -0.822 . . . . 119.04 109.825 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.87 96.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.904 -0.319 . . . . 157.06 111.175 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -83.99 -32.46 24.96 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.842 0.353 . . . . 258.73 111.3 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -75.75 160.35 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 339.06 110.842 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.4 t -115.98 149.67 38.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.351 -0.386 . . . . 50.72 110.113 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.3 p -135.64 153.69 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.723 -0.473 . . . . 39.11 109.723 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 9.5 p -165.87 117.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.486 -0.486 . . . . 261.82 110.515 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -103.5 119.63 39.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.185 -0.461 . . . . 135.42 110.852 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.954 -0.566 . . . . 156.21 109.774 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.72 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 122.079 0.943 . . . . 137.43 109.074 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.19 -94.1 0.17 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.876 -1.511 . . . . 67.15 111.428 -178.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -79.98 -19.67 47.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.189 -0.914 . . . . 451.81 111.131 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.92 -10.14 72.37 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.264 -0.734 . . . . 214.64 111.264 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.52 -41.79 95.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 328.18 109.487 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.443 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.9 mtm -138.6 99.17 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.358 -0.837 . . . . 386.81 109.414 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.88 145.2 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.208 0.528 . . . . 184.5 110.858 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 m -125.74 136.95 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.398 -0.819 . . . . 151.99 110.954 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -149.76 160.65 43.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 999.99 110.638 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -152.53 150.5 29.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.351 -0.386 . . . . 242.47 110.775 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.9 t -169.96 126.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.914 -0.585 . . . . 15.64 109.734 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.04 152.54 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 422.56 111.007 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -116.49 142.69 46.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.984 -0.553 . . . . 627.38 109.969 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 91.5 m -71.58 124.97 25.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.989 0.423 . . . . 220.71 110.508 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 35' ' ' ASN . 31.7 p -154.05 89.43 1.3 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.417 0.627 . . . . 255.23 110.543 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.81 -47.14 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.928 -1.033 . . . . 82.17 111.005 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.2 m120 -135.06 138.76 44.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.791 0.329 . . . . 405.39 110.253 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.9 m-85 -83.73 148.09 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 183.25 110.659 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.7 p -125.85 -144.96 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.951 0.405 . . . . 196.98 110.069 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -156.89 143.57 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 537.65 110.536 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.3 p -62.15 149.51 86.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 34.91 110.005 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 135.25 16.77 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.071 1.847 . . . . 87.7 111.74 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.93 -42.89 99.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.723 -0.951 . . . . 244.37 110.723 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.97 -0.381 . . . . 909.71 109.97 179.787 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 120.725 0.298 . . . . 206.49 110.596 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.6 -39.89 89.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.357 -0.383 . . . . 336.78 110.929 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.91 68.24 0.28 Allowed Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.17 -0.772 . . . . 108.67 111.17 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.9 -48.56 78.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.987 0.422 . . . . 133.27 110.617 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.99 -41.41 97.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.855 -0.611 . . . . 25.78 109.931 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.1 162.91 9.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.161 -0.927 . . . . 119.04 109.246 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.98 90.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.511 -0.476 . . . . 157.06 110.666 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.45 -37.83 71.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 258.73 110.857 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.14 161.14 30.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 339.06 111.163 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 50.2 t -111.05 158.98 18.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.157 -0.474 . . . . 50.72 110.411 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 49.7 t -149.13 130.35 14.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.441 -0.577 . . . . 39.11 109.441 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.3 p -149.14 129.89 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 261.82 110.434 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -93.0 119.21 32.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 135.42 110.772 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 26' ' ' THR . 21.2 p -103.69 161.66 13.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.994 -0.548 . . . . 156.21 109.949 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 p 179.54 117.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.796 0.808 . . . . 137.43 109.325 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -104.12 -62.8 1.27 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.357 -1.292 . . . . 67.15 111.28 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -103.23 -178.49 3.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.452 0.644 . . . . 451.81 111.991 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.77 -10.12 59.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.992 -1.004 . . . . 214.64 111.445 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -60.77 -44.48 96.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 328.18 110.927 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.82 170.18 22.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.013 -0.539 . . . . 386.81 111.022 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.85 143.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.896 -0.593 . . . . 184.5 110.512 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' A' ' 18' ' ' THR . 89.8 m -117.44 134.02 55.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 151.99 111.338 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -126.27 147.06 49.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.966 -0.561 . . . . 999.99 109.708 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -135.1 153.11 52.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.887 0.375 . . . . 242.47 110.727 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 3.0 t -166.0 132.17 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 15.64 109.952 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 75.5 mm-40 -81.39 155.74 25.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 422.56 111.439 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 143.17 50.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.584 -0.735 . . . . 627.38 109.399 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.412 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 98.2 m -85.61 121.34 28.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 220.71 110.68 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -152.29 88.81 1.39 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.82 -0.627 . . . . 255.23 110.42 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -50.88 1.6 Allowed Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.947 -1.024 . . . . 82.17 111.04 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.49 137.53 48.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.758 0.313 . . . . 405.39 110.434 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 97.0 m-85 -84.15 149.77 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 183.25 110.506 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 43.3 p -124.85 -145.2 0.33 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.847 0.356 . . . . 196.98 110.156 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 88.2 tt0 -152.86 139.31 18.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 537.65 110.77 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -57.05 152.37 29.46 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.96 -0.564 . . . . 34.91 109.994 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.14 157.38 46.43 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.343 2.029 . . . . 87.7 111.767 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.47 -90.7 2.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.997 -0.841 . . . . 244.37 110.997 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 909.71 110.697 -179.66 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 7' ' ' GLY . 21.3 pt-20 . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 121.057 0.455 . . . . 206.49 110.829 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 60.18 -5.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 336.78 111.569 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 5' ' ' GLU . . . -155.9 60.71 0.36 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.464 -1.054 . . . . 108.67 110.464 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 9' ' ' CYS . 52.8 p-10 -61.17 -29.25 69.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.727 0.298 . . . . 133.27 110.777 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 97.1 m -62.12 -43.19 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.324 0.583 . . . . 25.78 109.933 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.81 162.31 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.119 -0.946 . . . . 119.04 109.429 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.49 93.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.512 -0.475 . . . . 157.06 110.557 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.25 -38.36 68.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 258.73 110.965 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 32' ' ' THR . 75.8 mm-40 -72.33 157.96 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 339.06 111.435 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.2 t -104.24 156.44 17.9 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.986 -0.552 . . . . 50.72 110.327 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.452 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 54.1 t -147.73 128.86 14.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 39.11 109.99 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.3 134.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 261.82 110.251 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -101.0 119.47 38.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 135.42 110.994 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 p -100.38 164.53 11.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.911 -0.586 . . . . 156.21 110.018 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.08 119.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.131 0.967 . . . . 137.43 108.899 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.643 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.32 -95.09 0.16 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.74 -1.573 . . . . 67.15 111.469 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.42 -21.56 38.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.072 -0.967 . . . . 451.81 110.738 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.03 65.43 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.313 -0.715 . . . . 214.64 111.313 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.61 -39.64 84.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.203 -0.666 . . . . 328.18 109.203 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 24' ' ' MET . 19.1 tmm? -148.87 105.51 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.302 -0.863 . . . . 386.81 108.874 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 24' ' ' MET . 77.7 t -63.9 145.49 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.281 0.562 . . . . 184.5 111.343 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.7 m -125.09 135.14 52.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.288 -0.869 . . . . 151.99 110.945 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -128.55 148.83 50.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 999.99 109.909 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -132.95 144.55 50.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.855 0.36 . . . . 242.47 110.696 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.57 115.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 15.64 110.007 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.17 152.36 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 422.56 110.627 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -115.15 142.38 46.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.329 -0.396 . . . . 627.38 110.255 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.462 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 88.2 m -71.11 125.9 28.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 220.71 110.511 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.84 89.47 1.39 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.395 0.617 . . . . 255.23 110.503 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.44 -44.06 0.92 Allowed Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.932 -1.031 . . . . 82.17 110.887 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.0 m120 -136.41 139.32 42.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.82 0.343 . . . . 405.39 110.157 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.28 146.55 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 183.25 110.749 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.2 p -127.7 -146.79 0.34 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.284 -0.416 . . . . 196.98 109.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -160.92 148.42 15.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 537.65 110.595 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.1 p -61.88 149.9 84.22 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.229 -0.441 . . . . 34.91 109.89 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.76 134.62 18.47 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.064 1.842 . . . . 87.7 112.0 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.85 98.34 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.87 -0.892 . . . . 244.37 110.87 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 909.71 110.349 -179.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.679 0.276 . . . . 206.49 110.437 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.84 -39.49 85.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.914 0.388 . . . . 336.78 110.198 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.29 76.88 0.4 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.533 -1.027 . . . . 108.67 110.533 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.31 -43.53 98.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 133.27 110.614 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.1 m -62.06 -41.47 98.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 25.78 110.313 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.28 165.98 8.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.482 -0.781 . . . . 119.04 109.928 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.33 96.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.757 -0.377 . . . . 157.06 110.757 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.93 -33.53 33.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 258.73 110.958 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.5 mm-40 -74.3 158.01 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 339.06 111.293 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 34.1 t -107.71 154.31 21.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.984 -0.553 . . . . 50.72 110.614 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.6 t -142.8 128.12 18.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.58 -0.526 . . . . 39.11 109.58 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.11 128.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.905 -0.406 . . . . 261.82 109.905 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -107.97 118.11 35.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 135.42 111.39 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -102.82 166.44 10.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.459 -0.791 . . . . 156.21 109.449 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -179.57 117.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.909 0.861 . . . . 137.43 109.502 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.93 -62.18 1.33 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.174 -1.375 . . . . 67.15 110.784 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.2 pt-20 -114.9 -172.17 2.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.06 0.457 . . . . 451.81 111.284 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.09 -12.75 54.65 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.754 -0.657 . . . . 214.64 111.864 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.46 -40.72 95.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.668 0.271 . . . . 328.18 111.183 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 ttp -157.08 153.02 27.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.371 -0.377 . . . . 386.81 110.904 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -115.59 140.94 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.163 0.506 . . . . 184.5 110.67 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.4 m -110.96 132.3 54.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.514 -0.766 . . . . 151.99 111.373 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -133.98 148.3 51.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 999.99 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -138.45 147.71 43.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.926 0.393 . . . . 242.47 110.772 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.9 115.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 15.64 109.912 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -80.56 152.8 28.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 422.56 110.631 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.68 143.41 45.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.147 -0.479 . . . . 627.38 110.205 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.517 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.0 m -73.79 125.05 27.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 220.71 110.485 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.9 p -153.34 89.49 1.35 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.383 0.611 . . . . 255.23 110.559 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.16 -41.14 0.74 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.898 -1.046 . . . . 82.17 111.017 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 33' ' ' THR . 83.0 m-20 -133.93 140.05 46.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 405.39 110.341 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.04 144.81 26.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.157 -0.474 . . . . 183.25 110.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.6 p -134.52 -157.66 0.82 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.438 -0.579 . . . . 196.98 109.438 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -149.59 155.33 40.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.441 -0.8 . . . . 537.65 110.655 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.5 p -65.92 149.76 97.22 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.675 -0.491 . . . . 34.91 109.675 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.96 131.3 16.68 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.978 1.785 . . . . 87.7 111.946 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.98 98.36 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.063 -0.815 . . . . 244.37 111.063 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.849 0.357 . . . . 909.71 110.304 -179.801 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.688 0.28 . . . . 206.49 110.379 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -39.39 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 336.78 110.139 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.4 75.09 0.42 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.538 -1.025 . . . . 108.67 110.538 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -61.42 -43.12 99.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.939 0.4 . . . . 133.27 110.679 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.5 m -61.65 -42.56 99.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.007 -0.542 . . . . 25.78 110.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.93 167.13 13.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.334 -0.848 . . . . 119.04 109.871 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.5 95.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.515 -0.312 . . . . 157.06 111.117 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.44 -30.29 23.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.473 -0.331 . . . . 258.73 111.273 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.51 154.14 37.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 339.06 110.979 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 39.0 t -104.51 148.87 25.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.219 -0.446 . . . . 50.72 110.727 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -135.92 123.97 22.9 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.554 -0.535 . . . . 39.11 109.554 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.33 127.69 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.913 0.387 . . . . 261.82 110.21 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -109.66 118.78 37.46 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.047 -0.524 . . . . 135.42 111.022 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 46.5 p -104.54 167.53 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.826 -0.625 . . . . 156.21 109.867 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p 179.34 117.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.936 0.874 . . . . 137.43 109.304 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -100.57 -71.19 0.71 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.069 -1.423 . . . . 67.15 110.815 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.4 pt-20 -95.67 -177.57 4.1 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.608 -0.723 . . . . 451.81 111.782 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.05 -10.42 57.43 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.115 -0.948 . . . . 214.64 111.098 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.411 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.3 t0 -60.38 -43.71 96.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 328.18 110.975 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -159.39 168.99 24.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 386.81 110.963 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.919 -0.582 . . . . 184.5 110.852 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 51.5 m -121.72 138.13 54.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.504 -0.771 . . . . 151.99 111.251 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -150.5 158.09 43.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.264 -0.425 . . . . 999.99 110.492 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.8 m -142.31 153.76 44.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 242.47 111.078 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -167.05 121.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.8 -0.636 . . . . 15.64 109.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -83.95 155.09 23.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.014 0.435 . . . . 422.56 111.38 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.4 143.52 45.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.727 -0.67 . . . . 627.38 110.067 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.1 m -78.53 124.29 28.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 220.71 110.729 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 35' ' ' ASN . 34.0 p -152.91 89.03 1.35 Allowed 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.451 0.643 . . . . 255.23 110.518 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 -38.84 0.76 Allowed Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.899 -1.046 . . . . 82.17 111.222 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.7 m-20 -135.72 141.2 44.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.875 0.369 . . . . 405.39 110.365 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -90.03 146.5 24.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 183.25 110.573 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.8 p -132.77 -156.21 0.73 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.511 -0.552 . . . . 196.98 109.511 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -148.29 153.33 38.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.6 -0.727 . . . . 537.65 110.655 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 p -65.45 149.86 96.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.586 -0.524 . . . . 34.91 109.586 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.44 131.03 15.71 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.014 1.809 . . . . 87.7 112.121 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.83 -40.17 97.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.173 -0.771 . . . . 244.37 111.173 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.929 0.395 . . . . 909.71 110.584 -179.651 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.583 -1.407 . . . . 999.99 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.56 144.33 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.217 -0.29 . . . . 999.99 110.217 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 64.6 m -88.57 116.4 26.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.063 0.459 . . . . 296.55 111.027 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 t -73.16 -66.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.752 -0.658 . . . . 218.16 109.96 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -82.31 158.28 23.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.875 -1.057 . . . . 206.49 110.585 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.77 -42.81 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 336.78 110.947 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.07 53.64 1.61 Allowed Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.465 -0.654 . . . . 108.67 111.465 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.61 -46.53 87.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.83 0.348 . . . . 133.27 110.699 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.18 -42.08 99.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.289 0.566 . . . . 25.78 110.139 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.84 168.5 7.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.278 -0.874 . . . . 119.04 109.897 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.98 97.23 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.862 -0.335 . . . . 157.06 110.932 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.97 -32.15 27.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.429 -0.35 . . . . 258.73 111.023 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -75.1 166.98 22.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 339.06 110.938 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -130.9 143.89 51.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.01 -0.541 . . . . 50.72 110.629 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -135.58 138.53 43.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.3 -0.629 . . . . 39.11 109.3 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 9.9 p -148.3 118.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.56 -0.456 . . . . 261.82 110.402 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 3' ' ' CYS . 66.4 m-20 -75.61 118.93 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 135.42 111.094 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 26' ' ' THR . 16.2 p -97.53 160.57 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 156.21 109.344 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p 179.53 117.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.921 0.867 . . . . 137.43 109.252 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.626 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.42 -56.63 2.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.269 -1.332 . . . . 67.15 111.387 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -113.41 -174.5 2.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.188 0.518 . . . . 451.81 111.77 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.41 -9.62 57.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.352 -0.84 . . . . 214.64 111.911 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.11 -41.1 96.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.879 0.371 . . . . 328.18 110.85 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -163.01 169.42 19.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 386.81 110.866 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.78 143.13 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.554 . . . . 184.5 110.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 18' ' ' THR . 99.4 m -117.25 137.43 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.503 -0.771 . . . . 151.99 111.168 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -125.79 156.23 39.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.871 -0.604 . . . . 999.99 109.531 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -147.96 159.25 44.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.303 0.573 . . . . 242.47 111.253 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.6 t -175.14 137.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.41 -0.814 . . . . 15.64 109.194 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -110.67 134.74 52.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.948 0.404 . . . . 422.56 110.948 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -86.56 140.41 29.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.893 -0.594 . . . . 627.38 109.707 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -89.99 102.71 15.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.964 0.412 . . . . 220.71 110.659 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ASN . 21.5 m -138.04 126.51 23.39 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.495 0.664 . . . . 255.23 110.032 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.25 -71.11 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 CA-C-N 114.663 -1.153 . . . . 82.17 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 33' ' ' THR . 84.2 m-20 -111.98 142.21 44.68 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.789 -0.448 . . . . 405.39 109.789 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -70.92 143.86 50.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 183.25 110.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 p -147.02 117.05 7.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.134 -0.485 . . . . 196.98 110.209 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.42 161.61 23.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 537.65 110.978 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 7.5 p -64.05 150.19 92.4 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.855 -0.612 . . . . 34.91 110.143 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.01 137.56 21.85 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.069 1.846 . . . . 87.7 111.768 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.13 7.41 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.793 -0.923 . . . . 244.37 110.793 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 mt -107.79 147.23 31.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.857 0.36 . . . . 909.71 110.617 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -140.7 68.27 30.11 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.015 -0.539 . . . . 650.95 110.787 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.13 -9.42 19.19 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.87 2.38 . . . . 999.99 111.628 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.77 128.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.044 -0.525 . . . . 999.99 110.632 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.973 -1.013 . . . . 999.99 110.62 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.561 -1.416 . . . . 999.99 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 8.7 mp -62.87 -39.0 93.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 999.99 110.548 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 71.8 m -80.1 106.93 12.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 296.55 110.343 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.435 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 25.1 t -61.0 -43.12 99.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.398 0.618 . . . . 218.16 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -144.69 -164.62 1.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.966 -1.016 . . . . 206.49 110.21 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.41 85.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.872 0.368 . . . . 336.78 110.185 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.99 65.24 0.52 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.622 -0.991 . . . . 108.67 110.622 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 4' ' ' SER . 66.3 t0 -61.06 -41.72 97.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 133.27 110.588 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.9 m -61.31 -41.17 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 25.78 110.173 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.61 166.46 14.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.778 . . . . 119.04 109.954 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.48 95.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 157.06 110.926 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.22 -29.61 24.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 258.73 111.055 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.469 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.0 mm-40 -76.14 159.97 30.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.414 . . . . 339.06 111.136 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 35.1 t -109.88 153.3 24.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.922 -0.581 . . . . 50.72 110.366 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 16.7 t -144.65 127.27 16.11 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.242 -0.651 . . . . 39.11 109.242 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.483 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 13.8 p -147.61 128.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 261.82 110.614 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 2' ' ' LEU . 97.3 m-20 -99.28 132.87 44.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 135.42 110.733 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 24.0 p -122.32 161.09 24.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.871 -0.604 . . . . 156.21 109.51 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 179.27 118.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.988 0.899 . . . . 137.43 109.2 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.13 -64.06 1.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.972 -1.467 . . . . 67.15 110.973 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.7 pt-20 -109.89 -173.06 2.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.122 0.487 . . . . 451.81 111.479 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.69 -11.62 56.64 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.574 -0.739 . . . . 214.64 111.858 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.25 -39.93 92.17 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.927 -0.309 . . . . 328.18 110.957 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ptm -159.11 167.23 29.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 386.81 111.001 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.3 t -123.17 143.37 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.859 -0.61 . . . . 184.5 110.571 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 84.1 m -118.26 135.68 54.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.51 -0.768 . . . . 151.99 110.988 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -142.47 155.3 45.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.082 -0.508 . . . . 999.99 110.032 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -140.94 149.2 41.54 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.015 0.436 . . . . 242.47 111.012 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -172.09 116.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 15.64 109.794 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -82.2 150.1 27.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 422.56 110.88 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -112.75 141.71 46.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.086 -0.506 . . . . 627.38 109.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.469 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 92.4 m -69.34 126.73 30.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 220.71 110.529 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 35' ' ' ASN . 27.3 p -151.03 89.44 1.53 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.417 0.627 . . . . 255.23 110.448 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.08 -47.93 1.34 Allowed Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 114.984 -1.007 . . . . 82.17 110.946 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.0 m120 -131.77 139.84 49.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.1 -0.333 . . . . 405.39 110.1 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -82.51 145.42 29.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 183.25 110.781 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.8 p -129.5 -145.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.132 -0.486 . . . . 196.98 109.892 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -161.16 154.35 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.062 -0.517 . . . . 537.65 110.836 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.4 p -66.91 149.7 98.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 34.91 110.054 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.89 136.33 20.5 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.141 1.894 . . . . 87.7 111.849 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.38 -39.99 98.39 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.987 -0.845 . . . . 244.37 110.987 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.44 144.77 38.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.858 0.361 . . . . 909.71 110.463 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.6 p -69.8 149.48 96.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.18 -0.464 . . . . 650.95 110.294 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.92 -10.39 21.33 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.348 2.032 . . . . 999.99 112.418 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.0 tt -53.0 -31.14 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.417 -0.356 . . . . 999.99 110.65 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.975 -1.012 . . . . 999.99 110.63 -180.0 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.56 -1.416 . . . . 999.99 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.67 149.96 45.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.843 0.354 . . . . 999.99 110.285 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 75.0 m -84.68 104.95 15.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.187 -0.461 . . . . 296.55 110.771 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.7 t -62.31 -42.68 99.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 218.16 109.676 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -143.1 -171.34 3.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.905 -1.043 . . . . 206.49 110.252 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.16 -39.63 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 336.78 110.242 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.64 62.76 0.44 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.628 -0.989 . . . . 108.67 110.628 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.6 -46.55 89.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 133.27 110.766 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.5 m -63.1 -41.86 99.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 25.78 110.299 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.54 163.56 6.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.312 -0.858 . . . . 119.04 109.585 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.78 91.8 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.488 -0.485 . . . . 157.06 110.405 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.33 -38.69 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 258.73 110.48 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.26 156.52 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 339.06 110.515 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.623 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 1.8 p -108.12 171.22 7.53 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.197 -0.297 . . . . 50.72 110.197 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 11.4 t -156.17 127.71 7.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.312 -0.625 . . . . 39.11 109.312 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.536 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 7.4 p -150.95 129.13 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 261.82 110.38 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -94.9 120.26 34.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.017 -0.538 . . . . 135.42 110.948 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 26' ' ' THR . 15.5 p -104.4 164.86 11.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.034 -0.53 . . . . 156.21 109.653 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.04 119.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.833 0.825 . . . . 137.43 109.087 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.16 -65.94 0.93 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.336 -1.302 . . . . 67.15 111.013 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -108.66 -171.97 1.96 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.11 0.481 . . . . 451.81 111.567 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.35 -13.34 52.14 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.694 -0.685 . . . . 214.64 111.973 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -60.54 -41.58 94.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 328.18 110.722 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptp -160.87 161.71 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.922 -0.581 . . . . 386.81 110.495 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.14 160.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.907 -0.588 . . . . 184.5 110.956 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 18' ' ' THR . 78.0 m -129.75 138.55 51.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.734 -0.666 . . . . 151.99 111.232 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -128.13 154.51 45.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.578 . . . . 999.99 109.817 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -141.9 148.38 38.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.043 0.449 . . . . 242.47 110.822 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -171.92 101.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 15.64 109.339 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.623 ' CG ' ' H ' ' A' ' 14' ' ' CYS . 9.4 pt-20 -60.65 163.47 5.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.356 0.598 . . . . 422.56 111.375 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -136.35 143.27 43.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.833 -1.076 . . . . 627.38 110.07 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.1 m -112.06 122.8 48.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.909 0.385 . . . . 220.71 110.76 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.1 p -154.16 84.27 1.14 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.607 0.717 . . . . 255.23 110.321 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.88 -5.24 58.73 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.517 -1.22 . . . . 82.17 110.442 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.4 m-20 -154.77 149.37 26.4 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.936 -0.394 . . . . 405.39 109.936 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.88 143.21 32.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 183.25 110.935 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.418 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 10.2 t -155.46 124.53 6.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 196.98 110.107 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.6 mp0 -81.71 159.41 23.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.625 . . . . 537.65 110.808 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 160.23 0.22 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.466 -0.568 . . . . 34.91 109.466 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.09 133.04 15.99 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.06 1.84 . . . . 87.7 111.894 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.22 -40.36 98.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 244.37 111.212 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -113.88 145.68 41.12 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.833 0.349 . . . . 909.71 110.549 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p -76.6 173.75 6.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 650.95 109.655 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.17 -21.68 72.92 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.941 1.761 . . . . 999.99 111.6 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.421 ' O ' ' OXT' ' A' ' 46' ' ' ALA . 96.9 mt -60.1 -45.33 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.551 . . . . 999.99 110.437 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' A' ' 45' ' ' ILE . . . . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.021 -0.99 . . . . 999.99 110.603 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.555 -1.418 . . . . 999.99 109.555 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.26 152.77 18.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.815 0.34 . . . . 999.99 110.349 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 94.7 m -63.79 147.63 51.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 296.55 110.264 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -60.27 -43.24 96.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.149 0.5 . . . . 218.16 110.2 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -147.28 -170.83 3.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.426 -0.806 . . . . 206.49 110.607 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.34 84.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.882 0.373 . . . . 336.78 110.192 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.2 75.13 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.633 -0.987 . . . . 108.67 110.633 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 133.27 110.624 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.1 m -62.49 -41.77 99.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 25.78 110.202 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.73 163.15 9.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 119.04 110.09 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.38 88.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 157.06 110.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -91.89 11.4 25.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.256 -0.429 . . . . 258.73 111.441 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.0 mm-40 -119.12 159.4 24.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.071 0.462 . . . . 339.06 111.051 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.4 t -104.35 155.17 19.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.769 -0.65 . . . . 50.72 110.656 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.449 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 41.9 t -146.13 127.73 15.14 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.455 -0.572 . . . . 39.11 109.455 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.57 130.54 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 261.82 110.336 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 68.5 m-20 -106.89 123.32 47.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.183 -0.462 . . . . 135.42 111.078 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -110.12 161.99 15.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.787 -0.642 . . . . 156.21 109.546 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p -178.33 116.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 122.008 0.909 . . . . 137.43 109.636 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.81 -57.78 2.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.139 -1.391 . . . . 67.15 110.748 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -116.37 -176.78 3.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.296 0.569 . . . . 451.81 111.428 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.9 -12.27 56.81 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.197 -0.911 . . . . 214.64 111.048 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -61.69 -44.47 96.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.417 . . . . 328.18 111.211 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.9 ttp -154.28 145.0 22.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 386.81 110.924 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.03 143.28 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.002 -0.544 . . . . 184.5 110.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.3 m -115.28 132.61 56.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.589 -0.732 . . . . 151.99 111.083 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -132.65 155.36 48.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.983 -0.553 . . . . 999.99 109.939 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 t -144.47 146.22 32.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.946 0.403 . . . . 242.47 110.72 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.4 t -173.65 116.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 15.64 109.803 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 78.7 mm-40 -85.04 154.84 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 422.56 110.898 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.13 143.97 49.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.899 -0.591 . . . . 627.38 109.881 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.495 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 95.2 m -88.91 119.39 29.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.949 0.404 . . . . 220.71 110.751 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.2 p -153.01 82.68 1.21 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.559 0.695 . . . . 255.23 110.577 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 78.5 -4.46 59.76 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.501 -1.227 . . . . 82.17 110.935 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 34' ' ' GLY . 33.2 m120 -159.01 148.66 18.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 405.39 110.398 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.37 140.26 37.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.34 -0.391 . . . . 183.25 110.626 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.61 124.39 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.988 0.423 . . . . 196.98 110.444 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.4 mp0 -82.44 166.07 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 537.65 111.035 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 7.7 p -62.51 150.59 85.46 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.921 -0.582 . . . . 34.91 110.05 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.05 140.96 23.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.057 1.838 . . . . 87.7 111.964 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.72 -40.45 99.21 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 244.37 110.883 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.0 mt -114.25 143.48 44.79 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.784 0.325 . . . . 909.71 110.213 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.3 p -70.48 149.46 95.61 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.289 -0.414 . . . . 650.95 110.358 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.83 -1.82 11.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.226 1.951 . . . . 999.99 111.934 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -53.53 131.07 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 999.99 110.733 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 999.99 110.496 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.415 . . . . 999.99 109.564 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.54 149.1 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 999.99 110.256 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 73.9 m -81.64 109.41 16.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.336 -0.393 . . . . 296.55 110.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 t -61.91 -42.66 99.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.394 0.616 . . . . 218.16 109.881 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.99 -167.31 2.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.941 -1.027 . . . . 206.49 110.331 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.17 -39.56 86.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 336.78 110.217 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.3 64.89 0.5 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.605 -0.998 . . . . 108.67 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -60.86 -45.22 95.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.803 0.335 . . . . 133.27 110.656 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.4 m -62.51 -41.59 98.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.219 0.533 . . . . 25.78 110.167 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.18 165.8 7.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.388 -0.823 . . . . 119.04 109.899 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.35 95.74 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.828 -0.349 . . . . 157.06 110.821 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.59 -32.38 25.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 258.73 111.282 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 32' ' ' THR . 76.9 mm-40 -74.22 153.97 39.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 339.06 111.188 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.5 t -101.02 156.48 17.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.927 -0.578 . . . . 50.72 110.284 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 11.6 t -151.43 129.81 12.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.325 -0.62 . . . . 39.11 109.325 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.583 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.2 p -151.11 131.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 261.82 110.63 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -95.54 120.05 35.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.03 -0.532 . . . . 135.42 110.65 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 26' ' ' THR . 10.6 p -107.02 161.97 14.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.041 -0.527 . . . . 156.21 110.07 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.0 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.979 0.895 . . . . 137.43 108.981 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -93.61 -94.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.84 -1.527 . . . . 67.15 111.443 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -80.37 -18.65 48.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.202 -0.908 . . . . 451.81 111.239 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.19 -8.43 75.59 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.204 -0.758 . . . . 214.64 111.204 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.56 -42.12 91.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 328.18 109.388 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.404 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.6 ttp -142.57 104.59 4.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.312 -0.858 . . . . 386.81 109.284 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.27 146.9 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 184.5 110.96 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 18' ' ' THR . 73.2 m -125.37 134.66 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.354 -0.839 . . . . 151.99 110.944 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.74 146.23 51.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.006 -0.543 . . . . 999.99 109.903 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -134.09 145.38 49.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.87 0.367 . . . . 242.47 110.639 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -172.86 116.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 15.64 109.994 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -80.04 153.57 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 422.56 110.865 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.45 142.61 46.64 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.047 -0.524 . . . . 627.38 110.017 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.4 m -68.05 126.3 29.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.064 0.459 . . . . 220.71 110.374 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.8 p -151.31 88.85 1.46 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.827 -0.624 . . . . 255.23 110.539 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -47.65 1.22 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 114.875 -1.057 . . . . 82.17 110.979 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.438 ' H ' ' C ' ' A' ' 33' ' ' THR . 81.7 m-20 -133.34 138.72 46.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.158 -0.312 . . . . 405.39 110.158 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.3 m-85 -83.18 146.41 28.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 183.25 110.573 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.445 ' HG1' ' N ' ' A' ' 38' ' ' GLU . 38.6 p -133.36 -144.84 0.23 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.253 -0.431 . . . . 196.98 110.118 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' N ' ' HG1' ' A' ' 37' ' ' THR . 24.3 pt-20 -158.21 159.14 35.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 537.65 110.739 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 p -57.33 152.04 34.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.091 -0.504 . . . . 34.91 109.993 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.31 135.39 20.43 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.313 2.009 . . . . 87.7 112.259 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.35 96.88 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.706 -0.958 . . . . 244.37 110.706 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.88 144.1 31.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.876 0.37 . . . . 909.71 110.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 t -60.55 142.38 91.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.1 -0.5 . . . . 650.95 110.33 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 -10.87 23.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.171 1.914 . . . . 999.99 111.426 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.75 -44.82 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 999.99 110.234 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.008 -0.996 . . . . 999.99 110.538 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.528 -1.429 . . . . 999.99 109.528 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.06 140.8 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 999.99 110.315 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 m -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 296.55 110.179 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 t -61.05 -43.74 98.43 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.843 -0.617 . . . . 218.16 110.256 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -150.54 172.67 15.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.193 -0.912 . . . . 206.49 110.791 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 336.78 110.418 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.38 58.34 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.452 -0.659 . . . . 108.67 111.452 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.29 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.808 -0.357 . . . . 133.27 110.514 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.3 m -62.55 -43.68 98.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 25.78 109.848 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.42 165.55 3.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.27 -0.877 . . . . 119.04 109.854 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.5 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.937 -0.305 . . . . 157.06 111.079 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.79 -31.18 26.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.441 -0.345 . . . . 258.73 111.379 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 32' ' ' THR . 77.7 mm-40 -75.0 156.54 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.913 0.387 . . . . 339.06 111.356 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 t -108.85 157.81 18.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.935 -0.575 . . . . 50.72 110.395 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 48.1 t -146.18 133.68 20.85 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.845 -0.428 . . . . 39.11 109.845 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -154.15 117.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.613 -0.435 . . . . 261.82 109.854 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 97.3 m-20 -95.25 118.64 32.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 135.42 111.158 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -103.62 163.56 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.735 -0.666 . . . . 156.21 109.553 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 p -179.05 117.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.881 0.848 . . . . 137.43 109.412 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -100.89 -63.85 1.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.26 -1.336 . . . . 67.15 111.09 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.5 pt-20 -107.38 -177.22 3.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.33 0.586 . . . . 451.81 111.846 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.96 -12.02 57.03 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 115.01 -0.996 . . . . 214.64 111.352 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -60.22 -42.85 96.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 328.18 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptp -156.43 166.61 32.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 386.81 110.77 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.15 140.28 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.099 -0.501 . . . . 184.5 110.698 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 m -110.85 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 151.99 111.124 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' NH2' ' OD2' ' A' ' 17' ' ' ASP . 77.3 mtp85 -132.4 147.19 52.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.047 -0.524 . . . . 999.99 109.995 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -137.36 146.81 44.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.989 0.423 . . . . 242.47 110.74 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -175.01 117.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.821 -0.627 . . . . 15.64 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -83.39 155.79 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 422.56 111.195 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -118.3 144.21 46.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.942 -0.572 . . . . 627.38 109.877 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 96.0 m -80.1 123.89 28.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 220.71 110.708 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.96 89.7 1.4 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.882 -0.599 . . . . 255.23 110.395 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.35 -41.69 0.79 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.012 -0.994 . . . . 82.17 110.792 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.3 m-20 -134.39 139.72 45.79 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.079 -0.341 . . . . 405.39 110.079 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.78 147.59 27.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 183.25 110.858 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 p -146.92 119.62 8.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.041 -0.527 . . . . 196.98 109.89 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -73.98 158.07 35.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.966 -0.561 . . . . 537.65 111.133 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.6 p -64.82 149.67 95.82 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.975 -0.557 . . . . 34.91 110.058 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.72 138.96 21.98 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.101 1.868 . . . . 87.7 112.052 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.07 98.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 244.37 110.741 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.11 145.3 41.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.833 0.349 . . . . 909.71 110.252 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.7 p -69.25 149.37 97.48 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.248 -0.433 . . . . 650.95 110.331 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.69 -10.42 21.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.399 2.066 . . . . 999.99 112.282 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -52.56 -31.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.4 -0.364 . . . . 999.99 110.645 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.064 -0.97 . . . . 999.99 110.627 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' CA ' HH21 ' A' ' 27' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.492 -1.443 . . . . 999.99 109.492 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 83.2 mt -72.54 149.03 44.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 999.99 110.336 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.588 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 78.1 m -85.9 107.69 17.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 296.55 110.711 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.426 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 25.3 t -62.18 -42.75 99.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.381 0.61 . . . . 218.16 109.651 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -144.75 -167.34 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.989 -1.005 . . . . 206.49 110.24 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -39.74 87.26 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.746 -0.382 . . . . 336.78 110.124 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.43 62.02 0.48 Allowed Glycine 0 N--CA 1.466 0.652 0 N-CA-C 110.395 -1.082 . . . . 108.67 110.395 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 4' ' ' SER . 67.7 t0 -60.47 -45.75 92.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.771 0.32 . . . . 133.27 110.82 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.44 -42.12 99.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 25.78 110.232 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.71 167.88 7.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.286 -0.87 . . . . 119.04 109.874 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.04 96.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.874 -0.331 . . . . 157.06 110.776 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.15 -34.99 28.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.367 -0.379 . . . . 258.73 111.088 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.41 152.28 42.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 339.06 110.883 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 25.9 t -104.85 154.17 20.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 50.72 109.856 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 10.9 t -147.32 130.32 16.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.671 -0.492 . . . . 39.11 109.671 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.588 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.4 p -148.26 131.88 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.352 . . . . 261.82 110.482 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -100.62 120.83 40.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.119 -0.491 . . . . 135.42 110.529 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 27.5 p -107.37 164.91 11.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.187 -0.461 . . . . 156.21 109.931 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 178.07 117.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.924 0.868 . . . . 137.43 109.397 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.07 -55.59 2.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.224 -1.353 . . . . 67.15 110.586 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -118.17 -177.02 3.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.286 0.565 . . . . 451.81 111.425 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.33 -12.3 57.45 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.313 -0.858 . . . . 214.64 111.129 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -61.78 -44.74 96.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 328.18 111.153 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.1 ttp -154.74 144.64 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 386.81 110.95 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.0 t -103.9 147.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.078 -0.51 . . . . 184.5 110.318 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 77.3 m -123.94 139.84 53.56 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 151.99 111.346 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.404 HH21 ' CA ' ' A' ' 1' ' ' GLY . 20.9 ptp180 -145.89 160.61 41.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.906 -0.588 . . . . 999.99 109.788 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.3 p -150.14 161.92 41.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.958 0.408 . . . . 242.47 110.829 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -169.95 127.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 15.64 109.963 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.423 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 77.3 mm-40 -75.83 151.82 37.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 422.56 111.155 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -128.01 138.89 52.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.744 -0.662 . . . . 627.38 109.925 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 34' ' ' GLY . 27.7 p -71.45 69.81 0.6 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 220.71 110.378 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -78.4 45.2 0.55 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.909 0.861 . . . . 255.23 110.163 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 32' ' ' THR . . . 82.58 -0.92 88.88 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.194 -1.366 . . . . 82.17 110.146 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 80.6 m-20 -149.44 142.61 25.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.747 -0.464 . . . . 405.39 109.747 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.86 136.96 33.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 183.25 110.632 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 21.2 p -133.98 -150.28 0.39 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.693 -0.484 . . . . 196.98 109.693 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' N ' ' HG1' ' A' ' 37' ' ' THR . 98.3 mt-10 -144.73 142.87 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.845 -0.616 . . . . 537.65 110.766 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 p -65.13 150.41 95.5 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 109.61 -0.515 . . . . 34.91 109.61 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.07 130.35 15.3 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.988 1.792 . . . . 87.7 112.039 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.37 95.65 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.978 -0.849 . . . . 244.37 110.978 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -119.0 149.58 41.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.883 0.373 . . . . 909.71 110.615 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.6 p -69.2 151.07 97.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.902 -0.59 . . . . 650.95 110.013 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.05 -6.78 19.02 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.083 1.855 . . . . 999.99 111.568 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.3 mm -59.98 128.7 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 999.99 110.43 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.985 -1.007 . . . . 999.99 110.559 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' H3 ' ' NE ' ' A' ' 27' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 999.99 109.535 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.36 148.01 50.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 999.99 110.241 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 84.7 m -81.59 113.91 19.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 296.55 110.602 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.6 t -62.21 -42.75 99.58 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.466 0.651 . . . . 218.16 109.674 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -142.35 -163.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.861 -1.063 . . . . 206.49 110.288 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.26 -39.6 87.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.351 . . . . 336.78 110.391 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.2 65.81 0.55 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.773 -0.931 . . . . 108.67 110.773 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.868 0.366 . . . . 133.27 110.601 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.0 m -61.14 -42.58 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 25.78 109.916 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.09 163.99 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.338 -0.846 . . . . 119.04 109.744 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.15 95.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.589 -0.278 . . . . 157.06 111.145 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -86.38 -29.51 22.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 258.73 111.418 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -74.21 159.17 32.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.716 0.293 . . . . 339.06 111.028 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.3 t -102.77 150.2 23.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.147 -0.478 . . . . 50.72 110.28 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 9.1 t -149.42 124.82 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.122 -0.696 . . . . 39.11 109.122 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.517 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.0 p -145.9 131.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.984 0.421 . . . . 261.82 110.412 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 97.7 m-20 -95.58 120.98 36.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.936 -0.574 . . . . 135.42 110.752 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 26' ' ' THR . 36.2 p -104.81 165.32 11.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.942 -0.572 . . . . 156.21 109.947 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 176.18 118.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.772 0.796 . . . . 137.43 109.216 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.295 -1.321 . . . . 67.15 110.826 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -112.15 -173.05 2.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.076 0.465 . . . . 451.81 111.442 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.25 -11.98 56.72 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.662 -0.699 . . . . 214.64 111.918 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.32 -39.54 90.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.803 0.335 . . . . 328.18 111.041 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.4 ptp -157.78 167.99 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 386.81 111.057 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.3 t -124.04 146.62 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.986 -0.552 . . . . 184.5 110.475 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 18' ' ' THR . 83.7 m -125.28 142.11 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.731 -0.668 . . . . 151.99 111.219 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' NE ' ' H3 ' ' A' ' 1' ' ' GLY . 37.1 ptt-85 -137.36 154.74 49.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.053 -0.521 . . . . 999.99 110.218 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -134.18 150.4 51.08 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.024 0.44 . . . . 242.47 110.988 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -176.24 128.35 0.21 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.186 -0.672 . . . . 15.64 109.186 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 37' ' ' THR . 95.4 mt-10 -107.56 130.58 54.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.937 0.398 . . . . 422.56 111.326 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.0 150.07 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.574 . . . . 627.38 110.45 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -95.4 122.92 38.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 220.71 110.433 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -145.88 84.07 1.65 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.612 0.72 . . . . 255.23 110.875 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.54 -5.67 55.65 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.596 -1.184 . . . . 82.17 110.989 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.0 m-20 -155.93 148.98 24.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 405.39 110.253 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 137.72 37.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 183.25 110.525 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 56.6 p -151.23 119.24 6.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.263 -0.426 . . . . 196.98 110.438 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 99.7 mt-10 -75.06 161.69 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 537.65 110.392 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.2 p -52.03 157.5 2.13 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.475 -0.565 . . . . 34.91 109.475 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -55.63 163.1 5.64 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.594 1.53 . . . . 87.7 112.694 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.63 65.1 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.85 -1.068 . . . . 244.37 110.493 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.6 mt -122.73 158.33 30.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.024 -0.361 . . . . 909.71 110.024 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.9 p -61.46 148.18 86.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.429 -0.35 . . . . 650.95 110.234 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.98 -16.4 20.28 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.509 2.139 . . . . 999.99 113.152 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 pt -43.48 153.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 999.99 110.978 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.974 -1.012 . . . . 999.99 110.559 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.548 -1.421 . . . . 999.99 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 8' ' ' ASP . 86.3 mt -70.58 147.93 48.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 999.99 110.379 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 82.5 m -85.15 108.15 17.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.391 . . . . 296.55 110.393 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.432 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 28.2 t -61.5 -43.06 99.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.474 0.654 . . . . 218.16 109.781 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -144.05 -166.86 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.924 -1.035 . . . . 206.49 110.273 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.09 -39.48 86.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.994 -0.373 . . . . 336.78 109.994 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.65 62.2 0.48 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.687 -0.965 . . . . 108.67 110.687 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 4' ' ' SER . 67.2 t0 -60.72 -43.49 97.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.826 0.346 . . . . 133.27 110.515 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.3 m -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.261 0.553 . . . . 25.78 109.958 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.74 167.45 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.423 -0.808 . . . . 119.04 109.865 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.56 96.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.802 -0.359 . . . . 157.06 110.841 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.15 -32.66 24.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 258.73 111.05 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.82 158.52 35.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 339.06 110.901 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.9 t -111.51 146.81 36.63 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 50.72 110.169 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.456 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 15.8 t -140.97 129.04 22.02 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.046 -0.724 . . . . 39.11 109.046 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.541 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 12.9 p -148.48 131.48 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 261.82 110.422 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.92 121.35 38.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.997 -0.547 . . . . 135.42 110.939 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 p -103.51 166.31 10.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.927 -0.579 . . . . 156.21 109.84 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 178.09 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.993 0.901 . . . . 137.43 109.103 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.651 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.42 -95.01 0.17 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.913 -1.494 . . . . 67.15 111.269 -178.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.35 -28.08 59.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.954 -1.021 . . . . 451.81 111.084 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -13.73 58.82 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.274 -0.731 . . . . 214.64 111.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.79 -39.15 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 328.18 109.624 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.432 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 69.5 mtm -137.55 101.45 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.466 -0.788 . . . . 386.81 109.613 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.7 147.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.583 -0.447 . . . . 184.5 110.821 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.1 m -126.03 139.02 53.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.814 -0.63 . . . . 151.99 111.539 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.47 147.12 50.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 999.99 109.494 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -134.47 147.95 50.48 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.033 0.445 . . . . 242.47 111.224 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -175.42 130.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.219 -0.66 . . . . 15.64 109.219 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -108.12 167.09 10.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.942 0.401 . . . . 422.56 110.858 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.1 148.01 50.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.811 -0.631 . . . . 627.38 110.336 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.9 m -89.81 122.62 33.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 220.71 110.521 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -147.2 84.34 1.58 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.661 0.743 . . . . 255.23 110.768 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.57 -5.6 56.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.568 -1.196 . . . . 82.17 110.896 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -155.84 151.17 26.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.118 -0.327 . . . . 405.39 110.118 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.41 141.51 33.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.841 0.353 . . . . 183.25 110.992 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 t -161.48 130.7 4.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 196.98 109.837 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -86.39 169.6 12.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.833 -0.621 . . . . 537.65 111.032 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.3 p -58.71 152.13 48.9 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.939 -0.573 . . . . 34.91 109.968 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 134.9 16.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.101 1.867 . . . . 87.7 112.085 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.05 -39.75 97.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.909 -0.876 . . . . 244.37 110.909 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.57 142.26 42.64 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.965 0.412 . . . . 909.71 110.457 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p -70.01 150.46 96.26 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.954 -0.566 . . . . 650.95 110.133 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.08 -13.21 21.31 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.435 2.09 . . . . 999.99 112.76 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.9 pt -53.53 -23.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.791 0.329 . . . . 999.99 110.701 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 45' ' ' ILE . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.028 -0.987 . . . . 999.99 110.663 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.553 -1.419 . . . . 999.99 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.44 145.57 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.739 0.304 . . . . 999.99 110.407 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.527 ' C ' ' H ' ' A' ' 5' ' ' GLU . 82.9 m -62.39 -40.84 97.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.358 -0.383 . . . . 296.55 110.659 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 0.9 OUTLIER 76.2 -33.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.131 -0.486 . . . . 218.16 110.165 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.1 pt-20 -153.67 162.22 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.672 -0.694 . . . . 206.49 110.417 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.25 -40.35 93.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 336.78 111.054 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 49.82 0.9 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.978 -0.849 . . . . 108.67 110.978 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -61.21 -49.92 75.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 133.27 110.569 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.4 m -64.69 -41.61 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.315 0.579 . . . . 25.78 110.126 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.19 167.81 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 119.04 109.867 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.63 97.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.954 -0.298 . . . . 157.06 111.005 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.64 -30.98 24.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 258.73 111.243 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.55 158.58 33.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 339.06 110.994 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 38.6 t -112.91 144.19 42.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 50.72 110.602 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 29.7 t -137.89 128.3 26.35 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.194 -0.669 . . . . 39.11 109.194 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.5 p -143.11 133.18 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.878 0.37 . . . . 261.82 110.557 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 72.2 m-20 -92.5 121.96 34.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 135.42 110.808 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 26' ' ' THR . 14.6 p -101.01 164.73 11.67 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 156.21 109.946 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 176.38 119.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.079 0.942 . . . . 137.43 108.91 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.24 -94.39 0.18 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.751 -1.568 . . . . 67.15 111.48 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -77.71 -21.31 52.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.165 -0.925 . . . . 451.81 111.189 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.57 71.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.298 -0.721 . . . . 214.64 111.298 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.54 -42.64 92.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.327 -0.62 . . . . 328.18 109.327 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.6 ttp -141.75 111.27 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.322 -0.854 . . . . 386.81 109.111 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.93 150.03 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.177 0.513 . . . . 184.5 111.082 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' ' OG1' ' A' ' 18' ' ' THR . 89.2 m -132.89 143.95 49.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.484 -0.78 . . . . 151.99 111.057 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -132.13 163.84 27.61 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.95 -0.568 . . . . 999.99 110.116 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 t -148.62 150.49 33.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.987 0.422 . . . . 242.47 111.087 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.3 t -170.6 134.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 15.64 109.305 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -112.59 135.71 52.99 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.982 0.42 . . . . 422.56 111.337 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.43 144.96 26.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.848 -0.615 . . . . 627.38 110.203 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.6 m -93.66 102.93 15.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 220.71 110.612 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.5 m -140.28 125.89 19.16 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.491 0.662 . . . . 255.23 110.111 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.67 -64.85 0.45 Allowed Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.652 -1.158 . . . . 82.17 110.827 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' THR . 83.2 m-20 -122.53 146.89 47.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.977 -0.379 . . . . 405.39 109.977 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -73.25 146.22 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.422 -0.354 . . . . 183.25 110.902 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.15 122.11 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 196.98 110.391 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.06 165.15 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.61 . . . . 537.65 110.896 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 7.7 p -63.65 150.11 91.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 34.91 109.94 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.15 138.61 22.9 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.01 1.807 . . . . 87.7 111.841 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.85 0.43 67.2 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.954 -0.858 . . . . 244.37 110.954 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.05 145.14 42.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.92 0.391 . . . . 909.71 110.503 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -145.21 63.93 10.4 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.011 -0.54 . . . . 650.95 110.724 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 -14.8 23.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.966 2.444 . . . . 999.99 111.466 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 45' ' ' ILE . 39.1 pt -59.11 -21.32 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 115.821 -0.627 . . . . 999.99 110.835 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.936 -1.03 . . . . 999.99 110.598 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.506 -1.438 . . . . 999.99 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.21 146.82 40.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 999.99 110.341 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 5' ' ' GLU . 90.1 m -61.8 -42.61 99.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 296.55 110.791 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.18 -36.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.09 -0.504 . . . . 218.16 110.176 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.2 pt-20 -150.4 161.5 42.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.675 -0.693 . . . . 206.49 110.439 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -61.41 -40.6 94.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 336.78 111.122 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.31 47.76 1.12 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.953 -0.859 . . . . 108.67 110.953 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -61.24 -50.16 74.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.378 . . . . 133.27 110.638 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.61 -41.46 96.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.906 -0.588 . . . . 25.78 110.209 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -172.41 168.73 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.301 -0.863 . . . . 119.04 109.859 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.889 -0.324 . . . . 157.06 110.941 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.61 -31.35 24.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 258.73 111.11 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.82 156.29 36.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 339.06 111.014 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -112.95 144.46 42.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.132 -0.486 . . . . 50.72 110.515 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 26.8 t -136.73 127.17 26.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.832 -0.803 . . . . 39.11 108.832 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.1 p -137.64 130.37 42.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.04 0.448 . . . . 261.82 110.833 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 97.3 m-20 -93.4 138.57 31.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.828 -0.624 . . . . 135.42 110.898 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 26' ' ' THR . 19.0 p -128.06 159.22 35.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.884 -0.598 . . . . 156.21 109.834 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 p 178.67 118.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.685 -0.857 . . . . 137.43 108.685 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.4 -92.07 0.26 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.97 -1.468 . . . . 67.15 112.172 -177.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.586 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 4.0 pt-20 -70.92 -33.83 70.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 451.81 110.863 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.42 46.42 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 115.573 -0.739 . . . . 214.64 111.89 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.586 ' H ' ' CG ' ' A' ' 21' ' ' GLU . 37.8 t70 -60.41 -42.59 96.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.467 -0.568 . . . . 328.18 109.467 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.1 ttp -138.44 116.42 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 386.81 109.312 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.29 149.66 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.269 0.557 . . . . 184.5 110.754 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 18' ' ' THR . 75.5 m -128.66 142.37 51.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.391 -0.822 . . . . 151.99 110.928 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -145.3 162.17 37.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.031 -0.531 . . . . 999.99 110.048 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 t -149.75 152.84 35.92 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 242.47 110.986 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.7 t -168.58 131.82 1.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.849 -0.614 . . . . 15.64 109.427 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -102.91 149.21 24.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.942 0.401 . . . . 422.56 111.34 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.79 146.2 32.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.791 -0.641 . . . . 627.38 110.315 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.8 m -96.09 122.03 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 220.71 110.634 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.9 p -150.19 84.9 1.39 Allowed 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.55 0.691 . . . . 255.23 110.606 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 78.38 -3.98 60.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.636 -1.165 . . . . 82.17 110.723 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 34' ' ' GLY . 31.6 m120 -158.17 149.53 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.104 -0.332 . . . . 405.39 110.104 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -98.01 139.3 34.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 183.25 110.788 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.7 p -146.93 118.15 7.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 196.98 110.082 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -76.23 160.25 29.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 537.65 110.877 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 p -59.98 150.68 68.55 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.065 -0.516 . . . . 34.91 110.002 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.06 134.23 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.217 1.944 . . . . 87.7 111.909 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.72 -40.03 98.11 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.847 -0.901 . . . . 244.37 110.847 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt -116.66 147.05 42.3 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.847 0.356 . . . . 909.71 110.268 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.3 p -68.4 149.27 98.1 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.161 -0.472 . . . . 650.95 110.212 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.59 -12.77 27.11 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.332 2.021 . . . . 999.99 112.1 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.7 tt -41.9 139.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.391 . . . . 999.99 110.943 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.032 -0.985 . . . . 999.99 110.619 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.512 -1.435 . . . . 999.99 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.97 145.17 42.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.74 0.305 . . . . 999.99 110.494 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 5' ' ' GLU . 80.6 m -62.3 -40.79 97.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 296.55 110.619 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 1.1 t 75.53 -34.68 0.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 218.16 110.053 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.4 pt-20 -153.73 161.18 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.696 -0.683 . . . . 206.49 110.354 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.27 -40.17 93.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 336.78 110.814 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.58 46.84 1.29 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.068 -0.813 . . . . 108.67 111.068 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -60.84 -50.25 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.893 0.378 . . . . 133.27 110.571 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.95 -41.99 95.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 25.78 109.865 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.95 166.9 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.334 -0.848 . . . . 119.04 110.0 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 157.06 111.186 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -92.44 13.76 18.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.376 -0.374 . . . . 258.73 111.429 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.31 158.58 29.24 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.597 -0.274 . . . . 339.06 110.354 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.8 t -112.44 144.36 42.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.492 -0.322 . . . . 50.72 110.679 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 34.6 t -139.07 129.15 25.2 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.507 -0.553 . . . . 39.11 109.507 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.1 p -144.83 132.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 261.82 110.532 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -92.4 123.36 35.66 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.191 -0.459 . . . . 135.42 110.948 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -100.96 158.58 15.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.014 -0.539 . . . . 156.21 109.669 178.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p 179.32 116.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.983 0.896 . . . . 137.43 109.581 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -73.77 -92.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.925 -1.488 . . . . 67.15 111.148 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -90.22 -65.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.68 -0.691 . . . . 451.81 110.953 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.81 -10.54 0.11 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.808 -0.71 . . . . 214.64 111.352 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.6 -41.88 91.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.555 -0.535 . . . . 328.18 109.555 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.536 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 65.6 ttp -146.7 140.16 25.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.317 -0.856 . . . . 386.81 109.421 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.78 158.29 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 184.5 111.015 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 18' ' ' THR . 88.3 m -136.65 145.64 45.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.603 -0.726 . . . . 151.99 110.795 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.09 160.58 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.147 -0.479 . . . . 999.99 110.122 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -148.56 150.73 33.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.939 0.4 . . . . 242.47 110.832 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -170.58 129.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 15.64 109.691 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -107.03 138.25 43.55 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.893 0.377 . . . . 422.56 110.828 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -95.66 167.55 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.989 -0.55 . . . . 627.38 110.725 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.2 m -113.21 124.23 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.619 -0.719 . . . . 220.71 110.348 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -151.43 85.08 1.31 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.614 0.721 . . . . 255.23 110.733 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.59 -6.11 54.36 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.718 -1.128 . . . . 82.17 110.661 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -156.19 149.48 24.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.895 -0.409 . . . . 405.39 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 137.19 36.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 183.25 110.837 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.0 p -146.05 117.15 7.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.089 -0.505 . . . . 196.98 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.5 162.57 26.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 537.65 110.889 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 p -60.35 150.6 72.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.014 -0.539 . . . . 34.91 109.953 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.77 133.53 17.09 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.104 1.87 . . . . 87.7 112.05 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.73 97.76 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.825 -0.91 . . . . 244.37 110.825 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -90.64 159.82 16.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 909.71 110.621 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.2 p -65.51 150.03 96.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.131 -0.486 . . . . 650.95 110.223 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.34 -7.04 19.22 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.215 1.944 . . . . 999.99 111.532 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.5 129.82 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 999.99 110.52 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.006 -0.997 . . . . 999.99 110.57 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.556 -1.418 . . . . 999.99 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 84.7 mt -73.53 150.62 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 999.99 110.271 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 78.0 m -81.85 106.75 14.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 296.55 110.699 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 t -62.62 -42.85 99.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.609 . . . . 218.16 109.833 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -142.19 -165.6 2.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.004 -0.998 . . . . 206.49 110.417 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.05 -39.87 87.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 336.78 110.302 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.27 65.6 0.52 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.543 -1.023 . . . . 108.67 110.543 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 68.0 t0 -60.57 -44.86 95.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.879 0.371 . . . . 133.27 110.802 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.5 m -61.94 -43.1 99.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.384 0.611 . . . . 25.78 109.68 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.85 162.28 7.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.99 -1.005 . . . . 119.04 109.384 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.51 93.0 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.412 -0.515 . . . . 157.06 110.608 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.91 -38.97 69.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 258.73 111.073 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -73.83 161.07 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 339.06 111.146 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.7 t -109.28 155.52 21.05 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.361 -0.381 . . . . 50.72 110.351 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.453 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 9.3 t -149.62 129.19 13.11 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.524 -0.546 . . . . 39.11 109.524 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 11.6 p -148.33 132.21 8.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.837 0.351 . . . . 261.82 110.492 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.73 119.24 38.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.097 -0.501 . . . . 135.42 110.483 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 22.4 p -105.56 163.69 12.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.057 -0.519 . . . . 156.21 109.926 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p 178.38 117.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.84 0.829 . . . . 137.43 109.14 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.97 -62.36 1.32 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.231 -1.35 . . . . 67.15 111.123 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.8 pt-20 -104.5 -178.74 3.74 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.367 0.603 . . . . 451.81 111.913 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.44 -10.28 59.46 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.052 -0.976 . . . . 214.64 111.372 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.2 t0 -60.59 -44.07 96.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 328.18 110.84 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -159.94 168.75 24.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.038 -0.528 . . . . 386.81 110.953 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.0 t -118.15 143.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.026 -0.534 . . . . 184.5 110.547 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.1 m -118.34 137.6 52.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.742 . . . . 151.99 111.111 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -146.61 161.41 40.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.228 -0.442 . . . . 999.99 110.125 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -151.93 162.83 40.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.875 0.369 . . . . 242.47 110.859 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.3 t -168.48 131.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 15.64 110.03 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 74.5 mm-40 -77.87 154.46 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 422.56 111.277 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -121.37 138.67 54.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.746 -0.661 . . . . 627.38 109.555 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.6 m -79.87 123.09 27.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.145 -0.479 . . . . 220.71 110.589 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -154.77 88.28 1.19 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.494 0.664 . . . . 255.23 110.536 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -50.49 1.46 Allowed Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 114.812 -1.086 . . . . 82.17 111.1 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.73 136.68 47.81 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.749 0.309 . . . . 405.39 110.385 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -83.76 150.53 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 183.25 110.493 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.502 ' HG1' ' N ' ' A' ' 38' ' ' GLU . 32.2 p -126.86 -145.71 0.32 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.957 0.408 . . . . 196.98 110.296 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.502 ' N ' ' HG1' ' A' ' 37' ' ' THR . 52.6 tp10 -151.6 139.21 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 537.65 110.318 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 p -56.77 150.92 34.56 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.107 -0.497 . . . . 34.91 110.158 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.25 157.79 41.54 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.449 2.099 . . . . 87.7 112.162 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.41 -93.07 1.64 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.682 -0.967 . . . . 244.37 110.682 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -81.55 136.2 35.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 909.71 110.216 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 73.1 p -81.16 160.6 65.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.192 -0.458 . . . . 650.95 110.034 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.28 -22.81 59.42 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.673 1.582 . . . . 999.99 111.72 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -37.99 144.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 999.99 111.274 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 117.955 -1.022 . . . . 999.99 110.602 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.569 -1.413 . . . . 999.99 109.569 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.8 mt -121.36 149.24 43.26 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.177 -0.305 . . . . 999.99 110.177 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 89.7 m -65.78 146.32 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 296.55 110.308 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 t -60.2 -43.03 96.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 218.16 110.105 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.9 -172.81 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.149 -0.932 . . . . 206.49 110.524 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.83 -39.4 84.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 336.78 110.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.37 74.11 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.651 -0.98 . . . . 108.67 110.651 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.26 -44.01 97.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.368 . . . . 133.27 110.597 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -62.63 -41.78 99.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 25.78 110.39 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.47 163.64 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.597 -0.729 . . . . 119.04 110.095 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.73 90.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 157.06 110.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -91.62 10.52 27.74 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.349 -0.387 . . . . 258.73 111.431 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.506 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.3 mm-40 -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 339.06 110.865 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 40.5 t -106.06 156.99 17.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.81 -0.632 . . . . 50.72 110.854 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.5 t -147.64 126.36 12.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.514 -0.551 . . . . 39.11 109.514 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 p -150.99 131.98 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.01 -0.367 . . . . 261.82 110.01 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 97.7 m-20 -101.41 118.66 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 135.42 111.41 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' THR . 2.4 p -100.69 161.98 13.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.632 -0.713 . . . . 156.21 109.15 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p 178.41 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.815 0.817 . . . . 137.43 109.331 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -90.03 -62.57 1.44 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.25 -1.341 . . . . 67.15 110.184 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -117.91 -172.91 2.34 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.98 0.419 . . . . 451.81 110.736 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.01 -20.19 47.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.357 -0.697 . . . . 214.64 111.357 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.56 -40.13 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.595 0.236 . . . . 328.18 111.539 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mtp -137.0 153.44 50.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.123 0.487 . . . . 386.81 111.601 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.73 142.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.625 -0.716 . . . . 184.5 110.085 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.0 m -123.78 134.62 53.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.946 -0.57 . . . . 151.99 111.249 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -128.72 147.44 50.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.001 -0.545 . . . . 999.99 109.911 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -133.8 145.85 50.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.969 0.414 . . . . 242.47 110.715 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -173.41 115.25 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.837 -0.62 . . . . 15.64 109.745 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.5 mm-40 -84.78 155.01 22.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.954 0.407 . . . . 422.56 111.014 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -121.96 143.74 49.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.905 -0.588 . . . . 627.38 109.804 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.506 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 93.7 m -89.32 119.61 29.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.353 -0.385 . . . . 220.71 110.79 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.3 p -152.21 82.49 1.25 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.645 0.736 . . . . 255.23 110.468 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.66 -5.72 56.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.455 -1.248 . . . . 82.17 110.737 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.4 m-20 -156.58 149.04 23.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.704 0.287 . . . . 405.39 110.252 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.03 139.33 39.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.836 0.35 . . . . 183.25 110.717 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 123.97 4.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 196.98 110.384 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.455 ' OE2' ' N ' ' A' ' 38' ' ' GLU . 58.2 mp0 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 537.65 111.135 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.8 p -63.53 150.67 89.66 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.922 -0.581 . . . . 34.91 110.153 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.03 142.75 28.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.133 1.888 . . . . 87.7 111.841 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.77 0.82 74.03 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 244.37 110.924 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 mt -107.22 140.82 39.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.943 0.402 . . . . 909.71 110.524 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.7 p -134.65 64.84 65.11 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.08 -0.509 . . . . 650.95 110.407 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.27 -16.26 22.27 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.602 2.201 . . . . 999.99 111.766 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -53.35 139.07 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 999.99 110.614 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' OXT' ' CE2' ' A' ' 20' ' ' PHE . . . . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.032 -0.985 . . . . 999.99 110.572 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.494 -1.442 . . . . 999.99 109.494 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.34 151.84 27.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.726 0.298 . . . . 999.99 110.402 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 93.0 m -65.09 146.88 54.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.333 -0.394 . . . . 296.55 110.298 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -60.36 -43.04 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.316 0.579 . . . . 218.16 110.132 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -142.96 -170.86 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.129 -0.942 . . . . 206.49 110.446 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 336.78 110.137 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.27 81.74 0.32 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.493 -1.043 . . . . 108.67 110.493 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -61.2 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 133.27 110.597 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.2 m -62.34 -41.44 98.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.895 -0.593 . . . . 25.78 110.333 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.63 161.41 6.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.521 -0.763 . . . . 119.04 109.863 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -46.16 91.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.691 -0.403 . . . . 157.06 110.71 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.5 -38.33 74.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 258.73 110.525 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 32' ' ' THR . 69.2 mm-40 -75.72 167.88 21.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.702 -0.681 . . . . 339.06 111.018 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 16.2 p -112.57 171.1 7.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.218 -0.446 . . . . 50.72 110.324 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 48.9 t -152.48 126.92 9.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.453 -0.573 . . . . 39.11 109.453 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.2 p -148.86 129.67 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 261.82 110.512 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 66.3 m-20 -115.05 133.94 55.61 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.071 -0.513 . . . . 135.42 110.77 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 26' ' ' THR . 20.3 p -126.91 162.02 26.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 156.21 109.687 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -178.77 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.997 0.903 . . . . 137.43 109.455 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.78 -53.26 3.47 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.938 -1.483 . . . . 67.15 110.684 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -120.37 -178.05 3.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.307 0.575 . . . . 451.81 111.419 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.61 -11.16 59.62 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.148 -0.933 . . . . 214.64 111.049 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.73 -44.38 96.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.806 0.336 . . . . 328.18 111.13 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.3 ttp -155.12 147.3 23.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 386.81 110.92 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.36 142.71 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 184.5 110.403 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 18' ' ' THR . 73.1 m -117.05 133.59 55.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 151.99 110.798 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -151.6 163.45 39.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.178 -0.465 . . . . 999.99 110.398 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -149.47 148.03 28.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.054 0.454 . . . . 242.47 110.813 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.9 t -169.36 114.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 15.64 109.388 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.6 159.77 20.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 422.56 111.331 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -124.57 142.94 50.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.053 -0.521 . . . . 627.38 110.176 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.505 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 99.8 m -84.87 121.55 27.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 220.71 110.371 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.8 p -153.57 90.06 1.38 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.373 0.606 . . . . 255.23 110.61 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 -40.35 0.82 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.926 -1.034 . . . . 82.17 110.957 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 33' ' ' THR . 81.4 m-20 -134.62 139.42 45.31 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.845 0.355 . . . . 405.39 110.212 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.11 150.49 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 183.25 110.975 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.63 122.36 5.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 196.98 110.131 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' CYS . 88.1 tt0 -81.5 148.7 29.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.832 -0.622 . . . . 537.65 111.332 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -41.08 164.4 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.857 -0.61 . . . . 34.91 110.159 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -75.89 142.77 25.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.398 2.065 . . . . 87.7 111.789 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.94 -39.88 98.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 244.37 110.865 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.5 mt -115.71 147.94 40.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.816 0.341 . . . . 909.71 110.308 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.4 p -68.11 149.68 98.05 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.248 -0.433 . . . . 650.95 110.378 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.77 5.29 3.48 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.205 1.937 . . . . 999.99 111.768 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.0 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 999.99 110.235 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 118.08 -0.962 . . . . 999.99 110.548 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.435 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.504 -1.438 . . . . 999.99 109.504 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.6 mt -72.4 148.92 44.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.313 . . . . 999.99 110.399 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.1 m -60.44 133.83 56.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 296.55 110.64 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t -64.44 -42.51 95.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.358 0.599 . . . . 218.16 109.804 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -141.2 -164.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.069 -0.969 . . . . 206.49 110.614 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.69 -39.98 90.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.415 -0.357 . . . . 336.78 110.686 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.38 85.98 0.38 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.749 -0.94 . . . . 108.67 110.749 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -62.61 -43.38 98.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.705 0.288 . . . . 133.27 110.991 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.2 m -62.0 -43.11 99.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 25.78 110.281 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -166.66 166.04 16.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.391 -0.822 . . . . 119.04 109.825 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.87 96.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.904 -0.319 . . . . 157.06 111.175 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -83.99 -32.46 24.96 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.842 0.353 . . . . 258.73 111.3 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -75.75 160.35 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 339.06 110.842 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.4 t -115.98 149.67 38.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.351 -0.386 . . . . 50.72 110.113 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.3 p -135.64 153.69 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.723 -0.473 . . . . 39.11 109.723 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 9.5 p -165.87 117.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.486 -0.486 . . . . 261.82 110.515 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 1' ' ' GLY . 97.4 m-20 -103.5 119.63 39.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.185 -0.461 . . . . 135.42 110.852 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.954 -0.566 . . . . 156.21 109.774 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.72 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 122.079 0.943 . . . . 137.43 109.074 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.19 -94.1 0.17 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.876 -1.511 . . . . 67.15 111.428 -178.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -79.98 -19.67 47.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.189 -0.914 . . . . 451.81 111.131 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.92 -10.14 72.37 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.264 -0.734 . . . . 214.64 111.264 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.52 -41.79 95.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 328.18 109.487 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.443 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.9 mtm -138.6 99.17 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.358 -0.837 . . . . 386.81 109.414 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.88 145.2 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.208 0.528 . . . . 184.5 110.858 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 m -125.74 136.95 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.398 -0.819 . . . . 151.99 110.954 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -149.76 160.65 43.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 999.99 110.638 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -152.53 150.5 29.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.351 -0.386 . . . . 242.47 110.775 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.9 t -169.96 126.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.914 -0.585 . . . . 15.64 109.734 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.04 152.54 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 422.56 111.007 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -116.49 142.69 46.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.984 -0.553 . . . . 627.38 109.969 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 91.5 m -71.58 124.97 25.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.989 0.423 . . . . 220.71 110.508 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 35' ' ' ASN . 31.7 p -154.05 89.43 1.3 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.417 0.627 . . . . 255.23 110.543 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.81 -47.14 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.928 -1.033 . . . . 82.17 111.005 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.2 m120 -135.06 138.76 44.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.791 0.329 . . . . 405.39 110.253 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.9 m-85 -83.73 148.09 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 183.25 110.659 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.7 p -125.85 -144.96 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.951 0.405 . . . . 196.98 110.069 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -156.89 143.57 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 537.65 110.536 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.3 p -62.15 149.51 86.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 34.91 110.005 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 135.25 16.77 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.071 1.847 . . . . 87.7 111.74 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.93 -42.89 99.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.723 -0.951 . . . . 244.37 110.723 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.8 mt -127.49 140.03 52.41 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.97 -0.381 . . . . 909.71 109.97 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.1 m -110.15 116.04 53.87 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.435 -0.348 . . . . 650.95 110.235 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.62 64.15 8.11 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.259 1.973 . . . . 999.99 112.026 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.07 141.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 999.99 110.631 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.002 -0.999 . . . . 999.99 110.459 179.977 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.592 -1.403 . . . . 999.99 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.62 149.64 36.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.679 0.276 . . . . 999.99 110.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.528 ' C ' ' H ' ' A' ' 5' ' ' GLU . 77.0 m -62.09 -40.93 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 296.55 110.609 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER 75.17 -32.66 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 218.16 110.56 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.5 pt-20 -150.69 168.12 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 206.49 110.596 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.6 -39.89 89.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.357 -0.383 . . . . 336.78 110.929 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.91 68.24 0.28 Allowed Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.17 -0.772 . . . . 108.67 111.17 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.9 -48.56 78.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.987 0.422 . . . . 133.27 110.617 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.99 -41.41 97.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.855 -0.611 . . . . 25.78 109.931 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.1 162.91 9.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.161 -0.927 . . . . 119.04 109.246 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.98 90.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.511 -0.476 . . . . 157.06 110.666 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.45 -37.83 71.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 258.73 110.857 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.14 161.14 30.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 339.06 111.163 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 50.2 t -111.05 158.98 18.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.157 -0.474 . . . . 50.72 110.411 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 49.7 t -149.13 130.35 14.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.441 -0.577 . . . . 39.11 109.441 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.3 p -149.14 129.89 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 261.82 110.434 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -93.0 119.21 32.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 135.42 110.772 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 26' ' ' THR . 21.2 p -103.69 161.66 13.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.994 -0.548 . . . . 156.21 109.949 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 p 179.54 117.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.796 0.808 . . . . 137.43 109.325 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -104.12 -62.8 1.27 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.357 -1.292 . . . . 67.15 111.28 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -103.23 -178.49 3.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.452 0.644 . . . . 451.81 111.991 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.77 -10.12 59.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.992 -1.004 . . . . 214.64 111.445 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -60.77 -44.48 96.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 328.18 110.927 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.82 170.18 22.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.013 -0.539 . . . . 386.81 111.022 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.85 143.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.896 -0.593 . . . . 184.5 110.512 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' A' ' 18' ' ' THR . 89.8 m -117.44 134.02 55.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 151.99 111.338 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -126.27 147.06 49.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.966 -0.561 . . . . 999.99 109.708 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -135.1 153.11 52.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.887 0.375 . . . . 242.47 110.727 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 3.0 t -166.0 132.17 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 15.64 109.952 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 75.5 mm-40 -81.39 155.74 25.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 422.56 111.439 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 143.17 50.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.584 -0.735 . . . . 627.38 109.399 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.412 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 98.2 m -85.61 121.34 28.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 220.71 110.68 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -152.29 88.81 1.39 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.82 -0.627 . . . . 255.23 110.42 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -50.88 1.6 Allowed Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.947 -1.024 . . . . 82.17 111.04 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.49 137.53 48.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.758 0.313 . . . . 405.39 110.434 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 97.0 m-85 -84.15 149.77 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 183.25 110.506 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 43.3 p -124.85 -145.2 0.33 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.847 0.356 . . . . 196.98 110.156 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 88.2 tt0 -152.86 139.31 18.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 537.65 110.77 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -57.05 152.37 29.46 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.96 -0.564 . . . . 34.91 109.994 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.14 157.38 46.43 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.343 2.029 . . . . 87.7 111.767 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.47 -90.7 2.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.997 -0.841 . . . . 244.37 110.997 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.2 mt -77.14 143.76 38.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 909.71 110.697 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.4 p -72.33 150.62 91.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.021 -0.536 . . . . 650.95 110.164 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.07 -8.95 19.15 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.129 1.886 . . . . 999.99 111.659 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.96 129.45 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.041 -0.527 . . . . 999.99 110.594 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.012 -0.994 . . . . 999.99 110.571 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 999.99 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.79 144.09 44.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.664 0.269 . . . . 999.99 110.416 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.6 m -78.58 -177.63 5.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 296.55 110.198 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -58.81 -44.48 90.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 218.16 110.388 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 7' ' ' GLY . 21.3 pt-20 -153.1 47.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.636 -0.711 . . . . 206.49 110.829 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 60.18 -5.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 336.78 111.569 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 5' ' ' GLU . . . -155.9 60.71 0.36 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.464 -1.054 . . . . 108.67 110.464 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 9' ' ' CYS . 52.8 p-10 -61.17 -29.25 69.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.727 0.298 . . . . 133.27 110.777 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 97.1 m -62.12 -43.19 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.324 0.583 . . . . 25.78 109.933 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.81 162.31 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.119 -0.946 . . . . 119.04 109.429 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.49 93.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.512 -0.475 . . . . 157.06 110.557 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.25 -38.36 68.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 258.73 110.965 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 32' ' ' THR . 75.8 mm-40 -72.33 157.96 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 339.06 111.435 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.2 t -104.24 156.44 17.9 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.986 -0.552 . . . . 50.72 110.327 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 54.1 t -147.73 128.86 14.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 39.11 109.99 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.3 134.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 261.82 110.251 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -101.0 119.47 38.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 135.42 110.994 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 p -100.38 164.53 11.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.911 -0.586 . . . . 156.21 110.018 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.08 119.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.131 0.967 . . . . 137.43 108.899 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.643 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.32 -95.09 0.16 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.74 -1.573 . . . . 67.15 111.469 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.42 -21.56 38.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.072 -0.967 . . . . 451.81 110.738 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.03 65.43 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.313 -0.715 . . . . 214.64 111.313 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.61 -39.64 84.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.203 -0.666 . . . . 328.18 109.203 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 24' ' ' MET . 19.1 tmm? -148.87 105.51 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.302 -0.863 . . . . 386.81 108.874 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 24' ' ' MET . 77.7 t -63.9 145.49 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.281 0.562 . . . . 184.5 111.343 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.7 m -125.09 135.14 52.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.288 -0.869 . . . . 151.99 110.945 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -128.55 148.83 50.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 999.99 109.909 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -132.95 144.55 50.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.855 0.36 . . . . 242.47 110.696 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.57 115.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 15.64 110.007 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.17 152.36 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 422.56 110.627 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -115.15 142.38 46.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.329 -0.396 . . . . 627.38 110.255 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 88.2 m -71.11 125.9 28.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 220.71 110.511 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.84 89.47 1.39 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.395 0.617 . . . . 255.23 110.503 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.44 -44.06 0.92 Allowed Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.932 -1.031 . . . . 82.17 110.887 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.0 m120 -136.41 139.32 42.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.82 0.343 . . . . 405.39 110.157 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.28 146.55 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 183.25 110.749 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.2 p -127.7 -146.79 0.34 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.284 -0.416 . . . . 196.98 109.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -160.92 148.42 15.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 537.65 110.595 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.1 p -61.88 149.9 84.22 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.229 -0.441 . . . . 34.91 109.89 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.76 134.62 18.47 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.064 1.842 . . . . 87.7 112.0 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.85 98.34 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.87 -0.892 . . . . 244.37 110.87 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 mt -95.14 151.89 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 909.71 110.349 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.4 p -65.89 149.61 97.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 650.95 110.116 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.69 -9.89 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.011 1.807 . . . . 999.99 111.462 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.41 -45.08 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 999.99 110.324 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 117.975 -1.012 . . . . 999.99 110.598 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.478 -1.449 . . . . 999.99 109.478 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.2 mt -107.41 143.94 35.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.237 -0.282 . . . . 999.99 110.237 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 82.1 m -63.97 142.81 58.27 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.837 -0.345 . . . . 296.55 110.16 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 t -60.52 -43.8 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 218.16 110.185 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.8 -164.86 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.184 -0.916 . . . . 206.49 110.437 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.84 -39.49 85.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.914 0.388 . . . . 336.78 110.198 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.29 76.88 0.4 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.533 -1.027 . . . . 108.67 110.533 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.31 -43.53 98.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 133.27 110.614 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.1 m -62.06 -41.47 98.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 25.78 110.313 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.28 165.98 8.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.482 -0.781 . . . . 119.04 109.928 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.33 96.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.757 -0.377 . . . . 157.06 110.757 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.93 -33.53 33.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 258.73 110.958 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.5 mm-40 -74.3 158.01 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 339.06 111.293 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 34.1 t -107.71 154.31 21.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.984 -0.553 . . . . 50.72 110.614 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 42.6 t -142.8 128.12 18.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.58 -0.526 . . . . 39.11 109.58 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.11 128.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.905 -0.406 . . . . 261.82 109.905 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 70.1 m-20 -107.97 118.11 35.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 135.42 111.39 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -102.82 166.44 10.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.459 -0.791 . . . . 156.21 109.449 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -179.57 117.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.909 0.861 . . . . 137.43 109.502 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.93 -62.18 1.33 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.174 -1.375 . . . . 67.15 110.784 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.2 pt-20 -114.9 -172.17 2.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.06 0.457 . . . . 451.81 111.284 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.09 -12.75 54.65 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.754 -0.657 . . . . 214.64 111.864 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.46 -40.72 95.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.668 0.271 . . . . 328.18 111.183 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 ttp -157.08 153.02 27.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.371 -0.377 . . . . 386.81 110.904 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -115.59 140.94 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.163 0.506 . . . . 184.5 110.67 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.4 m -110.96 132.3 54.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.514 -0.766 . . . . 151.99 111.373 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -133.98 148.3 51.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 999.99 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -138.45 147.71 43.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.926 0.393 . . . . 242.47 110.772 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.9 115.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 15.64 109.912 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -80.56 152.8 28.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 422.56 110.631 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.68 143.41 45.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.147 -0.479 . . . . 627.38 110.205 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.517 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.0 m -73.79 125.05 27.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 220.71 110.485 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.9 p -153.34 89.49 1.35 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.383 0.611 . . . . 255.23 110.559 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.16 -41.14 0.74 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.898 -1.046 . . . . 82.17 111.017 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 33' ' ' THR . 83.0 m-20 -133.93 140.05 46.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 405.39 110.341 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.04 144.81 26.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.157 -0.474 . . . . 183.25 110.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.6 p -134.52 -157.66 0.82 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.438 -0.579 . . . . 196.98 109.438 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -149.59 155.33 40.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.441 -0.8 . . . . 537.65 110.655 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.5 p -65.92 149.76 97.22 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.675 -0.491 . . . . 34.91 109.675 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.96 131.3 16.68 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.978 1.785 . . . . 87.7 111.946 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.98 98.36 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.063 -0.815 . . . . 244.37 111.063 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.25 139.32 44.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.849 0.357 . . . . 909.71 110.304 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.2 p -71.01 150.45 94.94 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.196 -0.456 . . . . 650.95 110.049 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.55 -11.94 16.98 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.963 1.776 . . . . 999.99 111.282 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.87 127.3 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 999.99 110.693 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.108 -0.949 . . . . 999.99 110.582 -179.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.48 -1.448 . . . . 999.99 109.48 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.5 mt -73.63 144.41 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.662 0.267 . . . . 999.99 110.287 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 71.7 m -69.0 135.99 51.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.863 -0.335 . . . . 296.55 110.16 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.36 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.286 0.565 . . . . 218.16 110.002 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -149.27 -162.76 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.125 -0.943 . . . . 206.49 110.379 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -39.39 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 336.78 110.139 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.4 75.09 0.42 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.538 -1.025 . . . . 108.67 110.538 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -61.42 -43.12 99.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.939 0.4 . . . . 133.27 110.679 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.5 m -61.65 -42.56 99.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.007 -0.542 . . . . 25.78 110.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.93 167.13 13.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.334 -0.848 . . . . 119.04 109.871 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.5 95.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.515 -0.312 . . . . 157.06 111.117 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.44 -30.29 23.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.473 -0.331 . . . . 258.73 111.273 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.51 154.14 37.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 339.06 110.979 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 39.0 t -104.51 148.87 25.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.219 -0.446 . . . . 50.72 110.727 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.437 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 42.1 t -135.92 123.97 22.9 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.554 -0.535 . . . . 39.11 109.554 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.33 127.69 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.913 0.387 . . . . 261.82 110.21 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 3' ' ' CYS . 43.1 m-20 -109.66 118.78 37.46 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.047 -0.524 . . . . 135.42 111.022 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 46.5 p -104.54 167.53 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.826 -0.625 . . . . 156.21 109.867 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p 179.34 117.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.936 0.874 . . . . 137.43 109.304 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -100.57 -71.19 0.71 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.069 -1.423 . . . . 67.15 110.815 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.4 pt-20 -95.67 -177.57 4.1 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.608 -0.723 . . . . 451.81 111.782 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.05 -10.42 57.43 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.115 -0.948 . . . . 214.64 111.098 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.411 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.3 t0 -60.38 -43.71 96.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 328.18 110.975 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -159.39 168.99 24.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 386.81 110.963 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.919 -0.582 . . . . 184.5 110.852 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 51.5 m -121.72 138.13 54.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.504 -0.771 . . . . 151.99 111.251 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -150.5 158.09 43.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.264 -0.425 . . . . 999.99 110.492 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.8 m -142.31 153.76 44.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 242.47 111.078 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -167.05 121.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.8 -0.636 . . . . 15.64 109.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -83.95 155.09 23.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.014 0.435 . . . . 422.56 111.38 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.4 143.52 45.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.727 -0.67 . . . . 627.38 110.067 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.1 m -78.53 124.29 28.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 220.71 110.729 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 35' ' ' ASN . 34.0 p -152.91 89.03 1.35 Allowed 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.451 0.643 . . . . 255.23 110.518 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 -38.84 0.76 Allowed Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.899 -1.046 . . . . 82.17 111.222 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.7 m-20 -135.72 141.2 44.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.875 0.369 . . . . 405.39 110.365 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -90.03 146.5 24.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 183.25 110.573 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.8 p -132.77 -156.21 0.73 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.511 -0.552 . . . . 196.98 109.511 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -148.29 153.33 38.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.6 -0.727 . . . . 537.65 110.655 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 p -65.45 149.86 96.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.586 -0.524 . . . . 34.91 109.586 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.44 131.03 15.71 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.014 1.809 . . . . 87.7 112.121 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.83 -40.17 97.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.173 -0.771 . . . . 244.37 111.173 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.1 mt -109.3 149.02 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.929 0.395 . . . . 909.71 110.584 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.1 p -69.8 150.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 650.95 110.076 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.84 -13.13 17.83 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.14 1.894 . . . . 999.99 111.298 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -72.52 128.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.7 . . . . 999.99 110.613 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.034 -0.984 . . . . 999.99 110.539 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.796 0.332 . . . . 206.49000000000001 110.585 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.512 ' ND2' ' SG ' ' A' ' 14' ' ' CYS . 15.8 t-20 -60.77 -42.81 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 244.88 110.947 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.07 53.64 1.61 Allowed Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.465 -0.654 . . . . 71.469999999999999 111.465 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.61 -46.53 87.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.83 0.348 . . . . 133.27000000000001 110.699 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.18 -42.08 99.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.289 0.566 . . . . 25.780000000000001 110.139 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.84 168.5 7.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.278 -0.874 . . . . 119.04000000000001 109.897 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.98 97.23 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.862 -0.335 . . . . 60.490000000000002 110.932 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.97 -32.15 27.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.429 -0.35 . . . . 258.73000000000002 111.023 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -75.1 166.98 22.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 339.06 110.938 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' SG ' ' ND2' ' A' ' 6' ' ' ASN . 42.6 t -130.9 143.89 51.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.01 -0.541 . . . . 42.960000000000001 110.629 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -135.58 138.53 43.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.3 -0.629 . . . . 39.109999999999999 109.3 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.9 p -148.3 118.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.56 -0.456 . . . . 115.20999999999999 110.402 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.61 118.93 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 135.41999999999999 111.094 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.499 ' HG1' ' C ' ' A' ' 26' ' ' THR . 16.2 p -97.53 160.57 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 45.380000000000003 109.344 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p 179.53 117.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.921 0.867 . . . . 42.109999999999999 109.252 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.42 -56.63 2.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.269 -1.332 . . . . 66.019999999999996 111.387 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 22.6 pt-20 -113.41 -174.5 2.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.188 0.518 . . . . 451.81 111.77 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.41 -9.62 57.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.352 -0.84 . . . . 104.66 111.911 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.435 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.11 -41.1 96.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.879 0.371 . . . . 328.18000000000001 110.85 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -163.01 169.42 19.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 243.28999999999999 110.866 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.78 143.13 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.554 . . . . 58.390000000000001 110.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.499 ' C ' ' HG1' ' A' ' 18' ' ' THR . 99.4 m -117.25 137.43 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.503 -0.771 . . . . 44.390000000000001 111.168 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -125.79 156.23 39.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.871 -0.604 . . . . 767.09000000000003 109.531 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -147.96 159.25 44.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.303 0.573 . . . . 146.31999999999999 111.253 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.6 t -175.14 137.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.41 -0.814 . . . . 15.640000000000001 109.194 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -110.67 134.74 52.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.948 0.404 . . . . 422.56 110.948 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -86.56 140.41 29.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.893 -0.594 . . . . 462.10000000000002 109.707 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -89.99 102.71 15.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.964 0.412 . . . . 111.17 110.659 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ASN . 21.5 m -138.04 126.51 23.39 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.495 0.664 . . . . 121.65000000000001 110.032 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.25 -71.11 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 CA-C-N 114.663 -1.153 . . . . 82.170000000000002 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 33' ' ' THR . 84.2 m-20 -111.98 142.21 44.68 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.789 -0.448 . . . . 220.46000000000001 109.789 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -70.92 143.86 50.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 149.47999999999999 110.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 p -147.02 117.05 7.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.134 -0.485 . . . . 169.86000000000001 110.209 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.42 161.61 23.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 537.64999999999998 110.978 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.5 p -64.05 150.19 92.4 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.855 -0.612 . . . . 32.920000000000002 110.143 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.01 137.56 21.85 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.069 1.846 . . . . 87.700000000000003 111.768 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.13 7.41 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.793 -0.923 . . . . 244.37 110.793 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.857 0.36 . . . . 681.24000000000001 110.617 -179.612 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 21.9 pt-20 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.21 -0.293 . . . . 206.49000000000001 110.21 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.41 85.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.872 0.368 . . . . 244.88 110.185 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -122.99 65.24 0.52 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.622 -0.991 . . . . 71.469999999999999 110.622 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.06 -41.72 97.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 133.27000000000001 110.588 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.9 m -61.31 -41.17 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 25.780000000000001 110.173 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.61 166.46 14.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.778 . . . . 119.04000000000001 109.954 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.48 95.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 60.490000000000002 110.926 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.22 -29.61 24.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 258.73000000000002 111.055 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.469 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.0 mm-40 -76.14 159.97 30.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.414 . . . . 339.06 111.136 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 35.1 t -109.88 153.3 24.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.922 -0.581 . . . . 42.960000000000001 110.366 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.7 t -144.65 127.27 16.11 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.242 -0.651 . . . . 39.109999999999999 109.242 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 16' ' ' VAL . 13.8 p -147.61 128.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 115.20999999999999 110.614 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -99.28 132.87 44.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 135.41999999999999 110.733 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 24.0 p -122.32 161.09 24.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.871 -0.604 . . . . 45.380000000000003 109.51 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 179.27 118.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.988 0.899 . . . . 42.109999999999999 109.2 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.13 -64.06 1.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.972 -1.467 . . . . 66.019999999999996 110.973 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.7 pt-20 -109.89 -173.06 2.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.122 0.487 . . . . 451.81 111.479 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.69 -11.62 56.64 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.574 -0.739 . . . . 104.66 111.858 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.25 -39.93 92.17 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.927 -0.309 . . . . 328.18000000000001 110.957 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ptm -159.11 167.23 29.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 243.28999999999999 111.001 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.3 t -123.17 143.37 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.859 -0.61 . . . . 58.390000000000001 110.571 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 84.1 m -118.26 135.68 54.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.51 -0.768 . . . . 44.390000000000001 110.988 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -142.47 155.3 45.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.082 -0.508 . . . . 767.09000000000003 110.032 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -140.94 149.2 41.54 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.015 0.436 . . . . 146.31999999999999 111.012 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -172.09 116.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 15.640000000000001 109.794 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -82.2 150.1 27.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 422.56 110.88 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -112.75 141.71 46.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.086 -0.506 . . . . 462.10000000000002 109.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.469 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 92.4 m -69.34 126.73 30.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 111.17 110.529 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 p -151.03 89.44 1.53 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.417 0.627 . . . . 121.65000000000001 110.448 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.08 -47.93 1.34 Allowed Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 114.984 -1.007 . . . . 82.170000000000002 110.946 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -131.77 139.84 49.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.1 -0.333 . . . . 220.46000000000001 110.1 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -82.51 145.42 29.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 149.47999999999999 110.781 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.8 p -129.5 -145.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.132 -0.486 . . . . 169.86000000000001 109.892 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -161.16 154.35 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.062 -0.517 . . . . 537.64999999999998 110.836 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 12.4 p -66.91 149.7 98.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 32.920000000000002 110.054 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.89 136.33 20.5 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.141 1.894 . . . . 87.700000000000003 111.849 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.38 -39.99 98.39 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.987 -0.845 . . . . 244.37 110.987 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.858 0.361 . . . . 681.24000000000001 110.463 -179.831 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 110.252 -0.277 . . . . 206.49000000000001 110.252 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.16 -39.63 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 244.88 110.242 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.64 62.76 0.44 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.628 -0.989 . . . . 71.469999999999999 110.628 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.6 -46.55 89.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 133.27000000000001 110.766 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.5 m -63.1 -41.86 99.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 25.780000000000001 110.299 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.54 163.56 6.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.312 -0.858 . . . . 119.04000000000001 109.585 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.78 91.8 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.488 -0.485 . . . . 60.490000000000002 110.405 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.33 -38.69 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 258.73000000000002 110.48 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.26 156.52 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 339.06 110.515 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.656 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 1.8 p -108.12 171.22 7.53 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.197 -0.297 . . . . 42.960000000000001 110.197 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -156.17 127.71 7.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.312 -0.625 . . . . 39.109999999999999 109.312 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.95 129.13 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 115.20999999999999 110.38 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -94.9 120.26 34.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.017 -0.538 . . . . 135.41999999999999 110.948 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 26' ' ' THR . 15.5 p -104.4 164.86 11.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.034 -0.53 . . . . 45.380000000000003 109.653 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.04 119.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.833 0.825 . . . . 42.109999999999999 109.087 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.16 -65.94 0.93 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.336 -1.302 . . . . 66.019999999999996 111.013 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.0 pt-20 -108.66 -171.97 1.96 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.11 0.481 . . . . 451.81 111.567 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.35 -13.34 52.14 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.694 -0.685 . . . . 104.66 111.973 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.7 m-20 -60.54 -41.58 94.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 328.18000000000001 110.722 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptp -160.87 161.71 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.922 -0.581 . . . . 243.28999999999999 110.495 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.14 160.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.907 -0.588 . . . . 58.390000000000001 110.956 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 18' ' ' THR . 78.0 m -129.75 138.55 51.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.734 -0.666 . . . . 44.390000000000001 111.232 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -128.13 154.51 45.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.578 . . . . 767.09000000000003 109.817 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -141.9 148.38 38.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.043 0.449 . . . . 146.31999999999999 110.822 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -171.92 101.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 15.640000000000001 109.339 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.656 ' CG ' ' H ' ' A' ' 14' ' ' CYS . 9.4 pt-20 -60.65 163.47 5.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.356 0.598 . . . . 422.56 111.375 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -136.35 143.27 43.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.833 -1.076 . . . . 462.10000000000002 110.07 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.1 m -112.06 122.8 48.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.909 0.385 . . . . 111.17 110.76 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.1 p -154.16 84.27 1.14 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.607 0.717 . . . . 121.65000000000001 110.321 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.88 -5.24 58.73 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.517 -1.22 . . . . 82.170000000000002 110.442 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.4 m-20 -154.77 149.37 26.4 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.936 -0.394 . . . . 220.46000000000001 109.936 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.88 143.21 32.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 149.47999999999999 110.935 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 37' ' ' THR . 10.2 t -155.46 124.53 6.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 169.86000000000001 110.107 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.6 mp0 -81.71 159.41 23.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.625 . . . . 537.64999999999998 110.808 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 160.23 0.22 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.466 -0.568 . . . . 32.920000000000002 109.466 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.09 133.04 15.99 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.06 1.84 . . . . 87.700000000000003 111.894 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.22 -40.36 98.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 244.37 111.212 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.549 -179.703 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.716 0.293 . . . . 206.49000000000001 110.607 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.34 84.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.882 0.373 . . . . 244.88 110.192 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.2 75.13 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.633 -0.987 . . . . 71.469999999999999 110.633 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 133.27000000000001 110.624 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.1 m -62.49 -41.77 99.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 25.780000000000001 110.202 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.73 163.15 9.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 119.04000000000001 110.09 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.38 88.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 60.490000000000002 110.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -91.89 11.4 25.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.256 -0.429 . . . . 258.73000000000002 111.441 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.0 mm-40 -119.12 159.4 24.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.071 0.462 . . . . 339.06 111.051 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.4 t -104.35 155.17 19.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.769 -0.65 . . . . 42.960000000000001 110.656 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 41.9 t -146.13 127.73 15.14 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.455 -0.572 . . . . 39.109999999999999 109.455 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.57 130.54 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 115.20999999999999 110.336 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -106.89 123.32 47.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.183 -0.462 . . . . 135.41999999999999 111.078 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -110.12 161.99 15.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.787 -0.642 . . . . 45.380000000000003 109.546 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.1 p -178.33 116.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 122.008 0.909 . . . . 42.109999999999999 109.636 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.81 -57.78 2.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.139 -1.391 . . . . 66.019999999999996 110.748 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.7 pt-20 -116.37 -176.78 3.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.296 0.569 . . . . 451.81 111.428 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.9 -12.27 56.81 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.197 -0.911 . . . . 104.66 111.048 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.5 t0 -61.69 -44.47 96.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.417 . . . . 328.18000000000001 111.211 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.9 ttp -154.28 145.0 22.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 243.28999999999999 110.924 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.03 143.28 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.002 -0.544 . . . . 58.390000000000001 110.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.3 m -115.28 132.61 56.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.589 -0.732 . . . . 44.390000000000001 111.083 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -132.65 155.36 48.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.983 -0.553 . . . . 767.09000000000003 109.939 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 t -144.47 146.22 32.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.946 0.403 . . . . 146.31999999999999 110.72 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.4 t -173.65 116.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 15.640000000000001 109.803 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 78.7 mm-40 -85.04 154.84 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 422.56 110.898 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.13 143.97 49.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.899 -0.591 . . . . 462.10000000000002 109.881 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.495 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 95.2 m -88.91 119.39 29.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.949 0.404 . . . . 111.17 110.751 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.2 p -153.01 82.68 1.21 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.559 0.695 . . . . 121.65000000000001 110.577 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.5 -4.46 59.76 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.501 -1.227 . . . . 82.170000000000002 110.935 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -159.01 148.66 18.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 220.46000000000001 110.398 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.37 140.26 37.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.34 -0.391 . . . . 149.47999999999999 110.626 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.61 124.39 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.988 0.423 . . . . 169.86000000000001 110.444 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.4 mp0 -82.44 166.07 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 537.64999999999998 111.035 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.7 p -62.51 150.59 85.46 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.921 -0.582 . . . . 32.920000000000002 110.05 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.05 140.96 23.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.057 1.838 . . . . 87.700000000000003 111.964 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.72 -40.45 99.21 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 244.37 110.883 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.784 0.325 . . . . 681.24000000000001 110.213 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.719 0.295 . . . . 206.49000000000001 110.331 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.17 -39.56 86.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 244.88 110.217 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.3 64.89 0.5 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.605 -0.998 . . . . 71.469999999999999 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -60.86 -45.22 95.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.803 0.335 . . . . 133.27000000000001 110.656 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.4 m -62.51 -41.59 98.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.219 0.533 . . . . 25.780000000000001 110.167 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.18 165.8 7.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.388 -0.823 . . . . 119.04000000000001 109.899 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.35 95.74 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.828 -0.349 . . . . 60.490000000000002 110.821 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.59 -32.38 25.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 258.73000000000002 111.282 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 32' ' ' THR . 76.9 mm-40 -74.22 153.97 39.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 339.06 111.188 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.5 t -101.02 156.48 17.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.927 -0.578 . . . . 42.960000000000001 110.284 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -151.43 129.81 12.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.325 -0.62 . . . . 39.109999999999999 109.325 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 131.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 115.20999999999999 110.63 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -95.54 120.05 35.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.03 -0.532 . . . . 135.41999999999999 110.65 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -107.02 161.97 14.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.041 -0.527 . . . . 45.380000000000003 110.07 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.0 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.979 0.895 . . . . 42.109999999999999 108.981 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.635 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -93.61 -94.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.84 -1.527 . . . . 66.019999999999996 111.443 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -80.37 -18.65 48.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.202 -0.908 . . . . 451.81 111.239 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.19 -8.43 75.59 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.204 -0.758 . . . . 104.66 111.204 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.56 -42.12 91.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 328.18000000000001 109.388 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.404 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.6 ttp -142.57 104.59 4.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.312 -0.858 . . . . 243.28999999999999 109.284 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.27 146.9 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 58.390000000000001 110.96 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.2 m -125.37 134.66 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.354 -0.839 . . . . 44.390000000000001 110.944 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.74 146.23 51.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.006 -0.543 . . . . 767.09000000000003 109.903 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -134.09 145.38 49.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.87 0.367 . . . . 146.31999999999999 110.639 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -172.86 116.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 15.640000000000001 109.994 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -80.04 153.57 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 422.56 110.865 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.45 142.61 46.64 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.047 -0.524 . . . . 462.10000000000002 110.017 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.518 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.4 m -68.05 126.3 29.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.064 0.459 . . . . 111.17 110.374 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.8 p -151.31 88.85 1.46 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.827 -0.624 . . . . 121.65000000000001 110.539 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -47.65 1.22 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 114.875 -1.057 . . . . 82.170000000000002 110.979 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -133.34 138.72 46.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.158 -0.312 . . . . 220.46000000000001 110.158 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.3 m-85 -83.18 146.41 28.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 149.47999999999999 110.573 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -133.36 -144.84 0.23 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.253 -0.431 . . . . 169.86000000000001 110.118 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.21 159.14 35.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 537.64999999999998 110.739 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.42 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.4 p -57.33 152.04 34.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.091 -0.504 . . . . 32.920000000000002 109.993 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.31 135.39 20.43 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.313 2.009 . . . . 87.700000000000003 112.259 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.35 96.88 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.706 -0.958 . . . . 244.37 110.706 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.876 0.37 . . . . 681.24000000000001 110.302 -179.767 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 21.9 pt-20 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.917 0.389 . . . . 206.49000000000001 110.791 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 244.88 110.418 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -68.53 -9.38 58.34 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.452 -0.659 . . . . 71.469999999999999 111.452 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.29 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.808 -0.357 . . . . 133.27000000000001 110.514 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.3 m -62.55 -43.68 98.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 25.780000000000001 109.848 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.42 165.55 3.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.27 -0.877 . . . . 119.04000000000001 109.854 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.5 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.937 -0.305 . . . . 60.490000000000002 111.079 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.79 -31.18 26.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.441 -0.345 . . . . 258.73000000000002 111.379 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 32' ' ' THR . 77.7 mm-40 -75.0 156.54 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.913 0.387 . . . . 339.06 111.356 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 t -108.85 157.81 18.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.935 -0.575 . . . . 42.960000000000001 110.395 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 48.1 t -146.18 133.68 20.85 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.845 -0.428 . . . . 39.109999999999999 109.845 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -154.15 117.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.613 -0.435 . . . . 115.20999999999999 109.854 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 97.3 m-20 -95.25 118.64 32.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 135.41999999999999 111.158 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -103.62 163.56 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.735 -0.666 . . . . 45.380000000000003 109.553 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 p -179.05 117.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.881 0.848 . . . . 42.109999999999999 109.412 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -100.89 -63.85 1.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.26 -1.336 . . . . 66.019999999999996 111.09 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.5 pt-20 -107.38 -177.22 3.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.33 0.586 . . . . 451.81 111.846 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.96 -12.02 57.03 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 115.01 -0.996 . . . . 104.66 111.352 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -60.22 -42.85 96.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 328.18000000000001 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptp -156.43 166.61 32.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 243.28999999999999 110.77 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.15 140.28 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.099 -0.501 . . . . 58.390000000000001 110.698 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 m -110.85 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 44.390000000000001 111.124 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' NH2' ' OD2' ' A' ' 17' ' ' ASP . 77.3 mtp85 -132.4 147.19 52.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.047 -0.524 . . . . 767.09000000000003 109.995 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -137.36 146.81 44.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.989 0.423 . . . . 146.31999999999999 110.74 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -175.01 117.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.821 -0.627 . . . . 15.640000000000001 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -83.39 155.79 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 422.56 111.195 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -118.3 144.21 46.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.942 -0.572 . . . . 462.10000000000002 109.877 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 96.0 m -80.1 123.89 28.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 111.17 110.708 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.473 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.96 89.7 1.4 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.882 -0.599 . . . . 121.65000000000001 110.395 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.35 -41.69 0.79 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.012 -0.994 . . . . 82.170000000000002 110.792 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.3 m-20 -134.39 139.72 45.79 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.079 -0.341 . . . . 220.46000000000001 110.079 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.78 147.59 27.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 149.47999999999999 110.858 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 p -146.92 119.62 8.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.041 -0.527 . . . . 169.86000000000001 109.89 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -73.98 158.07 35.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.966 -0.561 . . . . 537.64999999999998 111.133 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 15.6 p -64.82 149.67 95.82 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.975 -0.557 . . . . 32.920000000000002 110.058 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.72 138.96 21.98 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.101 1.868 . . . . 87.700000000000003 112.052 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.07 98.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 244.37 110.741 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.252 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.24 -0.281 . . . . 206.49000000000001 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -39.74 87.26 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.746 -0.382 . . . . 244.88 110.124 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.43 62.02 0.48 Allowed Glycine 0 N--CA 1.466 0.652 0 N-CA-C 110.395 -1.082 . . . . 71.469999999999999 110.395 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.47 -45.75 92.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.771 0.32 . . . . 133.27000000000001 110.82 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.44 -42.12 99.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 25.780000000000001 110.232 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.71 167.88 7.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.286 -0.87 . . . . 119.04000000000001 109.874 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.04 96.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.874 -0.331 . . . . 60.490000000000002 110.776 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.15 -34.99 28.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.367 -0.379 . . . . 258.73000000000002 111.088 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.41 152.28 42.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 339.06 110.883 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 25.9 t -104.85 154.17 20.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 42.960000000000001 109.856 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.437 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 t -147.32 130.32 16.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.671 -0.492 . . . . 39.109999999999999 109.671 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.4 p -148.26 131.88 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.352 . . . . 115.20999999999999 110.482 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -100.62 120.83 40.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.119 -0.491 . . . . 135.41999999999999 110.529 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 27.5 p -107.37 164.91 11.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.187 -0.461 . . . . 45.380000000000003 109.931 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 178.07 117.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.924 0.868 . . . . 42.109999999999999 109.397 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.07 -55.59 2.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.224 -1.353 . . . . 66.019999999999996 110.586 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.8 pt-20 -118.17 -177.02 3.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.286 0.565 . . . . 451.81 111.425 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.33 -12.3 57.45 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.313 -0.858 . . . . 104.66 111.129 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -61.78 -44.74 96.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 328.18000000000001 111.153 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.1 ttp -154.74 144.64 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 243.28999999999999 110.95 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.0 t -103.9 147.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.078 -0.51 . . . . 58.390000000000001 110.318 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 77.3 m -123.94 139.84 53.56 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 44.390000000000001 111.346 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -145.89 160.61 41.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.906 -0.588 . . . . 767.09000000000003 109.788 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.3 p -150.14 161.92 41.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.958 0.408 . . . . 146.31999999999999 110.829 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -169.95 127.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 15.640000000000001 109.963 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 77.3 mm-40 -75.83 151.82 37.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 422.56 111.155 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -128.01 138.89 52.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.744 -0.662 . . . . 462.10000000000002 109.925 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 34' ' ' GLY . 27.7 p -71.45 69.81 0.6 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 111.17 110.378 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -78.4 45.2 0.55 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.909 0.861 . . . . 121.65000000000001 110.163 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 32' ' ' THR . . . 82.58 -0.92 88.88 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.194 -1.366 . . . . 82.170000000000002 110.146 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 80.6 m-20 -149.44 142.61 25.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.747 -0.464 . . . . 220.46000000000001 109.747 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.86 136.96 33.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 149.47999999999999 110.632 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.421 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 21.2 p -133.98 -150.28 0.39 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.693 -0.484 . . . . 169.86000000000001 109.693 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 98.3 mt-10 -144.73 142.87 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.845 -0.616 . . . . 537.64999999999998 110.766 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 p -65.13 150.41 95.5 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 109.61 -0.515 . . . . 32.920000000000002 109.61 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.07 130.35 15.3 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.988 1.792 . . . . 87.700000000000003 112.039 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.37 95.65 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.978 -0.849 . . . . 244.37 110.978 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.883 0.373 . . . . 681.24000000000001 110.615 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 110.288 -0.264 . . . . 206.49000000000001 110.288 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.26 -39.6 87.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.351 . . . . 244.88 110.391 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.2 65.81 0.55 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.773 -0.931 . . . . 71.469999999999999 110.773 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.868 0.366 . . . . 133.27000000000001 110.601 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.0 m -61.14 -42.58 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 25.780000000000001 109.916 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.09 163.99 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.338 -0.846 . . . . 119.04000000000001 109.744 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.15 95.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.589 -0.278 . . . . 60.490000000000002 111.145 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -86.38 -29.51 22.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 258.73000000000002 111.418 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -74.21 159.17 32.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.716 0.293 . . . . 339.06 111.028 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.3 t -102.77 150.2 23.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.147 -0.478 . . . . 42.960000000000001 110.28 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.42 124.82 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.122 -0.696 . . . . 39.109999999999999 109.122 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.9 131.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.984 0.421 . . . . 115.20999999999999 110.412 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -95.58 120.98 36.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.936 -0.574 . . . . 135.41999999999999 110.752 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.483 ' HG1' ' C ' ' A' ' 26' ' ' THR . 36.2 p -104.81 165.32 11.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.942 -0.572 . . . . 45.380000000000003 109.947 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 176.18 118.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.772 0.796 . . . . 42.109999999999999 109.216 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.295 -1.321 . . . . 66.019999999999996 110.826 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.6 pt-20 -112.15 -173.05 2.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.076 0.465 . . . . 451.81 111.442 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.25 -11.98 56.72 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.662 -0.699 . . . . 104.66 111.918 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.4 m-20 -61.32 -39.54 90.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.803 0.335 . . . . 328.18000000000001 111.041 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.4 ptp -157.78 167.99 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 243.28999999999999 111.057 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.3 t -124.04 146.62 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.986 -0.552 . . . . 58.390000000000001 110.475 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.483 ' C ' ' HG1' ' A' ' 18' ' ' THR . 83.7 m -125.28 142.11 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.731 -0.668 . . . . 44.390000000000001 111.219 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -137.36 154.74 49.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.053 -0.521 . . . . 767.09000000000003 110.218 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -134.18 150.4 51.08 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.024 0.44 . . . . 146.31999999999999 110.988 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -176.24 128.35 0.21 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.186 -0.672 . . . . 15.640000000000001 109.186 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 37' ' ' THR . 95.4 mt-10 -107.56 130.58 54.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.937 0.398 . . . . 422.56 111.326 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.0 150.07 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.574 . . . . 462.10000000000002 110.45 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -95.4 122.92 38.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 111.17 110.433 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -145.88 84.07 1.65 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.612 0.72 . . . . 121.65000000000001 110.875 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.54 -5.67 55.65 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.596 -1.184 . . . . 82.170000000000002 110.989 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.0 m-20 -155.93 148.98 24.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 220.46000000000001 110.253 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 137.72 37.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 149.47999999999999 110.525 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 56.6 p -151.23 119.24 6.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.263 -0.426 . . . . 169.86000000000001 110.438 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 99.7 mt-10 -75.06 161.69 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 537.64999999999998 110.392 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.506 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.2 p -52.03 157.5 2.13 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.475 -0.565 . . . . 32.920000000000002 109.475 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -55.63 163.1 5.64 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.594 1.53 . . . . 87.700000000000003 112.694 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.63 65.1 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.85 -1.068 . . . . 244.37 110.493 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 110.024 -0.361 . . . . 681.24000000000001 110.024 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.273 -0.269 . . . . 206.49000000000001 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.09 -39.48 86.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.994 -0.373 . . . . 244.88 109.994 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.65 62.2 0.48 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.687 -0.965 . . . . 71.469999999999999 110.687 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -60.72 -43.49 97.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.826 0.346 . . . . 133.27000000000001 110.515 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.3 m -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.261 0.553 . . . . 25.780000000000001 109.958 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.74 167.45 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.423 -0.808 . . . . 119.04000000000001 109.865 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.56 96.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.802 -0.359 . . . . 60.490000000000002 110.841 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.15 -32.66 24.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 258.73000000000002 111.05 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.82 158.52 35.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 339.06 110.901 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.547 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 41.9 t -111.51 146.81 36.63 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 42.960000000000001 110.169 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.8 t -140.97 129.04 22.02 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.046 -0.724 . . . . 39.109999999999999 109.046 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.9 p -148.48 131.48 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 115.20999999999999 110.422 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.92 121.35 38.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.997 -0.547 . . . . 135.41999999999999 110.939 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 p -103.51 166.31 10.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.927 -0.579 . . . . 45.380000000000003 109.84 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 178.09 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.993 0.901 . . . . 42.109999999999999 109.103 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.42 -95.01 0.17 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.913 -1.494 . . . . 66.019999999999996 111.269 -178.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.35 -28.08 59.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.954 -1.021 . . . . 451.81 111.084 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -13.73 58.82 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.274 -0.731 . . . . 104.66 111.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.79 -39.15 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 328.18000000000001 109.624 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.432 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 69.5 mtm -137.55 101.45 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.466 -0.788 . . . . 243.28999999999999 109.613 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.7 147.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.583 -0.447 . . . . 58.390000000000001 110.821 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.1 m -126.03 139.02 53.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.814 -0.63 . . . . 44.390000000000001 111.539 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.47 147.12 50.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 767.09000000000003 109.494 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -134.47 147.95 50.48 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.033 0.445 . . . . 146.31999999999999 111.224 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -175.42 130.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.219 -0.66 . . . . 15.640000000000001 109.219 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -108.12 167.09 10.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.942 0.401 . . . . 422.56 110.858 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.1 148.01 50.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.811 -0.631 . . . . 462.10000000000002 110.336 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.9 m -89.81 122.62 33.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 111.17 110.521 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -147.2 84.34 1.58 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.661 0.743 . . . . 121.65000000000001 110.768 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.57 -5.6 56.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.568 -1.196 . . . . 82.170000000000002 110.896 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -155.84 151.17 26.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.118 -0.327 . . . . 220.46000000000001 110.118 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.41 141.51 33.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.841 0.353 . . . . 149.47999999999999 110.992 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 37' ' ' THR . 10.9 t -161.48 130.7 4.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 169.86000000000001 109.837 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -86.39 169.6 12.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.833 -0.621 . . . . 537.64999999999998 111.032 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 2.3 p -58.71 152.13 48.9 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.939 -0.573 . . . . 32.920000000000002 109.968 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 134.9 16.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.101 1.867 . . . . 87.700000000000003 112.085 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.05 -39.75 97.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.909 -0.876 . . . . 244.37 110.909 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.965 0.412 . . . . 681.24000000000001 110.457 -179.723 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.735 0.302 . . . . 206.49000000000001 110.417 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.25 -40.35 93.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 244.88 111.054 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 49.82 0.9 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.978 -0.849 . . . . 71.469999999999999 110.978 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -61.21 -49.92 75.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 133.27000000000001 110.569 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.4 m -64.69 -41.61 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.315 0.579 . . . . 25.780000000000001 110.126 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.19 167.81 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 119.04000000000001 109.867 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.63 97.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.954 -0.298 . . . . 60.490000000000002 111.005 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.64 -30.98 24.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 258.73000000000002 111.243 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.55 158.58 33.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 339.06 110.994 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 38.6 t -112.91 144.19 42.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 42.960000000000001 110.602 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -137.89 128.3 26.35 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.194 -0.669 . . . . 39.109999999999999 109.194 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.5 p -143.11 133.18 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.878 0.37 . . . . 115.20999999999999 110.557 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.5 121.96 34.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 135.41999999999999 110.808 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.58 ' HG1' ' C ' ' A' ' 26' ' ' THR . 14.6 p -101.01 164.73 11.67 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 45.380000000000003 109.946 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 176.38 119.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.079 0.942 . . . . 42.109999999999999 108.91 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.24 -94.39 0.18 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.751 -1.568 . . . . 66.019999999999996 111.48 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -77.71 -21.31 52.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.165 -0.925 . . . . 451.81 111.189 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.57 71.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.298 -0.721 . . . . 104.66 111.298 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.54 -42.64 92.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.327 -0.62 . . . . 328.18000000000001 109.327 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.6 ttp -141.75 111.27 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.322 -0.854 . . . . 243.28999999999999 109.111 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 26' ' ' THR . 69.9 t -69.93 150.03 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.177 0.513 . . . . 58.390000000000001 111.082 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.58 ' C ' ' HG1' ' A' ' 18' ' ' THR . 89.2 m -132.89 143.95 49.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.484 -0.78 . . . . 44.390000000000001 111.057 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -132.13 163.84 27.61 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.95 -0.568 . . . . 767.09000000000003 110.116 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 t -148.62 150.49 33.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.987 0.422 . . . . 146.31999999999999 111.087 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.3 t -170.6 134.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 15.640000000000001 109.305 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -112.59 135.71 52.99 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.982 0.42 . . . . 422.56 111.337 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.43 144.96 26.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.848 -0.615 . . . . 462.10000000000002 110.203 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.6 m -93.66 102.93 15.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 111.17 110.612 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.5 m -140.28 125.89 19.16 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.491 0.662 . . . . 121.65000000000001 110.111 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.67 -64.85 0.45 Allowed Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.652 -1.158 . . . . 82.170000000000002 110.827 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' THR . 83.2 m-20 -122.53 146.89 47.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.977 -0.379 . . . . 220.46000000000001 109.977 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -73.25 146.22 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.422 -0.354 . . . . 149.47999999999999 110.902 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.15 122.11 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 169.86000000000001 110.391 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.06 165.15 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.61 . . . . 537.64999999999998 110.896 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.7 p -63.65 150.11 91.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 32.920000000000002 109.94 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.15 138.61 22.9 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.01 1.807 . . . . 87.700000000000003 111.841 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.85 0.43 67.2 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.954 -0.858 . . . . 244.37 110.954 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.92 0.391 . . . . 681.24000000000001 110.503 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.628 0.251 . . . . 206.49000000000001 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -61.41 -40.6 94.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 244.88 111.122 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.31 47.76 1.12 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.953 -0.859 . . . . 71.469999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -61.24 -50.16 74.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.378 . . . . 133.27000000000001 110.638 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.61 -41.46 96.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.906 -0.588 . . . . 25.780000000000001 110.209 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -172.41 168.73 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.301 -0.863 . . . . 119.04000000000001 109.859 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.889 -0.324 . . . . 60.490000000000002 110.941 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.61 -31.35 24.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 258.73000000000002 111.11 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.82 156.29 36.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 339.06 111.014 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -112.95 144.46 42.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.132 -0.486 . . . . 42.960000000000001 110.515 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -136.73 127.17 26.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.832 -0.803 . . . . 39.109999999999999 108.832 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.1 p -137.64 130.37 42.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.04 0.448 . . . . 115.20999999999999 110.833 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.4 138.57 31.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.828 -0.624 . . . . 135.41999999999999 110.898 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -128.06 159.22 35.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.884 -0.598 . . . . 45.380000000000003 109.834 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 p 178.67 118.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.685 -0.857 . . . . 42.109999999999999 108.685 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.636 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.4 -92.07 0.26 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.97 -1.468 . . . . 66.019999999999996 112.172 -177.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 4.0 pt-20 -70.92 -33.83 70.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 451.81 110.863 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.42 46.42 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 115.573 -0.739 . . . . 104.66 111.89 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.65 ' H ' ' CG ' ' A' ' 21' ' ' GLU . 37.8 t70 -60.41 -42.59 96.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.467 -0.568 . . . . 328.18000000000001 109.467 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.1 ttp -138.44 116.42 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 243.28999999999999 109.312 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.29 149.66 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.269 0.557 . . . . 58.390000000000001 110.754 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 m -128.66 142.37 51.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.391 -0.822 . . . . 44.390000000000001 110.928 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -145.3 162.17 37.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.031 -0.531 . . . . 767.09000000000003 110.048 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 t -149.75 152.84 35.92 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 146.31999999999999 110.986 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.7 t -168.58 131.82 1.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.849 -0.614 . . . . 15.640000000000001 109.427 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -102.91 149.21 24.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.942 0.401 . . . . 422.56 111.34 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.79 146.2 32.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.791 -0.641 . . . . 462.10000000000002 110.315 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.8 m -96.09 122.03 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 111.17 110.634 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.9 p -150.19 84.9 1.39 Allowed 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.55 0.691 . . . . 121.65000000000001 110.606 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.38 -3.98 60.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.636 -1.165 . . . . 82.170000000000002 110.723 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -158.17 149.53 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.104 -0.332 . . . . 220.46000000000001 110.104 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -98.01 139.3 34.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 149.47999999999999 110.788 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.7 p -146.93 118.15 7.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 169.86000000000001 110.082 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -76.23 160.25 29.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 537.64999999999998 110.877 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 2.5 p -59.98 150.68 68.55 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.065 -0.516 . . . . 32.920000000000002 110.002 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.06 134.23 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.217 1.944 . . . . 87.700000000000003 111.909 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.72 -40.03 98.11 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.847 -0.901 . . . . 244.37 110.847 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 120.847 0.356 . . . . 681.24000000000001 110.268 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.69 0.281 . . . . 206.49000000000001 110.354 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.27 -40.17 93.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 244.88 110.814 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.58 46.84 1.29 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.068 -0.813 . . . . 71.469999999999999 111.068 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -60.84 -50.25 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.893 0.378 . . . . 133.27000000000001 110.571 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.95 -41.99 95.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 25.780000000000001 109.865 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.95 166.9 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.334 -0.848 . . . . 119.04000000000001 110.0 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 60.490000000000002 111.186 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -92.44 13.76 18.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.376 -0.374 . . . . 258.73000000000002 111.429 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.31 158.58 29.24 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.597 -0.274 . . . . 339.06 110.354 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.8 t -112.44 144.36 42.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.492 -0.322 . . . . 42.960000000000001 110.679 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -139.07 129.15 25.2 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.507 -0.553 . . . . 39.109999999999999 109.507 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.83 132.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 115.20999999999999 110.532 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -92.4 123.36 35.66 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.191 -0.459 . . . . 135.41999999999999 110.948 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -100.96 158.58 15.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.014 -0.539 . . . . 45.380000000000003 109.669 178.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.1 p 179.32 116.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.983 0.896 . . . . 42.109999999999999 109.581 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -73.77 -92.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.925 -1.488 . . . . 66.019999999999996 111.148 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -90.22 -65.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.68 -0.691 . . . . 451.81 110.953 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.81 -10.54 0.11 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.808 -0.71 . . . . 104.66 111.352 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.6 -41.88 91.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.555 -0.535 . . . . 328.18000000000001 109.555 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.536 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 65.6 ttp -146.7 140.16 25.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.317 -0.856 . . . . 243.28999999999999 109.421 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 25' ' ' VAL . 4.9 m -101.78 158.29 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 58.390000000000001 111.015 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 18' ' ' THR . 88.3 m -136.65 145.64 45.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.603 -0.726 . . . . 44.390000000000001 110.795 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.09 160.58 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.147 -0.479 . . . . 767.09000000000003 110.122 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -148.56 150.73 33.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.939 0.4 . . . . 146.31999999999999 110.832 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -170.58 129.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 15.640000000000001 109.691 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -107.03 138.25 43.55 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.893 0.377 . . . . 422.56 110.828 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -95.66 167.55 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.989 -0.55 . . . . 462.10000000000002 110.725 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.2 m -113.21 124.23 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.619 -0.719 . . . . 111.17 110.348 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -151.43 85.08 1.31 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.614 0.721 . . . . 121.65000000000001 110.733 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.59 -6.11 54.36 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.718 -1.128 . . . . 82.170000000000002 110.661 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -156.19 149.48 24.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.895 -0.409 . . . . 220.46000000000001 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 137.19 36.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 149.47999999999999 110.837 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.0 p -146.05 117.15 7.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.089 -0.505 . . . . 169.86000000000001 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.5 162.57 26.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 537.64999999999998 110.889 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.464 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 3.8 p -60.35 150.6 72.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.014 -0.539 . . . . 32.920000000000002 109.953 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.77 133.53 17.09 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.104 1.87 . . . . 87.700000000000003 112.05 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.73 97.76 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.825 -0.91 . . . . 244.37 110.825 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 681.24000000000001 110.621 -179.795 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.597 0.237 . . . . 206.49000000000001 110.417 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.05 -39.87 87.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 244.88 110.302 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.27 65.6 0.52 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.543 -1.023 . . . . 71.469999999999999 110.543 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.57 -44.86 95.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.879 0.371 . . . . 133.27000000000001 110.802 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.5 m -61.94 -43.1 99.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.384 0.611 . . . . 25.780000000000001 109.68 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.85 162.28 7.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.99 -1.005 . . . . 119.04000000000001 109.384 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.51 93.0 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.412 -0.515 . . . . 60.490000000000002 110.608 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.91 -38.97 69.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 258.73000000000002 111.073 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -73.83 161.07 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 339.06 111.146 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.7 t -109.28 155.52 21.05 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.361 -0.381 . . . . 42.960000000000001 110.351 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.3 t -149.62 129.19 13.11 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.524 -0.546 . . . . 39.109999999999999 109.524 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 16' ' ' VAL . 11.6 p -148.33 132.21 8.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.837 0.351 . . . . 115.20999999999999 110.492 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.73 119.24 38.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.097 -0.501 . . . . 135.41999999999999 110.483 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 22.4 p -105.56 163.69 12.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.057 -0.519 . . . . 45.380000000000003 109.926 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p 178.38 117.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.84 0.829 . . . . 42.109999999999999 109.14 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.636 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.97 -62.36 1.32 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.231 -1.35 . . . . 66.019999999999996 111.123 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.8 pt-20 -104.5 -178.74 3.74 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.367 0.603 . . . . 451.81 111.913 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.44 -10.28 59.46 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.052 -0.976 . . . . 104.66 111.372 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.2 t0 -60.59 -44.07 96.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 328.18000000000001 110.84 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -159.94 168.75 24.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.038 -0.528 . . . . 243.28999999999999 110.953 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.0 t -118.15 143.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.026 -0.534 . . . . 58.390000000000001 110.547 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.1 m -118.34 137.6 52.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.742 . . . . 44.390000000000001 111.111 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -146.61 161.41 40.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.228 -0.442 . . . . 767.09000000000003 110.125 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -151.93 162.83 40.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.875 0.369 . . . . 146.31999999999999 110.859 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.3 t -168.48 131.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 15.640000000000001 110.03 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 74.5 mm-40 -77.87 154.46 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 422.56 111.277 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -121.37 138.67 54.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.746 -0.661 . . . . 462.10000000000002 109.555 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.488 HG23 ' CE2' ' A' ' 36' ' ' PHE . 93.6 m -79.87 123.09 27.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.145 -0.479 . . . . 111.17 110.589 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 32' ' ' THR . 32.4 p -154.77 88.28 1.19 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.494 0.664 . . . . 121.65000000000001 110.536 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -50.49 1.46 Allowed Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 114.812 -1.086 . . . . 82.170000000000002 111.1 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.73 136.68 47.81 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.749 0.309 . . . . 220.46000000000001 110.385 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.488 ' CE2' HG23 ' A' ' 32' ' ' THR . 94.2 m-85 -83.76 150.53 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 149.47999999999999 110.493 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.424 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 32.2 p -126.86 -145.71 0.32 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.957 0.408 . . . . 169.86000000000001 110.296 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 52.6 tp10 -151.6 139.21 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 537.64999999999998 110.318 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 p -56.77 150.92 34.56 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.107 -0.497 . . . . 32.920000000000002 110.158 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.25 157.79 41.54 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.449 2.099 . . . . 87.700000000000003 112.162 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.41 -93.07 1.64 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.682 -0.967 . . . . 244.37 110.682 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.216 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.715 0.293 . . . . 206.49000000000001 110.524 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.83 -39.4 84.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 244.88 110.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.37 74.11 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.651 -0.98 . . . . 71.469999999999999 110.651 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.26 -44.01 97.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.368 . . . . 133.27000000000001 110.597 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -62.63 -41.78 99.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 25.780000000000001 110.39 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.47 163.64 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.597 -0.729 . . . . 119.04000000000001 110.095 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.73 90.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 60.490000000000002 110.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -91.62 10.52 27.74 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.349 -0.387 . . . . 258.73000000000002 111.431 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.506 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.3 mm-40 -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 339.06 110.865 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 40.5 t -106.06 156.99 17.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.81 -0.632 . . . . 42.960000000000001 110.854 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.5 t -147.64 126.36 12.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.514 -0.551 . . . . 39.109999999999999 109.514 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 p -150.99 131.98 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.01 -0.367 . . . . 115.20999999999999 110.01 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -101.41 118.66 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 135.41999999999999 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' THR . 2.4 p -100.69 161.98 13.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.632 -0.713 . . . . 45.380000000000003 109.15 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 19' ' ' VAL . 3.5 p 178.41 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.815 0.817 . . . . 42.109999999999999 109.331 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.638 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -90.03 -62.57 1.44 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.25 -1.341 . . . . 66.019999999999996 110.184 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -117.91 -172.91 2.34 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.98 0.419 . . . . 451.81 110.736 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.01 -20.19 47.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.357 -0.697 . . . . 104.66 111.357 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.56 -40.13 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.595 0.236 . . . . 328.18000000000001 111.539 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mtp -137.0 153.44 50.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.123 0.487 . . . . 243.28999999999999 111.601 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.73 142.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.625 -0.716 . . . . 58.390000000000001 110.085 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.0 m -123.78 134.62 53.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.946 -0.57 . . . . 44.390000000000001 111.249 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -128.72 147.44 50.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.001 -0.545 . . . . 767.09000000000003 109.911 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -133.8 145.85 50.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.969 0.414 . . . . 146.31999999999999 110.715 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -173.41 115.25 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.837 -0.62 . . . . 15.640000000000001 109.745 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.5 mm-40 -84.78 155.01 22.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.954 0.407 . . . . 422.56 111.014 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -121.96 143.74 49.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.905 -0.588 . . . . 462.10000000000002 109.804 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.506 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 93.7 m -89.32 119.61 29.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.353 -0.385 . . . . 111.17 110.79 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.3 p -152.21 82.49 1.25 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.645 0.736 . . . . 121.65000000000001 110.468 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.66 -5.72 56.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.455 -1.248 . . . . 82.170000000000002 110.737 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.4 m-20 -156.58 149.04 23.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.704 0.287 . . . . 220.46000000000001 110.252 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.03 139.33 39.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.836 0.35 . . . . 149.47999999999999 110.717 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 123.97 4.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 169.86000000000001 110.384 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.455 ' OE2' ' N ' ' A' ' 38' ' ' GLU . 58.2 mp0 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 537.64999999999998 111.135 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.8 p -63.53 150.67 89.66 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.922 -0.581 . . . . 32.920000000000002 110.153 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.03 142.75 28.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.133 1.888 . . . . 87.700000000000003 111.841 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.77 0.82 74.03 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 244.37 110.924 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.943 0.402 . . . . 681.24000000000001 110.524 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.808 0.337 . . . . 206.49000000000001 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 244.88 110.137 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.27 81.74 0.32 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.493 -1.043 . . . . 71.469999999999999 110.493 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -61.2 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 133.27000000000001 110.597 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.2 m -62.34 -41.44 98.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.895 -0.593 . . . . 25.780000000000001 110.333 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.63 161.41 6.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.521 -0.763 . . . . 119.04000000000001 109.863 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -46.16 91.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.691 -0.403 . . . . 60.490000000000002 110.71 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.5 -38.33 74.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 258.73000000000002 110.525 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 32' ' ' THR . 69.2 mm-40 -75.72 167.88 21.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.702 -0.681 . . . . 339.06 111.018 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 16.2 p -112.57 171.1 7.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.218 -0.446 . . . . 42.960000000000001 110.324 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -152.48 126.92 9.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.453 -0.573 . . . . 39.109999999999999 109.453 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 16' ' ' VAL . 10.2 p -148.86 129.67 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 115.20999999999999 110.512 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -115.05 133.94 55.61 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.071 -0.513 . . . . 135.41999999999999 110.77 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 26' ' ' THR . 20.3 p -126.91 162.02 26.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 45.380000000000003 109.687 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -178.77 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.997 0.903 . . . . 42.109999999999999 109.455 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.78 -53.26 3.47 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.938 -1.483 . . . . 66.019999999999996 110.684 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.3 pt-20 -120.37 -178.05 3.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.307 0.575 . . . . 451.81 111.419 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.61 -11.16 59.62 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.148 -0.933 . . . . 104.66 111.049 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.6 t0 -62.73 -44.38 96.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.806 0.336 . . . . 328.18000000000001 111.13 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.3 ttp -155.12 147.3 23.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 243.28999999999999 110.92 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.36 142.71 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 58.390000000000001 110.403 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 18' ' ' THR . 73.1 m -117.05 133.59 55.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 44.390000000000001 110.798 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -151.6 163.45 39.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.178 -0.465 . . . . 767.09000000000003 110.398 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -149.47 148.03 28.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.054 0.454 . . . . 146.31999999999999 110.813 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.9 t -169.36 114.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 15.640000000000001 109.388 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.6 159.77 20.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 422.56 111.331 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -124.57 142.94 50.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.053 -0.521 . . . . 462.10000000000002 110.176 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.505 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 99.8 m -84.87 121.55 27.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 111.17 110.371 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.8 p -153.57 90.06 1.38 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.373 0.606 . . . . 121.65000000000001 110.61 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 -40.35 0.82 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.926 -1.034 . . . . 82.170000000000002 110.957 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 33' ' ' THR . 81.4 m-20 -134.62 139.42 45.31 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.845 0.355 . . . . 220.46000000000001 110.212 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.11 150.49 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 149.47999999999999 110.975 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.63 122.36 5.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 169.86000000000001 110.131 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' CYS . 88.1 tt0 -81.5 148.7 29.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.832 -0.622 . . . . 537.64999999999998 111.332 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -41.08 164.4 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.857 -0.61 . . . . 32.920000000000002 110.159 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -75.89 142.77 25.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.398 2.065 . . . . 87.700000000000003 111.789 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.94 -39.88 98.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 244.37 110.865 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.816 0.341 . . . . 681.24000000000001 110.308 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.709 0.29 . . . . 206.49000000000001 110.614 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.69 -39.98 90.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.415 -0.357 . . . . 244.88 110.686 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.38 85.98 0.38 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.749 -0.94 . . . . 71.469999999999999 110.749 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -62.61 -43.38 98.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.705 0.288 . . . . 133.27000000000001 110.991 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.2 m -62.0 -43.11 99.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 25.780000000000001 110.281 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -166.66 166.04 16.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.391 -0.822 . . . . 119.04000000000001 109.825 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.87 96.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.904 -0.319 . . . . 60.490000000000002 111.175 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -83.99 -32.46 24.96 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.842 0.353 . . . . 258.73000000000002 111.3 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -75.75 160.35 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 339.06 110.842 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.4 t -115.98 149.67 38.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.351 -0.386 . . . . 42.960000000000001 110.113 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.3 p -135.64 153.69 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.723 -0.473 . . . . 39.109999999999999 109.723 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.5 p -165.87 117.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.486 -0.486 . . . . 115.20999999999999 110.515 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -103.5 119.63 39.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.185 -0.461 . . . . 135.41999999999999 110.852 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.954 -0.566 . . . . 45.380000000000003 109.774 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.72 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 122.079 0.943 . . . . 42.109999999999999 109.074 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.648 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.19 -94.1 0.17 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.876 -1.511 . . . . 66.019999999999996 111.428 -178.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -79.98 -19.67 47.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.189 -0.914 . . . . 451.81 111.131 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.92 -10.14 72.37 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.264 -0.734 . . . . 104.66 111.264 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.52 -41.79 95.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 328.18000000000001 109.487 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.443 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.9 mtm -138.6 99.17 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.358 -0.837 . . . . 243.28999999999999 109.414 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.88 145.2 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.208 0.528 . . . . 58.390000000000001 110.858 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 m -125.74 136.95 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.398 -0.819 . . . . 44.390000000000001 110.954 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -149.76 160.65 43.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 767.09000000000003 110.638 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -152.53 150.5 29.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.351 -0.386 . . . . 146.31999999999999 110.775 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.9 t -169.96 126.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.914 -0.585 . . . . 15.640000000000001 109.734 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.04 152.54 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 422.56 111.007 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -116.49 142.69 46.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.984 -0.553 . . . . 462.10000000000002 109.969 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 91.5 m -71.58 124.97 25.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.989 0.423 . . . . 111.17 110.508 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -154.05 89.43 1.3 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.417 0.627 . . . . 121.65000000000001 110.543 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.81 -47.14 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.928 -1.033 . . . . 82.170000000000002 111.005 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -135.06 138.76 44.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.791 0.329 . . . . 220.46000000000001 110.253 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.9 m-85 -83.73 148.09 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 149.47999999999999 110.659 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.7 p -125.85 -144.96 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.951 0.405 . . . . 169.86000000000001 110.069 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -156.89 143.57 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 537.64999999999998 110.536 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.3 p -62.15 149.51 86.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 32.920000000000002 110.005 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 135.25 16.77 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.071 1.847 . . . . 87.700000000000003 111.74 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.93 -42.89 99.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.723 -0.951 . . . . 244.37 110.723 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.97 -0.381 . . . . 681.24000000000001 109.97 179.787 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 120.725 0.298 . . . . 206.49000000000001 110.596 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.6 -39.89 89.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.357 -0.383 . . . . 244.88 110.929 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.91 68.24 0.28 Allowed Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.17 -0.772 . . . . 71.469999999999999 111.17 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.9 -48.56 78.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.987 0.422 . . . . 133.27000000000001 110.617 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.99 -41.41 97.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.855 -0.611 . . . . 25.780000000000001 109.931 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.1 162.91 9.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.161 -0.927 . . . . 119.04000000000001 109.246 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.98 90.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.511 -0.476 . . . . 60.490000000000002 110.666 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.45 -37.83 71.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 258.73000000000002 110.857 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.14 161.14 30.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 339.06 111.163 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 50.2 t -111.05 158.98 18.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.157 -0.474 . . . . 42.960000000000001 110.411 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 49.7 t -149.13 130.35 14.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.441 -0.577 . . . . 39.109999999999999 109.441 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 16' ' ' VAL . 13.3 p -149.14 129.89 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 115.20999999999999 110.434 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -93.0 119.21 32.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 135.41999999999999 110.772 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p -103.69 161.66 13.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.994 -0.548 . . . . 45.380000000000003 109.949 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.0 p 179.54 117.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.796 0.808 . . . . 42.109999999999999 109.325 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -104.12 -62.8 1.27 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.357 -1.292 . . . . 66.019999999999996 111.28 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.9 pt-20 -103.23 -178.49 3.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.452 0.644 . . . . 451.81 111.991 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.77 -10.12 59.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.992 -1.004 . . . . 104.66 111.445 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 66.4 t0 -60.77 -44.48 96.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 328.18000000000001 110.927 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.82 170.18 22.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.013 -0.539 . . . . 243.28999999999999 111.022 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.85 143.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.896 -0.593 . . . . 58.390000000000001 110.512 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.8 m -117.44 134.02 55.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 44.390000000000001 111.338 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -126.27 147.06 49.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.966 -0.561 . . . . 767.09000000000003 109.708 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -135.1 153.11 52.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.887 0.375 . . . . 146.31999999999999 110.727 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 3.0 t -166.0 132.17 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 15.640000000000001 109.952 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 75.5 mm-40 -81.39 155.74 25.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 422.56 111.439 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 143.17 50.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.584 -0.735 . . . . 462.10000000000002 109.399 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.482 HG23 ' CE2' ' A' ' 36' ' ' PHE . 98.2 m -85.61 121.34 28.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 111.17 110.68 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -152.29 88.81 1.39 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.82 -0.627 . . . . 121.65000000000001 110.42 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -50.88 1.6 Allowed Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.947 -1.024 . . . . 82.170000000000002 111.04 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.49 137.53 48.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.758 0.313 . . . . 220.46000000000001 110.434 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 32' ' ' THR . 97.0 m-85 -84.15 149.77 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 149.47999999999999 110.506 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 43.3 p -124.85 -145.2 0.33 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.847 0.356 . . . . 169.86000000000001 110.156 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 88.2 tt0 -152.86 139.31 18.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 537.64999999999998 110.77 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -57.05 152.37 29.46 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.96 -0.564 . . . . 32.920000000000002 109.994 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.14 157.38 46.43 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.343 2.029 . . . . 87.700000000000003 111.767 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.47 -90.7 2.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.997 -0.841 . . . . 244.37 110.997 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 681.24000000000001 110.697 -179.66 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' A' ' 7' ' ' GLY . 21.3 pt-20 . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 121.057 0.455 . . . . 206.49000000000001 110.829 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 60.18 -5.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 244.88 111.569 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 5' ' ' GLU . . . -155.9 60.71 0.36 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.464 -1.054 . . . . 71.469999999999999 110.464 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.56 ' CG ' ' HG ' ' A' ' 15' ' ' CYS . 52.8 p-10 -61.17 -29.25 69.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.727 0.298 . . . . 133.27000000000001 110.777 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 97.1 m -62.12 -43.19 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.324 0.583 . . . . 25.780000000000001 109.933 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.81 162.31 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.119 -0.946 . . . . 119.04000000000001 109.429 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.49 93.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.512 -0.475 . . . . 60.490000000000002 110.557 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.25 -38.36 68.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 258.73000000000002 110.965 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 32' ' ' THR . 75.8 mm-40 -72.33 157.96 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 339.06 111.435 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.2 t -104.24 156.44 17.9 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.986 -0.552 . . . . 42.960000000000001 110.327 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.56 ' HG ' ' CG ' ' A' ' 8' ' ' ASP . 54.1 t -147.73 128.86 14.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 39.109999999999999 109.99 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.3 134.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 115.20999999999999 110.251 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -101.0 119.47 38.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 135.41999999999999 110.994 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 p -100.38 164.53 11.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.911 -0.586 . . . . 45.380000000000003 110.018 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.08 119.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.131 0.967 . . . . 42.109999999999999 108.899 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.32 -95.09 0.16 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.74 -1.573 . . . . 66.019999999999996 111.469 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.42 -21.56 38.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.072 -0.967 . . . . 451.81 110.738 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.03 65.43 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.313 -0.715 . . . . 104.66 111.313 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.61 -39.64 84.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.203 -0.666 . . . . 328.18000000000001 109.203 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' A' ' 24' ' ' MET . 19.1 tmm? -148.87 105.51 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.302 -0.863 . . . . 243.28999999999999 108.874 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 24' ' ' MET . 77.7 t -63.9 145.49 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.281 0.562 . . . . 58.390000000000001 111.343 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.7 m -125.09 135.14 52.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.288 -0.869 . . . . 44.390000000000001 110.945 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -128.55 148.83 50.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 767.09000000000003 109.909 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -132.95 144.55 50.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.855 0.36 . . . . 146.31999999999999 110.696 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.57 115.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 15.640000000000001 110.007 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.17 152.36 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 422.56 110.627 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -115.15 142.38 46.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.329 -0.396 . . . . 462.10000000000002 110.255 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.462 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 88.2 m -71.11 125.9 28.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 111.17 110.511 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.84 89.47 1.39 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.395 0.617 . . . . 121.65000000000001 110.503 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.44 -44.06 0.92 Allowed Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.932 -1.031 . . . . 82.170000000000002 110.887 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.0 m120 -136.41 139.32 42.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.82 0.343 . . . . 220.46000000000001 110.157 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.28 146.55 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 149.47999999999999 110.749 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.2 p -127.7 -146.79 0.34 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.284 -0.416 . . . . 169.86000000000001 109.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -160.92 148.42 15.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 537.64999999999998 110.595 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 8.1 p -61.88 149.9 84.22 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.229 -0.441 . . . . 32.920000000000002 109.89 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.76 134.62 18.47 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.064 1.842 . . . . 87.700000000000003 112.0 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.85 98.34 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.87 -0.892 . . . . 244.37 110.87 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 681.24000000000001 110.349 -179.81 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.679 0.276 . . . . 206.49000000000001 110.437 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.84 -39.49 85.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.914 0.388 . . . . 244.88 110.198 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.29 76.88 0.4 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.533 -1.027 . . . . 71.469999999999999 110.533 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.31 -43.53 98.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 133.27000000000001 110.614 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.1 m -62.06 -41.47 98.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 25.780000000000001 110.313 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.28 165.98 8.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.482 -0.781 . . . . 119.04000000000001 109.928 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.33 96.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.757 -0.377 . . . . 60.490000000000002 110.757 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.93 -33.53 33.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 258.73000000000002 110.958 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.5 mm-40 -74.3 158.01 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 339.06 111.293 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 34.1 t -107.71 154.31 21.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.984 -0.553 . . . . 42.960000000000001 110.614 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.6 t -142.8 128.12 18.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.58 -0.526 . . . . 39.109999999999999 109.58 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -151.11 128.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.905 -0.406 . . . . 115.20999999999999 109.905 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -107.97 118.11 35.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 135.41999999999999 111.39 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -102.82 166.44 10.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.459 -0.791 . . . . 45.380000000000003 109.449 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 19' ' ' VAL . 3.5 p -179.57 117.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.909 0.861 . . . . 42.109999999999999 109.502 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.93 -62.18 1.33 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.174 -1.375 . . . . 66.019999999999996 110.784 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.2 pt-20 -114.9 -172.17 2.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.06 0.457 . . . . 451.81 111.284 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.09 -12.75 54.65 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.754 -0.657 . . . . 104.66 111.864 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.46 -40.72 95.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.668 0.271 . . . . 328.18000000000001 111.183 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 ttp -157.08 153.02 27.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.371 -0.377 . . . . 243.28999999999999 110.904 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -115.59 140.94 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.163 0.506 . . . . 58.390000000000001 110.67 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.4 m -110.96 132.3 54.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.514 -0.766 . . . . 44.390000000000001 111.373 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -133.98 148.3 51.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 767.09000000000003 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -138.45 147.71 43.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.926 0.393 . . . . 146.31999999999999 110.772 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.9 115.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 15.640000000000001 109.912 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -80.56 152.8 28.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 422.56 110.631 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.68 143.41 45.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.147 -0.479 . . . . 462.10000000000002 110.205 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.517 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.0 m -73.79 125.05 27.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 111.17 110.485 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.9 p -153.34 89.49 1.35 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.383 0.611 . . . . 121.65000000000001 110.559 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.16 -41.14 0.74 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.898 -1.046 . . . . 82.170000000000002 111.017 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 33' ' ' THR . 83.0 m-20 -133.93 140.05 46.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 220.46000000000001 110.341 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.04 144.81 26.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.157 -0.474 . . . . 149.47999999999999 110.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.6 p -134.52 -157.66 0.82 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.438 -0.579 . . . . 169.86000000000001 109.438 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -149.59 155.33 40.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.441 -0.8 . . . . 537.64999999999998 110.655 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.5 p -65.92 149.76 97.22 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.675 -0.491 . . . . 32.920000000000002 109.675 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.96 131.3 16.68 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.978 1.785 . . . . 87.700000000000003 111.946 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.98 98.36 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.063 -0.815 . . . . 244.37 111.063 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.849 0.357 . . . . 681.24000000000001 110.304 -179.801 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 9.7 pt-20 . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.688 0.28 . . . . 206.49000000000001 110.379 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -39.39 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 244.88 110.139 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -127.4 75.09 0.42 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.538 -1.025 . . . . 71.469999999999999 110.538 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -61.42 -43.12 99.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.939 0.4 . . . . 133.27000000000001 110.679 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.5 m -61.65 -42.56 99.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.007 -0.542 . . . . 25.780000000000001 110.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.93 167.13 13.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.334 -0.848 . . . . 119.04000000000001 109.871 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.5 95.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.515 -0.312 . . . . 60.490000000000002 111.117 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.44 -30.29 23.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.473 -0.331 . . . . 258.73000000000002 111.273 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.51 154.14 37.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 339.06 110.979 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 39.0 t -104.51 148.87 25.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.219 -0.446 . . . . 42.960000000000001 110.727 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -135.92 123.97 22.9 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.554 -0.535 . . . . 39.109999999999999 109.554 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.4 p -143.33 127.69 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.913 0.387 . . . . 115.20999999999999 110.21 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -109.66 118.78 37.46 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.047 -0.524 . . . . 135.41999999999999 111.022 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 46.5 p -104.54 167.53 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.826 -0.625 . . . . 45.380000000000003 109.867 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p 179.34 117.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.936 0.874 . . . . 42.109999999999999 109.304 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -100.57 -71.19 0.71 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.069 -1.423 . . . . 66.019999999999996 110.815 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.4 pt-20 -95.67 -177.57 4.1 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.608 -0.723 . . . . 451.81 111.782 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.05 -10.42 57.43 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.115 -0.948 . . . . 104.66 111.098 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.3 t0 -60.38 -43.71 96.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 328.18000000000001 110.975 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -159.39 168.99 24.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 243.28999999999999 110.963 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.919 -0.582 . . . . 58.390000000000001 110.852 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 51.5 m -121.72 138.13 54.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.504 -0.771 . . . . 44.390000000000001 111.251 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -150.5 158.09 43.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.264 -0.425 . . . . 767.09000000000003 110.492 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.8 m -142.31 153.76 44.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 146.31999999999999 111.078 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -167.05 121.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.8 -0.636 . . . . 15.640000000000001 109.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -83.95 155.09 23.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.014 0.435 . . . . 422.56 111.38 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.4 143.52 45.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.727 -0.67 . . . . 462.10000000000002 110.067 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.1 m -78.53 124.29 28.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 111.17 110.729 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ASN . 34.0 p -152.91 89.03 1.35 Allowed 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.451 0.643 . . . . 121.65000000000001 110.518 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 -38.84 0.76 Allowed Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.899 -1.046 . . . . 82.170000000000002 111.222 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.7 m-20 -135.72 141.2 44.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.875 0.369 . . . . 220.46000000000001 110.365 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -90.03 146.5 24.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 149.47999999999999 110.573 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.8 p -132.77 -156.21 0.73 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.511 -0.552 . . . . 169.86000000000001 109.511 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -148.29 153.33 38.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.6 -0.727 . . . . 537.64999999999998 110.655 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 p -65.45 149.86 96.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.586 -0.524 . . . . 32.920000000000002 109.586 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.44 131.03 15.71 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.014 1.809 . . . . 87.700000000000003 112.121 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.83 -40.17 97.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.173 -0.771 . . . . 244.37 111.173 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.929 0.395 . . . . 681.24000000000001 110.584 -179.651 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.583 -1.407 . . . . 999.99000000000001 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.56 144.33 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.217 -0.29 . . . . 999.99000000000001 110.217 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.554 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 64.6 m -88.57 116.4 26.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.063 0.459 . . . . 271.27999999999997 111.027 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 t -73.16 -66.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.752 -0.658 . . . . 178.88999999999999 109.96 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 5' ' ' GLU . 20.3 pt-20 -82.31 158.28 23.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.875 -1.057 . . . . 206.49000000000001 110.585 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.512 ' ND2' ' SG ' ' A' ' 14' ' ' CYS . 15.8 t-20 -60.77 -42.81 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 244.88 110.947 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.07 53.64 1.61 Allowed Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.465 -0.654 . . . . 71.469999999999999 111.465 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.61 -46.53 87.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.83 0.348 . . . . 133.27000000000001 110.699 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.18 -42.08 99.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.289 0.566 . . . . 25.780000000000001 110.139 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.84 168.5 7.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.278 -0.874 . . . . 119.04000000000001 109.897 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.98 97.23 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.862 -0.335 . . . . 60.490000000000002 110.932 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.97 -32.15 27.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.429 -0.35 . . . . 258.73000000000002 111.023 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -75.1 166.98 22.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 339.06 110.938 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' SG ' ' ND2' ' A' ' 6' ' ' ASN . 42.6 t -130.9 143.89 51.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.01 -0.541 . . . . 42.960000000000001 110.629 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -135.58 138.53 43.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.3 -0.629 . . . . 39.109999999999999 109.3 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.9 p -148.3 118.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.56 -0.456 . . . . 115.20999999999999 110.402 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 66.4 m-20 -75.61 118.93 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 135.41999999999999 111.094 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.499 ' HG1' ' C ' ' A' ' 26' ' ' THR . 16.2 p -97.53 160.57 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 45.380000000000003 109.344 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p 179.53 117.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.921 0.867 . . . . 42.109999999999999 109.252 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.42 -56.63 2.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.269 -1.332 . . . . 66.019999999999996 111.387 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 22.6 pt-20 -113.41 -174.5 2.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.188 0.518 . . . . 451.81 111.77 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.41 -9.62 57.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.352 -0.84 . . . . 104.66 111.911 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.435 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.11 -41.1 96.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.879 0.371 . . . . 328.18000000000001 110.85 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -163.01 169.42 19.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 243.28999999999999 110.866 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.78 143.13 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.554 . . . . 58.390000000000001 110.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.499 ' C ' ' HG1' ' A' ' 18' ' ' THR . 99.4 m -117.25 137.43 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.503 -0.771 . . . . 44.390000000000001 111.168 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -125.79 156.23 39.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.871 -0.604 . . . . 767.09000000000003 109.531 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -147.96 159.25 44.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.303 0.573 . . . . 146.31999999999999 111.253 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.6 t -175.14 137.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.41 -0.814 . . . . 15.640000000000001 109.194 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -110.67 134.74 52.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.948 0.404 . . . . 422.56 110.948 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -86.56 140.41 29.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.893 -0.594 . . . . 462.10000000000002 109.707 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -89.99 102.71 15.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.964 0.412 . . . . 111.17 110.659 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ASN . 21.5 m -138.04 126.51 23.39 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.495 0.664 . . . . 121.65000000000001 110.032 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.25 -71.11 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 CA-C-N 114.663 -1.153 . . . . 82.170000000000002 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 33' ' ' THR . 84.2 m-20 -111.98 142.21 44.68 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.789 -0.448 . . . . 220.46000000000001 109.789 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -70.92 143.86 50.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 149.47999999999999 110.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 p -147.02 117.05 7.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.134 -0.485 . . . . 169.86000000000001 110.209 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.42 161.61 23.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 537.64999999999998 110.978 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.5 p -64.05 150.19 92.4 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.855 -0.612 . . . . 32.920000000000002 110.143 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.01 137.56 21.85 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.069 1.846 . . . . 87.700000000000003 111.768 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.13 7.41 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.793 -0.923 . . . . 244.37 110.793 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 mt -107.79 147.23 31.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.857 0.36 . . . . 681.24000000000001 110.617 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -140.7 68.27 30.11 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.015 -0.539 . . . . 508.5 110.787 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.13 -9.42 19.19 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.87 2.38 . . . . 999.99000000000001 111.628 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.77 128.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.044 -0.525 . . . . 898.75 110.632 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.973 -1.013 . . . . 999.99000000000001 110.62 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.561 -1.416 . . . . 999.99000000000001 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 2' ' ' LEU . 8.7 mp -62.87 -39.0 93.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 999.99000000000001 110.548 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 71.8 m -80.1 106.93 12.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 271.27999999999997 110.343 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 25.1 t -61.0 -43.12 99.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.398 0.618 . . . . 178.88999999999999 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 21.9 pt-20 -144.69 -164.62 1.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.966 -1.016 . . . . 206.49000000000001 110.21 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.41 85.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.872 0.368 . . . . 244.88 110.185 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -122.99 65.24 0.52 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.622 -0.991 . . . . 71.469999999999999 110.622 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 4' ' ' SER . 66.3 t0 -61.06 -41.72 97.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 133.27000000000001 110.588 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.9 m -61.31 -41.17 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 25.780000000000001 110.173 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.61 166.46 14.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.778 . . . . 119.04000000000001 109.954 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.48 95.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 60.490000000000002 110.926 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.22 -29.61 24.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 258.73000000000002 111.055 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.469 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.0 mm-40 -76.14 159.97 30.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.414 . . . . 339.06 111.136 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 35.1 t -109.88 153.3 24.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.922 -0.581 . . . . 42.960000000000001 110.366 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 16.7 t -144.65 127.27 16.11 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.242 -0.651 . . . . 39.109999999999999 109.242 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.483 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 13.8 p -147.61 128.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 115.20999999999999 110.614 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 2' ' ' LEU . 97.3 m-20 -99.28 132.87 44.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 135.41999999999999 110.733 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 24.0 p -122.32 161.09 24.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.871 -0.604 . . . . 45.380000000000003 109.51 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 179.27 118.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.988 0.899 . . . . 42.109999999999999 109.2 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.13 -64.06 1.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.972 -1.467 . . . . 66.019999999999996 110.973 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.7 pt-20 -109.89 -173.06 2.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.122 0.487 . . . . 451.81 111.479 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.69 -11.62 56.64 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.574 -0.739 . . . . 104.66 111.858 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.25 -39.93 92.17 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.927 -0.309 . . . . 328.18000000000001 110.957 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ptm -159.11 167.23 29.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 243.28999999999999 111.001 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.3 t -123.17 143.37 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.859 -0.61 . . . . 58.390000000000001 110.571 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 84.1 m -118.26 135.68 54.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.51 -0.768 . . . . 44.390000000000001 110.988 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -142.47 155.3 45.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.082 -0.508 . . . . 767.09000000000003 110.032 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -140.94 149.2 41.54 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.015 0.436 . . . . 146.31999999999999 111.012 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -172.09 116.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 15.640000000000001 109.794 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -82.2 150.1 27.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 422.56 110.88 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -112.75 141.71 46.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.086 -0.506 . . . . 462.10000000000002 109.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.469 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 92.4 m -69.34 126.73 30.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 111.17 110.529 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 p -151.03 89.44 1.53 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.417 0.627 . . . . 121.65000000000001 110.448 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.08 -47.93 1.34 Allowed Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 114.984 -1.007 . . . . 82.170000000000002 110.946 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -131.77 139.84 49.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.1 -0.333 . . . . 220.46000000000001 110.1 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -82.51 145.42 29.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 149.47999999999999 110.781 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.8 p -129.5 -145.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.132 -0.486 . . . . 169.86000000000001 109.892 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -161.16 154.35 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.062 -0.517 . . . . 537.64999999999998 110.836 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 12.4 p -66.91 149.7 98.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 32.920000000000002 110.054 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.89 136.33 20.5 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.141 1.894 . . . . 87.700000000000003 111.849 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.38 -39.99 98.39 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.987 -0.845 . . . . 244.37 110.987 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.44 144.77 38.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.858 0.361 . . . . 681.24000000000001 110.463 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.426 ' OG1' HG22 ' A' ' 45' ' ' ILE . 76.6 p -69.8 149.48 96.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.18 -0.464 . . . . 508.5 110.294 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.92 -10.39 21.33 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.348 2.032 . . . . 999.99000000000001 112.418 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG22 ' OG1' ' A' ' 43' ' ' THR . 20.0 tt -53.0 -31.14 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.417 -0.356 . . . . 898.75 110.65 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.975 -1.012 . . . . 999.99000000000001 110.63 -180.0 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.56 -1.416 . . . . 999.99000000000001 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.67 149.96 45.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.843 0.354 . . . . 999.99000000000001 110.285 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 75.0 m -84.68 104.95 15.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.187 -0.461 . . . . 271.27999999999997 110.771 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.7 t -62.31 -42.68 99.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 178.88999999999999 109.676 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -143.1 -171.34 3.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.905 -1.043 . . . . 206.49000000000001 110.252 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.16 -39.63 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 244.88 110.242 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.64 62.76 0.44 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.628 -0.989 . . . . 71.469999999999999 110.628 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.6 -46.55 89.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 133.27000000000001 110.766 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.5 m -63.1 -41.86 99.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 25.780000000000001 110.299 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.54 163.56 6.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.312 -0.858 . . . . 119.04000000000001 109.585 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.78 91.8 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.488 -0.485 . . . . 60.490000000000002 110.405 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.33 -38.69 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 258.73000000000002 110.48 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.26 156.52 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 339.06 110.515 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.656 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 1.8 p -108.12 171.22 7.53 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.197 -0.297 . . . . 42.960000000000001 110.197 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 11.4 t -156.17 127.71 7.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.312 -0.625 . . . . 39.109999999999999 109.312 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.536 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 7.4 p -150.95 129.13 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 115.20999999999999 110.38 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -94.9 120.26 34.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.017 -0.538 . . . . 135.41999999999999 110.948 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 26' ' ' THR . 15.5 p -104.4 164.86 11.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.034 -0.53 . . . . 45.380000000000003 109.653 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.04 119.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.833 0.825 . . . . 42.109999999999999 109.087 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.16 -65.94 0.93 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.336 -1.302 . . . . 66.019999999999996 111.013 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.0 pt-20 -108.66 -171.97 1.96 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.11 0.481 . . . . 451.81 111.567 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.35 -13.34 52.14 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.694 -0.685 . . . . 104.66 111.973 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.7 m-20 -60.54 -41.58 94.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 328.18000000000001 110.722 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptp -160.87 161.71 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.922 -0.581 . . . . 243.28999999999999 110.495 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.14 160.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.907 -0.588 . . . . 58.390000000000001 110.956 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 18' ' ' THR . 78.0 m -129.75 138.55 51.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.734 -0.666 . . . . 44.390000000000001 111.232 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -128.13 154.51 45.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.578 . . . . 767.09000000000003 109.817 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -141.9 148.38 38.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.043 0.449 . . . . 146.31999999999999 110.822 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -171.92 101.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 15.640000000000001 109.339 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.656 ' CG ' ' H ' ' A' ' 14' ' ' CYS . 9.4 pt-20 -60.65 163.47 5.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.356 0.598 . . . . 422.56 111.375 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -136.35 143.27 43.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.833 -1.076 . . . . 462.10000000000002 110.07 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.1 m -112.06 122.8 48.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.909 0.385 . . . . 111.17 110.76 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.1 p -154.16 84.27 1.14 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.607 0.717 . . . . 121.65000000000001 110.321 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.88 -5.24 58.73 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.517 -1.22 . . . . 82.170000000000002 110.442 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.4 m-20 -154.77 149.37 26.4 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.936 -0.394 . . . . 220.46000000000001 109.936 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.88 143.21 32.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 149.47999999999999 110.935 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 37' ' ' THR . 10.2 t -155.46 124.53 6.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 169.86000000000001 110.107 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.6 mp0 -81.71 159.41 23.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.625 . . . . 537.64999999999998 110.808 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 160.23 0.22 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.466 -0.568 . . . . 32.920000000000002 109.466 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.09 133.04 15.99 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.06 1.84 . . . . 87.700000000000003 111.894 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.22 -40.36 98.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 244.37 111.212 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -113.88 145.68 41.12 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.549 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 43' ' ' THR . 1.5 p -76.6 173.75 6.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 508.5 109.655 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.17 -21.68 72.92 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.941 1.761 . . . . 999.99000000000001 111.6 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.421 ' O ' ' OXT' ' A' ' 46' ' ' ALA . 96.9 mt -60.1 -45.33 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.551 . . . . 898.75 110.437 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' A' ' 45' ' ' ILE . . . . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.021 -0.99 . . . . 999.99000000000001 110.603 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.555 -1.418 . . . . 999.99000000000001 109.555 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.26 152.77 18.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.815 0.34 . . . . 999.99000000000001 110.349 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 94.7 m -63.79 147.63 51.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 271.27999999999997 110.264 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -60.27 -43.24 96.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.149 0.5 . . . . 178.88999999999999 110.2 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -147.28 -170.83 3.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.426 -0.806 . . . . 206.49000000000001 110.607 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.34 84.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.882 0.373 . . . . 244.88 110.192 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.2 75.13 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.633 -0.987 . . . . 71.469999999999999 110.633 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 133.27000000000001 110.624 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.1 m -62.49 -41.77 99.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 25.780000000000001 110.202 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.73 163.15 9.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 119.04000000000001 110.09 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.38 88.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 60.490000000000002 110.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -91.89 11.4 25.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.256 -0.429 . . . . 258.73000000000002 111.441 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.0 mm-40 -119.12 159.4 24.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.071 0.462 . . . . 339.06 111.051 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.4 t -104.35 155.17 19.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.769 -0.65 . . . . 42.960000000000001 110.656 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.449 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 41.9 t -146.13 127.73 15.14 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.455 -0.572 . . . . 39.109999999999999 109.455 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.57 130.54 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 115.20999999999999 110.336 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 68.5 m-20 -106.89 123.32 47.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.183 -0.462 . . . . 135.41999999999999 111.078 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -110.12 161.99 15.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.787 -0.642 . . . . 45.380000000000003 109.546 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.1 p -178.33 116.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 122.008 0.909 . . . . 42.109999999999999 109.636 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.81 -57.78 2.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.139 -1.391 . . . . 66.019999999999996 110.748 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.7 pt-20 -116.37 -176.78 3.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.296 0.569 . . . . 451.81 111.428 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.9 -12.27 56.81 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.197 -0.911 . . . . 104.66 111.048 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.5 t0 -61.69 -44.47 96.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.417 . . . . 328.18000000000001 111.211 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.9 ttp -154.28 145.0 22.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 243.28999999999999 110.924 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.03 143.28 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.002 -0.544 . . . . 58.390000000000001 110.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.3 m -115.28 132.61 56.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.589 -0.732 . . . . 44.390000000000001 111.083 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -132.65 155.36 48.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.983 -0.553 . . . . 767.09000000000003 109.939 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 t -144.47 146.22 32.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.946 0.403 . . . . 146.31999999999999 110.72 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.4 t -173.65 116.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 15.640000000000001 109.803 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 78.7 mm-40 -85.04 154.84 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 422.56 110.898 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.13 143.97 49.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.899 -0.591 . . . . 462.10000000000002 109.881 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.495 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 95.2 m -88.91 119.39 29.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.949 0.404 . . . . 111.17 110.751 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.2 p -153.01 82.68 1.21 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.559 0.695 . . . . 121.65000000000001 110.577 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.5 -4.46 59.76 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.501 -1.227 . . . . 82.170000000000002 110.935 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -159.01 148.66 18.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 220.46000000000001 110.398 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.37 140.26 37.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.34 -0.391 . . . . 149.47999999999999 110.626 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.61 124.39 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.988 0.423 . . . . 169.86000000000001 110.444 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.4 mp0 -82.44 166.07 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 537.64999999999998 111.035 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.7 p -62.51 150.59 85.46 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.921 -0.582 . . . . 32.920000000000002 110.05 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.05 140.96 23.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.057 1.838 . . . . 87.700000000000003 111.964 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.72 -40.45 99.21 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 244.37 110.883 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.0 mt -114.25 143.48 44.79 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.784 0.325 . . . . 681.24000000000001 110.213 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.3 p -70.48 149.46 95.61 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.289 -0.414 . . . . 508.5 110.358 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.83 -1.82 11.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.226 1.951 . . . . 999.99000000000001 111.934 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -53.53 131.07 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 898.75 110.733 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 999.99000000000001 110.496 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.415 . . . . 999.99000000000001 109.564 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.54 149.1 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 999.99000000000001 110.256 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 73.9 m -81.64 109.41 16.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.336 -0.393 . . . . 271.27999999999997 110.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 t -61.91 -42.66 99.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.394 0.616 . . . . 178.88999999999999 109.881 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.99 -167.31 2.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.941 -1.027 . . . . 206.49000000000001 110.331 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.17 -39.56 86.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 244.88 110.217 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.3 64.89 0.5 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.605 -0.998 . . . . 71.469999999999999 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -60.86 -45.22 95.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.803 0.335 . . . . 133.27000000000001 110.656 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.4 m -62.51 -41.59 98.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.219 0.533 . . . . 25.780000000000001 110.167 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.18 165.8 7.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.388 -0.823 . . . . 119.04000000000001 109.899 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.35 95.74 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.828 -0.349 . . . . 60.490000000000002 110.821 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.59 -32.38 25.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 258.73000000000002 111.282 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 32' ' ' THR . 76.9 mm-40 -74.22 153.97 39.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 339.06 111.188 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.5 t -101.02 156.48 17.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.927 -0.578 . . . . 42.960000000000001 110.284 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 11.6 t -151.43 129.81 12.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.325 -0.62 . . . . 39.109999999999999 109.325 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.583 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.2 p -151.11 131.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 115.20999999999999 110.63 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -95.54 120.05 35.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.03 -0.532 . . . . 135.41999999999999 110.65 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -107.02 161.97 14.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.041 -0.527 . . . . 45.380000000000003 110.07 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.0 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.979 0.895 . . . . 42.109999999999999 108.981 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -93.61 -94.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.84 -1.527 . . . . 66.019999999999996 111.443 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -80.37 -18.65 48.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.202 -0.908 . . . . 451.81 111.239 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.19 -8.43 75.59 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.204 -0.758 . . . . 104.66 111.204 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.56 -42.12 91.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 328.18000000000001 109.388 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.404 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.6 ttp -142.57 104.59 4.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.312 -0.858 . . . . 243.28999999999999 109.284 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.27 146.9 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 58.390000000000001 110.96 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.2 m -125.37 134.66 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.354 -0.839 . . . . 44.390000000000001 110.944 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.74 146.23 51.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.006 -0.543 . . . . 767.09000000000003 109.903 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -134.09 145.38 49.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.87 0.367 . . . . 146.31999999999999 110.639 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -172.86 116.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 15.640000000000001 109.994 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -80.04 153.57 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 422.56 110.865 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.45 142.61 46.64 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.047 -0.524 . . . . 462.10000000000002 110.017 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.518 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.4 m -68.05 126.3 29.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.064 0.459 . . . . 111.17 110.374 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.8 p -151.31 88.85 1.46 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.827 -0.624 . . . . 121.65000000000001 110.539 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -47.65 1.22 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 114.875 -1.057 . . . . 82.170000000000002 110.979 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -133.34 138.72 46.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.158 -0.312 . . . . 220.46000000000001 110.158 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.3 m-85 -83.18 146.41 28.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 149.47999999999999 110.573 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -133.36 -144.84 0.23 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.253 -0.431 . . . . 169.86000000000001 110.118 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.21 159.14 35.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 537.64999999999998 110.739 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.42 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.4 p -57.33 152.04 34.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.091 -0.504 . . . . 32.920000000000002 109.993 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.31 135.39 20.43 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.313 2.009 . . . . 87.700000000000003 112.259 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.35 96.88 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.706 -0.958 . . . . 244.37 110.706 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.88 144.1 31.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.876 0.37 . . . . 681.24000000000001 110.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 t -60.55 142.38 91.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.1 -0.5 . . . . 508.5 110.33 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 -10.87 23.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.171 1.914 . . . . 999.99000000000001 111.426 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.75 -44.82 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 898.75 110.234 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.008 -0.996 . . . . 999.99000000000001 110.538 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.528 -1.429 . . . . 999.99000000000001 109.528 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.06 140.8 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 999.99000000000001 110.315 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 m -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 271.27999999999997 110.179 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 t -61.05 -43.74 98.43 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.843 -0.617 . . . . 178.88999999999999 110.256 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 21.9 pt-20 -150.54 172.67 15.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.193 -0.912 . . . . 206.49000000000001 110.791 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 244.88 110.418 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -68.53 -9.38 58.34 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.452 -0.659 . . . . 71.469999999999999 111.452 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.29 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.808 -0.357 . . . . 133.27000000000001 110.514 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.3 m -62.55 -43.68 98.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 25.780000000000001 109.848 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.42 165.55 3.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.27 -0.877 . . . . 119.04000000000001 109.854 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.5 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.937 -0.305 . . . . 60.490000000000002 111.079 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.79 -31.18 26.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.441 -0.345 . . . . 258.73000000000002 111.379 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 32' ' ' THR . 77.7 mm-40 -75.0 156.54 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.913 0.387 . . . . 339.06 111.356 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 t -108.85 157.81 18.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.935 -0.575 . . . . 42.960000000000001 110.395 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 48.1 t -146.18 133.68 20.85 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.845 -0.428 . . . . 39.109999999999999 109.845 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -154.15 117.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.613 -0.435 . . . . 115.20999999999999 109.854 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 97.3 m-20 -95.25 118.64 32.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 135.41999999999999 111.158 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -103.62 163.56 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.735 -0.666 . . . . 45.380000000000003 109.553 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 p -179.05 117.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.881 0.848 . . . . 42.109999999999999 109.412 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -100.89 -63.85 1.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.26 -1.336 . . . . 66.019999999999996 111.09 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.5 pt-20 -107.38 -177.22 3.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.33 0.586 . . . . 451.81 111.846 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.96 -12.02 57.03 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 115.01 -0.996 . . . . 104.66 111.352 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -60.22 -42.85 96.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 328.18000000000001 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptp -156.43 166.61 32.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 243.28999999999999 110.77 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.15 140.28 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.099 -0.501 . . . . 58.390000000000001 110.698 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 m -110.85 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 44.390000000000001 111.124 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' NH2' ' OD2' ' A' ' 17' ' ' ASP . 77.3 mtp85 -132.4 147.19 52.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.047 -0.524 . . . . 767.09000000000003 109.995 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -137.36 146.81 44.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.989 0.423 . . . . 146.31999999999999 110.74 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -175.01 117.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.821 -0.627 . . . . 15.640000000000001 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -83.39 155.79 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 422.56 111.195 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -118.3 144.21 46.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.942 -0.572 . . . . 462.10000000000002 109.877 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 96.0 m -80.1 123.89 28.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 111.17 110.708 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.473 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.96 89.7 1.4 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.882 -0.599 . . . . 121.65000000000001 110.395 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.35 -41.69 0.79 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.012 -0.994 . . . . 82.170000000000002 110.792 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.3 m-20 -134.39 139.72 45.79 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.079 -0.341 . . . . 220.46000000000001 110.079 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.78 147.59 27.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 149.47999999999999 110.858 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 p -146.92 119.62 8.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.041 -0.527 . . . . 169.86000000000001 109.89 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -73.98 158.07 35.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.966 -0.561 . . . . 537.64999999999998 111.133 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 15.6 p -64.82 149.67 95.82 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.975 -0.557 . . . . 32.920000000000002 110.058 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.72 138.96 21.98 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.101 1.868 . . . . 87.700000000000003 112.052 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.07 98.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 244.37 110.741 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.11 145.3 41.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.252 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.44 ' OG1' HG22 ' A' ' 45' ' ' ILE . 73.7 p -69.25 149.37 97.48 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.248 -0.433 . . . . 508.5 110.331 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.69 -10.42 21.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.399 2.066 . . . . 999.99000000000001 112.282 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.44 HG22 ' OG1' ' A' ' 43' ' ' THR . 19.7 tt -52.56 -31.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.4 -0.364 . . . . 898.75 110.645 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.064 -0.97 . . . . 999.99000000000001 110.627 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.419 ' CA ' HH21 ' A' ' 27' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.492 -1.443 . . . . 999.99000000000001 109.492 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 83.2 mt -72.54 149.03 44.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 999.99000000000001 110.336 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.588 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 78.1 m -85.9 107.69 17.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 271.27999999999997 110.711 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.467 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 25.3 t -62.18 -42.75 99.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.381 0.61 . . . . 178.88999999999999 109.651 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -144.75 -167.34 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.989 -1.005 . . . . 206.49000000000001 110.24 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -39.74 87.26 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.746 -0.382 . . . . 244.88 110.124 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.43 62.02 0.48 Allowed Glycine 0 N--CA 1.466 0.652 0 N-CA-C 110.395 -1.082 . . . . 71.469999999999999 110.395 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 4' ' ' SER . 67.7 t0 -60.47 -45.75 92.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.771 0.32 . . . . 133.27000000000001 110.82 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.44 -42.12 99.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 25.780000000000001 110.232 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.71 167.88 7.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.286 -0.87 . . . . 119.04000000000001 109.874 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.04 96.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.874 -0.331 . . . . 60.490000000000002 110.776 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.15 -34.99 28.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.367 -0.379 . . . . 258.73000000000002 111.088 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.41 152.28 42.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 339.06 110.883 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 25.9 t -104.85 154.17 20.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 42.960000000000001 109.856 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 10.9 t -147.32 130.32 16.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.671 -0.492 . . . . 39.109999999999999 109.671 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.588 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.4 p -148.26 131.88 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.352 . . . . 115.20999999999999 110.482 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -100.62 120.83 40.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.119 -0.491 . . . . 135.41999999999999 110.529 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 27.5 p -107.37 164.91 11.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.187 -0.461 . . . . 45.380000000000003 109.931 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 178.07 117.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.924 0.868 . . . . 42.109999999999999 109.397 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.07 -55.59 2.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.224 -1.353 . . . . 66.019999999999996 110.586 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.8 pt-20 -118.17 -177.02 3.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.286 0.565 . . . . 451.81 111.425 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.33 -12.3 57.45 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.313 -0.858 . . . . 104.66 111.129 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -61.78 -44.74 96.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 328.18000000000001 111.153 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.1 ttp -154.74 144.64 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 243.28999999999999 110.95 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.0 t -103.9 147.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.078 -0.51 . . . . 58.390000000000001 110.318 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 77.3 m -123.94 139.84 53.56 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 44.390000000000001 111.346 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.419 HH21 ' CA ' ' A' ' 1' ' ' GLY . 20.9 ptp180 -145.89 160.61 41.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.906 -0.588 . . . . 767.09000000000003 109.788 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.3 p -150.14 161.92 41.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.958 0.408 . . . . 146.31999999999999 110.829 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -169.95 127.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 15.640000000000001 109.963 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 77.3 mm-40 -75.83 151.82 37.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 422.56 111.155 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -128.01 138.89 52.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.744 -0.662 . . . . 462.10000000000002 109.925 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 34' ' ' GLY . 27.7 p -71.45 69.81 0.6 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 111.17 110.378 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -78.4 45.2 0.55 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.909 0.861 . . . . 121.65000000000001 110.163 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 32' ' ' THR . . . 82.58 -0.92 88.88 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.194 -1.366 . . . . 82.170000000000002 110.146 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 80.6 m-20 -149.44 142.61 25.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.747 -0.464 . . . . 220.46000000000001 109.747 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.86 136.96 33.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 149.47999999999999 110.632 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.421 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 21.2 p -133.98 -150.28 0.39 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.693 -0.484 . . . . 169.86000000000001 109.693 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 98.3 mt-10 -144.73 142.87 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.845 -0.616 . . . . 537.64999999999998 110.766 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 p -65.13 150.41 95.5 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 109.61 -0.515 . . . . 32.920000000000002 109.61 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.07 130.35 15.3 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.988 1.792 . . . . 87.700000000000003 112.039 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.37 95.65 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.978 -0.849 . . . . 244.37 110.978 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -119.0 149.58 41.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.883 0.373 . . . . 681.24000000000001 110.615 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.6 p -69.2 151.07 97.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.902 -0.59 . . . . 508.5 110.013 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.05 -6.78 19.02 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.083 1.855 . . . . 999.99000000000001 111.568 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.3 mm -59.98 128.7 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 898.75 110.43 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.985 -1.007 . . . . 999.99000000000001 110.559 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 999.99000000000001 109.535 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.36 148.01 50.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 999.99000000000001 110.241 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 84.7 m -81.59 113.91 19.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 271.27999999999997 110.602 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.446 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 25.6 t -62.21 -42.75 99.58 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.466 0.651 . . . . 178.88999999999999 109.674 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -142.35 -163.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.861 -1.063 . . . . 206.49000000000001 110.288 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.26 -39.6 87.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.351 . . . . 244.88 110.391 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.2 65.81 0.55 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.773 -0.931 . . . . 71.469999999999999 110.773 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 4' ' ' SER . 66.3 t0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.868 0.366 . . . . 133.27000000000001 110.601 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.0 m -61.14 -42.58 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 25.780000000000001 109.916 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.09 163.99 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.338 -0.846 . . . . 119.04000000000001 109.744 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.15 95.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.589 -0.278 . . . . 60.490000000000002 111.145 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -86.38 -29.51 22.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 258.73000000000002 111.418 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -74.21 159.17 32.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.716 0.293 . . . . 339.06 111.028 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.3 t -102.77 150.2 23.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.147 -0.478 . . . . 42.960000000000001 110.28 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 9.1 t -149.42 124.82 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.122 -0.696 . . . . 39.109999999999999 109.122 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.517 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.0 p -145.9 131.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.984 0.421 . . . . 115.20999999999999 110.412 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 97.7 m-20 -95.58 120.98 36.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.936 -0.574 . . . . 135.41999999999999 110.752 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.496 HG21 HG22 ' A' ' 43' ' ' THR . 36.2 p -104.81 165.32 11.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.942 -0.572 . . . . 45.380000000000003 109.947 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 176.18 118.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.772 0.796 . . . . 42.109999999999999 109.216 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.295 -1.321 . . . . 66.019999999999996 110.826 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.6 pt-20 -112.15 -173.05 2.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.076 0.465 . . . . 451.81 111.442 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.25 -11.98 56.72 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.662 -0.699 . . . . 104.66 111.918 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.4 m-20 -61.32 -39.54 90.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.803 0.335 . . . . 328.18000000000001 111.041 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.4 ptp -157.78 167.99 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 243.28999999999999 111.057 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.3 t -124.04 146.62 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.986 -0.552 . . . . 58.390000000000001 110.475 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.483 ' C ' ' HG1' ' A' ' 18' ' ' THR . 83.7 m -125.28 142.11 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.731 -0.668 . . . . 44.390000000000001 111.219 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -137.36 154.74 49.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.053 -0.521 . . . . 767.09000000000003 110.218 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -134.18 150.4 51.08 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.024 0.44 . . . . 146.31999999999999 110.988 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -176.24 128.35 0.21 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.186 -0.672 . . . . 15.640000000000001 109.186 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 37' ' ' THR . 95.4 mt-10 -107.56 130.58 54.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.937 0.398 . . . . 422.56 111.326 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.0 150.07 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.574 . . . . 462.10000000000002 110.45 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -95.4 122.92 38.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 111.17 110.433 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -145.88 84.07 1.65 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.612 0.72 . . . . 121.65000000000001 110.875 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.54 -5.67 55.65 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.596 -1.184 . . . . 82.170000000000002 110.989 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.0 m-20 -155.93 148.98 24.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 220.46000000000001 110.253 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 137.72 37.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 149.47999999999999 110.525 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 56.6 p -151.23 119.24 6.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.263 -0.426 . . . . 169.86000000000001 110.438 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 99.7 mt-10 -75.06 161.69 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 537.64999999999998 110.392 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.506 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.2 p -52.03 157.5 2.13 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.475 -0.565 . . . . 32.920000000000002 109.475 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -55.63 163.1 5.64 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.594 1.53 . . . . 87.700000000000003 112.694 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.63 65.1 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.85 -1.068 . . . . 244.37 110.493 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.6 mt -122.73 158.33 30.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.024 -0.361 . . . . 681.24000000000001 110.024 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.496 HG22 HG21 ' A' ' 18' ' ' THR . 69.9 p -61.46 148.18 86.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.429 -0.35 . . . . 508.5 110.234 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.98 -16.4 20.28 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.509 2.139 . . . . 999.99000000000001 113.152 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 45' ' ' ILE . 20.4 pt -43.48 153.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 898.75 110.978 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.974 -1.012 . . . . 999.99000000000001 110.559 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.548 -1.421 . . . . 999.99000000000001 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 8' ' ' ASP . 86.3 mt -70.58 147.93 48.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 999.99000000000001 110.379 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 82.5 m -85.15 108.15 17.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.391 . . . . 271.27999999999997 110.393 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.469 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 28.2 t -61.5 -43.06 99.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.474 0.654 . . . . 178.88999999999999 109.781 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -144.05 -166.86 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.924 -1.035 . . . . 206.49000000000001 110.273 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.09 -39.48 86.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.994 -0.373 . . . . 244.88 109.994 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.65 62.2 0.48 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.687 -0.965 . . . . 71.469999999999999 110.687 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 4' ' ' SER . 67.2 t0 -60.72 -43.49 97.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.826 0.346 . . . . 133.27000000000001 110.515 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.3 m -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.261 0.553 . . . . 25.780000000000001 109.958 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.74 167.45 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.423 -0.808 . . . . 119.04000000000001 109.865 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.56 96.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.802 -0.359 . . . . 60.490000000000002 110.841 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.15 -32.66 24.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 258.73000000000002 111.05 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.82 158.52 35.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 339.06 110.901 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.547 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 41.9 t -111.51 146.81 36.63 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 42.960000000000001 110.169 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.456 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 15.8 t -140.97 129.04 22.02 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.046 -0.724 . . . . 39.109999999999999 109.046 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.541 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 12.9 p -148.48 131.48 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 115.20999999999999 110.422 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.92 121.35 38.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.997 -0.547 . . . . 135.41999999999999 110.939 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 p -103.51 166.31 10.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.927 -0.579 . . . . 45.380000000000003 109.84 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 178.09 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.993 0.901 . . . . 42.109999999999999 109.103 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.42 -95.01 0.17 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.913 -1.494 . . . . 66.019999999999996 111.269 -178.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.35 -28.08 59.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.954 -1.021 . . . . 451.81 111.084 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -13.73 58.82 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.274 -0.731 . . . . 104.66 111.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.79 -39.15 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 328.18000000000001 109.624 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.432 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 69.5 mtm -137.55 101.45 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.466 -0.788 . . . . 243.28999999999999 109.613 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.7 147.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.583 -0.447 . . . . 58.390000000000001 110.821 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.1 m -126.03 139.02 53.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.814 -0.63 . . . . 44.390000000000001 111.539 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.47 147.12 50.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 767.09000000000003 109.494 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -134.47 147.95 50.48 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.033 0.445 . . . . 146.31999999999999 111.224 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -175.42 130.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.219 -0.66 . . . . 15.640000000000001 109.219 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -108.12 167.09 10.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.942 0.401 . . . . 422.56 110.858 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.1 148.01 50.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.811 -0.631 . . . . 462.10000000000002 110.336 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.9 m -89.81 122.62 33.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 111.17 110.521 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -147.2 84.34 1.58 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.661 0.743 . . . . 121.65000000000001 110.768 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.57 -5.6 56.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.568 -1.196 . . . . 82.170000000000002 110.896 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -155.84 151.17 26.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.118 -0.327 . . . . 220.46000000000001 110.118 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.41 141.51 33.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.841 0.353 . . . . 149.47999999999999 110.992 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 37' ' ' THR . 10.9 t -161.48 130.7 4.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 169.86000000000001 109.837 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -86.39 169.6 12.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.833 -0.621 . . . . 537.64999999999998 111.032 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 2.3 p -58.71 152.13 48.9 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.939 -0.573 . . . . 32.920000000000002 109.968 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 134.9 16.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.101 1.867 . . . . 87.700000000000003 112.085 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.05 -39.75 97.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.909 -0.876 . . . . 244.37 110.909 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.57 142.26 42.64 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.965 0.412 . . . . 681.24000000000001 110.457 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p -70.01 150.46 96.26 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.954 -0.566 . . . . 508.5 110.133 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.08 -13.21 21.31 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.435 2.09 . . . . 999.99000000000001 112.76 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.9 pt -53.53 -23.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.791 0.329 . . . . 898.75 110.701 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 45' ' ' ILE . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.028 -0.987 . . . . 999.99000000000001 110.663 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.553 -1.419 . . . . 999.99000000000001 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.44 145.57 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.739 0.304 . . . . 999.99000000000001 110.407 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 5' ' ' GLU . 82.9 m -62.39 -40.84 97.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.358 -0.383 . . . . 271.27999999999997 110.659 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 0.9 OUTLIER 76.2 -33.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.131 -0.486 . . . . 178.88999999999999 110.165 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.1 pt-20 -153.67 162.22 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.672 -0.694 . . . . 206.49000000000001 110.417 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.25 -40.35 93.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 244.88 111.054 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 49.82 0.9 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.978 -0.849 . . . . 71.469999999999999 110.978 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -61.21 -49.92 75.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 133.27000000000001 110.569 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.4 m -64.69 -41.61 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.315 0.579 . . . . 25.780000000000001 110.126 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.19 167.81 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 119.04000000000001 109.867 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.63 97.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.954 -0.298 . . . . 60.490000000000002 111.005 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.64 -30.98 24.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 258.73000000000002 111.243 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.55 158.58 33.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 339.06 110.994 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 38.6 t -112.91 144.19 42.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 42.960000000000001 110.602 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 29.7 t -137.89 128.3 26.35 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.194 -0.669 . . . . 39.109999999999999 109.194 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.5 p -143.11 133.18 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.878 0.37 . . . . 115.20999999999999 110.557 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 72.2 m-20 -92.5 121.96 34.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 135.41999999999999 110.808 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.58 ' HG1' ' C ' ' A' ' 26' ' ' THR . 14.6 p -101.01 164.73 11.67 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 45.380000000000003 109.946 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 176.38 119.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.079 0.942 . . . . 42.109999999999999 108.91 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.24 -94.39 0.18 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.751 -1.568 . . . . 66.019999999999996 111.48 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -77.71 -21.31 52.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.165 -0.925 . . . . 451.81 111.189 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.57 71.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.298 -0.721 . . . . 104.66 111.298 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.54 -42.64 92.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.327 -0.62 . . . . 328.18000000000001 109.327 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.6 ttp -141.75 111.27 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.322 -0.854 . . . . 243.28999999999999 109.111 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 26' ' ' THR . 69.9 t -69.93 150.03 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.177 0.513 . . . . 58.390000000000001 111.082 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.58 ' C ' ' HG1' ' A' ' 18' ' ' THR . 89.2 m -132.89 143.95 49.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.484 -0.78 . . . . 44.390000000000001 111.057 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -132.13 163.84 27.61 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.95 -0.568 . . . . 767.09000000000003 110.116 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 t -148.62 150.49 33.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.987 0.422 . . . . 146.31999999999999 111.087 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.3 t -170.6 134.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 15.640000000000001 109.305 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -112.59 135.71 52.99 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.982 0.42 . . . . 422.56 111.337 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.43 144.96 26.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.848 -0.615 . . . . 462.10000000000002 110.203 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.6 m -93.66 102.93 15.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 111.17 110.612 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.5 m -140.28 125.89 19.16 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.491 0.662 . . . . 121.65000000000001 110.111 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.67 -64.85 0.45 Allowed Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.652 -1.158 . . . . 82.170000000000002 110.827 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' THR . 83.2 m-20 -122.53 146.89 47.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.977 -0.379 . . . . 220.46000000000001 109.977 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -73.25 146.22 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.422 -0.354 . . . . 149.47999999999999 110.902 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.15 122.11 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 169.86000000000001 110.391 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.06 165.15 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.61 . . . . 537.64999999999998 110.896 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.7 p -63.65 150.11 91.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 32.920000000000002 109.94 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.15 138.61 22.9 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.01 1.807 . . . . 87.700000000000003 111.841 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.85 0.43 67.2 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.954 -0.858 . . . . 244.37 110.954 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.05 145.14 42.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.92 0.391 . . . . 681.24000000000001 110.503 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -145.21 63.93 10.4 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.011 -0.54 . . . . 508.5 110.724 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 -14.8 23.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.966 2.444 . . . . 999.99000000000001 111.466 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.1 pt -59.11 -21.32 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 115.821 -0.627 . . . . 898.75 110.835 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.936 -1.03 . . . . 999.99000000000001 110.598 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.506 -1.438 . . . . 999.99000000000001 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.21 146.82 40.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 999.99000000000001 110.341 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.552 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 90.1 m -61.8 -42.61 99.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 271.27999999999997 110.791 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.18 -36.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.09 -0.504 . . . . 178.88999999999999 110.176 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.2 pt-20 -150.4 161.5 42.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.675 -0.693 . . . . 206.49000000000001 110.439 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -61.41 -40.6 94.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 244.88 111.122 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.31 47.76 1.12 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.953 -0.859 . . . . 71.469999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -61.24 -50.16 74.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.378 . . . . 133.27000000000001 110.638 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.61 -41.46 96.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.906 -0.588 . . . . 25.780000000000001 110.209 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -172.41 168.73 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.301 -0.863 . . . . 119.04000000000001 109.859 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.889 -0.324 . . . . 60.490000000000002 110.941 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.61 -31.35 24.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 258.73000000000002 111.11 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.82 156.29 36.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 339.06 111.014 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -112.95 144.46 42.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.132 -0.486 . . . . 42.960000000000001 110.515 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 26.8 t -136.73 127.17 26.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.832 -0.803 . . . . 39.109999999999999 108.832 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.1 p -137.64 130.37 42.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.04 0.448 . . . . 115.20999999999999 110.833 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 97.3 m-20 -93.4 138.57 31.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.828 -0.624 . . . . 135.41999999999999 110.898 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -128.06 159.22 35.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.884 -0.598 . . . . 45.380000000000003 109.834 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 p 178.67 118.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.685 -0.857 . . . . 42.109999999999999 108.685 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.636 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.4 -92.07 0.26 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.97 -1.468 . . . . 66.019999999999996 112.172 -177.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 4.0 pt-20 -70.92 -33.83 70.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 451.81 110.863 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.42 46.42 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 115.573 -0.739 . . . . 104.66 111.89 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.65 ' H ' ' CG ' ' A' ' 21' ' ' GLU . 37.8 t70 -60.41 -42.59 96.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.467 -0.568 . . . . 328.18000000000001 109.467 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.1 ttp -138.44 116.42 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 243.28999999999999 109.312 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.29 149.66 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.269 0.557 . . . . 58.390000000000001 110.754 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 m -128.66 142.37 51.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.391 -0.822 . . . . 44.390000000000001 110.928 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -145.3 162.17 37.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.031 -0.531 . . . . 767.09000000000003 110.048 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 t -149.75 152.84 35.92 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 146.31999999999999 110.986 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.7 t -168.58 131.82 1.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.849 -0.614 . . . . 15.640000000000001 109.427 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -102.91 149.21 24.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.942 0.401 . . . . 422.56 111.34 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.79 146.2 32.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.791 -0.641 . . . . 462.10000000000002 110.315 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.8 m -96.09 122.03 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 111.17 110.634 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.9 p -150.19 84.9 1.39 Allowed 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.55 0.691 . . . . 121.65000000000001 110.606 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.38 -3.98 60.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.636 -1.165 . . . . 82.170000000000002 110.723 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -158.17 149.53 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.104 -0.332 . . . . 220.46000000000001 110.104 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -98.01 139.3 34.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 149.47999999999999 110.788 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.7 p -146.93 118.15 7.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 169.86000000000001 110.082 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -76.23 160.25 29.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 537.64999999999998 110.877 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 2.5 p -59.98 150.68 68.55 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.065 -0.516 . . . . 32.920000000000002 110.002 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.06 134.23 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.217 1.944 . . . . 87.700000000000003 111.909 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.72 -40.03 98.11 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.847 -0.901 . . . . 244.37 110.847 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt -116.66 147.05 42.3 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.847 0.356 . . . . 681.24000000000001 110.268 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.445 ' OG1' HG22 ' A' ' 45' ' ' ILE . 72.3 p -68.4 149.27 98.1 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.161 -0.472 . . . . 508.5 110.212 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.59 -12.77 27.11 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.332 2.021 . . . . 999.99000000000001 112.1 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.445 HG22 ' OG1' ' A' ' 43' ' ' THR . 20.7 tt -41.9 139.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.391 . . . . 898.75 110.943 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.032 -0.985 . . . . 999.99000000000001 110.619 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.512 -1.435 . . . . 999.99000000000001 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.97 145.17 42.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.74 0.305 . . . . 999.99000000000001 110.494 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 5' ' ' GLU . 80.6 m -62.3 -40.79 97.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 271.27999999999997 110.619 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 1.1 t 75.53 -34.68 0.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 178.88999999999999 110.053 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.4 pt-20 -153.73 161.18 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.696 -0.683 . . . . 206.49000000000001 110.354 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.27 -40.17 93.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 244.88 110.814 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.58 46.84 1.29 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.068 -0.813 . . . . 71.469999999999999 111.068 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -60.84 -50.25 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.893 0.378 . . . . 133.27000000000001 110.571 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.95 -41.99 95.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 25.780000000000001 109.865 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.95 166.9 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.334 -0.848 . . . . 119.04000000000001 110.0 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 60.490000000000002 111.186 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -92.44 13.76 18.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.376 -0.374 . . . . 258.73000000000002 111.429 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.31 158.58 29.24 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.597 -0.274 . . . . 339.06 110.354 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.8 t -112.44 144.36 42.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.492 -0.322 . . . . 42.960000000000001 110.679 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 34.6 t -139.07 129.15 25.2 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.507 -0.553 . . . . 39.109999999999999 109.507 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.1 p -144.83 132.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 115.20999999999999 110.532 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -92.4 123.36 35.66 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.191 -0.459 . . . . 135.41999999999999 110.948 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -100.96 158.58 15.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.014 -0.539 . . . . 45.380000000000003 109.669 178.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.1 p 179.32 116.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.983 0.896 . . . . 42.109999999999999 109.581 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -73.77 -92.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.925 -1.488 . . . . 66.019999999999996 111.148 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -90.22 -65.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.68 -0.691 . . . . 451.81 110.953 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.81 -10.54 0.11 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.808 -0.71 . . . . 104.66 111.352 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.6 -41.88 91.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.555 -0.535 . . . . 328.18000000000001 109.555 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.536 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 65.6 ttp -146.7 140.16 25.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.317 -0.856 . . . . 243.28999999999999 109.421 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 25' ' ' VAL . 4.9 m -101.78 158.29 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 58.390000000000001 111.015 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 18' ' ' THR . 88.3 m -136.65 145.64 45.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.603 -0.726 . . . . 44.390000000000001 110.795 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.09 160.58 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.147 -0.479 . . . . 767.09000000000003 110.122 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -148.56 150.73 33.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.939 0.4 . . . . 146.31999999999999 110.832 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -170.58 129.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 15.640000000000001 109.691 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -107.03 138.25 43.55 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.893 0.377 . . . . 422.56 110.828 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -95.66 167.55 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.989 -0.55 . . . . 462.10000000000002 110.725 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.2 m -113.21 124.23 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.619 -0.719 . . . . 111.17 110.348 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -151.43 85.08 1.31 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.614 0.721 . . . . 121.65000000000001 110.733 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.59 -6.11 54.36 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.718 -1.128 . . . . 82.170000000000002 110.661 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -156.19 149.48 24.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.895 -0.409 . . . . 220.46000000000001 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 137.19 36.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 149.47999999999999 110.837 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.0 p -146.05 117.15 7.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.089 -0.505 . . . . 169.86000000000001 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.5 162.57 26.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 537.64999999999998 110.889 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.464 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 3.8 p -60.35 150.6 72.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.014 -0.539 . . . . 32.920000000000002 109.953 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.77 133.53 17.09 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.104 1.87 . . . . 87.700000000000003 112.05 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.73 97.76 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.825 -0.91 . . . . 244.37 110.825 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -90.64 159.82 16.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 681.24000000000001 110.621 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.2 p -65.51 150.03 96.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.131 -0.486 . . . . 508.5 110.223 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.34 -7.04 19.22 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.215 1.944 . . . . 999.99000000000001 111.532 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.5 129.82 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 898.75 110.52 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.006 -0.997 . . . . 999.99000000000001 110.57 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.556 -1.418 . . . . 999.99000000000001 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 84.7 mt -73.53 150.62 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 999.99000000000001 110.271 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 78.0 m -81.85 106.75 14.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 271.27999999999997 110.699 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 t -62.62 -42.85 99.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.609 . . . . 178.88999999999999 109.833 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -142.19 -165.6 2.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.004 -0.998 . . . . 206.49000000000001 110.417 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.05 -39.87 87.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 244.88 110.302 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.27 65.6 0.52 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.543 -1.023 . . . . 71.469999999999999 110.543 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 68.0 t0 -60.57 -44.86 95.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.879 0.371 . . . . 133.27000000000001 110.802 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.5 m -61.94 -43.1 99.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.384 0.611 . . . . 25.780000000000001 109.68 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.85 162.28 7.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.99 -1.005 . . . . 119.04000000000001 109.384 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.51 93.0 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.412 -0.515 . . . . 60.490000000000002 110.608 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.91 -38.97 69.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 258.73000000000002 111.073 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -73.83 161.07 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 339.06 111.146 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.7 t -109.28 155.52 21.05 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.361 -0.381 . . . . 42.960000000000001 110.351 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.453 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 9.3 t -149.62 129.19 13.11 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.524 -0.546 . . . . 39.109999999999999 109.524 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 11.6 p -148.33 132.21 8.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.837 0.351 . . . . 115.20999999999999 110.492 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.73 119.24 38.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.097 -0.501 . . . . 135.41999999999999 110.483 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 22.4 p -105.56 163.69 12.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.057 -0.519 . . . . 45.380000000000003 109.926 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p 178.38 117.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.84 0.829 . . . . 42.109999999999999 109.14 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.636 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.97 -62.36 1.32 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.231 -1.35 . . . . 66.019999999999996 111.123 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.8 pt-20 -104.5 -178.74 3.74 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.367 0.603 . . . . 451.81 111.913 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.44 -10.28 59.46 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.052 -0.976 . . . . 104.66 111.372 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.2 t0 -60.59 -44.07 96.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 328.18000000000001 110.84 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -159.94 168.75 24.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.038 -0.528 . . . . 243.28999999999999 110.953 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.0 t -118.15 143.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.026 -0.534 . . . . 58.390000000000001 110.547 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.1 m -118.34 137.6 52.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.742 . . . . 44.390000000000001 111.111 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -146.61 161.41 40.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.228 -0.442 . . . . 767.09000000000003 110.125 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -151.93 162.83 40.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.875 0.369 . . . . 146.31999999999999 110.859 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.3 t -168.48 131.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 15.640000000000001 110.03 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 74.5 mm-40 -77.87 154.46 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 422.56 111.277 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -121.37 138.67 54.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.746 -0.661 . . . . 462.10000000000002 109.555 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.488 HG23 ' CE2' ' A' ' 36' ' ' PHE . 93.6 m -79.87 123.09 27.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.145 -0.479 . . . . 111.17 110.589 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 32' ' ' THR . 32.4 p -154.77 88.28 1.19 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.494 0.664 . . . . 121.65000000000001 110.536 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -50.49 1.46 Allowed Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 114.812 -1.086 . . . . 82.170000000000002 111.1 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.73 136.68 47.81 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.749 0.309 . . . . 220.46000000000001 110.385 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.488 ' CE2' HG23 ' A' ' 32' ' ' THR . 94.2 m-85 -83.76 150.53 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 149.47999999999999 110.493 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.424 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 32.2 p -126.86 -145.71 0.32 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.957 0.408 . . . . 169.86000000000001 110.296 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 52.6 tp10 -151.6 139.21 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 537.64999999999998 110.318 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 p -56.77 150.92 34.56 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.107 -0.497 . . . . 32.920000000000002 110.158 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.25 157.79 41.54 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.449 2.099 . . . . 87.700000000000003 112.162 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.41 -93.07 1.64 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.682 -0.967 . . . . 244.37 110.682 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -81.55 136.2 35.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.216 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.539 ' OG1' HG22 ' A' ' 45' ' ' ILE . 73.1 p -81.16 160.6 65.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.192 -0.458 . . . . 508.5 110.034 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.28 -22.81 59.42 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.673 1.582 . . . . 999.99000000000001 111.72 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.539 HG22 ' OG1' ' A' ' 43' ' ' THR . 18.6 tt -37.99 144.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 898.75 111.274 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 117.955 -1.022 . . . . 999.99000000000001 110.602 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.569 -1.413 . . . . 999.99000000000001 109.569 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.8 mt -121.36 149.24 43.26 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.177 -0.305 . . . . 999.99000000000001 110.177 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 89.7 m -65.78 146.32 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 271.27999999999997 110.308 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 t -60.2 -43.03 96.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 178.88999999999999 110.105 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.9 -172.81 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.149 -0.932 . . . . 206.49000000000001 110.524 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.83 -39.4 84.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 244.88 110.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.37 74.11 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.651 -0.98 . . . . 71.469999999999999 110.651 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.26 -44.01 97.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.368 . . . . 133.27000000000001 110.597 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -62.63 -41.78 99.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 25.780000000000001 110.39 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.47 163.64 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.597 -0.729 . . . . 119.04000000000001 110.095 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.73 90.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 60.490000000000002 110.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -91.62 10.52 27.74 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.349 -0.387 . . . . 258.73000000000002 111.431 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.506 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.3 mm-40 -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 339.06 110.865 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 40.5 t -106.06 156.99 17.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.81 -0.632 . . . . 42.960000000000001 110.854 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.5 t -147.64 126.36 12.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.514 -0.551 . . . . 39.109999999999999 109.514 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 p -150.99 131.98 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.01 -0.367 . . . . 115.20999999999999 110.01 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 97.7 m-20 -101.41 118.66 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 135.41999999999999 111.41 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' THR . 2.4 p -100.69 161.98 13.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.632 -0.713 . . . . 45.380000000000003 109.15 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 19' ' ' VAL . 3.5 p 178.41 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.815 0.817 . . . . 42.109999999999999 109.331 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.638 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -90.03 -62.57 1.44 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.25 -1.341 . . . . 66.019999999999996 110.184 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -117.91 -172.91 2.34 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.98 0.419 . . . . 451.81 110.736 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.01 -20.19 47.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.357 -0.697 . . . . 104.66 111.357 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.56 -40.13 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.595 0.236 . . . . 328.18000000000001 111.539 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mtp -137.0 153.44 50.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.123 0.487 . . . . 243.28999999999999 111.601 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.73 142.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.625 -0.716 . . . . 58.390000000000001 110.085 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.0 m -123.78 134.62 53.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.946 -0.57 . . . . 44.390000000000001 111.249 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -128.72 147.44 50.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.001 -0.545 . . . . 767.09000000000003 109.911 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -133.8 145.85 50.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.969 0.414 . . . . 146.31999999999999 110.715 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -173.41 115.25 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.837 -0.62 . . . . 15.640000000000001 109.745 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.5 mm-40 -84.78 155.01 22.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.954 0.407 . . . . 422.56 111.014 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -121.96 143.74 49.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.905 -0.588 . . . . 462.10000000000002 109.804 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.506 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 93.7 m -89.32 119.61 29.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.353 -0.385 . . . . 111.17 110.79 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.3 p -152.21 82.49 1.25 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.645 0.736 . . . . 121.65000000000001 110.468 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.66 -5.72 56.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.455 -1.248 . . . . 82.170000000000002 110.737 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.4 m-20 -156.58 149.04 23.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.704 0.287 . . . . 220.46000000000001 110.252 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.03 139.33 39.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.836 0.35 . . . . 149.47999999999999 110.717 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 123.97 4.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 169.86000000000001 110.384 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.455 ' OE2' ' N ' ' A' ' 38' ' ' GLU . 58.2 mp0 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 537.64999999999998 111.135 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.8 p -63.53 150.67 89.66 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.922 -0.581 . . . . 32.920000000000002 110.153 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.03 142.75 28.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.133 1.888 . . . . 87.700000000000003 111.841 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.77 0.82 74.03 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 244.37 110.924 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 mt -107.22 140.82 39.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.943 0.402 . . . . 681.24000000000001 110.524 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.7 p -134.65 64.84 65.11 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.08 -0.509 . . . . 508.5 110.407 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.27 -16.26 22.27 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.602 2.201 . . . . 999.99000000000001 111.766 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -53.35 139.07 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 898.75 110.614 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' OXT' ' CE2' ' A' ' 20' ' ' PHE . . . . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.032 -0.985 . . . . 999.99000000000001 110.572 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.494 -1.442 . . . . 999.99000000000001 109.494 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.34 151.84 27.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.726 0.298 . . . . 999.99000000000001 110.402 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 93.0 m -65.09 146.88 54.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.333 -0.394 . . . . 271.27999999999997 110.298 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -60.36 -43.04 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.316 0.579 . . . . 178.88999999999999 110.132 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -142.96 -170.86 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.129 -0.942 . . . . 206.49000000000001 110.446 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 244.88 110.137 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.27 81.74 0.32 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.493 -1.043 . . . . 71.469999999999999 110.493 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -61.2 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 133.27000000000001 110.597 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.2 m -62.34 -41.44 98.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.895 -0.593 . . . . 25.780000000000001 110.333 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.63 161.41 6.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.521 -0.763 . . . . 119.04000000000001 109.863 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -46.16 91.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.691 -0.403 . . . . 60.490000000000002 110.71 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.5 -38.33 74.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 258.73000000000002 110.525 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 32' ' ' THR . 69.2 mm-40 -75.72 167.88 21.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.702 -0.681 . . . . 339.06 111.018 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 16.2 p -112.57 171.1 7.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.218 -0.446 . . . . 42.960000000000001 110.324 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 48.9 t -152.48 126.92 9.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.453 -0.573 . . . . 39.109999999999999 109.453 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 16' ' ' VAL . 10.2 p -148.86 129.67 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 115.20999999999999 110.512 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 66.3 m-20 -115.05 133.94 55.61 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.071 -0.513 . . . . 135.41999999999999 110.77 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 26' ' ' THR . 20.3 p -126.91 162.02 26.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 45.380000000000003 109.687 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -178.77 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.997 0.903 . . . . 42.109999999999999 109.455 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.78 -53.26 3.47 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.938 -1.483 . . . . 66.019999999999996 110.684 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.3 pt-20 -120.37 -178.05 3.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.307 0.575 . . . . 451.81 111.419 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.61 -11.16 59.62 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.148 -0.933 . . . . 104.66 111.049 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.6 t0 -62.73 -44.38 96.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.806 0.336 . . . . 328.18000000000001 111.13 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.3 ttp -155.12 147.3 23.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 243.28999999999999 110.92 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.36 142.71 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 58.390000000000001 110.403 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 18' ' ' THR . 73.1 m -117.05 133.59 55.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 44.390000000000001 110.798 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -151.6 163.45 39.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.178 -0.465 . . . . 767.09000000000003 110.398 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -149.47 148.03 28.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.054 0.454 . . . . 146.31999999999999 110.813 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.9 t -169.36 114.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 15.640000000000001 109.388 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.6 159.77 20.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 422.56 111.331 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -124.57 142.94 50.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.053 -0.521 . . . . 462.10000000000002 110.176 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.505 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 99.8 m -84.87 121.55 27.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 111.17 110.371 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.8 p -153.57 90.06 1.38 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.373 0.606 . . . . 121.65000000000001 110.61 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 -40.35 0.82 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.926 -1.034 . . . . 82.170000000000002 110.957 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 33' ' ' THR . 81.4 m-20 -134.62 139.42 45.31 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.845 0.355 . . . . 220.46000000000001 110.212 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.11 150.49 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 149.47999999999999 110.975 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.63 122.36 5.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 169.86000000000001 110.131 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' CYS . 88.1 tt0 -81.5 148.7 29.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.832 -0.622 . . . . 537.64999999999998 111.332 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -41.08 164.4 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.857 -0.61 . . . . 32.920000000000002 110.159 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -75.89 142.77 25.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.398 2.065 . . . . 87.700000000000003 111.789 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.94 -39.88 98.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 244.37 110.865 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.5 mt -115.71 147.94 40.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.816 0.341 . . . . 681.24000000000001 110.308 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.4 p -68.11 149.68 98.05 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.248 -0.433 . . . . 508.5 110.378 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.77 5.29 3.48 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.205 1.937 . . . . 999.99000000000001 111.768 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.0 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 898.75 110.235 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 118.08 -0.962 . . . . 999.99000000000001 110.548 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.435 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.504 -1.438 . . . . 999.99000000000001 109.504 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.6 mt -72.4 148.92 44.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.313 . . . . 999.99000000000001 110.399 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.1 m -60.44 133.83 56.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 271.27999999999997 110.64 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t -64.44 -42.51 95.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.358 0.599 . . . . 178.88999999999999 109.804 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -141.2 -164.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.069 -0.969 . . . . 206.49000000000001 110.614 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.69 -39.98 90.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.415 -0.357 . . . . 244.88 110.686 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.38 85.98 0.38 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.749 -0.94 . . . . 71.469999999999999 110.749 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -62.61 -43.38 98.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.705 0.288 . . . . 133.27000000000001 110.991 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.2 m -62.0 -43.11 99.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 25.780000000000001 110.281 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -166.66 166.04 16.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.391 -0.822 . . . . 119.04000000000001 109.825 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.87 96.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.904 -0.319 . . . . 60.490000000000002 111.175 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -83.99 -32.46 24.96 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.842 0.353 . . . . 258.73000000000002 111.3 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -75.75 160.35 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 339.06 110.842 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.4 t -115.98 149.67 38.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.351 -0.386 . . . . 42.960000000000001 110.113 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.3 p -135.64 153.69 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.723 -0.473 . . . . 39.109999999999999 109.723 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.5 p -165.87 117.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.486 -0.486 . . . . 115.20999999999999 110.515 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 1' ' ' GLY . 97.4 m-20 -103.5 119.63 39.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.185 -0.461 . . . . 135.41999999999999 110.852 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.954 -0.566 . . . . 45.380000000000003 109.774 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.72 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 122.079 0.943 . . . . 42.109999999999999 109.074 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.648 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.19 -94.1 0.17 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.876 -1.511 . . . . 66.019999999999996 111.428 -178.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -79.98 -19.67 47.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.189 -0.914 . . . . 451.81 111.131 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.92 -10.14 72.37 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.264 -0.734 . . . . 104.66 111.264 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.52 -41.79 95.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 328.18000000000001 109.487 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.443 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.9 mtm -138.6 99.17 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.358 -0.837 . . . . 243.28999999999999 109.414 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.88 145.2 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.208 0.528 . . . . 58.390000000000001 110.858 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 m -125.74 136.95 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.398 -0.819 . . . . 44.390000000000001 110.954 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -149.76 160.65 43.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 767.09000000000003 110.638 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -152.53 150.5 29.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.351 -0.386 . . . . 146.31999999999999 110.775 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.9 t -169.96 126.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.914 -0.585 . . . . 15.640000000000001 109.734 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.04 152.54 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 422.56 111.007 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -116.49 142.69 46.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.984 -0.553 . . . . 462.10000000000002 109.969 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 91.5 m -71.58 124.97 25.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.989 0.423 . . . . 111.17 110.508 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -154.05 89.43 1.3 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.417 0.627 . . . . 121.65000000000001 110.543 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.81 -47.14 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.928 -1.033 . . . . 82.170000000000002 111.005 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -135.06 138.76 44.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.791 0.329 . . . . 220.46000000000001 110.253 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.9 m-85 -83.73 148.09 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 149.47999999999999 110.659 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.7 p -125.85 -144.96 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.951 0.405 . . . . 169.86000000000001 110.069 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -156.89 143.57 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 537.64999999999998 110.536 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.3 p -62.15 149.51 86.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 32.920000000000002 110.005 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 135.25 16.77 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.071 1.847 . . . . 87.700000000000003 111.74 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.93 -42.89 99.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.723 -0.951 . . . . 244.37 110.723 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.8 mt -127.49 140.03 52.41 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.97 -0.381 . . . . 681.24000000000001 109.97 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.1 m -110.15 116.04 53.87 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.435 -0.348 . . . . 508.5 110.235 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.62 64.15 8.11 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.259 1.973 . . . . 999.99000000000001 112.026 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.07 141.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 898.75 110.631 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.002 -0.999 . . . . 999.99000000000001 110.459 179.977 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.592 -1.403 . . . . 999.99000000000001 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.62 149.64 36.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.679 0.276 . . . . 999.99000000000001 110.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.493 ' C ' ' H ' ' A' ' 5' ' ' GLU . 77.0 m -62.09 -40.93 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 271.27999999999997 110.609 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER 75.17 -32.66 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 178.88999999999999 110.56 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.5 pt-20 -150.69 168.12 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 206.49000000000001 110.596 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.6 -39.89 89.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.357 -0.383 . . . . 244.88 110.929 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.91 68.24 0.28 Allowed Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.17 -0.772 . . . . 71.469999999999999 111.17 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.9 -48.56 78.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.987 0.422 . . . . 133.27000000000001 110.617 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.99 -41.41 97.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.855 -0.611 . . . . 25.780000000000001 109.931 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.1 162.91 9.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.161 -0.927 . . . . 119.04000000000001 109.246 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.98 90.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.511 -0.476 . . . . 60.490000000000002 110.666 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.45 -37.83 71.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 258.73000000000002 110.857 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.14 161.14 30.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 339.06 111.163 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 50.2 t -111.05 158.98 18.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.157 -0.474 . . . . 42.960000000000001 110.411 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 49.7 t -149.13 130.35 14.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.441 -0.577 . . . . 39.109999999999999 109.441 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 16' ' ' VAL . 13.3 p -149.14 129.89 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 115.20999999999999 110.434 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -93.0 119.21 32.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 135.41999999999999 110.772 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p -103.69 161.66 13.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.994 -0.548 . . . . 45.380000000000003 109.949 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.0 p 179.54 117.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.796 0.808 . . . . 42.109999999999999 109.325 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -104.12 -62.8 1.27 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.357 -1.292 . . . . 66.019999999999996 111.28 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.9 pt-20 -103.23 -178.49 3.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.452 0.644 . . . . 451.81 111.991 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.77 -10.12 59.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.992 -1.004 . . . . 104.66 111.445 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 66.4 t0 -60.77 -44.48 96.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 328.18000000000001 110.927 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.82 170.18 22.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.013 -0.539 . . . . 243.28999999999999 111.022 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.85 143.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.896 -0.593 . . . . 58.390000000000001 110.512 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.8 m -117.44 134.02 55.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 44.390000000000001 111.338 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -126.27 147.06 49.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.966 -0.561 . . . . 767.09000000000003 109.708 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -135.1 153.11 52.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.887 0.375 . . . . 146.31999999999999 110.727 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 3.0 t -166.0 132.17 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 15.640000000000001 109.952 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 75.5 mm-40 -81.39 155.74 25.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 422.56 111.439 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 143.17 50.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.584 -0.735 . . . . 462.10000000000002 109.399 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.482 HG23 ' CE2' ' A' ' 36' ' ' PHE . 98.2 m -85.61 121.34 28.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 111.17 110.68 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -152.29 88.81 1.39 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.82 -0.627 . . . . 121.65000000000001 110.42 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -50.88 1.6 Allowed Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.947 -1.024 . . . . 82.170000000000002 111.04 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.49 137.53 48.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.758 0.313 . . . . 220.46000000000001 110.434 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 32' ' ' THR . 97.0 m-85 -84.15 149.77 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 149.47999999999999 110.506 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 43.3 p -124.85 -145.2 0.33 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.847 0.356 . . . . 169.86000000000001 110.156 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 88.2 tt0 -152.86 139.31 18.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 537.64999999999998 110.77 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -57.05 152.37 29.46 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.96 -0.564 . . . . 32.920000000000002 109.994 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.14 157.38 46.43 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.343 2.029 . . . . 87.700000000000003 111.767 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.47 -90.7 2.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.997 -0.841 . . . . 244.37 110.997 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.2 mt -77.14 143.76 38.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 681.24000000000001 110.697 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.4 p -72.33 150.62 91.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.021 -0.536 . . . . 508.5 110.164 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.07 -8.95 19.15 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.129 1.886 . . . . 999.99000000000001 111.659 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.96 129.45 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.041 -0.527 . . . . 898.75 110.594 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.012 -0.994 . . . . 999.99000000000001 110.571 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 999.99000000000001 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.79 144.09 44.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.664 0.269 . . . . 999.99000000000001 110.416 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.6 m -78.58 -177.63 5.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 271.27999999999997 110.198 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -58.81 -44.48 90.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 178.88999999999999 110.388 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' A' ' 7' ' ' GLY . 21.3 pt-20 -153.1 47.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.636 -0.711 . . . . 206.49000000000001 110.829 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 60.18 -5.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 244.88 111.569 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 5' ' ' GLU . . . -155.9 60.71 0.36 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.464 -1.054 . . . . 71.469999999999999 110.464 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 9' ' ' CYS . 52.8 p-10 -61.17 -29.25 69.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.727 0.298 . . . . 133.27000000000001 110.777 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 97.1 m -62.12 -43.19 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.324 0.583 . . . . 25.780000000000001 109.933 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.81 162.31 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.119 -0.946 . . . . 119.04000000000001 109.429 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.49 93.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.512 -0.475 . . . . 60.490000000000002 110.557 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.25 -38.36 68.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 258.73000000000002 110.965 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 32' ' ' THR . 75.8 mm-40 -72.33 157.96 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 339.06 111.435 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.2 t -104.24 156.44 17.9 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.986 -0.552 . . . . 42.960000000000001 110.327 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 54.1 t -147.73 128.86 14.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 39.109999999999999 109.99 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.3 134.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 115.20999999999999 110.251 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -101.0 119.47 38.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 135.41999999999999 110.994 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 p -100.38 164.53 11.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.911 -0.586 . . . . 45.380000000000003 110.018 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.08 119.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.131 0.967 . . . . 42.109999999999999 108.899 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.32 -95.09 0.16 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.74 -1.573 . . . . 66.019999999999996 111.469 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.42 -21.56 38.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.072 -0.967 . . . . 451.81 110.738 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.03 65.43 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.313 -0.715 . . . . 104.66 111.313 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.61 -39.64 84.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.203 -0.666 . . . . 328.18000000000001 109.203 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' A' ' 24' ' ' MET . 19.1 tmm? -148.87 105.51 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.302 -0.863 . . . . 243.28999999999999 108.874 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 24' ' ' MET . 77.7 t -63.9 145.49 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.281 0.562 . . . . 58.390000000000001 111.343 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.7 m -125.09 135.14 52.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.288 -0.869 . . . . 44.390000000000001 110.945 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -128.55 148.83 50.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 767.09000000000003 109.909 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -132.95 144.55 50.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.855 0.36 . . . . 146.31999999999999 110.696 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.57 115.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 15.640000000000001 110.007 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.17 152.36 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 422.56 110.627 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -115.15 142.38 46.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.329 -0.396 . . . . 462.10000000000002 110.255 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.462 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 88.2 m -71.11 125.9 28.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 111.17 110.511 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.84 89.47 1.39 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.395 0.617 . . . . 121.65000000000001 110.503 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.44 -44.06 0.92 Allowed Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.932 -1.031 . . . . 82.170000000000002 110.887 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.0 m120 -136.41 139.32 42.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.82 0.343 . . . . 220.46000000000001 110.157 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.28 146.55 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 149.47999999999999 110.749 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.2 p -127.7 -146.79 0.34 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.284 -0.416 . . . . 169.86000000000001 109.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -160.92 148.42 15.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 537.64999999999998 110.595 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 8.1 p -61.88 149.9 84.22 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.229 -0.441 . . . . 32.920000000000002 109.89 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.76 134.62 18.47 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.064 1.842 . . . . 87.700000000000003 112.0 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.85 98.34 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.87 -0.892 . . . . 244.37 110.87 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 mt -95.14 151.89 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 681.24000000000001 110.349 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.4 p -65.89 149.61 97.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 508.5 110.116 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.69 -9.89 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.011 1.807 . . . . 999.99000000000001 111.462 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.41 -45.08 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 898.75 110.324 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 117.975 -1.012 . . . . 999.99000000000001 110.598 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.478 -1.449 . . . . 999.99000000000001 109.478 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.2 mt -107.41 143.94 35.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.237 -0.282 . . . . 999.99000000000001 110.237 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 82.1 m -63.97 142.81 58.27 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.837 -0.345 . . . . 271.27999999999997 110.16 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 t -60.52 -43.8 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 178.88999999999999 110.185 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.8 -164.86 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.184 -0.916 . . . . 206.49000000000001 110.437 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.84 -39.49 85.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.914 0.388 . . . . 244.88 110.198 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.29 76.88 0.4 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.533 -1.027 . . . . 71.469999999999999 110.533 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.31 -43.53 98.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 133.27000000000001 110.614 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.1 m -62.06 -41.47 98.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 25.780000000000001 110.313 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.28 165.98 8.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.482 -0.781 . . . . 119.04000000000001 109.928 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.33 96.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.757 -0.377 . . . . 60.490000000000002 110.757 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.93 -33.53 33.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 258.73000000000002 110.958 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.5 mm-40 -74.3 158.01 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 339.06 111.293 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 34.1 t -107.71 154.31 21.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.984 -0.553 . . . . 42.960000000000001 110.614 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 42.6 t -142.8 128.12 18.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.58 -0.526 . . . . 39.109999999999999 109.58 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -151.11 128.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.905 -0.406 . . . . 115.20999999999999 109.905 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 70.1 m-20 -107.97 118.11 35.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 135.41999999999999 111.39 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -102.82 166.44 10.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.459 -0.791 . . . . 45.380000000000003 109.449 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 19' ' ' VAL . 3.5 p -179.57 117.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.909 0.861 . . . . 42.109999999999999 109.502 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.93 -62.18 1.33 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.174 -1.375 . . . . 66.019999999999996 110.784 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.2 pt-20 -114.9 -172.17 2.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.06 0.457 . . . . 451.81 111.284 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.09 -12.75 54.65 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.754 -0.657 . . . . 104.66 111.864 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.46 -40.72 95.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.668 0.271 . . . . 328.18000000000001 111.183 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 ttp -157.08 153.02 27.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.371 -0.377 . . . . 243.28999999999999 110.904 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -115.59 140.94 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.163 0.506 . . . . 58.390000000000001 110.67 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.4 m -110.96 132.3 54.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.514 -0.766 . . . . 44.390000000000001 111.373 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -133.98 148.3 51.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 767.09000000000003 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -138.45 147.71 43.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.926 0.393 . . . . 146.31999999999999 110.772 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.9 115.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 15.640000000000001 109.912 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -80.56 152.8 28.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 422.56 110.631 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.68 143.41 45.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.147 -0.479 . . . . 462.10000000000002 110.205 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.517 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.0 m -73.79 125.05 27.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 111.17 110.485 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.9 p -153.34 89.49 1.35 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.383 0.611 . . . . 121.65000000000001 110.559 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.16 -41.14 0.74 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.898 -1.046 . . . . 82.170000000000002 111.017 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 33' ' ' THR . 83.0 m-20 -133.93 140.05 46.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 220.46000000000001 110.341 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.04 144.81 26.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.157 -0.474 . . . . 149.47999999999999 110.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.6 p -134.52 -157.66 0.82 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.438 -0.579 . . . . 169.86000000000001 109.438 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -149.59 155.33 40.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.441 -0.8 . . . . 537.64999999999998 110.655 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.5 p -65.92 149.76 97.22 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.675 -0.491 . . . . 32.920000000000002 109.675 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.96 131.3 16.68 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.978 1.785 . . . . 87.700000000000003 111.946 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.98 98.36 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.063 -0.815 . . . . 244.37 111.063 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.25 139.32 44.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.849 0.357 . . . . 681.24000000000001 110.304 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.2 p -71.01 150.45 94.94 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.196 -0.456 . . . . 508.5 110.049 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.55 -11.94 16.98 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.963 1.776 . . . . 999.99000000000001 111.282 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.87 127.3 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 898.75 110.693 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.108 -0.949 . . . . 999.99000000000001 110.582 -179.992 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.48 -1.448 . . . . 999.99000000000001 109.48 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.5 mt -73.63 144.41 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.662 0.267 . . . . 999.99000000000001 110.287 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 71.7 m -69.0 135.99 51.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.863 -0.335 . . . . 271.27999999999997 110.16 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.36 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.286 0.565 . . . . 178.88999999999999 110.002 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 9.7 pt-20 -149.27 -162.76 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.125 -0.943 . . . . 206.49000000000001 110.379 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -39.39 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 244.88 110.139 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -127.4 75.09 0.42 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.538 -1.025 . . . . 71.469999999999999 110.538 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -61.42 -43.12 99.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.939 0.4 . . . . 133.27000000000001 110.679 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.5 m -61.65 -42.56 99.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.007 -0.542 . . . . 25.780000000000001 110.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.93 167.13 13.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.334 -0.848 . . . . 119.04000000000001 109.871 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.5 95.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.515 -0.312 . . . . 60.490000000000002 111.117 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.44 -30.29 23.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.473 -0.331 . . . . 258.73000000000002 111.273 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.51 154.14 37.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 339.06 110.979 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 39.0 t -104.51 148.87 25.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.219 -0.446 . . . . 42.960000000000001 110.727 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.437 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 42.1 t -135.92 123.97 22.9 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.554 -0.535 . . . . 39.109999999999999 109.554 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.4 p -143.33 127.69 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.913 0.387 . . . . 115.20999999999999 110.21 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 3' ' ' CYS . 43.1 m-20 -109.66 118.78 37.46 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.047 -0.524 . . . . 135.41999999999999 111.022 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 46.5 p -104.54 167.53 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.826 -0.625 . . . . 45.380000000000003 109.867 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p 179.34 117.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.936 0.874 . . . . 42.109999999999999 109.304 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -100.57 -71.19 0.71 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.069 -1.423 . . . . 66.019999999999996 110.815 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.4 pt-20 -95.67 -177.57 4.1 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.608 -0.723 . . . . 451.81 111.782 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.05 -10.42 57.43 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.115 -0.948 . . . . 104.66 111.098 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.3 t0 -60.38 -43.71 96.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 328.18000000000001 110.975 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -159.39 168.99 24.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 243.28999999999999 110.963 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.919 -0.582 . . . . 58.390000000000001 110.852 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 51.5 m -121.72 138.13 54.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.504 -0.771 . . . . 44.390000000000001 111.251 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -150.5 158.09 43.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.264 -0.425 . . . . 767.09000000000003 110.492 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.8 m -142.31 153.76 44.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 146.31999999999999 111.078 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -167.05 121.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.8 -0.636 . . . . 15.640000000000001 109.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -83.95 155.09 23.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.014 0.435 . . . . 422.56 111.38 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.4 143.52 45.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.727 -0.67 . . . . 462.10000000000002 110.067 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.1 m -78.53 124.29 28.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 111.17 110.729 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ASN . 34.0 p -152.91 89.03 1.35 Allowed 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.451 0.643 . . . . 121.65000000000001 110.518 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 -38.84 0.76 Allowed Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.899 -1.046 . . . . 82.170000000000002 111.222 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.7 m-20 -135.72 141.2 44.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.875 0.369 . . . . 220.46000000000001 110.365 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -90.03 146.5 24.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 149.47999999999999 110.573 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.8 p -132.77 -156.21 0.73 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.511 -0.552 . . . . 169.86000000000001 109.511 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -148.29 153.33 38.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.6 -0.727 . . . . 537.64999999999998 110.655 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 p -65.45 149.86 96.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.586 -0.524 . . . . 32.920000000000002 109.586 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.44 131.03 15.71 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.014 1.809 . . . . 87.700000000000003 112.121 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.83 -40.17 97.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.173 -0.771 . . . . 244.37 111.173 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.1 mt -109.3 149.02 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.929 0.395 . . . . 681.24000000000001 110.584 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.1 p -69.8 150.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 508.5 110.076 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.84 -13.13 17.83 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.14 1.894 . . . . 999.99000000000001 111.298 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -72.52 128.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.7 . . . . 898.75 110.613 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.034 -0.984 . . . . 999.99000000000001 110.539 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.796 0.332 . . . . 206.49000000000001 110.585 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.77 -42.81 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 244.88 110.947 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.07 53.64 1.61 Allowed Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.465 -0.654 . . . . 71.469999999999999 111.465 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.61 -46.53 87.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.83 0.348 . . . . 133.27000000000001 110.699 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.18 -42.08 99.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.289 0.566 . . . . 25.780000000000001 110.139 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.84 168.5 7.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.278 -0.874 . . . . 119.04000000000001 109.897 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.98 97.23 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.862 -0.335 . . . . 60.490000000000002 110.932 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.97 -32.15 27.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.429 -0.35 . . . . 258.73000000000002 111.023 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -75.1 166.98 22.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 339.06 110.938 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -130.9 143.89 51.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.01 -0.541 . . . . 42.960000000000001 110.629 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -135.58 138.53 43.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.3 -0.629 . . . . 39.109999999999999 109.3 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.9 p -148.3 118.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.56 -0.456 . . . . 115.20999999999999 110.402 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -75.61 118.93 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 135.41999999999999 111.094 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.499 ' HG1' ' C ' ' A' ' 26' ' ' THR . 16.2 p -97.53 160.57 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 45.380000000000003 109.344 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p 179.53 117.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.921 0.867 . . . . 42.109999999999999 109.252 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.42 -56.63 2.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.269 -1.332 . . . . 66.019999999999996 111.387 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 22.6 pt-20 -113.41 -174.5 2.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.188 0.518 . . . . 451.81 111.77 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.41 -9.62 57.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.352 -0.84 . . . . 104.66 111.911 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.435 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.11 -41.1 96.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.879 0.371 . . . . 328.18000000000001 110.85 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -163.01 169.42 19.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 243.28999999999999 110.866 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.78 143.13 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.554 . . . . 58.390000000000001 110.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.499 ' C ' ' HG1' ' A' ' 18' ' ' THR . 99.4 m -117.25 137.43 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.503 -0.771 . . . . 44.390000000000001 111.168 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -125.79 156.23 39.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.871 -0.604 . . . . 767.09000000000003 109.531 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -147.96 159.25 44.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.303 0.573 . . . . 146.31999999999999 111.253 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.6 t -175.14 137.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.41 -0.814 . . . . 15.640000000000001 109.194 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -110.67 134.74 52.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.948 0.404 . . . . 422.56 110.948 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -86.56 140.41 29.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.893 -0.594 . . . . 462.10000000000002 109.707 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -89.99 102.71 15.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.964 0.412 . . . . 111.17 110.659 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ASN . 21.5 m -138.04 126.51 23.39 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.495 0.664 . . . . 121.65000000000001 110.032 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.25 -71.11 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 CA-C-N 114.663 -1.153 . . . . 82.170000000000002 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 33' ' ' THR . 84.2 m-20 -111.98 142.21 44.68 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.789 -0.448 . . . . 220.46000000000001 109.789 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -70.92 143.86 50.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 149.47999999999999 110.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 p -147.02 117.05 7.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.134 -0.485 . . . . 169.86000000000001 110.209 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.42 161.61 23.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 537.64999999999998 110.978 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.5 p -64.05 150.19 92.4 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.855 -0.612 . . . . 32.920000000000002 110.143 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.01 137.56 21.85 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.069 1.846 . . . . 87.700000000000003 111.768 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.13 7.41 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.793 -0.923 . . . . 244.37 110.793 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.857 0.36 . . . . 681.24000000000001 110.617 -179.612 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 21.9 pt-20 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.21 -0.293 . . . . 206.49000000000001 110.21 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.41 85.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.872 0.368 . . . . 244.88 110.185 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -122.99 65.24 0.52 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.622 -0.991 . . . . 71.469999999999999 110.622 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.06 -41.72 97.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 133.27000000000001 110.588 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.9 m -61.31 -41.17 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 25.780000000000001 110.173 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.61 166.46 14.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.778 . . . . 119.04000000000001 109.954 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.48 95.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 60.490000000000002 110.926 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.22 -29.61 24.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 258.73000000000002 111.055 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.469 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.0 mm-40 -76.14 159.97 30.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.414 . . . . 339.06 111.136 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 35.1 t -109.88 153.3 24.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.922 -0.581 . . . . 42.960000000000001 110.366 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.7 t -144.65 127.27 16.11 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.242 -0.651 . . . . 39.109999999999999 109.242 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 16' ' ' VAL . 13.8 p -147.61 128.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 115.20999999999999 110.614 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -99.28 132.87 44.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 135.41999999999999 110.733 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 24.0 p -122.32 161.09 24.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.871 -0.604 . . . . 45.380000000000003 109.51 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 179.27 118.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.988 0.899 . . . . 42.109999999999999 109.2 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.13 -64.06 1.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.972 -1.467 . . . . 66.019999999999996 110.973 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.7 pt-20 -109.89 -173.06 2.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.122 0.487 . . . . 451.81 111.479 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.69 -11.62 56.64 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.574 -0.739 . . . . 104.66 111.858 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.25 -39.93 92.17 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.927 -0.309 . . . . 328.18000000000001 110.957 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ptm -159.11 167.23 29.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 243.28999999999999 111.001 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.3 t -123.17 143.37 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.859 -0.61 . . . . 58.390000000000001 110.571 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 84.1 m -118.26 135.68 54.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.51 -0.768 . . . . 44.390000000000001 110.988 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -142.47 155.3 45.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.082 -0.508 . . . . 767.09000000000003 110.032 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -140.94 149.2 41.54 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.015 0.436 . . . . 146.31999999999999 111.012 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -172.09 116.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 15.640000000000001 109.794 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -82.2 150.1 27.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 422.56 110.88 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -112.75 141.71 46.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.086 -0.506 . . . . 462.10000000000002 109.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.469 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 92.4 m -69.34 126.73 30.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 111.17 110.529 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 p -151.03 89.44 1.53 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.417 0.627 . . . . 121.65000000000001 110.448 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.08 -47.93 1.34 Allowed Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 114.984 -1.007 . . . . 82.170000000000002 110.946 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -131.77 139.84 49.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.1 -0.333 . . . . 220.46000000000001 110.1 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -82.51 145.42 29.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 149.47999999999999 110.781 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.8 p -129.5 -145.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.132 -0.486 . . . . 169.86000000000001 109.892 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -161.16 154.35 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.062 -0.517 . . . . 537.64999999999998 110.836 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 12.4 p -66.91 149.7 98.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 32.920000000000002 110.054 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.89 136.33 20.5 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.141 1.894 . . . . 87.700000000000003 111.849 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.38 -39.99 98.39 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.987 -0.845 . . . . 244.37 110.987 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.858 0.361 . . . . 681.24000000000001 110.463 -179.831 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 110.252 -0.277 . . . . 206.49000000000001 110.252 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.16 -39.63 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 244.88 110.242 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.64 62.76 0.44 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.628 -0.989 . . . . 71.469999999999999 110.628 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.6 -46.55 89.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 133.27000000000001 110.766 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.5 m -63.1 -41.86 99.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 25.780000000000001 110.299 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.54 163.56 6.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.312 -0.858 . . . . 119.04000000000001 109.585 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.78 91.8 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.488 -0.485 . . . . 60.490000000000002 110.405 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.33 -38.69 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 258.73000000000002 110.48 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.26 156.52 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 339.06 110.515 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.656 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 1.8 p -108.12 171.22 7.53 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.197 -0.297 . . . . 42.960000000000001 110.197 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -156.17 127.71 7.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.312 -0.625 . . . . 39.109999999999999 109.312 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.95 129.13 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 115.20999999999999 110.38 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -94.9 120.26 34.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.017 -0.538 . . . . 135.41999999999999 110.948 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 26' ' ' THR . 15.5 p -104.4 164.86 11.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.034 -0.53 . . . . 45.380000000000003 109.653 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.04 119.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.833 0.825 . . . . 42.109999999999999 109.087 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.16 -65.94 0.93 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.336 -1.302 . . . . 66.019999999999996 111.013 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.0 pt-20 -108.66 -171.97 1.96 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.11 0.481 . . . . 451.81 111.567 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.35 -13.34 52.14 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.694 -0.685 . . . . 104.66 111.973 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.7 m-20 -60.54 -41.58 94.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 328.18000000000001 110.722 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptp -160.87 161.71 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.922 -0.581 . . . . 243.28999999999999 110.495 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.14 160.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.907 -0.588 . . . . 58.390000000000001 110.956 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 18' ' ' THR . 78.0 m -129.75 138.55 51.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.734 -0.666 . . . . 44.390000000000001 111.232 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -128.13 154.51 45.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.578 . . . . 767.09000000000003 109.817 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -141.9 148.38 38.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.043 0.449 . . . . 146.31999999999999 110.822 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -171.92 101.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 15.640000000000001 109.339 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.656 ' CG ' ' H ' ' A' ' 14' ' ' CYS . 9.4 pt-20 -60.65 163.47 5.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.356 0.598 . . . . 422.56 111.375 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -136.35 143.27 43.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.833 -1.076 . . . . 462.10000000000002 110.07 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.1 m -112.06 122.8 48.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.909 0.385 . . . . 111.17 110.76 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.1 p -154.16 84.27 1.14 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.607 0.717 . . . . 121.65000000000001 110.321 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.88 -5.24 58.73 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.517 -1.22 . . . . 82.170000000000002 110.442 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.4 m-20 -154.77 149.37 26.4 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.936 -0.394 . . . . 220.46000000000001 109.936 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.88 143.21 32.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 149.47999999999999 110.935 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 37' ' ' THR . 10.2 t -155.46 124.53 6.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 169.86000000000001 110.107 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.6 mp0 -81.71 159.41 23.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.625 . . . . 537.64999999999998 110.808 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 160.23 0.22 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.466 -0.568 . . . . 32.920000000000002 109.466 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.09 133.04 15.99 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.06 1.84 . . . . 87.700000000000003 111.894 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.22 -40.36 98.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 244.37 111.212 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.549 -179.703 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.716 0.293 . . . . 206.49000000000001 110.607 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.34 84.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.882 0.373 . . . . 244.88 110.192 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.2 75.13 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.633 -0.987 . . . . 71.469999999999999 110.633 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 133.27000000000001 110.624 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.1 m -62.49 -41.77 99.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 25.780000000000001 110.202 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.73 163.15 9.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 119.04000000000001 110.09 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.38 88.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 60.490000000000002 110.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -91.89 11.4 25.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.256 -0.429 . . . . 258.73000000000002 111.441 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.0 mm-40 -119.12 159.4 24.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.071 0.462 . . . . 339.06 111.051 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.4 t -104.35 155.17 19.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.769 -0.65 . . . . 42.960000000000001 110.656 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 41.9 t -146.13 127.73 15.14 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.455 -0.572 . . . . 39.109999999999999 109.455 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.57 130.54 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 115.20999999999999 110.336 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -106.89 123.32 47.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.183 -0.462 . . . . 135.41999999999999 111.078 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -110.12 161.99 15.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.787 -0.642 . . . . 45.380000000000003 109.546 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.1 p -178.33 116.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 122.008 0.909 . . . . 42.109999999999999 109.636 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.81 -57.78 2.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.139 -1.391 . . . . 66.019999999999996 110.748 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.7 pt-20 -116.37 -176.78 3.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.296 0.569 . . . . 451.81 111.428 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.9 -12.27 56.81 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.197 -0.911 . . . . 104.66 111.048 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.5 t0 -61.69 -44.47 96.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.417 . . . . 328.18000000000001 111.211 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.9 ttp -154.28 145.0 22.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 243.28999999999999 110.924 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.03 143.28 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.002 -0.544 . . . . 58.390000000000001 110.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.3 m -115.28 132.61 56.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.589 -0.732 . . . . 44.390000000000001 111.083 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -132.65 155.36 48.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.983 -0.553 . . . . 767.09000000000003 109.939 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 t -144.47 146.22 32.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.946 0.403 . . . . 146.31999999999999 110.72 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.4 t -173.65 116.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 15.640000000000001 109.803 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 78.7 mm-40 -85.04 154.84 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 422.56 110.898 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.13 143.97 49.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.899 -0.591 . . . . 462.10000000000002 109.881 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.495 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 95.2 m -88.91 119.39 29.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.949 0.404 . . . . 111.17 110.751 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.2 p -153.01 82.68 1.21 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.559 0.695 . . . . 121.65000000000001 110.577 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 78.5 -4.46 59.76 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.501 -1.227 . . . . 82.170000000000002 110.935 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 34' ' ' GLY . 33.2 m120 -159.01 148.66 18.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 220.46000000000001 110.398 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.37 140.26 37.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.34 -0.391 . . . . 149.47999999999999 110.626 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.61 124.39 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.988 0.423 . . . . 169.86000000000001 110.444 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.4 mp0 -82.44 166.07 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 537.64999999999998 111.035 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.7 p -62.51 150.59 85.46 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.921 -0.582 . . . . 32.920000000000002 110.05 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.05 140.96 23.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.057 1.838 . . . . 87.700000000000003 111.964 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.72 -40.45 99.21 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 244.37 110.883 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.784 0.325 . . . . 681.24000000000001 110.213 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.719 0.295 . . . . 206.49000000000001 110.331 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.17 -39.56 86.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 244.88 110.217 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.3 64.89 0.5 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.605 -0.998 . . . . 71.469999999999999 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -60.86 -45.22 95.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.803 0.335 . . . . 133.27000000000001 110.656 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.4 m -62.51 -41.59 98.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.219 0.533 . . . . 25.780000000000001 110.167 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.18 165.8 7.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.388 -0.823 . . . . 119.04000000000001 109.899 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.35 95.74 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.828 -0.349 . . . . 60.490000000000002 110.821 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.59 -32.38 25.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 258.73000000000002 111.282 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 32' ' ' THR . 76.9 mm-40 -74.22 153.97 39.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 339.06 111.188 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.5 t -101.02 156.48 17.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.927 -0.578 . . . . 42.960000000000001 110.284 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -151.43 129.81 12.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.325 -0.62 . . . . 39.109999999999999 109.325 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 131.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 115.20999999999999 110.63 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -95.54 120.05 35.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.03 -0.532 . . . . 135.41999999999999 110.65 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -107.02 161.97 14.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.041 -0.527 . . . . 45.380000000000003 110.07 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.0 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.979 0.895 . . . . 42.109999999999999 108.981 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.635 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -93.61 -94.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.84 -1.527 . . . . 66.019999999999996 111.443 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -80.37 -18.65 48.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.202 -0.908 . . . . 451.81 111.239 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.19 -8.43 75.59 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.204 -0.758 . . . . 104.66 111.204 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.56 -42.12 91.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 328.18000000000001 109.388 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.404 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.6 ttp -142.57 104.59 4.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.312 -0.858 . . . . 243.28999999999999 109.284 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.27 146.9 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 58.390000000000001 110.96 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.2 m -125.37 134.66 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.354 -0.839 . . . . 44.390000000000001 110.944 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.74 146.23 51.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.006 -0.543 . . . . 767.09000000000003 109.903 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -134.09 145.38 49.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.87 0.367 . . . . 146.31999999999999 110.639 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -172.86 116.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 15.640000000000001 109.994 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -80.04 153.57 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 422.56 110.865 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.45 142.61 46.64 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.047 -0.524 . . . . 462.10000000000002 110.017 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.518 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.4 m -68.05 126.3 29.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.064 0.459 . . . . 111.17 110.374 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.8 p -151.31 88.85 1.46 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.827 -0.624 . . . . 121.65000000000001 110.539 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -47.65 1.22 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 114.875 -1.057 . . . . 82.170000000000002 110.979 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -133.34 138.72 46.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.158 -0.312 . . . . 220.46000000000001 110.158 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.428 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.3 m-85 -83.18 146.41 28.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 149.47999999999999 110.573 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -133.36 -144.84 0.23 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.253 -0.431 . . . . 169.86000000000001 110.118 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.21 159.14 35.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 537.64999999999998 110.739 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.42 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.4 p -57.33 152.04 34.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.091 -0.504 . . . . 32.920000000000002 109.993 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.31 135.39 20.43 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.313 2.009 . . . . 87.700000000000003 112.259 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.35 96.88 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.706 -0.958 . . . . 244.37 110.706 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.876 0.37 . . . . 681.24000000000001 110.302 -179.767 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 21.9 pt-20 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.917 0.389 . . . . 206.49000000000001 110.791 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 244.88 110.418 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -68.53 -9.38 58.34 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.452 -0.659 . . . . 71.469999999999999 111.452 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.29 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.808 -0.357 . . . . 133.27000000000001 110.514 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.3 m -62.55 -43.68 98.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 25.780000000000001 109.848 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.42 165.55 3.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.27 -0.877 . . . . 119.04000000000001 109.854 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.5 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.937 -0.305 . . . . 60.490000000000002 111.079 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.79 -31.18 26.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.441 -0.345 . . . . 258.73000000000002 111.379 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 32' ' ' THR . 77.7 mm-40 -75.0 156.54 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.913 0.387 . . . . 339.06 111.356 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 t -108.85 157.81 18.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.935 -0.575 . . . . 42.960000000000001 110.395 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 48.1 t -146.18 133.68 20.85 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.845 -0.428 . . . . 39.109999999999999 109.845 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -154.15 117.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.613 -0.435 . . . . 115.20999999999999 109.854 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 97.3 m-20 -95.25 118.64 32.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 135.41999999999999 111.158 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -103.62 163.56 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.735 -0.666 . . . . 45.380000000000003 109.553 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 p -179.05 117.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.881 0.848 . . . . 42.109999999999999 109.412 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -100.89 -63.85 1.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.26 -1.336 . . . . 66.019999999999996 111.09 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.5 pt-20 -107.38 -177.22 3.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.33 0.586 . . . . 451.81 111.846 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.96 -12.02 57.03 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 115.01 -0.996 . . . . 104.66 111.352 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -60.22 -42.85 96.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 328.18000000000001 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptp -156.43 166.61 32.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 243.28999999999999 110.77 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.15 140.28 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.099 -0.501 . . . . 58.390000000000001 110.698 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 m -110.85 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 44.390000000000001 111.124 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' NH2' ' OD2' ' A' ' 17' ' ' ASP . 77.3 mtp85 -132.4 147.19 52.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.047 -0.524 . . . . 767.09000000000003 109.995 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -137.36 146.81 44.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.989 0.423 . . . . 146.31999999999999 110.74 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -175.01 117.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.821 -0.627 . . . . 15.640000000000001 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -83.39 155.79 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 422.56 111.195 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -118.3 144.21 46.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.942 -0.572 . . . . 462.10000000000002 109.877 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 96.0 m -80.1 123.89 28.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 111.17 110.708 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.473 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.96 89.7 1.4 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.882 -0.599 . . . . 121.65000000000001 110.395 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.35 -41.69 0.79 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.012 -0.994 . . . . 82.170000000000002 110.792 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.3 m-20 -134.39 139.72 45.79 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.079 -0.341 . . . . 220.46000000000001 110.079 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.78 147.59 27.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 149.47999999999999 110.858 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 p -146.92 119.62 8.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.041 -0.527 . . . . 169.86000000000001 109.89 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -73.98 158.07 35.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.966 -0.561 . . . . 537.64999999999998 111.133 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 15.6 p -64.82 149.67 95.82 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.975 -0.557 . . . . 32.920000000000002 110.058 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.72 138.96 21.98 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.101 1.868 . . . . 87.700000000000003 112.052 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.07 98.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 244.37 110.741 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.252 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.24 -0.281 . . . . 206.49000000000001 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -39.74 87.26 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.746 -0.382 . . . . 244.88 110.124 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.43 62.02 0.48 Allowed Glycine 0 N--CA 1.466 0.652 0 N-CA-C 110.395 -1.082 . . . . 71.469999999999999 110.395 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -60.47 -45.75 92.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.771 0.32 . . . . 133.27000000000001 110.82 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.44 -42.12 99.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 25.780000000000001 110.232 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.71 167.88 7.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.286 -0.87 . . . . 119.04000000000001 109.874 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.04 96.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.874 -0.331 . . . . 60.490000000000002 110.776 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.15 -34.99 28.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.367 -0.379 . . . . 258.73000000000002 111.088 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.41 152.28 42.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 339.06 110.883 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 25.9 t -104.85 154.17 20.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 42.960000000000001 109.856 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.437 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 t -147.32 130.32 16.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.671 -0.492 . . . . 39.109999999999999 109.671 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.4 p -148.26 131.88 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.352 . . . . 115.20999999999999 110.482 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -100.62 120.83 40.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.119 -0.491 . . . . 135.41999999999999 110.529 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 27.5 p -107.37 164.91 11.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.187 -0.461 . . . . 45.380000000000003 109.931 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 178.07 117.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.924 0.868 . . . . 42.109999999999999 109.397 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.07 -55.59 2.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.224 -1.353 . . . . 66.019999999999996 110.586 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.8 pt-20 -118.17 -177.02 3.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.286 0.565 . . . . 451.81 111.425 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.33 -12.3 57.45 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.313 -0.858 . . . . 104.66 111.129 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -61.78 -44.74 96.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 328.18000000000001 111.153 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.1 ttp -154.74 144.64 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 243.28999999999999 110.95 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.0 t -103.9 147.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.078 -0.51 . . . . 58.390000000000001 110.318 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 77.3 m -123.94 139.84 53.56 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 44.390000000000001 111.346 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -145.89 160.61 41.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.906 -0.588 . . . . 767.09000000000003 109.788 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.3 p -150.14 161.92 41.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.958 0.408 . . . . 146.31999999999999 110.829 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -169.95 127.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 15.640000000000001 109.963 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 77.3 mm-40 -75.83 151.82 37.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 422.56 111.155 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -128.01 138.89 52.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.744 -0.662 . . . . 462.10000000000002 109.925 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 34' ' ' GLY . 27.7 p -71.45 69.81 0.6 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 111.17 110.378 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -78.4 45.2 0.55 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.909 0.861 . . . . 121.65000000000001 110.163 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 32' ' ' THR . . . 82.58 -0.92 88.88 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.194 -1.366 . . . . 82.170000000000002 110.146 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 80.6 m-20 -149.44 142.61 25.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.747 -0.464 . . . . 220.46000000000001 109.747 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.86 136.96 33.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 149.47999999999999 110.632 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.421 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 21.2 p -133.98 -150.28 0.39 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.693 -0.484 . . . . 169.86000000000001 109.693 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 98.3 mt-10 -144.73 142.87 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.845 -0.616 . . . . 537.64999999999998 110.766 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 p -65.13 150.41 95.5 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 109.61 -0.515 . . . . 32.920000000000002 109.61 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.07 130.35 15.3 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.988 1.792 . . . . 87.700000000000003 112.039 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.37 95.65 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.978 -0.849 . . . . 244.37 110.978 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.883 0.373 . . . . 681.24000000000001 110.615 -179.616 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 . . . . . 0 C--O 1.232 0.155 0 N-CA-C 110.288 -0.264 . . . . 206.49000000000001 110.288 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.26 -39.6 87.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.351 . . . . 244.88 110.391 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.2 65.81 0.55 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.773 -0.931 . . . . 71.469999999999999 110.773 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.868 0.366 . . . . 133.27000000000001 110.601 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.0 m -61.14 -42.58 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 25.780000000000001 109.916 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.09 163.99 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.338 -0.846 . . . . 119.04000000000001 109.744 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.15 95.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.589 -0.278 . . . . 60.490000000000002 111.145 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -86.38 -29.51 22.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 258.73000000000002 111.418 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -74.21 159.17 32.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.716 0.293 . . . . 339.06 111.028 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.3 t -102.77 150.2 23.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.147 -0.478 . . . . 42.960000000000001 110.28 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.1 t -149.42 124.82 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.122 -0.696 . . . . 39.109999999999999 109.122 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.9 131.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.984 0.421 . . . . 115.20999999999999 110.412 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -95.58 120.98 36.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.936 -0.574 . . . . 135.41999999999999 110.752 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.483 ' HG1' ' C ' ' A' ' 26' ' ' THR . 36.2 p -104.81 165.32 11.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.942 -0.572 . . . . 45.380000000000003 109.947 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 176.18 118.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.772 0.796 . . . . 42.109999999999999 109.216 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.295 -1.321 . . . . 66.019999999999996 110.826 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.6 pt-20 -112.15 -173.05 2.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.076 0.465 . . . . 451.81 111.442 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.25 -11.98 56.72 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.662 -0.699 . . . . 104.66 111.918 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.4 m-20 -61.32 -39.54 90.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.803 0.335 . . . . 328.18000000000001 111.041 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.4 ptp -157.78 167.99 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 243.28999999999999 111.057 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.3 t -124.04 146.62 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.986 -0.552 . . . . 58.390000000000001 110.475 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.483 ' C ' ' HG1' ' A' ' 18' ' ' THR . 83.7 m -125.28 142.11 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.731 -0.668 . . . . 44.390000000000001 111.219 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -137.36 154.74 49.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.053 -0.521 . . . . 767.09000000000003 110.218 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -134.18 150.4 51.08 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.024 0.44 . . . . 146.31999999999999 110.988 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -176.24 128.35 0.21 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.186 -0.672 . . . . 15.640000000000001 109.186 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 37' ' ' THR . 95.4 mt-10 -107.56 130.58 54.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.937 0.398 . . . . 422.56 111.326 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.0 150.07 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.574 . . . . 462.10000000000002 110.45 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -95.4 122.92 38.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 111.17 110.433 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -145.88 84.07 1.65 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.612 0.72 . . . . 121.65000000000001 110.875 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.54 -5.67 55.65 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.596 -1.184 . . . . 82.170000000000002 110.989 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.0 m-20 -155.93 148.98 24.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 220.46000000000001 110.253 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 137.72 37.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 149.47999999999999 110.525 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 56.6 p -151.23 119.24 6.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.263 -0.426 . . . . 169.86000000000001 110.438 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 99.7 mt-10 -75.06 161.69 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 537.64999999999998 110.392 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.506 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.2 p -52.03 157.5 2.13 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.475 -0.565 . . . . 32.920000000000002 109.475 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -55.63 163.1 5.64 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.594 1.53 . . . . 87.700000000000003 112.694 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.63 65.1 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.85 -1.068 . . . . 244.37 110.493 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 110.024 -0.361 . . . . 681.24000000000001 110.024 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.273 -0.269 . . . . 206.49000000000001 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.09 -39.48 86.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.994 -0.373 . . . . 244.88 109.994 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.65 62.2 0.48 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.687 -0.965 . . . . 71.469999999999999 110.687 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -60.72 -43.49 97.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.826 0.346 . . . . 133.27000000000001 110.515 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.3 m -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.261 0.553 . . . . 25.780000000000001 109.958 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.74 167.45 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.423 -0.808 . . . . 119.04000000000001 109.865 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.56 96.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.802 -0.359 . . . . 60.490000000000002 110.841 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.15 -32.66 24.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 258.73000000000002 111.05 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.82 158.52 35.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 339.06 110.901 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.547 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 41.9 t -111.51 146.81 36.63 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 42.960000000000001 110.169 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.8 t -140.97 129.04 22.02 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.046 -0.724 . . . . 39.109999999999999 109.046 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.9 p -148.48 131.48 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 115.20999999999999 110.422 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.92 121.35 38.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.997 -0.547 . . . . 135.41999999999999 110.939 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 p -103.51 166.31 10.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.927 -0.579 . . . . 45.380000000000003 109.84 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 178.09 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.993 0.901 . . . . 42.109999999999999 109.103 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.42 -95.01 0.17 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.913 -1.494 . . . . 66.019999999999996 111.269 -178.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.35 -28.08 59.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.954 -1.021 . . . . 451.81 111.084 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -13.73 58.82 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.274 -0.731 . . . . 104.66 111.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.79 -39.15 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 328.18000000000001 109.624 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.432 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 69.5 mtm -137.55 101.45 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.466 -0.788 . . . . 243.28999999999999 109.613 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.7 147.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.583 -0.447 . . . . 58.390000000000001 110.821 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.1 m -126.03 139.02 53.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.814 -0.63 . . . . 44.390000000000001 111.539 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.47 147.12 50.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 767.09000000000003 109.494 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -134.47 147.95 50.48 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.033 0.445 . . . . 146.31999999999999 111.224 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -175.42 130.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.219 -0.66 . . . . 15.640000000000001 109.219 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -108.12 167.09 10.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.942 0.401 . . . . 422.56 110.858 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.1 148.01 50.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.811 -0.631 . . . . 462.10000000000002 110.336 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.9 m -89.81 122.62 33.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 111.17 110.521 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -147.2 84.34 1.58 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.661 0.743 . . . . 121.65000000000001 110.768 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.57 -5.6 56.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.568 -1.196 . . . . 82.170000000000002 110.896 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -155.84 151.17 26.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.118 -0.327 . . . . 220.46000000000001 110.118 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.41 141.51 33.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.841 0.353 . . . . 149.47999999999999 110.992 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 37' ' ' THR . 10.9 t -161.48 130.7 4.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 169.86000000000001 109.837 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -86.39 169.6 12.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.833 -0.621 . . . . 537.64999999999998 111.032 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 2.3 p -58.71 152.13 48.9 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.939 -0.573 . . . . 32.920000000000002 109.968 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 134.9 16.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.101 1.867 . . . . 87.700000000000003 112.085 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.05 -39.75 97.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.909 -0.876 . . . . 244.37 110.909 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.965 0.412 . . . . 681.24000000000001 110.457 -179.723 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.735 0.302 . . . . 206.49000000000001 110.417 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.25 -40.35 93.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 244.88 111.054 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 49.82 0.9 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.978 -0.849 . . . . 71.469999999999999 110.978 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -61.21 -49.92 75.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 133.27000000000001 110.569 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.4 m -64.69 -41.61 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.315 0.579 . . . . 25.780000000000001 110.126 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.19 167.81 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 119.04000000000001 109.867 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.63 97.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.954 -0.298 . . . . 60.490000000000002 111.005 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.64 -30.98 24.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 258.73000000000002 111.243 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.55 158.58 33.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 339.06 110.994 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 38.6 t -112.91 144.19 42.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 42.960000000000001 110.602 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -137.89 128.3 26.35 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.194 -0.669 . . . . 39.109999999999999 109.194 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.5 p -143.11 133.18 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.878 0.37 . . . . 115.20999999999999 110.557 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.5 121.96 34.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 135.41999999999999 110.808 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.58 ' HG1' ' C ' ' A' ' 26' ' ' THR . 14.6 p -101.01 164.73 11.67 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 45.380000000000003 109.946 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 176.38 119.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.079 0.942 . . . . 42.109999999999999 108.91 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.24 -94.39 0.18 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.751 -1.568 . . . . 66.019999999999996 111.48 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -77.71 -21.31 52.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.165 -0.925 . . . . 451.81 111.189 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.57 71.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.298 -0.721 . . . . 104.66 111.298 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.54 -42.64 92.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.327 -0.62 . . . . 328.18000000000001 109.327 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.6 ttp -141.75 111.27 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.322 -0.854 . . . . 243.28999999999999 109.111 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 26' ' ' THR . 69.9 t -69.93 150.03 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.177 0.513 . . . . 58.390000000000001 111.082 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.58 ' C ' ' HG1' ' A' ' 18' ' ' THR . 89.2 m -132.89 143.95 49.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.484 -0.78 . . . . 44.390000000000001 111.057 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -132.13 163.84 27.61 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.95 -0.568 . . . . 767.09000000000003 110.116 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 t -148.62 150.49 33.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.987 0.422 . . . . 146.31999999999999 111.087 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.3 t -170.6 134.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 15.640000000000001 109.305 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -112.59 135.71 52.99 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.982 0.42 . . . . 422.56 111.337 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.43 144.96 26.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.848 -0.615 . . . . 462.10000000000002 110.203 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.6 m -93.66 102.93 15.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 111.17 110.612 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.5 m -140.28 125.89 19.16 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.491 0.662 . . . . 121.65000000000001 110.111 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.67 -64.85 0.45 Allowed Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.652 -1.158 . . . . 82.170000000000002 110.827 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' THR . 83.2 m-20 -122.53 146.89 47.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.977 -0.379 . . . . 220.46000000000001 109.977 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -73.25 146.22 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.422 -0.354 . . . . 149.47999999999999 110.902 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.15 122.11 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 169.86000000000001 110.391 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.06 165.15 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.61 . . . . 537.64999999999998 110.896 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.7 p -63.65 150.11 91.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 32.920000000000002 109.94 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.15 138.61 22.9 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.01 1.807 . . . . 87.700000000000003 111.841 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.85 0.43 67.2 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.954 -0.858 . . . . 244.37 110.954 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.92 0.391 . . . . 681.24000000000001 110.503 -179.685 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.628 0.251 . . . . 206.49000000000001 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -61.41 -40.6 94.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 244.88 111.122 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.31 47.76 1.12 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.953 -0.859 . . . . 71.469999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -61.24 -50.16 74.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.378 . . . . 133.27000000000001 110.638 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.61 -41.46 96.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.906 -0.588 . . . . 25.780000000000001 110.209 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -172.41 168.73 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.301 -0.863 . . . . 119.04000000000001 109.859 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.889 -0.324 . . . . 60.490000000000002 110.941 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.61 -31.35 24.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 258.73000000000002 111.11 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.82 156.29 36.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 339.06 111.014 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -112.95 144.46 42.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.132 -0.486 . . . . 42.960000000000001 110.515 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -136.73 127.17 26.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.832 -0.803 . . . . 39.109999999999999 108.832 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.1 p -137.64 130.37 42.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.04 0.448 . . . . 115.20999999999999 110.833 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.4 138.57 31.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.828 -0.624 . . . . 135.41999999999999 110.898 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -128.06 159.22 35.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.884 -0.598 . . . . 45.380000000000003 109.834 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 p 178.67 118.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.685 -0.857 . . . . 42.109999999999999 108.685 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.636 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.4 -92.07 0.26 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.97 -1.468 . . . . 66.019999999999996 112.172 -177.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 4.0 pt-20 -70.92 -33.83 70.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 451.81 110.863 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.42 46.42 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 115.573 -0.739 . . . . 104.66 111.89 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.65 ' H ' ' CG ' ' A' ' 21' ' ' GLU . 37.8 t70 -60.41 -42.59 96.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.467 -0.568 . . . . 328.18000000000001 109.467 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.1 ttp -138.44 116.42 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 243.28999999999999 109.312 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.29 149.66 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.269 0.557 . . . . 58.390000000000001 110.754 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 m -128.66 142.37 51.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.391 -0.822 . . . . 44.390000000000001 110.928 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -145.3 162.17 37.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.031 -0.531 . . . . 767.09000000000003 110.048 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 t -149.75 152.84 35.92 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 146.31999999999999 110.986 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.7 t -168.58 131.82 1.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.849 -0.614 . . . . 15.640000000000001 109.427 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -102.91 149.21 24.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.942 0.401 . . . . 422.56 111.34 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.79 146.2 32.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.791 -0.641 . . . . 462.10000000000002 110.315 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.8 m -96.09 122.03 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 111.17 110.634 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.9 p -150.19 84.9 1.39 Allowed 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.55 0.691 . . . . 121.65000000000001 110.606 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.517 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 78.38 -3.98 60.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.636 -1.165 . . . . 82.170000000000002 110.723 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 34' ' ' GLY . 31.6 m120 -158.17 149.53 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.104 -0.332 . . . . 220.46000000000001 110.104 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -98.01 139.3 34.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 149.47999999999999 110.788 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.7 p -146.93 118.15 7.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 169.86000000000001 110.082 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -76.23 160.25 29.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 537.64999999999998 110.877 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 2.5 p -59.98 150.68 68.55 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.065 -0.516 . . . . 32.920000000000002 110.002 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.06 134.23 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.217 1.944 . . . . 87.700000000000003 111.909 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.72 -40.03 98.11 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.847 -0.901 . . . . 244.37 110.847 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 120.847 0.356 . . . . 681.24000000000001 110.268 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.69 0.281 . . . . 206.49000000000001 110.354 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.27 -40.17 93.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 244.88 110.814 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.58 46.84 1.29 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.068 -0.813 . . . . 71.469999999999999 111.068 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -60.84 -50.25 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.893 0.378 . . . . 133.27000000000001 110.571 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.95 -41.99 95.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 25.780000000000001 109.865 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.95 166.9 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.334 -0.848 . . . . 119.04000000000001 110.0 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 60.490000000000002 111.186 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -92.44 13.76 18.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.376 -0.374 . . . . 258.73000000000002 111.429 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.31 158.58 29.24 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.597 -0.274 . . . . 339.06 110.354 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.8 t -112.44 144.36 42.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.492 -0.322 . . . . 42.960000000000001 110.679 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -139.07 129.15 25.2 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.507 -0.553 . . . . 39.109999999999999 109.507 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.83 132.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 115.20999999999999 110.532 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -92.4 123.36 35.66 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.191 -0.459 . . . . 135.41999999999999 110.948 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -100.96 158.58 15.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.014 -0.539 . . . . 45.380000000000003 109.669 178.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.1 p 179.32 116.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.983 0.896 . . . . 42.109999999999999 109.581 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -73.77 -92.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.925 -1.488 . . . . 66.019999999999996 111.148 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -90.22 -65.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.68 -0.691 . . . . 451.81 110.953 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.81 -10.54 0.11 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.808 -0.71 . . . . 104.66 111.352 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.6 -41.88 91.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.555 -0.535 . . . . 328.18000000000001 109.555 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.536 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 65.6 ttp -146.7 140.16 25.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.317 -0.856 . . . . 243.28999999999999 109.421 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 25' ' ' VAL . 4.9 m -101.78 158.29 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 58.390000000000001 111.015 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 18' ' ' THR . 88.3 m -136.65 145.64 45.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.603 -0.726 . . . . 44.390000000000001 110.795 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.09 160.58 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.147 -0.479 . . . . 767.09000000000003 110.122 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -148.56 150.73 33.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.939 0.4 . . . . 146.31999999999999 110.832 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -170.58 129.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 15.640000000000001 109.691 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -107.03 138.25 43.55 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.893 0.377 . . . . 422.56 110.828 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -95.66 167.55 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.989 -0.55 . . . . 462.10000000000002 110.725 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.2 m -113.21 124.23 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.619 -0.719 . . . . 111.17 110.348 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -151.43 85.08 1.31 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.614 0.721 . . . . 121.65000000000001 110.733 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.59 -6.11 54.36 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.718 -1.128 . . . . 82.170000000000002 110.661 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -156.19 149.48 24.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.895 -0.409 . . . . 220.46000000000001 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 137.19 36.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 149.47999999999999 110.837 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.0 p -146.05 117.15 7.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.089 -0.505 . . . . 169.86000000000001 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.5 162.57 26.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 537.64999999999998 110.889 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.464 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 3.8 p -60.35 150.6 72.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.014 -0.539 . . . . 32.920000000000002 109.953 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.77 133.53 17.09 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.104 1.87 . . . . 87.700000000000003 112.05 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.73 97.76 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.825 -0.91 . . . . 244.37 110.825 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 681.24000000000001 110.621 -179.795 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.597 0.237 . . . . 206.49000000000001 110.417 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.05 -39.87 87.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 244.88 110.302 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.27 65.6 0.52 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.543 -1.023 . . . . 71.469999999999999 110.543 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.57 -44.86 95.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.879 0.371 . . . . 133.27000000000001 110.802 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.5 m -61.94 -43.1 99.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.384 0.611 . . . . 25.780000000000001 109.68 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.85 162.28 7.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.99 -1.005 . . . . 119.04000000000001 109.384 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.51 93.0 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.412 -0.515 . . . . 60.490000000000002 110.608 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.91 -38.97 69.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 258.73000000000002 111.073 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -73.83 161.07 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 339.06 111.146 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.7 t -109.28 155.52 21.05 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.361 -0.381 . . . . 42.960000000000001 110.351 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.3 t -149.62 129.19 13.11 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.524 -0.546 . . . . 39.109999999999999 109.524 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 16' ' ' VAL . 11.6 p -148.33 132.21 8.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.837 0.351 . . . . 115.20999999999999 110.492 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.73 119.24 38.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.097 -0.501 . . . . 135.41999999999999 110.483 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 22.4 p -105.56 163.69 12.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.057 -0.519 . . . . 45.380000000000003 109.926 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p 178.38 117.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.84 0.829 . . . . 42.109999999999999 109.14 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.636 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.97 -62.36 1.32 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.231 -1.35 . . . . 66.019999999999996 111.123 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.8 pt-20 -104.5 -178.74 3.74 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.367 0.603 . . . . 451.81 111.913 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.44 -10.28 59.46 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.052 -0.976 . . . . 104.66 111.372 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.2 t0 -60.59 -44.07 96.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 328.18000000000001 110.84 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -159.94 168.75 24.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.038 -0.528 . . . . 243.28999999999999 110.953 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.0 t -118.15 143.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.026 -0.534 . . . . 58.390000000000001 110.547 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.1 m -118.34 137.6 52.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.742 . . . . 44.390000000000001 111.111 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -146.61 161.41 40.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.228 -0.442 . . . . 767.09000000000003 110.125 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -151.93 162.83 40.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.875 0.369 . . . . 146.31999999999999 110.859 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.3 t -168.48 131.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 15.640000000000001 110.03 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 74.5 mm-40 -77.87 154.46 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 422.56 111.277 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -121.37 138.67 54.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.746 -0.661 . . . . 462.10000000000002 109.555 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.488 HG23 ' CE2' ' A' ' 36' ' ' PHE . 93.6 m -79.87 123.09 27.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.145 -0.479 . . . . 111.17 110.589 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 32' ' ' THR . 32.4 p -154.77 88.28 1.19 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.494 0.664 . . . . 121.65000000000001 110.536 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -50.49 1.46 Allowed Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 114.812 -1.086 . . . . 82.170000000000002 111.1 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.73 136.68 47.81 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.749 0.309 . . . . 220.46000000000001 110.385 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.488 ' CE2' HG23 ' A' ' 32' ' ' THR . 94.2 m-85 -83.76 150.53 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 149.47999999999999 110.493 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.424 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 32.2 p -126.86 -145.71 0.32 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.957 0.408 . . . . 169.86000000000001 110.296 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 52.6 tp10 -151.6 139.21 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 537.64999999999998 110.318 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 p -56.77 150.92 34.56 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.107 -0.497 . . . . 32.920000000000002 110.158 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.25 157.79 41.54 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.449 2.099 . . . . 87.700000000000003 112.162 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.41 -93.07 1.64 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.682 -0.967 . . . . 244.37 110.682 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.216 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.715 0.293 . . . . 206.49000000000001 110.524 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.83 -39.4 84.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 244.88 110.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.37 74.11 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.651 -0.98 . . . . 71.469999999999999 110.651 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.26 -44.01 97.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.368 . . . . 133.27000000000001 110.597 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -62.63 -41.78 99.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 25.780000000000001 110.39 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.47 163.64 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.597 -0.729 . . . . 119.04000000000001 110.095 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.73 90.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 60.490000000000002 110.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -91.62 10.52 27.74 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.349 -0.387 . . . . 258.73000000000002 111.431 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.506 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.3 mm-40 -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 339.06 110.865 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 40.5 t -106.06 156.99 17.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.81 -0.632 . . . . 42.960000000000001 110.854 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.5 t -147.64 126.36 12.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.514 -0.551 . . . . 39.109999999999999 109.514 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 p -150.99 131.98 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.01 -0.367 . . . . 115.20999999999999 110.01 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -101.41 118.66 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 135.41999999999999 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' THR . 2.4 p -100.69 161.98 13.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.632 -0.713 . . . . 45.380000000000003 109.15 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 19' ' ' VAL . 3.5 p 178.41 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.815 0.817 . . . . 42.109999999999999 109.331 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.638 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -90.03 -62.57 1.44 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.25 -1.341 . . . . 66.019999999999996 110.184 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -117.91 -172.91 2.34 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.98 0.419 . . . . 451.81 110.736 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.01 -20.19 47.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.357 -0.697 . . . . 104.66 111.357 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.56 -40.13 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.595 0.236 . . . . 328.18000000000001 111.539 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mtp -137.0 153.44 50.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.123 0.487 . . . . 243.28999999999999 111.601 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.73 142.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.625 -0.716 . . . . 58.390000000000001 110.085 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.0 m -123.78 134.62 53.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.946 -0.57 . . . . 44.390000000000001 111.249 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -128.72 147.44 50.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.001 -0.545 . . . . 767.09000000000003 109.911 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -133.8 145.85 50.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.969 0.414 . . . . 146.31999999999999 110.715 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -173.41 115.25 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.837 -0.62 . . . . 15.640000000000001 109.745 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.5 mm-40 -84.78 155.01 22.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.954 0.407 . . . . 422.56 111.014 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -121.96 143.74 49.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.905 -0.588 . . . . 462.10000000000002 109.804 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.506 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 93.7 m -89.32 119.61 29.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.353 -0.385 . . . . 111.17 110.79 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.3 p -152.21 82.49 1.25 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.645 0.736 . . . . 121.65000000000001 110.468 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.66 -5.72 56.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.455 -1.248 . . . . 82.170000000000002 110.737 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.4 m-20 -156.58 149.04 23.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.704 0.287 . . . . 220.46000000000001 110.252 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.03 139.33 39.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.836 0.35 . . . . 149.47999999999999 110.717 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 123.97 4.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 169.86000000000001 110.384 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.455 ' OE2' ' N ' ' A' ' 38' ' ' GLU . 58.2 mp0 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 537.64999999999998 111.135 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.8 p -63.53 150.67 89.66 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.922 -0.581 . . . . 32.920000000000002 110.153 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.03 142.75 28.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.133 1.888 . . . . 87.700000000000003 111.841 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.77 0.82 74.03 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 244.37 110.924 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.943 0.402 . . . . 681.24000000000001 110.524 -179.753 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.808 0.337 . . . . 206.49000000000001 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 244.88 110.137 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.27 81.74 0.32 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.493 -1.043 . . . . 71.469999999999999 110.493 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -61.2 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 133.27000000000001 110.597 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.2 m -62.34 -41.44 98.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.895 -0.593 . . . . 25.780000000000001 110.333 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.63 161.41 6.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.521 -0.763 . . . . 119.04000000000001 109.863 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -46.16 91.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.691 -0.403 . . . . 60.490000000000002 110.71 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.5 -38.33 74.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 258.73000000000002 110.525 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 32' ' ' THR . 69.2 mm-40 -75.72 167.88 21.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.702 -0.681 . . . . 339.06 111.018 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 16.2 p -112.57 171.1 7.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.218 -0.446 . . . . 42.960000000000001 110.324 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.9 t -152.48 126.92 9.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.453 -0.573 . . . . 39.109999999999999 109.453 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 16' ' ' VAL . 10.2 p -148.86 129.67 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 115.20999999999999 110.512 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -115.05 133.94 55.61 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.071 -0.513 . . . . 135.41999999999999 110.77 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 26' ' ' THR . 20.3 p -126.91 162.02 26.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 45.380000000000003 109.687 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -178.77 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.997 0.903 . . . . 42.109999999999999 109.455 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.78 -53.26 3.47 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.938 -1.483 . . . . 66.019999999999996 110.684 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.3 pt-20 -120.37 -178.05 3.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.307 0.575 . . . . 451.81 111.419 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.61 -11.16 59.62 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.148 -0.933 . . . . 104.66 111.049 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.6 t0 -62.73 -44.38 96.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.806 0.336 . . . . 328.18000000000001 111.13 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.3 ttp -155.12 147.3 23.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 243.28999999999999 110.92 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.36 142.71 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 58.390000000000001 110.403 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 18' ' ' THR . 73.1 m -117.05 133.59 55.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 44.390000000000001 110.798 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -151.6 163.45 39.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.178 -0.465 . . . . 767.09000000000003 110.398 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -149.47 148.03 28.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.054 0.454 . . . . 146.31999999999999 110.813 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.9 t -169.36 114.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 15.640000000000001 109.388 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.6 159.77 20.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 422.56 111.331 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -124.57 142.94 50.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.053 -0.521 . . . . 462.10000000000002 110.176 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.505 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 99.8 m -84.87 121.55 27.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 111.17 110.371 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.8 p -153.57 90.06 1.38 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.373 0.606 . . . . 121.65000000000001 110.61 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 -40.35 0.82 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.926 -1.034 . . . . 82.170000000000002 110.957 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 33' ' ' THR . 81.4 m-20 -134.62 139.42 45.31 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.845 0.355 . . . . 220.46000000000001 110.212 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.11 150.49 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 149.47999999999999 110.975 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.63 122.36 5.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 169.86000000000001 110.131 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' CYS . 88.1 tt0 -81.5 148.7 29.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.832 -0.622 . . . . 537.64999999999998 111.332 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -41.08 164.4 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.857 -0.61 . . . . 32.920000000000002 110.159 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -75.89 142.77 25.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.398 2.065 . . . . 87.700000000000003 111.789 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.94 -39.88 98.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 244.37 110.865 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 120.816 0.341 . . . . 681.24000000000001 110.308 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.709 0.29 . . . . 206.49000000000001 110.614 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.69 -39.98 90.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.415 -0.357 . . . . 244.88 110.686 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.38 85.98 0.38 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.749 -0.94 . . . . 71.469999999999999 110.749 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -62.61 -43.38 98.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.705 0.288 . . . . 133.27000000000001 110.991 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.2 m -62.0 -43.11 99.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 25.780000000000001 110.281 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -166.66 166.04 16.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.391 -0.822 . . . . 119.04000000000001 109.825 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.87 96.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.904 -0.319 . . . . 60.490000000000002 111.175 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -83.99 -32.46 24.96 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.842 0.353 . . . . 258.73000000000002 111.3 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -75.75 160.35 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 339.06 110.842 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.4 t -115.98 149.67 38.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.351 -0.386 . . . . 42.960000000000001 110.113 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.3 p -135.64 153.69 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.723 -0.473 . . . . 39.109999999999999 109.723 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.5 p -165.87 117.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.486 -0.486 . . . . 115.20999999999999 110.515 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -103.5 119.63 39.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.185 -0.461 . . . . 135.41999999999999 110.852 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.954 -0.566 . . . . 45.380000000000003 109.774 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.72 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 122.079 0.943 . . . . 42.109999999999999 109.074 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.648 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.19 -94.1 0.17 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.876 -1.511 . . . . 66.019999999999996 111.428 -178.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -79.98 -19.67 47.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.189 -0.914 . . . . 451.81 111.131 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.92 -10.14 72.37 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.264 -0.734 . . . . 104.66 111.264 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.52 -41.79 95.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 328.18000000000001 109.487 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.443 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.9 mtm -138.6 99.17 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.358 -0.837 . . . . 243.28999999999999 109.414 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.88 145.2 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.208 0.528 . . . . 58.390000000000001 110.858 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 m -125.74 136.95 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.398 -0.819 . . . . 44.390000000000001 110.954 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -149.76 160.65 43.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 767.09000000000003 110.638 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -152.53 150.5 29.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.351 -0.386 . . . . 146.31999999999999 110.775 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.9 t -169.96 126.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.914 -0.585 . . . . 15.640000000000001 109.734 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.04 152.54 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 422.56 111.007 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -116.49 142.69 46.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.984 -0.553 . . . . 462.10000000000002 109.969 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 91.5 m -71.58 124.97 25.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.989 0.423 . . . . 111.17 110.508 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -154.05 89.43 1.3 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.417 0.627 . . . . 121.65000000000001 110.543 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.81 -47.14 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.928 -1.033 . . . . 82.170000000000002 111.005 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -135.06 138.76 44.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.791 0.329 . . . . 220.46000000000001 110.253 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.9 m-85 -83.73 148.09 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 149.47999999999999 110.659 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.7 p -125.85 -144.96 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.951 0.405 . . . . 169.86000000000001 110.069 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -156.89 143.57 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 537.64999999999998 110.536 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.3 p -62.15 149.51 86.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 32.920000000000002 110.005 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 135.25 16.77 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.071 1.847 . . . . 87.700000000000003 111.74 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.93 -42.89 99.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.723 -0.951 . . . . 244.37 110.723 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.97 -0.381 . . . . 681.24000000000001 109.97 179.787 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 120.725 0.298 . . . . 206.49000000000001 110.596 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.6 -39.89 89.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.357 -0.383 . . . . 244.88 110.929 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.91 68.24 0.28 Allowed Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.17 -0.772 . . . . 71.469999999999999 111.17 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.9 -48.56 78.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.987 0.422 . . . . 133.27000000000001 110.617 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.99 -41.41 97.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.855 -0.611 . . . . 25.780000000000001 109.931 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.1 162.91 9.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.161 -0.927 . . . . 119.04000000000001 109.246 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.98 90.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.511 -0.476 . . . . 60.490000000000002 110.666 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.45 -37.83 71.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 258.73000000000002 110.857 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.14 161.14 30.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 339.06 111.163 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 50.2 t -111.05 158.98 18.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.157 -0.474 . . . . 42.960000000000001 110.411 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 49.7 t -149.13 130.35 14.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.441 -0.577 . . . . 39.109999999999999 109.441 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 16' ' ' VAL . 13.3 p -149.14 129.89 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 115.20999999999999 110.434 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -93.0 119.21 32.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 135.41999999999999 110.772 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p -103.69 161.66 13.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.994 -0.548 . . . . 45.380000000000003 109.949 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.0 p 179.54 117.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.796 0.808 . . . . 42.109999999999999 109.325 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -104.12 -62.8 1.27 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.357 -1.292 . . . . 66.019999999999996 111.28 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.9 pt-20 -103.23 -178.49 3.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.452 0.644 . . . . 451.81 111.991 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.77 -10.12 59.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.992 -1.004 . . . . 104.66 111.445 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 66.4 t0 -60.77 -44.48 96.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 328.18000000000001 110.927 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.82 170.18 22.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.013 -0.539 . . . . 243.28999999999999 111.022 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.85 143.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.896 -0.593 . . . . 58.390000000000001 110.512 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.8 m -117.44 134.02 55.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 44.390000000000001 111.338 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -126.27 147.06 49.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.966 -0.561 . . . . 767.09000000000003 109.708 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -135.1 153.11 52.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.887 0.375 . . . . 146.31999999999999 110.727 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 3.0 t -166.0 132.17 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 15.640000000000001 109.952 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 75.5 mm-40 -81.39 155.74 25.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 422.56 111.439 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 143.17 50.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.584 -0.735 . . . . 462.10000000000002 109.399 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.482 HG23 ' CE2' ' A' ' 36' ' ' PHE . 98.2 m -85.61 121.34 28.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 111.17 110.68 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -152.29 88.81 1.39 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.82 -0.627 . . . . 121.65000000000001 110.42 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -50.88 1.6 Allowed Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.947 -1.024 . . . . 82.170000000000002 111.04 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.49 137.53 48.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.758 0.313 . . . . 220.46000000000001 110.434 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 32' ' ' THR . 97.0 m-85 -84.15 149.77 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 149.47999999999999 110.506 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 43.3 p -124.85 -145.2 0.33 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.847 0.356 . . . . 169.86000000000001 110.156 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 88.2 tt0 -152.86 139.31 18.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 537.64999999999998 110.77 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -57.05 152.37 29.46 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.96 -0.564 . . . . 32.920000000000002 109.994 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.14 157.38 46.43 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.343 2.029 . . . . 87.700000000000003 111.767 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.47 -90.7 2.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.997 -0.841 . . . . 244.37 110.997 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 681.24000000000001 110.697 -179.66 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' A' ' 7' ' ' GLY . 21.3 pt-20 . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 121.057 0.455 . . . . 206.49000000000001 110.829 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 60.18 -5.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 244.88 111.569 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 5' ' ' GLU . . . -155.9 60.71 0.36 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.464 -1.054 . . . . 71.469999999999999 110.464 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.56 ' CG ' ' HG ' ' A' ' 15' ' ' CYS . 52.8 p-10 -61.17 -29.25 69.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.727 0.298 . . . . 133.27000000000001 110.777 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 97.1 m -62.12 -43.19 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.324 0.583 . . . . 25.780000000000001 109.933 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.81 162.31 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.119 -0.946 . . . . 119.04000000000001 109.429 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.49 93.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.512 -0.475 . . . . 60.490000000000002 110.557 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.25 -38.36 68.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 258.73000000000002 110.965 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 32' ' ' THR . 75.8 mm-40 -72.33 157.96 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 339.06 111.435 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.2 t -104.24 156.44 17.9 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.986 -0.552 . . . . 42.960000000000001 110.327 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.56 ' HG ' ' CG ' ' A' ' 8' ' ' ASP . 54.1 t -147.73 128.86 14.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 39.109999999999999 109.99 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.3 134.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 115.20999999999999 110.251 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -101.0 119.47 38.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 135.41999999999999 110.994 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 p -100.38 164.53 11.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.911 -0.586 . . . . 45.380000000000003 110.018 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.08 119.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.131 0.967 . . . . 42.109999999999999 108.899 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.32 -95.09 0.16 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.74 -1.573 . . . . 66.019999999999996 111.469 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.42 -21.56 38.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.072 -0.967 . . . . 451.81 110.738 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.03 65.43 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.313 -0.715 . . . . 104.66 111.313 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.61 -39.64 84.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.203 -0.666 . . . . 328.18000000000001 109.203 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' A' ' 24' ' ' MET . 19.1 tmm? -148.87 105.51 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.302 -0.863 . . . . 243.28999999999999 108.874 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 24' ' ' MET . 77.7 t -63.9 145.49 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.281 0.562 . . . . 58.390000000000001 111.343 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.7 m -125.09 135.14 52.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.288 -0.869 . . . . 44.390000000000001 110.945 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -128.55 148.83 50.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 767.09000000000003 109.909 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -132.95 144.55 50.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.855 0.36 . . . . 146.31999999999999 110.696 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.57 115.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 15.640000000000001 110.007 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.17 152.36 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 422.56 110.627 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -115.15 142.38 46.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.329 -0.396 . . . . 462.10000000000002 110.255 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.462 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 88.2 m -71.11 125.9 28.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 111.17 110.511 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.84 89.47 1.39 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.395 0.617 . . . . 121.65000000000001 110.503 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.44 -44.06 0.92 Allowed Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.932 -1.031 . . . . 82.170000000000002 110.887 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.0 m120 -136.41 139.32 42.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.82 0.343 . . . . 220.46000000000001 110.157 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.28 146.55 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 149.47999999999999 110.749 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.2 p -127.7 -146.79 0.34 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.284 -0.416 . . . . 169.86000000000001 109.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -160.92 148.42 15.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 537.64999999999998 110.595 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 8.1 p -61.88 149.9 84.22 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.229 -0.441 . . . . 32.920000000000002 109.89 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.76 134.62 18.47 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.064 1.842 . . . . 87.700000000000003 112.0 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.85 98.34 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.87 -0.892 . . . . 244.37 110.87 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 681.24000000000001 110.349 -179.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.679 0.276 . . . . 206.49000000000001 110.437 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.84 -39.49 85.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.914 0.388 . . . . 244.88 110.198 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.29 76.88 0.4 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.533 -1.027 . . . . 71.469999999999999 110.533 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.31 -43.53 98.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 133.27000000000001 110.614 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.1 m -62.06 -41.47 98.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 25.780000000000001 110.313 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.28 165.98 8.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.482 -0.781 . . . . 119.04000000000001 109.928 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.33 96.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.757 -0.377 . . . . 60.490000000000002 110.757 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.93 -33.53 33.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 258.73000000000002 110.958 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.5 mm-40 -74.3 158.01 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 339.06 111.293 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 34.1 t -107.71 154.31 21.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.984 -0.553 . . . . 42.960000000000001 110.614 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.6 t -142.8 128.12 18.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.58 -0.526 . . . . 39.109999999999999 109.58 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -151.11 128.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.905 -0.406 . . . . 115.20999999999999 109.905 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -107.97 118.11 35.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 135.41999999999999 111.39 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -102.82 166.44 10.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.459 -0.791 . . . . 45.380000000000003 109.449 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 19' ' ' VAL . 3.5 p -179.57 117.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.909 0.861 . . . . 42.109999999999999 109.502 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.93 -62.18 1.33 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.174 -1.375 . . . . 66.019999999999996 110.784 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.2 pt-20 -114.9 -172.17 2.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.06 0.457 . . . . 451.81 111.284 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.09 -12.75 54.65 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.754 -0.657 . . . . 104.66 111.864 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.46 -40.72 95.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.668 0.271 . . . . 328.18000000000001 111.183 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 ttp -157.08 153.02 27.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.371 -0.377 . . . . 243.28999999999999 110.904 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -115.59 140.94 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.163 0.506 . . . . 58.390000000000001 110.67 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.4 m -110.96 132.3 54.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.514 -0.766 . . . . 44.390000000000001 111.373 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -133.98 148.3 51.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 767.09000000000003 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -138.45 147.71 43.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.926 0.393 . . . . 146.31999999999999 110.772 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.9 115.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 15.640000000000001 109.912 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -80.56 152.8 28.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 422.56 110.631 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.68 143.41 45.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.147 -0.479 . . . . 462.10000000000002 110.205 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.517 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.0 m -73.79 125.05 27.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 111.17 110.485 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.9 p -153.34 89.49 1.35 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.383 0.611 . . . . 121.65000000000001 110.559 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.16 -41.14 0.74 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.898 -1.046 . . . . 82.170000000000002 111.017 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 33' ' ' THR . 83.0 m-20 -133.93 140.05 46.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 220.46000000000001 110.341 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.04 144.81 26.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.157 -0.474 . . . . 149.47999999999999 110.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.6 p -134.52 -157.66 0.82 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.438 -0.579 . . . . 169.86000000000001 109.438 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -149.59 155.33 40.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.441 -0.8 . . . . 537.64999999999998 110.655 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.5 p -65.92 149.76 97.22 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.675 -0.491 . . . . 32.920000000000002 109.675 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.96 131.3 16.68 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.978 1.785 . . . . 87.700000000000003 111.946 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.98 98.36 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.063 -0.815 . . . . 244.37 111.063 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.849 0.357 . . . . 681.24000000000001 110.304 -179.801 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 9.7 pt-20 . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.688 0.28 . . . . 206.49000000000001 110.379 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -39.39 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 244.88 110.139 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -127.4 75.09 0.42 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.538 -1.025 . . . . 71.469999999999999 110.538 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -61.42 -43.12 99.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.939 0.4 . . . . 133.27000000000001 110.679 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.5 m -61.65 -42.56 99.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.007 -0.542 . . . . 25.780000000000001 110.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.93 167.13 13.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.334 -0.848 . . . . 119.04000000000001 109.871 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.5 95.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.515 -0.312 . . . . 60.490000000000002 111.117 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.44 -30.29 23.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.473 -0.331 . . . . 258.73000000000002 111.273 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.51 154.14 37.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 339.06 110.979 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 39.0 t -104.51 148.87 25.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.219 -0.446 . . . . 42.960000000000001 110.727 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -135.92 123.97 22.9 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.554 -0.535 . . . . 39.109999999999999 109.554 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.4 p -143.33 127.69 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.913 0.387 . . . . 115.20999999999999 110.21 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -109.66 118.78 37.46 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.047 -0.524 . . . . 135.41999999999999 111.022 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 46.5 p -104.54 167.53 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.826 -0.625 . . . . 45.380000000000003 109.867 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p 179.34 117.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.936 0.874 . . . . 42.109999999999999 109.304 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -100.57 -71.19 0.71 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.069 -1.423 . . . . 66.019999999999996 110.815 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.4 pt-20 -95.67 -177.57 4.1 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.608 -0.723 . . . . 451.81 111.782 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.05 -10.42 57.43 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.115 -0.948 . . . . 104.66 111.098 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.3 t0 -60.38 -43.71 96.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 328.18000000000001 110.975 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -159.39 168.99 24.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 243.28999999999999 110.963 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.919 -0.582 . . . . 58.390000000000001 110.852 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 51.5 m -121.72 138.13 54.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.504 -0.771 . . . . 44.390000000000001 111.251 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -150.5 158.09 43.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.264 -0.425 . . . . 767.09000000000003 110.492 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.8 m -142.31 153.76 44.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 146.31999999999999 111.078 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -167.05 121.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.8 -0.636 . . . . 15.640000000000001 109.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -83.95 155.09 23.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.014 0.435 . . . . 422.56 111.38 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.4 143.52 45.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.727 -0.67 . . . . 462.10000000000002 110.067 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.1 m -78.53 124.29 28.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 111.17 110.729 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ASN . 34.0 p -152.91 89.03 1.35 Allowed 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.451 0.643 . . . . 121.65000000000001 110.518 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 -38.84 0.76 Allowed Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.899 -1.046 . . . . 82.170000000000002 111.222 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.7 m-20 -135.72 141.2 44.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.875 0.369 . . . . 220.46000000000001 110.365 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -90.03 146.5 24.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 149.47999999999999 110.573 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.8 p -132.77 -156.21 0.73 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.511 -0.552 . . . . 169.86000000000001 109.511 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -148.29 153.33 38.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.6 -0.727 . . . . 537.64999999999998 110.655 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 p -65.45 149.86 96.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.586 -0.524 . . . . 32.920000000000002 109.586 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.44 131.03 15.71 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.014 1.809 . . . . 87.700000000000003 112.121 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.83 -40.17 97.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.173 -0.771 . . . . 244.37 111.173 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.929 0.395 . . . . 681.24000000000001 110.584 -179.651 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.583 -1.407 . . . . 999.99000000000001 109.583 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.56 144.33 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.217 -0.29 . . . . 999.99000000000001 110.217 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.554 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 64.6 m -88.57 116.4 26.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.063 0.459 . . . . 271.27999999999997 111.027 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 t -73.16 -66.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.752 -0.658 . . . . 178.88999999999999 109.96 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' A' ' 5' ' ' GLU . 20.3 pt-20 -82.31 158.28 23.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.875 -1.057 . . . . 206.49000000000001 110.585 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.77 -42.81 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 244.88 110.947 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.07 53.64 1.61 Allowed Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.465 -0.654 . . . . 71.469999999999999 111.465 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -62.61 -46.53 87.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.83 0.348 . . . . 133.27000000000001 110.699 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.18 -42.08 99.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.289 0.566 . . . . 25.780000000000001 110.139 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.84 168.5 7.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.278 -0.874 . . . . 119.04000000000001 109.897 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.98 97.23 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.862 -0.335 . . . . 60.490000000000002 110.932 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.97 -32.15 27.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.429 -0.35 . . . . 258.73000000000002 111.023 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -75.1 166.98 22.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 339.06 110.938 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -130.9 143.89 51.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.01 -0.541 . . . . 42.960000000000001 110.629 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.7 t -135.58 138.53 43.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.3 -0.629 . . . . 39.109999999999999 109.3 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.9 p -148.3 118.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.56 -0.456 . . . . 115.20999999999999 110.402 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 66.4 m-20 -75.61 118.93 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 135.41999999999999 111.094 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.499 ' HG1' ' C ' ' A' ' 26' ' ' THR . 16.2 p -97.53 160.57 14.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.344 -0.613 . . . . 45.380000000000003 109.344 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p 179.53 117.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.921 0.867 . . . . 42.109999999999999 109.252 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.42 -56.63 2.18 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.269 -1.332 . . . . 66.019999999999996 111.387 -179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 22.6 pt-20 -113.41 -174.5 2.47 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 121.188 0.518 . . . . 451.81 111.77 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.41 -9.62 57.69 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.352 -0.84 . . . . 104.66 111.911 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.435 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.11 -41.1 96.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.879 0.371 . . . . 328.18000000000001 110.85 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -163.01 169.42 19.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.024 -0.535 . . . . 243.28999999999999 110.866 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.78 143.13 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.554 . . . . 58.390000000000001 110.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.499 ' C ' ' HG1' ' A' ' 18' ' ' THR . 99.4 m -117.25 137.43 52.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.503 -0.771 . . . . 44.390000000000001 111.168 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -125.79 156.23 39.83 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.871 -0.604 . . . . 767.09000000000003 109.531 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -147.96 159.25 44.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.303 0.573 . . . . 146.31999999999999 111.253 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.6 t -175.14 137.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.41 -0.814 . . . . 15.640000000000001 109.194 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -110.67 134.74 52.18 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.948 0.404 . . . . 422.56 110.948 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -86.56 140.41 29.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.893 -0.594 . . . . 462.10000000000002 109.707 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.0 m -89.99 102.71 15.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.964 0.412 . . . . 111.17 110.659 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ASN . 21.5 m -138.04 126.51 23.39 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.495 0.664 . . . . 121.65000000000001 110.032 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.25 -71.11 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 CA-C-N 114.663 -1.153 . . . . 82.170000000000002 110.644 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 33' ' ' THR . 84.2 m-20 -111.98 142.21 44.68 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.789 -0.448 . . . . 220.46000000000001 109.789 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -70.92 143.86 50.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 149.47999999999999 110.805 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 p -147.02 117.05 7.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.134 -0.485 . . . . 169.86000000000001 110.209 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.42 161.61 23.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 537.64999999999998 110.978 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.5 p -64.05 150.19 92.4 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.855 -0.612 . . . . 32.920000000000002 110.143 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.01 137.56 21.85 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.069 1.846 . . . . 87.700000000000003 111.768 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.13 7.41 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.793 -0.923 . . . . 244.37 110.793 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 mt -107.79 147.23 31.13 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.857 0.36 . . . . 681.24000000000001 110.617 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -140.7 68.27 30.11 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.015 -0.539 . . . . 508.5 110.787 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -76.13 -9.42 19.19 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.87 2.38 . . . . 999.99000000000001 111.628 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.77 128.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.044 -0.525 . . . . 898.75 110.632 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.973 -1.013 . . . . 999.99000000000001 110.62 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.561 -1.416 . . . . 999.99000000000001 109.561 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 2' ' ' LEU . 8.7 mp -62.87 -39.0 93.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 999.99000000000001 110.548 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 71.8 m -80.1 106.93 12.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 271.27999999999997 110.343 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 25.1 t -61.0 -43.12 99.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.398 0.618 . . . . 178.88999999999999 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 21.9 pt-20 -144.69 -164.62 1.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.966 -1.016 . . . . 206.49000000000001 110.21 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.41 85.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.872 0.368 . . . . 244.88 110.185 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -122.99 65.24 0.52 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.622 -0.991 . . . . 71.469999999999999 110.622 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 4' ' ' SER . 66.3 t0 -61.06 -41.72 97.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 133.27000000000001 110.588 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.9 m -61.31 -41.17 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.142 0.496 . . . . 25.780000000000001 110.173 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.61 166.46 14.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.778 . . . . 119.04000000000001 109.954 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.48 95.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 60.490000000000002 110.926 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.22 -29.61 24.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 258.73000000000002 111.055 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.469 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.0 mm-40 -76.14 159.97 30.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.968 0.414 . . . . 339.06 111.136 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.502 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 35.1 t -109.88 153.3 24.65 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.922 -0.581 . . . . 42.960000000000001 110.366 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 16.7 t -144.65 127.27 16.11 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.242 -0.651 . . . . 39.109999999999999 109.242 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.483 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 13.8 p -147.61 128.41 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 115.20999999999999 110.614 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 2' ' ' LEU . 97.3 m-20 -99.28 132.87 44.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 135.41999999999999 110.733 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 24.0 p -122.32 161.09 24.01 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.871 -0.604 . . . . 45.380000000000003 109.51 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 179.27 118.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.988 0.899 . . . . 42.109999999999999 109.2 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.13 -64.06 1.07 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.972 -1.467 . . . . 66.019999999999996 110.973 -179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.452 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.7 pt-20 -109.89 -173.06 2.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.122 0.487 . . . . 451.81 111.479 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.69 -11.62 56.64 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.574 -0.739 . . . . 104.66 111.858 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.25 -39.93 92.17 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.927 -0.309 . . . . 328.18000000000001 110.957 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.6 ptm -159.11 167.23 29.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 243.28999999999999 111.001 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.3 t -123.17 143.37 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.859 -0.61 . . . . 58.390000000000001 110.571 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 84.1 m -118.26 135.68 54.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.51 -0.768 . . . . 44.390000000000001 110.988 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt-85 -142.47 155.3 45.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.082 -0.508 . . . . 767.09000000000003 110.032 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.4 m -140.94 149.2 41.54 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.015 0.436 . . . . 146.31999999999999 111.012 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -172.09 116.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 15.640000000000001 109.794 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -82.2 150.1 27.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 422.56 110.88 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -112.75 141.71 46.23 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.086 -0.506 . . . . 462.10000000000002 109.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.469 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 92.4 m -69.34 126.73 30.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 111.17 110.529 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.3 p -151.03 89.44 1.53 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.417 0.627 . . . . 121.65000000000001 110.448 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.08 -47.93 1.34 Allowed Glycine 0 N--CA 1.439 -1.117 0 CA-C-N 114.984 -1.007 . . . . 82.170000000000002 110.946 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -131.77 139.84 49.05 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.1 -0.333 . . . . 220.46000000000001 110.1 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -82.51 145.42 29.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 149.47999999999999 110.781 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.8 p -129.5 -145.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.132 -0.486 . . . . 169.86000000000001 109.892 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -161.16 154.35 21.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.062 -0.517 . . . . 537.64999999999998 110.836 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 12.4 p -66.91 149.7 98.28 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 32.920000000000002 110.054 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.89 136.33 20.5 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.141 1.894 . . . . 87.700000000000003 111.849 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.38 -39.99 98.39 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.987 -0.845 . . . . 244.37 110.987 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.3 mt -110.44 144.77 38.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.858 0.361 . . . . 681.24000000000001 110.463 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.426 ' OG1' HG22 ' A' ' 45' ' ' ILE . 76.6 p -69.8 149.48 96.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.18 -0.464 . . . . 508.5 110.294 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.92 -10.39 21.33 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.348 2.032 . . . . 999.99000000000001 112.418 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG22 ' OG1' ' A' ' 43' ' ' THR . 20.0 tt -53.0 -31.14 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.417 -0.356 . . . . 898.75 110.65 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.975 -1.012 . . . . 999.99000000000001 110.63 -180.0 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.56 -1.416 . . . . 999.99000000000001 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.8 mt -71.67 149.96 45.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.843 0.354 . . . . 999.99000000000001 110.285 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 75.0 m -84.68 104.95 15.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.187 -0.461 . . . . 271.27999999999997 110.771 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.7 t -62.31 -42.68 99.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 178.88999999999999 109.676 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -143.1 -171.34 3.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.905 -1.043 . . . . 206.49000000000001 110.252 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.16 -39.63 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 244.88 110.242 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.64 62.76 0.44 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.628 -0.989 . . . . 71.469999999999999 110.628 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.6 -46.55 89.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.904 0.383 . . . . 133.27000000000001 110.766 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.5 m -63.1 -41.86 99.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.179 0.514 . . . . 25.780000000000001 110.299 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.54 163.56 6.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.312 -0.858 . . . . 119.04000000000001 109.585 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.78 91.8 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.488 -0.485 . . . . 60.490000000000002 110.405 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.33 -38.69 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 258.73000000000002 110.48 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.26 156.52 31.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 339.06 110.515 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.656 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 1.8 p -108.12 171.22 7.53 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.197 -0.297 . . . . 42.960000000000001 110.197 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 11.4 t -156.17 127.71 7.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.312 -0.625 . . . . 39.109999999999999 109.312 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.536 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 7.4 p -150.95 129.13 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.009 0.433 . . . . 115.20999999999999 110.38 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -94.9 120.26 34.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.017 -0.538 . . . . 135.41999999999999 110.948 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 26' ' ' THR . 15.5 p -104.4 164.86 11.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.034 -0.53 . . . . 45.380000000000003 109.653 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.04 119.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.833 0.825 . . . . 42.109999999999999 109.087 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.16 -65.94 0.93 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.336 -1.302 . . . . 66.019999999999996 111.013 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.0 pt-20 -108.66 -171.97 1.96 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.11 0.481 . . . . 451.81 111.567 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.35 -13.34 52.14 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 115.694 -0.685 . . . . 104.66 111.973 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.7 m-20 -60.54 -41.58 94.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 328.18000000000001 110.722 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptp -160.87 161.71 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.922 -0.581 . . . . 243.28999999999999 110.495 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.5 m -120.14 160.53 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.907 -0.588 . . . . 58.390000000000001 110.956 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 18' ' ' THR . 78.0 m -129.75 138.55 51.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.734 -0.666 . . . . 44.390000000000001 111.232 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -128.13 154.51 45.67 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.578 . . . . 767.09000000000003 109.817 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -141.9 148.38 38.62 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.043 0.449 . . . . 146.31999999999999 110.822 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.6 t -171.92 101.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 15.640000000000001 109.339 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.656 ' CG ' ' H ' ' A' ' 14' ' ' CYS . 9.4 pt-20 -60.65 163.47 5.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.356 0.598 . . . . 422.56 111.375 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -136.35 143.27 43.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.833 -1.076 . . . . 462.10000000000002 110.07 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.1 m -112.06 122.8 48.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.909 0.385 . . . . 111.17 110.76 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.1 p -154.16 84.27 1.14 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.607 0.717 . . . . 121.65000000000001 110.321 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.88 -5.24 58.73 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 114.517 -1.22 . . . . 82.170000000000002 110.442 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.4 m-20 -154.77 149.37 26.4 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.936 -0.394 . . . . 220.46000000000001 109.936 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.88 143.21 32.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.872 0.368 . . . . 149.47999999999999 110.935 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 37' ' ' THR . 10.2 t -155.46 124.53 6.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 169.86000000000001 110.107 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.6 mp0 -81.71 159.41 23.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.826 -0.625 . . . . 537.64999999999998 110.808 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.55 160.23 0.22 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 109.466 -0.568 . . . . 32.920000000000002 109.466 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.09 133.04 15.99 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.06 1.84 . . . . 87.700000000000003 111.894 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.22 -40.36 98.98 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 244.37 111.212 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -113.88 145.68 41.12 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.549 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 43' ' ' THR . 1.5 p -76.6 173.75 6.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 508.5 109.655 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.17 -21.68 72.92 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.941 1.761 . . . . 999.99000000000001 111.6 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.421 ' O ' ' OXT' ' A' ' 46' ' ' ALA . 96.9 mt -60.1 -45.33 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.989 -0.551 . . . . 898.75 110.437 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' A' ' 45' ' ' ILE . . . . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.021 -0.99 . . . . 999.99000000000001 110.603 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.555 -1.418 . . . . 999.99000000000001 109.555 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.26 152.77 18.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.815 0.34 . . . . 999.99000000000001 110.349 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.449 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 94.7 m -63.79 147.63 51.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 271.27999999999997 110.264 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -60.27 -43.24 96.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.149 0.5 . . . . 178.88999999999999 110.2 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -147.28 -170.83 3.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.426 -0.806 . . . . 206.49000000000001 110.607 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.89 -39.34 84.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.882 0.373 . . . . 244.88 110.192 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.2 75.13 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.633 -0.987 . . . . 71.469999999999999 110.633 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.24 -43.66 98.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 133.27000000000001 110.624 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.1 m -62.49 -41.77 99.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 25.780000000000001 110.202 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.73 163.15 9.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 119.04000000000001 110.09 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.86 -39.38 88.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.452 -0.34 . . . . 60.490000000000002 110.973 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -91.89 11.4 25.06 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.256 -0.429 . . . . 258.73000000000002 111.441 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.0 mm-40 -119.12 159.4 24.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.071 0.462 . . . . 339.06 111.051 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.4 t -104.35 155.17 19.0 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.769 -0.65 . . . . 42.960000000000001 110.656 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.449 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 41.9 t -146.13 127.73 15.14 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.455 -0.572 . . . . 39.109999999999999 109.455 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.57 130.54 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.74 -0.384 . . . . 115.20999999999999 110.336 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 68.5 m-20 -106.89 123.32 47.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.183 -0.462 . . . . 135.41999999999999 111.078 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -110.12 161.99 15.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.787 -0.642 . . . . 45.380000000000003 109.546 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.1 p -178.33 116.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 122.008 0.909 . . . . 42.109999999999999 109.636 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.81 -57.78 2.15 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.139 -1.391 . . . . 66.019999999999996 110.748 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.7 pt-20 -116.37 -176.78 3.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.296 0.569 . . . . 451.81 111.428 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.9 -12.27 56.81 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.197 -0.911 . . . . 104.66 111.048 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.5 t0 -61.69 -44.47 96.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.975 0.417 . . . . 328.18000000000001 111.211 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.9 ttp -154.28 145.0 22.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 243.28999999999999 110.924 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.3 t -107.03 143.28 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.002 -0.544 . . . . 58.390000000000001 110.481 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.3 m -115.28 132.61 56.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.589 -0.732 . . . . 44.390000000000001 111.083 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -132.65 155.36 48.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.983 -0.553 . . . . 767.09000000000003 109.939 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 t -144.47 146.22 32.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.946 0.403 . . . . 146.31999999999999 110.72 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.4 t -173.65 116.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 15.640000000000001 109.803 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 78.7 mm-40 -85.04 154.84 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.997 0.427 . . . . 422.56 110.898 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.13 143.97 49.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.899 -0.591 . . . . 462.10000000000002 109.881 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.495 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 95.2 m -88.91 119.39 29.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.949 0.404 . . . . 111.17 110.751 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.2 p -153.01 82.68 1.21 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.559 0.695 . . . . 121.65000000000001 110.577 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 78.5 -4.46 59.76 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.501 -1.227 . . . . 82.170000000000002 110.935 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 34' ' ' GLY . 33.2 m120 -159.01 148.66 18.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.676 0.274 . . . . 220.46000000000001 110.398 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.37 140.26 37.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.34 -0.391 . . . . 149.47999999999999 110.626 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.61 124.39 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.988 0.423 . . . . 169.86000000000001 110.444 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 58.4 mp0 -82.44 166.07 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 537.64999999999998 111.035 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.7 p -62.51 150.59 85.46 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.921 -0.582 . . . . 32.920000000000002 110.05 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.05 140.96 23.22 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.057 1.838 . . . . 87.700000000000003 111.964 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.72 -40.45 99.21 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.883 -0.887 . . . . 244.37 110.883 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.0 mt -114.25 143.48 44.79 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.784 0.325 . . . . 681.24000000000001 110.213 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.3 p -70.48 149.46 95.61 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.289 -0.414 . . . . 508.5 110.358 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.83 -1.82 11.36 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.226 1.951 . . . . 999.99000000000001 111.934 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -53.53 131.07 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 898.75 110.733 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.987 -1.006 . . . . 999.99000000000001 110.496 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.564 -1.415 . . . . 999.99000000000001 109.564 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.54 149.1 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 999.99000000000001 110.256 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 73.9 m -81.64 109.41 16.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.336 -0.393 . . . . 271.27999999999997 110.418 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.8 t -61.91 -42.66 99.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.394 0.616 . . . . 178.88999999999999 109.881 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -142.99 -167.31 2.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.941 -1.027 . . . . 206.49000000000001 110.331 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.17 -39.56 86.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.447 -0.342 . . . . 244.88 110.217 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.3 64.89 0.5 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.605 -0.998 . . . . 71.469999999999999 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -60.86 -45.22 95.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.803 0.335 . . . . 133.27000000000001 110.656 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.4 m -62.51 -41.59 98.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.219 0.533 . . . . 25.780000000000001 110.167 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.18 165.8 7.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.388 -0.823 . . . . 119.04000000000001 109.899 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.35 95.74 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.828 -0.349 . . . . 60.490000000000002 110.821 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -83.59 -32.38 25.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.374 -0.375 . . . . 258.73000000000002 111.282 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' OE2' ' N ' ' A' ' 32' ' ' THR . 76.9 mm-40 -74.22 153.97 39.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 339.06 111.188 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.5 t -101.02 156.48 17.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.927 -0.578 . . . . 42.960000000000001 110.284 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 11.6 t -151.43 129.81 12.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.325 -0.62 . . . . 39.109999999999999 109.325 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.583 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.2 p -151.11 131.62 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 115.20999999999999 110.63 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -95.54 120.05 35.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.03 -0.532 . . . . 135.41999999999999 110.65 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -107.02 161.97 14.26 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.041 -0.527 . . . . 45.380000000000003 110.07 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.0 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.979 0.895 . . . . 42.109999999999999 108.981 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -93.61 -94.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.84 -1.527 . . . . 66.019999999999996 111.443 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -80.37 -18.65 48.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.202 -0.908 . . . . 451.81 111.239 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.19 -8.43 75.59 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.204 -0.758 . . . . 104.66 111.204 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.56 -42.12 91.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 328.18000000000001 109.388 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.404 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.6 ttp -142.57 104.59 4.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.312 -0.858 . . . . 243.28999999999999 109.284 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.27 146.9 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.207 0.527 . . . . 58.390000000000001 110.96 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.2 m -125.37 134.66 52.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.354 -0.839 . . . . 44.390000000000001 110.944 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -129.74 146.23 51.51 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.006 -0.543 . . . . 767.09000000000003 109.903 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -134.09 145.38 49.3 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.87 0.367 . . . . 146.31999999999999 110.639 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -172.86 116.22 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 15.640000000000001 109.994 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -80.04 153.57 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 422.56 110.865 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -116.45 142.61 46.64 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.047 -0.524 . . . . 462.10000000000002 110.017 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.518 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.4 m -68.05 126.3 29.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.064 0.459 . . . . 111.17 110.374 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.8 p -151.31 88.85 1.46 Allowed 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.827 -0.624 . . . . 121.65000000000001 110.539 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -47.65 1.22 Allowed Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 114.875 -1.057 . . . . 82.170000000000002 110.979 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -133.34 138.72 46.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.158 -0.312 . . . . 220.46000000000001 110.158 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.428 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.3 m-85 -83.18 146.41 28.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 149.47999999999999 110.573 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 38.6 p -133.36 -144.84 0.23 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.253 -0.431 . . . . 169.86000000000001 110.118 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.21 159.14 35.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 537.64999999999998 110.739 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.42 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.4 p -57.33 152.04 34.34 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 116.091 -0.504 . . . . 32.920000000000002 109.993 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -74.31 135.39 20.43 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.313 2.009 . . . . 87.700000000000003 112.259 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.35 96.88 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.706 -0.958 . . . . 244.37 110.706 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.4 mt -103.88 144.1 31.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.876 0.37 . . . . 681.24000000000001 110.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 t -60.55 142.38 91.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.1 -0.5 . . . . 508.5 110.33 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.74 -10.87 23.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.171 1.914 . . . . 999.99000000000001 111.426 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.75 -44.82 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 898.75 110.234 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.008 -0.996 . . . . 999.99000000000001 110.538 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.528 -1.429 . . . . 999.99000000000001 109.528 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.06 140.8 49.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.673 0.273 . . . . 999.99000000000001 110.315 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 m -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 271.27999999999997 110.179 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 t -61.05 -43.74 98.43 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.843 -0.617 . . . . 178.88999999999999 110.256 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 21.9 pt-20 -150.54 172.67 15.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.193 -0.912 . . . . 206.49000000000001 110.791 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -14.89 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 244.88 110.418 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -68.53 -9.38 58.34 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.452 -0.659 . . . . 71.469999999999999 111.452 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -48.29 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.808 -0.357 . . . . 133.27000000000001 110.514 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 67.3 m -62.55 -43.68 98.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.197 0.522 . . . . 25.780000000000001 109.848 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.42 165.55 3.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.27 -0.877 . . . . 119.04000000000001 109.854 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.5 96.97 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.937 -0.305 . . . . 60.490000000000002 111.079 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -83.79 -31.18 26.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.441 -0.345 . . . . 258.73000000000002 111.379 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 32' ' ' THR . 77.7 mm-40 -75.0 156.54 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.913 0.387 . . . . 339.06 111.356 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.9 t -108.85 157.81 18.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.935 -0.575 . . . . 42.960000000000001 110.395 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 48.1 t -146.18 133.68 20.85 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.845 -0.428 . . . . 39.109999999999999 109.845 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -154.15 117.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.613 -0.435 . . . . 115.20999999999999 109.854 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 97.3 m-20 -95.25 118.64 32.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.033 -0.531 . . . . 135.41999999999999 111.158 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -103.62 163.56 12.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.735 -0.666 . . . . 45.380000000000003 109.553 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 p -179.05 117.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.881 0.848 . . . . 42.109999999999999 109.412 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -100.89 -63.85 1.1 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.26 -1.336 . . . . 66.019999999999996 111.09 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.5 pt-20 -107.38 -177.22 3.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.33 0.586 . . . . 451.81 111.846 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.96 -12.02 57.03 Favored Glycine 0 N--CA 1.466 0.695 0 CA-C-N 115.01 -0.996 . . . . 104.66 111.352 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -60.22 -42.85 96.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 328.18000000000001 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.9 ptp -156.43 166.61 32.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 243.28999999999999 110.77 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.15 140.28 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.099 -0.501 . . . . 58.390000000000001 110.698 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.2 m -110.85 131.55 54.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 44.390000000000001 111.124 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' NH2' ' OD2' ' A' ' 17' ' ' ASP . 77.3 mtp85 -132.4 147.19 52.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.047 -0.524 . . . . 767.09000000000003 109.995 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -137.36 146.81 44.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.989 0.423 . . . . 146.31999999999999 110.74 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.4 t -175.01 117.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.821 -0.627 . . . . 15.640000000000001 109.593 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -83.39 155.79 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.961 0.41 . . . . 422.56 111.195 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -118.3 144.21 46.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.942 -0.572 . . . . 462.10000000000002 109.877 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.524 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 96.0 m -80.1 123.89 28.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 111.17 110.708 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.473 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.96 89.7 1.4 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 115.882 -0.599 . . . . 121.65000000000001 110.395 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.35 -41.69 0.79 Allowed Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.012 -0.994 . . . . 82.170000000000002 110.792 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.3 m-20 -134.39 139.72 45.79 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.079 -0.341 . . . . 220.46000000000001 110.079 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.78 147.59 27.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.327 -0.397 . . . . 149.47999999999999 110.858 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 p -146.92 119.62 8.59 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.041 -0.527 . . . . 169.86000000000001 109.89 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -73.98 158.07 35.04 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.966 -0.561 . . . . 537.64999999999998 111.133 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 15.6 p -64.82 149.67 95.82 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.975 -0.557 . . . . 32.920000000000002 110.058 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.72 138.96 21.98 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.101 1.868 . . . . 87.700000000000003 112.052 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.07 98.7 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.741 -0.944 . . . . 244.37 110.741 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.11 145.3 41.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.252 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.44 ' OG1' HG22 ' A' ' 45' ' ' ILE . 73.7 p -69.25 149.37 97.48 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.248 -0.433 . . . . 508.5 110.331 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.69 -10.42 21.74 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.399 2.066 . . . . 999.99000000000001 112.282 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.44 HG22 ' OG1' ' A' ' 43' ' ' THR . 19.7 tt -52.56 -31.15 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.4 -0.364 . . . . 898.75 110.645 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.064 -0.97 . . . . 999.99000000000001 110.627 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.419 ' CA ' HH21 ' A' ' 27' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.492 -1.443 . . . . 999.99000000000001 109.492 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 83.2 mt -72.54 149.03 44.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 999.99000000000001 110.336 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.588 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 78.1 m -85.9 107.69 17.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 271.27999999999997 110.711 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.467 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 25.3 t -62.18 -42.75 99.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.381 0.61 . . . . 178.88999999999999 109.651 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -144.75 -167.34 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.989 -1.005 . . . . 206.49000000000001 110.24 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.11 -39.74 87.26 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.746 -0.382 . . . . 244.88 110.124 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.43 62.02 0.48 Allowed Glycine 0 N--CA 1.466 0.652 0 N-CA-C 110.395 -1.082 . . . . 71.469999999999999 110.395 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 4' ' ' SER . 67.7 t0 -60.47 -45.75 92.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.771 0.32 . . . . 133.27000000000001 110.82 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.44 -42.12 99.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.315 0.578 . . . . 25.780000000000001 110.232 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.71 167.88 7.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.286 -0.87 . . . . 119.04000000000001 109.874 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.04 96.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.874 -0.331 . . . . 60.490000000000002 110.776 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -82.15 -34.99 28.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.367 -0.379 . . . . 258.73000000000002 111.088 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.41 152.28 42.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 339.06 110.883 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 25.9 t -104.85 154.17 20.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 42.960000000000001 109.856 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 10.9 t -147.32 130.32 16.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.671 -0.492 . . . . 39.109999999999999 109.671 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.588 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.4 p -148.26 131.88 8.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.352 . . . . 115.20999999999999 110.482 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -100.62 120.83 40.64 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.119 -0.491 . . . . 135.41999999999999 110.529 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 26' ' ' THR . 27.5 p -107.37 164.91 11.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.187 -0.461 . . . . 45.380000000000003 109.931 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 p 178.07 117.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 121.924 0.868 . . . . 42.109999999999999 109.397 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.07 -55.59 2.74 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.224 -1.353 . . . . 66.019999999999996 110.586 -179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.8 pt-20 -118.17 -177.02 3.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.286 0.565 . . . . 451.81 111.425 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.33 -12.3 57.45 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.313 -0.858 . . . . 104.66 111.129 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.9 t0 -61.78 -44.74 96.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.863 0.363 . . . . 328.18000000000001 111.153 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.1 ttp -154.74 144.64 21.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 243.28999999999999 110.95 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.0 t -103.9 147.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.078 -0.51 . . . . 58.390000000000001 110.318 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 77.3 m -123.94 139.84 53.56 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.798 -0.637 . . . . 44.390000000000001 111.346 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.419 HH21 ' CA ' ' A' ' 1' ' ' GLY . 20.9 ptp180 -145.89 160.61 41.57 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.906 -0.588 . . . . 767.09000000000003 109.788 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 91.3 p -150.14 161.92 41.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.958 0.408 . . . . 146.31999999999999 110.829 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -169.95 127.68 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 15.640000000000001 109.963 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 77.3 mm-40 -75.83 151.82 37.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 422.56 111.155 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -128.01 138.89 52.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.744 -0.662 . . . . 462.10000000000002 109.925 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 34' ' ' GLY . 27.7 p -71.45 69.81 0.6 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.115 -0.493 . . . . 111.17 110.378 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -78.4 45.2 0.55 Allowed 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 121.909 0.861 . . . . 121.65000000000001 110.163 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 32' ' ' THR . . . 82.58 -0.92 88.88 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.194 -1.366 . . . . 82.170000000000002 110.146 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 80.6 m-20 -149.44 142.61 25.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.747 -0.464 . . . . 220.46000000000001 109.747 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.86 136.96 33.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 149.47999999999999 110.632 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.421 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 21.2 p -133.98 -150.28 0.39 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.693 -0.484 . . . . 169.86000000000001 109.693 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 98.3 mt-10 -144.73 142.87 30.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.845 -0.616 . . . . 537.64999999999998 110.766 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 p -65.13 150.41 95.5 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 109.61 -0.515 . . . . 32.920000000000002 109.61 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.07 130.35 15.3 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.988 1.792 . . . . 87.700000000000003 112.039 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.37 95.65 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.978 -0.849 . . . . 244.37 110.978 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -119.0 149.58 41.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.883 0.373 . . . . 681.24000000000001 110.615 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 56.6 p -69.2 151.07 97.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.902 -0.59 . . . . 508.5 110.013 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.05 -6.78 19.02 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.083 1.855 . . . . 999.99000000000001 111.568 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.3 mm -59.98 128.7 21.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 898.75 110.43 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.985 -1.007 . . . . 999.99000000000001 110.559 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 999.99000000000001 109.535 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.36 148.01 50.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 999.99000000000001 110.241 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 84.7 m -81.59 113.91 19.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 271.27999999999997 110.602 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.446 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 25.6 t -62.21 -42.75 99.58 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.466 0.651 . . . . 178.88999999999999 109.674 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -142.35 -163.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.861 -1.063 . . . . 206.49000000000001 110.288 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.26 -39.6 87.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.351 . . . . 244.88 110.391 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.2 65.81 0.55 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.773 -0.931 . . . . 71.469999999999999 110.773 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 4' ' ' SER . 66.3 t0 -61.28 -42.05 97.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.868 0.366 . . . . 133.27000000000001 110.601 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.0 m -61.14 -42.58 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.234 0.54 . . . . 25.780000000000001 109.916 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.09 163.99 15.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.338 -0.846 . . . . 119.04000000000001 109.744 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.15 95.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.589 -0.278 . . . . 60.490000000000002 111.145 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -86.38 -29.51 22.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 258.73000000000002 111.418 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -74.21 159.17 32.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.716 0.293 . . . . 339.06 111.028 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 53.3 t -102.77 150.2 23.71 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.147 -0.478 . . . . 42.960000000000001 110.28 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 9.1 t -149.42 124.82 10.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.122 -0.696 . . . . 39.109999999999999 109.122 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.517 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.0 p -145.9 131.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.984 0.421 . . . . 115.20999999999999 110.412 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 97.7 m-20 -95.58 120.98 36.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.936 -0.574 . . . . 135.41999999999999 110.752 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.496 HG21 HG22 ' A' ' 43' ' ' THR . 36.2 p -104.81 165.32 11.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.942 -0.572 . . . . 45.380000000000003 109.947 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 176.18 118.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.772 0.796 . . . . 42.109999999999999 109.216 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -98.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.295 -1.321 . . . . 66.019999999999996 110.826 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.6 pt-20 -112.15 -173.05 2.16 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.076 0.465 . . . . 451.81 111.442 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.25 -11.98 56.72 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.662 -0.699 . . . . 104.66 111.918 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.4 m-20 -61.32 -39.54 90.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.803 0.335 . . . . 328.18000000000001 111.041 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.4 ptp -157.78 167.99 28.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 243.28999999999999 111.057 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.3 t -124.04 146.62 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.986 -0.552 . . . . 58.390000000000001 110.475 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.483 ' C ' ' HG1' ' A' ' 18' ' ' THR . 83.7 m -125.28 142.11 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.731 -0.668 . . . . 44.390000000000001 111.219 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ptt-85 -137.36 154.74 49.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.053 -0.521 . . . . 767.09000000000003 110.218 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -134.18 150.4 51.08 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.024 0.44 . . . . 146.31999999999999 110.988 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -176.24 128.35 0.21 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.186 -0.672 . . . . 15.640000000000001 109.186 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 37' ' ' THR . 95.4 mt-10 -107.56 130.58 54.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.937 0.398 . . . . 422.56 111.326 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -87.0 150.07 24.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.936 -0.574 . . . . 462.10000000000002 110.45 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.6 m -95.4 122.92 38.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 111.17 110.433 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -145.88 84.07 1.65 Allowed 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.612 0.72 . . . . 121.65000000000001 110.875 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.54 -5.67 55.65 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.596 -1.184 . . . . 82.170000000000002 110.989 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 78.0 m-20 -155.93 148.98 24.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 220.46000000000001 110.253 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 137.72 37.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 149.47999999999999 110.525 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.43 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 56.6 p -151.23 119.24 6.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.263 -0.426 . . . . 169.86000000000001 110.438 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 99.7 mt-10 -75.06 161.69 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.904 -0.589 . . . . 537.64999999999998 110.392 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.506 ' H ' ' CB ' ' A' ' 14' ' ' CYS . 1.2 p -52.03 157.5 2.13 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 109.475 -0.565 . . . . 32.920000000000002 109.475 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -55.63 163.1 5.64 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.594 1.53 . . . . 87.700000000000003 112.694 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.63 65.1 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 114.85 -1.068 . . . . 244.37 110.493 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 73.6 mt -122.73 158.33 30.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.024 -0.361 . . . . 681.24000000000001 110.024 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.496 HG22 HG21 ' A' ' 18' ' ' THR . 69.9 p -61.46 148.18 86.51 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.429 -0.35 . . . . 508.5 110.234 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.98 -16.4 20.28 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 122.509 2.139 . . . . 999.99000000000001 113.152 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 45' ' ' ILE . 20.4 pt -43.48 153.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 898.75 110.978 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.974 -1.012 . . . . 999.99000000000001 110.559 179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.548 -1.421 . . . . 999.99000000000001 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.419 ' O ' ' OD2' ' A' ' 8' ' ' ASP . 86.3 mt -70.58 147.93 48.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 999.99000000000001 110.379 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 82.5 m -85.15 108.15 17.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.391 . . . . 271.27999999999997 110.393 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.469 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 28.2 t -61.5 -43.06 99.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.474 0.654 . . . . 178.88999999999999 109.781 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -144.05 -166.86 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.924 -1.035 . . . . 206.49000000000001 110.273 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.09 -39.48 86.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.994 -0.373 . . . . 244.88 109.994 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.65 62.2 0.48 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.687 -0.965 . . . . 71.469999999999999 110.687 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 4' ' ' SER . 67.2 t0 -60.72 -43.49 97.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.826 0.346 . . . . 133.27000000000001 110.515 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.3 m -61.84 -41.37 97.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.261 0.553 . . . . 25.780000000000001 109.958 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.74 167.45 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.423 -0.808 . . . . 119.04000000000001 109.865 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.56 96.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.802 -0.359 . . . . 60.490000000000002 110.841 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -84.15 -32.66 24.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 258.73000000000002 111.05 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.82 158.52 35.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 339.06 110.901 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.547 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 41.9 t -111.51 146.81 36.63 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.137 -0.483 . . . . 42.960000000000001 110.169 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.456 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 15.8 t -140.97 129.04 22.02 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.046 -0.724 . . . . 39.109999999999999 109.046 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.541 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 12.9 p -148.48 131.48 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 115.20999999999999 110.422 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.92 121.35 38.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.997 -0.547 . . . . 135.41999999999999 110.939 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 p -103.51 166.31 10.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.927 -0.579 . . . . 45.380000000000003 109.84 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 p 178.09 119.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.993 0.901 . . . . 42.109999999999999 109.103 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.42 -95.01 0.17 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.913 -1.494 . . . . 66.019999999999996 111.269 -178.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -75.35 -28.08 59.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.954 -1.021 . . . . 451.81 111.084 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -13.73 58.82 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.274 -0.731 . . . . 104.66 111.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.79 -39.15 87.81 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.624 -0.51 . . . . 328.18000000000001 109.624 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.432 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 69.5 mtm -137.55 101.45 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.466 -0.788 . . . . 243.28999999999999 109.613 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.7 147.24 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.583 -0.447 . . . . 58.390000000000001 110.821 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 56.1 m -126.03 139.02 53.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.814 -0.63 . . . . 44.390000000000001 111.539 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.47 147.12 50.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.655 -0.702 . . . . 767.09000000000003 109.494 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -134.47 147.95 50.48 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.033 0.445 . . . . 146.31999999999999 111.224 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -175.42 130.86 0.28 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.219 -0.66 . . . . 15.640000000000001 109.219 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -108.12 167.09 10.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.942 0.401 . . . . 422.56 110.858 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -128.1 148.01 50.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.811 -0.631 . . . . 462.10000000000002 110.336 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.9 m -89.81 122.62 33.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 111.17 110.521 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.2 p -147.2 84.34 1.58 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.661 0.743 . . . . 121.65000000000001 110.768 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.57 -5.6 56.05 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.568 -1.196 . . . . 82.170000000000002 110.896 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -155.84 151.17 26.82 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.118 -0.327 . . . . 220.46000000000001 110.118 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.41 141.51 33.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.841 0.353 . . . . 149.47999999999999 110.992 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 37' ' ' THR . 10.9 t -161.48 130.7 4.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 169.86000000000001 109.837 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -86.39 169.6 12.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.833 -0.621 . . . . 537.64999999999998 111.032 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 2.3 p -58.71 152.13 48.9 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.939 -0.573 . . . . 32.920000000000002 109.968 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.92 134.9 16.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.101 1.867 . . . . 87.700000000000003 112.085 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.05 -39.75 97.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.909 -0.876 . . . . 244.37 110.909 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -110.57 142.26 42.64 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.965 0.412 . . . . 681.24000000000001 110.457 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p -70.01 150.46 96.26 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.954 -0.566 . . . . 508.5 110.133 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.08 -13.21 21.31 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.435 2.09 . . . . 999.99000000000001 112.76 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 46' ' ' ALA . 30.9 pt -53.53 -23.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 120.791 0.329 . . . . 898.75 110.701 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 45' ' ' ILE . . . . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.028 -0.987 . . . . 999.99000000000001 110.663 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.553 -1.419 . . . . 999.99000000000001 109.553 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.44 145.57 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.739 0.304 . . . . 999.99000000000001 110.407 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 5' ' ' GLU . 82.9 m -62.39 -40.84 97.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.358 -0.383 . . . . 271.27999999999997 110.659 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 0.9 OUTLIER 76.2 -33.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.131 -0.486 . . . . 178.88999999999999 110.165 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.1 pt-20 -153.67 162.22 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.672 -0.694 . . . . 206.49000000000001 110.417 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.25 -40.35 93.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 244.88 111.054 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 49.82 0.9 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 110.978 -0.849 . . . . 71.469999999999999 110.978 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -61.21 -49.92 75.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.877 0.37 . . . . 133.27000000000001 110.569 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.4 m -64.69 -41.61 95.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.315 0.579 . . . . 25.780000000000001 110.126 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.19 167.81 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 119.04000000000001 109.867 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.63 97.28 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.954 -0.298 . . . . 60.490000000000002 111.005 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.64 -30.98 24.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.755 0.312 . . . . 258.73000000000002 111.243 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.55 158.58 33.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 339.06 110.994 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 38.6 t -112.91 144.19 42.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.241 -0.436 . . . . 42.960000000000001 110.602 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 29.7 t -137.89 128.3 26.35 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.194 -0.669 . . . . 39.109999999999999 109.194 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.5 p -143.11 133.18 21.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.878 0.37 . . . . 115.20999999999999 110.557 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 72.2 m-20 -92.5 121.96 34.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.023 -0.535 . . . . 135.41999999999999 110.808 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.58 ' HG1' ' C ' ' A' ' 26' ' ' THR . 14.6 p -101.01 164.73 11.67 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.02 -0.536 . . . . 45.380000000000003 109.946 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 176.38 119.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.079 0.942 . . . . 42.109999999999999 108.91 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.24 -94.39 0.18 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.751 -1.568 . . . . 66.019999999999996 111.48 -178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -77.71 -21.31 52.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.165 -0.925 . . . . 451.81 111.189 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.57 71.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.298 -0.721 . . . . 104.66 111.298 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -59.54 -42.64 92.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.327 -0.62 . . . . 328.18000000000001 109.327 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.6 ttp -141.75 111.27 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.322 -0.854 . . . . 243.28999999999999 109.111 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 26' ' ' THR . 69.9 t -69.93 150.03 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.177 0.513 . . . . 58.390000000000001 111.082 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.58 ' C ' ' HG1' ' A' ' 18' ' ' THR . 89.2 m -132.89 143.95 49.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.484 -0.78 . . . . 44.390000000000001 111.057 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -132.13 163.84 27.61 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.95 -0.568 . . . . 767.09000000000003 110.116 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 t -148.62 150.49 33.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.987 0.422 . . . . 146.31999999999999 111.087 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.3 t -170.6 134.85 1.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 15.640000000000001 109.305 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -112.59 135.71 52.99 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.982 0.42 . . . . 422.56 111.337 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.43 144.96 26.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.848 -0.615 . . . . 462.10000000000002 110.203 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 94.6 m -93.66 102.93 15.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 111.17 110.612 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.5 m -140.28 125.89 19.16 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.491 0.662 . . . . 121.65000000000001 110.111 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.67 -64.85 0.45 Allowed Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.652 -1.158 . . . . 82.170000000000002 110.827 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' THR . 83.2 m-20 -122.53 146.89 47.0 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.977 -0.379 . . . . 220.46000000000001 109.977 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -73.25 146.22 45.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.422 -0.354 . . . . 149.47999999999999 110.902 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.15 122.11 5.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.144 0.497 . . . . 169.86000000000001 110.391 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.06 165.15 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.857 -0.61 . . . . 537.64999999999998 110.896 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 7.7 p -63.65 150.11 91.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.961 -0.563 . . . . 32.920000000000002 109.94 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.15 138.61 22.9 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.01 1.807 . . . . 87.700000000000003 111.841 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.85 0.43 67.2 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.954 -0.858 . . . . 244.37 110.954 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.05 145.14 42.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.92 0.391 . . . . 681.24000000000001 110.503 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.1 t -145.21 63.93 10.4 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.011 -0.54 . . . . 508.5 110.724 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.25 -14.8 23.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.966 2.444 . . . . 999.99000000000001 111.466 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.1 pt -59.11 -21.32 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 115.821 -0.627 . . . . 898.75 110.835 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.936 -1.03 . . . . 999.99000000000001 110.598 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.506 -1.438 . . . . 999.99000000000001 109.506 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.21 146.82 40.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 999.99000000000001 110.341 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.552 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 90.1 m -61.8 -42.61 99.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.258 -0.428 . . . . 271.27999999999997 110.791 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 74.18 -36.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.09 -0.504 . . . . 178.88999999999999 110.176 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.2 pt-20 -150.4 161.5 42.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.675 -0.693 . . . . 206.49000000000001 110.439 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -61.41 -40.6 94.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 244.88 111.122 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.31 47.76 1.12 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.953 -0.859 . . . . 71.469999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -61.24 -50.16 74.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.895 0.378 . . . . 133.27000000000001 110.638 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.61 -41.46 96.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.906 -0.588 . . . . 25.780000000000001 110.209 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -172.41 168.73 5.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.301 -0.863 . . . . 119.04000000000001 109.859 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.65 96.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.889 -0.324 . . . . 60.490000000000002 110.941 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -84.61 -31.35 24.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 258.73000000000002 111.11 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -74.82 156.29 36.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.343 -0.39 . . . . 339.06 111.014 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.6 t -112.95 144.46 42.49 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.132 -0.486 . . . . 42.960000000000001 110.515 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 26.8 t -136.73 127.17 26.72 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.832 -0.803 . . . . 39.109999999999999 108.832 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 9.1 p -137.64 130.37 42.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.04 0.448 . . . . 115.20999999999999 110.833 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 97.3 m-20 -93.4 138.57 31.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.828 -0.624 . . . . 135.41999999999999 110.898 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -128.06 159.22 35.73 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.884 -0.598 . . . . 45.380000000000003 109.834 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 p 178.67 118.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 108.685 -0.857 . . . . 42.109999999999999 108.685 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.636 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -98.4 -92.07 0.26 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.97 -1.468 . . . . 66.019999999999996 112.172 -177.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 4.0 pt-20 -70.92 -33.83 70.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.073 -0.512 . . . . 451.81 110.863 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.6 -11.42 46.42 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 115.573 -0.739 . . . . 104.66 111.89 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.65 ' H ' ' CG ' ' A' ' 21' ' ' GLU . 37.8 t70 -60.41 -42.59 96.28 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.467 -0.568 . . . . 328.18000000000001 109.467 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.1 ttp -138.44 116.42 11.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.315 -0.857 . . . . 243.28999999999999 109.312 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.29 149.66 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.269 0.557 . . . . 58.390000000000001 110.754 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 75.5 m -128.66 142.37 51.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.391 -0.822 . . . . 44.390000000000001 110.928 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -145.3 162.17 37.84 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.031 -0.531 . . . . 767.09000000000003 110.048 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.3 t -149.75 152.84 35.92 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.967 0.413 . . . . 146.31999999999999 110.986 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.7 t -168.58 131.82 1.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.849 -0.614 . . . . 15.640000000000001 109.427 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -102.91 149.21 24.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.942 0.401 . . . . 422.56 111.34 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -107.79 146.2 32.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.791 -0.641 . . . . 462.10000000000002 110.315 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.8 m -96.09 122.03 38.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 111.17 110.634 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.9 p -150.19 84.9 1.39 Allowed 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.55 0.691 . . . . 121.65000000000001 110.606 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 78.38 -3.98 60.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 114.636 -1.165 . . . . 82.170000000000002 110.723 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 34' ' ' GLY . 31.6 m120 -158.17 149.53 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.104 -0.332 . . . . 220.46000000000001 110.104 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -98.01 139.3 34.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.944 0.402 . . . . 149.47999999999999 110.788 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.7 p -146.93 118.15 7.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 169.86000000000001 110.082 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -76.23 160.25 29.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 537.64999999999998 110.877 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 2.5 p -59.98 150.68 68.55 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.065 -0.516 . . . . 32.920000000000002 110.002 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.06 134.23 17.47 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.217 1.944 . . . . 87.700000000000003 111.909 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.72 -40.03 98.11 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.847 -0.901 . . . . 244.37 110.847 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.1 mt -116.66 147.05 42.3 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.847 0.356 . . . . 681.24000000000001 110.268 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.445 ' OG1' HG22 ' A' ' 45' ' ' ILE . 72.3 p -68.4 149.27 98.1 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.161 -0.472 . . . . 508.5 110.212 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.59 -12.77 27.11 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.332 2.021 . . . . 999.99000000000001 112.1 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.445 HG22 ' OG1' ' A' ' 43' ' ' THR . 20.7 tt -41.9 139.66 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.339 -0.391 . . . . 898.75 110.943 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.032 -0.985 . . . . 999.99000000000001 110.619 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.512 -1.435 . . . . 999.99000000000001 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.97 145.17 42.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.74 0.305 . . . . 999.99000000000001 110.494 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 5' ' ' GLU . 80.6 m -62.3 -40.79 97.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 271.27999999999997 110.619 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 1.1 t 75.53 -34.68 0.25 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 178.88999999999999 110.053 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.4 pt-20 -153.73 161.18 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.696 -0.683 . . . . 206.49000000000001 110.354 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.27 -40.17 93.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 244.88 110.814 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.58 46.84 1.29 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.068 -0.813 . . . . 71.469999999999999 111.068 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -60.84 -50.25 74.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.893 0.378 . . . . 133.27000000000001 110.571 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.4 m -64.95 -41.99 95.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 25.780000000000001 109.865 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.95 166.9 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.334 -0.848 . . . . 119.04000000000001 110.0 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.74 92.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 60.490000000000002 111.186 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 48.7 p-10 -92.44 13.76 18.63 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.376 -0.374 . . . . 258.73000000000002 111.429 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -122.31 158.58 29.24 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.597 -0.274 . . . . 339.06 110.354 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.8 t -112.44 144.36 42.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.492 -0.322 . . . . 42.960000000000001 110.679 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 34.6 t -139.07 129.15 25.2 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.507 -0.553 . . . . 39.109999999999999 109.507 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 8.1 p -144.83 132.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.822 0.344 . . . . 115.20999999999999 110.532 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -92.4 123.36 35.66 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.191 -0.459 . . . . 135.41999999999999 110.948 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 26' ' ' THR . 0.8 OUTLIER -100.96 158.58 15.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.014 -0.539 . . . . 45.380000000000003 109.669 178.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.1 p 179.32 116.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 121.983 0.896 . . . . 42.109999999999999 109.581 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -73.77 -92.63 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.925 -1.488 . . . . 66.019999999999996 111.148 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -90.22 -65.26 1.03 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.68 -0.691 . . . . 451.81 110.953 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.81 -10.54 0.11 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.808 -0.71 . . . . 104.66 111.352 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -59.6 -41.88 91.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.555 -0.535 . . . . 328.18000000000001 109.555 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.536 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 65.6 ttp -146.7 140.16 25.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.317 -0.856 . . . . 243.28999999999999 109.421 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 25' ' ' VAL . 4.9 m -101.78 158.29 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 58.390000000000001 111.015 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 18' ' ' THR . 88.3 m -136.65 145.64 45.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.603 -0.726 . . . . 44.390000000000001 110.795 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.09 160.58 37.89 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.147 -0.479 . . . . 767.09000000000003 110.122 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -148.56 150.73 33.86 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.939 0.4 . . . . 146.31999999999999 110.832 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -170.58 129.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 15.640000000000001 109.691 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -107.03 138.25 43.55 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.893 0.377 . . . . 422.56 110.828 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -95.66 167.55 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.989 -0.55 . . . . 462.10000000000002 110.725 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 95.2 m -113.21 124.23 52.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.619 -0.719 . . . . 111.17 110.348 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.3 p -151.43 85.08 1.31 Allowed 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.614 0.721 . . . . 121.65000000000001 110.733 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.59 -6.11 54.36 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.718 -1.128 . . . . 82.170000000000002 110.661 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.3 m-20 -156.19 149.48 24.49 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.895 -0.409 . . . . 220.46000000000001 109.895 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.42 137.19 36.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 149.47999999999999 110.837 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.0 p -146.05 117.15 7.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.089 -0.505 . . . . 169.86000000000001 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.5 162.57 26.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 537.64999999999998 110.889 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.464 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 3.8 p -60.35 150.6 72.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.014 -0.539 . . . . 32.920000000000002 109.953 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.77 133.53 17.09 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.104 1.87 . . . . 87.700000000000003 112.05 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.73 97.76 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.825 -0.91 . . . . 244.37 110.825 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.9 mt -90.64 159.82 16.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.865 0.364 . . . . 681.24000000000001 110.621 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.2 p -65.51 150.03 96.48 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.131 -0.486 . . . . 508.5 110.223 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.34 -7.04 19.22 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.215 1.944 . . . . 999.99000000000001 111.532 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.5 129.82 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.526 . . . . 898.75 110.52 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.006 -0.997 . . . . 999.99000000000001 110.57 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.556 -1.418 . . . . 999.99000000000001 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 84.7 mt -73.53 150.62 41.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 999.99000000000001 110.271 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 78.0 m -81.85 106.75 14.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 271.27999999999997 110.699 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 t -62.62 -42.85 99.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.609 . . . . 178.88999999999999 109.833 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -142.19 -165.6 2.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.004 -0.998 . . . . 206.49000000000001 110.417 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -60.05 -39.87 87.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 244.88 110.302 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.27 65.6 0.52 Allowed Glycine 0 N--CA 1.465 0.608 0 N-CA-C 110.543 -1.023 . . . . 71.469999999999999 110.543 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 2' ' ' LEU . 68.0 t0 -60.57 -44.86 95.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.879 0.371 . . . . 133.27000000000001 110.802 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 99.5 m -61.94 -43.1 99.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.384 0.611 . . . . 25.780000000000001 109.68 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.85 162.28 7.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.99 -1.005 . . . . 119.04000000000001 109.384 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.24 -45.51 93.0 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.412 -0.515 . . . . 60.490000000000002 110.608 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.91 -38.97 69.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.398 . . . . 258.73000000000002 111.073 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -73.83 161.07 30.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 339.06 111.146 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 41.7 t -109.28 155.52 21.05 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.361 -0.381 . . . . 42.960000000000001 110.351 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.453 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 9.3 t -149.62 129.19 13.11 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.524 -0.546 . . . . 39.109999999999999 109.524 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' A' ' 3' ' ' CYS . 11.6 p -148.33 132.21 8.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.837 0.351 . . . . 115.20999999999999 110.492 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -102.73 119.24 38.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.097 -0.501 . . . . 135.41999999999999 110.483 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 22.4 p -105.56 163.69 12.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.057 -0.519 . . . . 45.380000000000003 109.926 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p 178.38 117.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-O 121.84 0.829 . . . . 42.109999999999999 109.14 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.636 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -103.97 -62.36 1.32 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.231 -1.35 . . . . 66.019999999999996 111.123 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.8 pt-20 -104.5 -178.74 3.74 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.367 0.603 . . . . 451.81 111.913 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.44 -10.28 59.46 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.052 -0.976 . . . . 104.66 111.372 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.2 t0 -60.59 -44.07 96.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.789 0.328 . . . . 328.18000000000001 110.84 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -159.94 168.75 24.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.038 -0.528 . . . . 243.28999999999999 110.953 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.0 t -118.15 143.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.026 -0.534 . . . . 58.390000000000001 110.547 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.1 m -118.34 137.6 52.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.569 -0.742 . . . . 44.390000000000001 111.111 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -146.61 161.41 40.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.228 -0.442 . . . . 767.09000000000003 110.125 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -151.93 162.83 40.44 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.875 0.369 . . . . 146.31999999999999 110.859 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.3 t -168.48 131.2 1.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 15.640000000000001 110.03 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 74.5 mm-40 -77.87 154.46 31.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 422.56 111.277 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -121.37 138.67 54.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.746 -0.661 . . . . 462.10000000000002 109.555 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.488 HG23 ' CE2' ' A' ' 36' ' ' PHE . 93.6 m -79.87 123.09 27.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.145 -0.479 . . . . 111.17 110.589 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 32' ' ' THR . 32.4 p -154.77 88.28 1.19 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.494 0.664 . . . . 121.65000000000001 110.536 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.73 -50.49 1.46 Allowed Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 114.812 -1.086 . . . . 82.170000000000002 111.1 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.73 136.68 47.81 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.749 0.309 . . . . 220.46000000000001 110.385 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.488 ' CE2' HG23 ' A' ' 32' ' ' THR . 94.2 m-85 -83.76 150.53 25.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 149.47999999999999 110.493 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.424 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 32.2 p -126.86 -145.71 0.32 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.957 0.408 . . . . 169.86000000000001 110.296 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 52.6 tp10 -151.6 139.21 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 537.64999999999998 110.318 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 p -56.77 150.92 34.56 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.107 -0.497 . . . . 32.920000000000002 110.158 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.25 157.79 41.54 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.449 2.099 . . . . 87.700000000000003 112.162 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.41 -93.07 1.64 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.682 -0.967 . . . . 244.37 110.682 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -81.55 136.2 35.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 681.24000000000001 110.216 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.539 ' OG1' HG22 ' A' ' 45' ' ' ILE . 73.1 p -81.16 160.6 65.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.192 -0.458 . . . . 508.5 110.034 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.28 -22.81 59.42 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 121.673 1.582 . . . . 999.99000000000001 111.72 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.539 HG22 ' OG1' ' A' ' 43' ' ' THR . 18.6 tt -37.99 144.88 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.884 -0.598 . . . . 898.75 111.274 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 117.955 -1.022 . . . . 999.99000000000001 110.602 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.569 -1.413 . . . . 999.99000000000001 109.569 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.8 mt -121.36 149.24 43.26 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 110.177 -0.305 . . . . 999.99000000000001 110.177 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 89.7 m -65.78 146.32 54.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 271.27999999999997 110.308 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 t -60.2 -43.03 96.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.293 0.568 . . . . 178.88999999999999 110.105 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.9 -172.81 4.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.149 -0.932 . . . . 206.49000000000001 110.524 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.83 -39.4 84.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 244.88 110.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.37 74.11 0.42 Allowed Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.651 -0.98 . . . . 71.469999999999999 110.651 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -61.26 -44.01 97.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.872 0.368 . . . . 133.27000000000001 110.597 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -62.63 -41.78 99.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.949 -0.569 . . . . 25.780000000000001 110.39 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.47 163.64 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.597 -0.729 . . . . 119.04000000000001 110.095 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.73 90.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 60.490000000000002 110.846 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -91.62 10.52 27.74 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.349 -0.387 . . . . 258.73000000000002 111.431 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.506 ' OE2' ' N ' ' A' ' 32' ' ' THR . 70.3 mm-40 -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 339.06 110.865 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 40.5 t -106.06 156.99 17.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.81 -0.632 . . . . 42.960000000000001 110.854 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 42.5 t -147.64 126.36 12.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.514 -0.551 . . . . 39.109999999999999 109.514 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 p -150.99 131.98 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.01 -0.367 . . . . 115.20999999999999 110.01 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 97.7 m-20 -101.41 118.66 37.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.058 0.456 . . . . 135.41999999999999 111.41 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 26' ' ' THR . 2.4 p -100.69 161.98 13.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.632 -0.713 . . . . 45.380000000000003 109.15 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 19' ' ' VAL . 3.5 p 178.41 118.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.815 0.817 . . . . 42.109999999999999 109.331 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.638 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -90.03 -62.57 1.44 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.25 -1.341 . . . . 66.019999999999996 110.184 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -117.91 -172.91 2.34 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 120.98 0.419 . . . . 451.81 110.736 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.01 -20.19 47.52 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.357 -0.697 . . . . 104.66 111.357 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -64.56 -40.13 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.595 0.236 . . . . 328.18000000000001 111.539 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 95.4 mtp -137.0 153.44 50.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.123 0.487 . . . . 243.28999999999999 111.601 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.73 142.2 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.625 -0.716 . . . . 58.390000000000001 110.085 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 18' ' ' THR . 99.0 m -123.78 134.62 53.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.946 -0.57 . . . . 44.390000000000001 111.249 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -128.72 147.44 50.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.001 -0.545 . . . . 767.09000000000003 109.911 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -133.8 145.85 50.14 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.969 0.414 . . . . 146.31999999999999 110.715 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.0 t -173.41 115.25 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.837 -0.62 . . . . 15.640000000000001 109.745 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.5 mm-40 -84.78 155.01 22.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.954 0.407 . . . . 422.56 111.014 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -121.96 143.74 49.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.905 -0.588 . . . . 462.10000000000002 109.804 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.506 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 93.7 m -89.32 119.61 29.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.353 -0.385 . . . . 111.17 110.79 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.3 p -152.21 82.49 1.25 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.645 0.736 . . . . 121.65000000000001 110.468 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' O ' ' OD1' ' A' ' 35' ' ' ASN . . . 78.66 -5.72 56.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 114.455 -1.248 . . . . 82.170000000000002 110.737 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 77.4 m-20 -156.58 149.04 23.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.704 0.287 . . . . 220.46000000000001 110.252 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.03 139.33 39.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.836 0.35 . . . . 149.47999999999999 110.717 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 123.97 4.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 169.86000000000001 110.384 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.455 ' OE2' ' N ' ' A' ' 38' ' ' GLU . 58.2 mp0 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 537.64999999999998 111.135 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.8 p -63.53 150.67 89.66 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.922 -0.581 . . . . 32.920000000000002 110.153 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.03 142.75 28.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.133 1.888 . . . . 87.700000000000003 111.841 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.77 0.82 74.03 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 244.37 110.924 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 mt -107.22 140.82 39.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.943 0.402 . . . . 681.24000000000001 110.524 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.7 p -134.65 64.84 65.11 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.08 -0.509 . . . . 508.5 110.407 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.27 -16.26 22.27 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.602 2.201 . . . . 999.99000000000001 111.766 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 tt -53.35 139.07 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 898.75 110.614 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' OXT' ' CE2' ' A' ' 20' ' ' PHE . . . . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.032 -0.985 . . . . 999.99000000000001 110.572 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.494 -1.442 . . . . 999.99000000000001 109.494 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.9 mt -81.34 151.84 27.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.726 0.298 . . . . 999.99000000000001 110.402 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 93.0 m -65.09 146.88 54.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.333 -0.394 . . . . 271.27999999999997 110.298 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -60.36 -43.04 96.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.316 0.579 . . . . 178.88999999999999 110.132 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -142.96 -170.86 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.129 -0.942 . . . . 206.49000000000001 110.446 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.342 -0.39 . . . . 244.88 110.137 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.27 81.74 0.32 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.493 -1.043 . . . . 71.469999999999999 110.493 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -61.2 -43.34 99.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 133.27000000000001 110.597 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.2 m -62.34 -41.44 98.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.895 -0.593 . . . . 25.780000000000001 110.333 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -171.63 161.41 6.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.521 -0.763 . . . . 119.04000000000001 109.863 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -46.16 91.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.691 -0.403 . . . . 60.490000000000002 110.71 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.5 -38.33 74.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.056 0.455 . . . . 258.73000000000002 110.525 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 32' ' ' THR . 69.2 mm-40 -75.72 167.88 21.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.702 -0.681 . . . . 339.06 111.018 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 16.2 p -112.57 171.1 7.72 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.218 -0.446 . . . . 42.960000000000001 110.324 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 48.9 t -152.48 126.92 9.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.453 -0.573 . . . . 39.109999999999999 109.453 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 16' ' ' VAL . 10.2 p -148.86 129.67 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.928 0.394 . . . . 115.20999999999999 110.512 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 66.3 m-20 -115.05 133.94 55.61 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.071 -0.513 . . . . 135.41999999999999 110.77 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 26' ' ' THR . 20.3 p -126.91 162.02 26.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.808 -0.633 . . . . 45.380000000000003 109.687 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -178.77 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-O 121.997 0.903 . . . . 42.109999999999999 109.455 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -97.78 -53.26 3.47 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.938 -1.483 . . . . 66.019999999999996 110.684 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.3 pt-20 -120.37 -178.05 3.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.307 0.575 . . . . 451.81 111.419 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.61 -11.16 59.62 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.148 -0.933 . . . . 104.66 111.049 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 64.6 t0 -62.73 -44.38 96.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.806 0.336 . . . . 328.18000000000001 111.13 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 66.3 ttp -155.12 147.3 23.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.513 . . . . 243.28999999999999 110.92 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.4 t -107.36 142.71 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.074 -0.512 . . . . 58.390000000000001 110.403 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 18' ' ' THR . 73.1 m -117.05 133.59 55.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.485 -0.78 . . . . 44.390000000000001 110.798 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -151.6 163.45 39.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.178 -0.465 . . . . 767.09000000000003 110.398 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -149.47 148.03 28.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.054 0.454 . . . . 146.31999999999999 110.813 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.9 t -169.36 114.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.741 -0.663 . . . . 15.640000000000001 109.388 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.6 159.77 20.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 422.56 111.331 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -124.57 142.94 50.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.053 -0.521 . . . . 462.10000000000002 110.176 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.505 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 99.8 m -84.87 121.55 27.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 111.17 110.371 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.8 p -153.57 90.06 1.38 Allowed 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.373 0.606 . . . . 121.65000000000001 110.61 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 -40.35 0.82 Allowed Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 114.926 -1.034 . . . . 82.170000000000002 110.957 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 33' ' ' THR . 81.4 m-20 -134.62 139.42 45.31 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.845 0.355 . . . . 220.46000000000001 110.212 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.11 150.49 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 149.47999999999999 110.975 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.63 122.36 5.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 169.86000000000001 110.131 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' CYS . 88.1 tt0 -81.5 148.7 29.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.832 -0.622 . . . . 537.64999999999998 111.332 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -41.08 164.4 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 115.857 -0.61 . . . . 32.920000000000002 110.159 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -75.89 142.77 25.6 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.398 2.065 . . . . 87.700000000000003 111.789 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.94 -39.88 98.59 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 244.37 110.865 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.5 mt -115.71 147.94 40.32 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.816 0.341 . . . . 681.24000000000001 110.308 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.4 p -68.11 149.68 98.05 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.248 -0.433 . . . . 508.5 110.378 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.77 5.29 3.48 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.205 1.937 . . . . 999.99000000000001 111.768 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 98.0 mt -59.77 -45.13 95.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 898.75 110.235 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 118.08 -0.962 . . . . 999.99000000000001 110.548 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.435 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.504 -1.438 . . . . 999.99000000000001 109.504 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.6 mt -72.4 148.92 44.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.756 0.313 . . . . 999.99000000000001 110.399 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.1 m -60.44 133.83 56.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 271.27999999999997 110.64 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t -64.44 -42.51 95.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.358 0.599 . . . . 178.88999999999999 109.804 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -141.2 -164.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.069 -0.969 . . . . 206.49000000000001 110.614 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.69 -39.98 90.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.415 -0.357 . . . . 244.88 110.686 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.38 85.98 0.38 Allowed Glycine 0 N--CA 1.467 0.731 0 N-CA-C 110.749 -0.94 . . . . 71.469999999999999 110.749 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -62.61 -43.38 98.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.705 0.288 . . . . 133.27000000000001 110.991 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.2 m -62.0 -43.11 99.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 25.780000000000001 110.281 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -166.66 166.04 16.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.391 -0.822 . . . . 119.04000000000001 109.825 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.87 96.21 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.904 -0.319 . . . . 60.490000000000002 111.175 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -83.99 -32.46 24.96 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.842 0.353 . . . . 258.73000000000002 111.3 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -75.75 160.35 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.345 -0.389 . . . . 339.06 110.842 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.4 t -115.98 149.67 38.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.351 -0.386 . . . . 42.960000000000001 110.113 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.3 p -135.64 153.69 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.723 -0.473 . . . . 39.109999999999999 109.723 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.5 p -165.87 117.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.486 -0.486 . . . . 115.20999999999999 110.515 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 1' ' ' GLY . 97.4 m-20 -103.5 119.63 39.27 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.185 -0.461 . . . . 135.41999999999999 110.852 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.954 -0.566 . . . . 45.380000000000003 109.774 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 p 177.72 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 122.079 0.943 . . . . 42.109999999999999 109.074 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.648 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.19 -94.1 0.17 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.876 -1.511 . . . . 66.019999999999996 111.428 -178.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -79.98 -19.67 47.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.189 -0.914 . . . . 451.81 111.131 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.92 -10.14 72.37 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.264 -0.734 . . . . 104.66 111.264 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -60.52 -41.79 95.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 328.18000000000001 109.487 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.443 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 66.9 mtm -138.6 99.17 3.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.358 -0.837 . . . . 243.28999999999999 109.414 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.88 145.2 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.208 0.528 . . . . 58.390000000000001 110.858 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 77.6 m -125.74 136.95 53.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.398 -0.819 . . . . 44.390000000000001 110.954 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -149.76 160.65 43.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.219 -0.446 . . . . 767.09000000000003 110.638 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -152.53 150.5 29.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.351 -0.386 . . . . 146.31999999999999 110.775 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 2.9 t -169.96 126.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.914 -0.585 . . . . 15.640000000000001 109.734 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -85.04 152.54 23.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.984 0.421 . . . . 422.56 111.007 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -116.49 142.69 46.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.984 -0.553 . . . . 462.10000000000002 109.969 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 36' ' ' PHE . 91.5 m -71.58 124.97 25.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.989 0.423 . . . . 111.17 110.508 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -154.05 89.43 1.3 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.417 0.627 . . . . 121.65000000000001 110.543 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.81 -47.14 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.928 -1.033 . . . . 82.170000000000002 111.005 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -135.06 138.76 44.18 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.791 0.329 . . . . 220.46000000000001 110.253 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 96.9 m-85 -83.73 148.09 27.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 149.47999999999999 110.659 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.7 p -125.85 -144.96 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.951 0.405 . . . . 169.86000000000001 110.069 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -156.89 143.57 18.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.074 -0.512 . . . . 537.64999999999998 110.536 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.3 p -62.15 149.51 86.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 32.920000000000002 110.005 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 135.25 16.77 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.071 1.847 . . . . 87.700000000000003 111.74 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -62.93 -42.89 99.58 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.723 -0.951 . . . . 244.37 110.723 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 79.8 mt -127.49 140.03 52.41 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.97 -0.381 . . . . 681.24000000000001 109.97 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.1 m -110.15 116.04 53.87 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.435 -0.348 . . . . 508.5 110.235 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.62 64.15 8.11 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.259 1.973 . . . . 999.99000000000001 112.026 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.07 141.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 898.75 110.631 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.002 -0.999 . . . . 999.99000000000001 110.459 179.977 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.592 -1.403 . . . . 999.99000000000001 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.62 149.64 36.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.679 0.276 . . . . 999.99000000000001 110.361 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.493 ' C ' ' H ' ' A' ' 5' ' ' GLU . 77.0 m -62.09 -40.93 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.875 0.369 . . . . 271.27999999999997 110.609 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER 75.17 -32.66 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 178.88999999999999 110.56 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 3' ' ' CYS . 22.5 pt-20 -150.69 168.12 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.634 . . . . 206.49000000000001 110.596 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.6 -39.89 89.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.357 -0.383 . . . . 244.88 110.929 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.91 68.24 0.28 Allowed Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.17 -0.772 . . . . 71.469999999999999 111.17 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -62.9 -48.56 78.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.987 0.422 . . . . 133.27000000000001 110.617 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.2 m -63.99 -41.41 97.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.855 -0.611 . . . . 25.780000000000001 109.931 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.1 162.91 9.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.161 -0.927 . . . . 119.04000000000001 109.246 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.98 90.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.511 -0.476 . . . . 60.490000000000002 110.666 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -71.45 -37.83 71.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 258.73000000000002 110.857 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -73.14 161.14 30.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 339.06 111.163 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 50.2 t -111.05 158.98 18.21 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.157 -0.474 . . . . 42.960000000000001 110.411 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 49.7 t -149.13 130.35 14.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.441 -0.577 . . . . 39.109999999999999 109.441 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 16' ' ' VAL . 13.3 p -149.14 129.89 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.91 0.386 . . . . 115.20999999999999 110.434 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -93.0 119.21 32.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 135.41999999999999 110.772 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.2 p -103.69 161.66 13.73 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.994 -0.548 . . . . 45.380000000000003 109.949 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 19' ' ' VAL . 4.0 p 179.54 117.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-O 121.796 0.808 . . . . 42.109999999999999 109.325 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -104.12 -62.8 1.27 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.357 -1.292 . . . . 66.019999999999996 111.28 -178.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.9 pt-20 -103.23 -178.49 3.68 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.452 0.644 . . . . 451.81 111.991 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -93.77 -10.12 59.22 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.992 -1.004 . . . . 104.66 111.445 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 66.4 t0 -60.77 -44.48 96.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 328.18000000000001 110.927 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -159.82 170.18 22.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.013 -0.539 . . . . 243.28999999999999 111.022 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.85 143.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.896 -0.593 . . . . 58.390000000000001 110.512 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.8 m -117.44 134.02 55.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 44.390000000000001 111.338 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -126.27 147.06 49.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.966 -0.561 . . . . 767.09000000000003 109.708 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.2 m -135.1 153.11 52.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.887 0.375 . . . . 146.31999999999999 110.727 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 3.0 t -166.0 132.17 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.962 -0.563 . . . . 15.640000000000001 109.952 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 75.5 mm-40 -81.39 155.74 25.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 422.56 111.439 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 143.17 50.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.584 -0.735 . . . . 462.10000000000002 109.399 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.482 HG23 ' CE2' ' A' ' 36' ' ' PHE . 98.2 m -85.61 121.34 28.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 111.17 110.68 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 p -152.29 88.81 1.39 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.82 -0.627 . . . . 121.65000000000001 110.42 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -50.88 1.6 Allowed Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.947 -1.024 . . . . 82.170000000000002 111.04 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -131.49 137.53 48.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.758 0.313 . . . . 220.46000000000001 110.434 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 32' ' ' THR . 97.0 m-85 -84.15 149.77 25.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 149.47999999999999 110.506 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 30' ' ' GLU . 43.3 p -124.85 -145.2 0.33 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.847 0.356 . . . . 169.86000000000001 110.156 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 88.2 tt0 -152.86 139.31 18.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.09 -0.505 . . . . 537.64999999999998 110.77 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.6 p -57.05 152.37 29.46 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.96 -0.564 . . . . 32.920000000000002 109.994 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.14 157.38 46.43 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.343 2.029 . . . . 87.700000000000003 111.767 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.47 -90.7 2.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.997 -0.841 . . . . 244.37 110.997 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.2 mt -77.14 143.76 38.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 681.24000000000001 110.697 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.4 p -72.33 150.62 91.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.021 -0.536 . . . . 508.5 110.164 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.07 -8.95 19.15 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.129 1.886 . . . . 999.99000000000001 111.659 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.96 129.45 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.041 -0.527 . . . . 898.75 110.594 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 118.012 -0.994 . . . . 999.99000000000001 110.571 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.513 -1.435 . . . . 999.99000000000001 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.79 144.09 44.89 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.664 0.269 . . . . 999.99000000000001 110.416 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 73.6 m -78.58 -177.63 5.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 271.27999999999997 110.198 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t -58.81 -44.48 90.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 178.88999999999999 110.388 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' A' ' 7' ' ' GLY . 21.3 pt-20 -153.1 47.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.636 -0.711 . . . . 206.49000000000001 110.829 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 60.18 -5.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 244.88 111.569 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 5' ' ' GLU . . . -155.9 60.71 0.36 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.464 -1.054 . . . . 71.469999999999999 110.464 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 9' ' ' CYS . 52.8 p-10 -61.17 -29.25 69.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.727 0.298 . . . . 133.27000000000001 110.777 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.537 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 97.1 m -62.12 -43.19 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.324 0.583 . . . . 25.780000000000001 109.933 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.81 162.31 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.119 -0.946 . . . . 119.04000000000001 109.429 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.49 93.65 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.512 -0.475 . . . . 60.490000000000002 110.557 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.25 -38.36 68.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 258.73000000000002 110.965 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' A' ' 32' ' ' THR . 75.8 mm-40 -72.33 157.96 36.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 339.06 111.435 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 42.2 t -104.24 156.44 17.9 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.986 -0.552 . . . . 42.960000000000001 110.327 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 54.1 t -147.73 128.86 14.62 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.219 -0.446 . . . . 39.109999999999999 109.99 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.3 134.2 4.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.806 0.336 . . . . 115.20999999999999 110.251 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -101.0 119.47 38.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.196 -0.456 . . . . 135.41999999999999 110.994 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 p -100.38 164.53 11.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.911 -0.586 . . . . 45.380000000000003 110.018 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p 177.08 119.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-O 122.131 0.967 . . . . 42.109999999999999 108.899 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -94.32 -95.09 0.16 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 113.74 -1.573 . . . . 66.019999999999996 111.469 -178.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.42 -21.56 38.82 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.072 -0.967 . . . . 451.81 110.738 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.54 -3.03 65.43 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.313 -0.715 . . . . 104.66 111.313 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -59.61 -39.64 84.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.203 -0.666 . . . . 328.18000000000001 109.203 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' A' ' 24' ' ' MET . 19.1 tmm? -148.87 105.51 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.302 -0.863 . . . . 243.28999999999999 108.874 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' SD ' ' A' ' 24' ' ' MET . 77.7 t -63.9 145.49 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.281 0.562 . . . . 58.390000000000001 111.343 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.7 m -125.09 135.14 52.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.288 -0.869 . . . . 44.390000000000001 110.945 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -128.55 148.83 50.79 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 767.09000000000003 109.909 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -132.95 144.55 50.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.855 0.36 . . . . 146.31999999999999 110.696 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.57 115.16 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.043 -0.526 . . . . 15.640000000000001 110.007 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -79.17 152.36 30.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.829 0.347 . . . . 422.56 110.627 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -115.15 142.38 46.73 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.329 -0.396 . . . . 462.10000000000002 110.255 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.462 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 88.2 m -71.11 125.9 28.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 111.17 110.511 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 35' ' ' ASN . 30.9 p -152.84 89.47 1.39 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.395 0.617 . . . . 121.65000000000001 110.503 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.44 -44.06 0.92 Allowed Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.932 -1.031 . . . . 82.170000000000002 110.887 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 33' ' ' THR . 30.0 m120 -136.41 139.32 42.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.82 0.343 . . . . 220.46000000000001 110.157 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -83.28 146.55 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 149.47999999999999 110.749 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.2 p -127.7 -146.79 0.34 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.284 -0.416 . . . . 169.86000000000001 109.917 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -160.92 148.42 15.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.941 -0.572 . . . . 537.64999999999998 110.595 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 8.1 p -61.88 149.9 84.22 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.229 -0.441 . . . . 32.920000000000002 109.89 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.76 134.62 18.47 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.064 1.842 . . . . 87.700000000000003 112.0 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.26 -39.85 98.34 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.87 -0.892 . . . . 244.37 110.87 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.0 mt -95.14 151.89 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 681.24000000000001 110.349 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 48.4 p -65.89 149.61 97.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 508.5 110.116 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.69 -9.89 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.011 1.807 . . . . 999.99000000000001 111.462 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -61.41 -45.08 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.836 -0.62 . . . . 898.75 110.324 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 117.975 -1.012 . . . . 999.99000000000001 110.598 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 17' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.478 -1.449 . . . . 999.99000000000001 109.478 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.2 mt -107.41 143.94 35.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.237 -0.282 . . . . 999.99000000000001 110.237 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 15' ' ' CYS . 82.1 m -63.97 142.81 58.27 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.837 -0.345 . . . . 271.27999999999997 110.16 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 t -60.52 -43.8 96.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.256 0.551 . . . . 178.88999999999999 110.185 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.8 -164.86 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.184 -0.916 . . . . 206.49000000000001 110.437 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.84 -39.49 85.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.914 0.388 . . . . 244.88 110.198 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.29 76.88 0.4 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 110.533 -1.027 . . . . 71.469999999999999 110.533 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.31 -43.53 98.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 133.27000000000001 110.614 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.1 m -62.06 -41.47 98.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.979 -0.555 . . . . 25.780000000000001 110.313 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.28 165.98 8.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.482 -0.781 . . . . 119.04000000000001 109.928 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.33 96.85 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.757 -0.377 . . . . 60.490000000000002 110.757 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -80.93 -33.53 33.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 258.73000000000002 110.958 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.517 ' OE2' ' N ' ' A' ' 32' ' ' THR . 75.5 mm-40 -74.3 158.01 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 339.06 111.293 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 34.1 t -107.71 154.31 21.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.984 -0.553 . . . . 42.960000000000001 110.614 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 42.6 t -142.8 128.12 18.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.58 -0.526 . . . . 39.109999999999999 109.58 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.6 p -151.11 128.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.905 -0.406 . . . . 115.20999999999999 109.905 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 70.1 m-20 -107.97 118.11 35.88 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.128 -0.487 . . . . 135.41999999999999 111.39 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.4 p -102.82 166.44 10.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.459 -0.791 . . . . 45.380000000000003 109.449 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 19' ' ' VAL . 3.5 p -179.57 117.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.909 0.861 . . . . 42.109999999999999 109.502 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -95.93 -62.18 1.33 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.174 -1.375 . . . . 66.019999999999996 110.784 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 21.2 pt-20 -114.9 -172.17 2.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.06 0.457 . . . . 451.81 111.284 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.09 -12.75 54.65 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.754 -0.657 . . . . 104.66 111.864 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 97.5 m-20 -61.46 -40.72 95.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.668 0.271 . . . . 328.18000000000001 111.183 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.5 ttp -157.08 153.02 27.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.371 -0.377 . . . . 243.28999999999999 110.904 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.0 t -115.59 140.94 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.163 0.506 . . . . 58.390000000000001 110.67 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.4 m -110.96 132.3 54.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.514 -0.766 . . . . 44.390000000000001 111.373 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -133.98 148.3 51.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.059 -0.519 . . . . 767.09000000000003 110.184 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -138.45 147.71 43.58 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.926 0.393 . . . . 146.31999999999999 110.772 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -172.9 115.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 15.640000000000001 109.912 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 80.9 mm-40 -80.56 152.8 28.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 422.56 110.631 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.68 143.41 45.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.147 -0.479 . . . . 462.10000000000002 110.205 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.517 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 87.0 m -73.79 125.05 27.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 111.17 110.485 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 35' ' ' ASN . 32.9 p -153.34 89.49 1.35 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.383 0.611 . . . . 121.65000000000001 110.559 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.16 -41.14 0.74 Allowed Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.898 -1.046 . . . . 82.170000000000002 111.017 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 33' ' ' THR . 83.0 m-20 -133.93 140.05 46.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.854 0.359 . . . . 220.46000000000001 110.341 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.04 144.81 26.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.157 -0.474 . . . . 149.47999999999999 110.623 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.6 p -134.52 -157.66 0.82 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.438 -0.579 . . . . 169.86000000000001 109.438 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -149.59 155.33 40.11 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.441 -0.8 . . . . 537.64999999999998 110.655 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 14' ' ' CYS . 10.5 p -65.92 149.76 97.22 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.675 -0.491 . . . . 32.920000000000002 109.675 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.96 131.3 16.68 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.978 1.785 . . . . 87.700000000000003 111.946 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.98 98.36 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.063 -0.815 . . . . 244.37 111.063 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.1 mt -109.25 139.32 44.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.849 0.357 . . . . 681.24000000000001 110.304 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.2 p -71.01 150.45 94.94 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.196 -0.456 . . . . 508.5 110.049 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.55 -11.94 16.98 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.963 1.776 . . . . 999.99000000000001 111.282 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.87 127.3 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 898.75 110.693 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.108 -0.949 . . . . 999.99000000000001 110.582 -179.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.48 -1.448 . . . . 999.99000000000001 109.48 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.5 mt -73.63 144.41 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.662 0.267 . . . . 999.99000000000001 110.287 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 71.7 m -69.0 135.99 51.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.863 -0.335 . . . . 271.27999999999997 110.16 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.36 -43.25 99.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.286 0.565 . . . . 178.88999999999999 110.002 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 7' ' ' GLY . 9.7 pt-20 -149.27 -162.76 1.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.125 -0.943 . . . . 206.49000000000001 110.379 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -59.96 -39.39 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 244.88 110.139 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' H ' ' HG3' ' A' ' 5' ' ' GLU . . . -127.4 75.09 0.42 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.538 -1.025 . . . . 71.469999999999999 110.538 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -61.42 -43.12 99.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.939 0.4 . . . . 133.27000000000001 110.679 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.5 m -61.65 -42.56 99.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.007 -0.542 . . . . 25.780000000000001 110.199 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.93 167.13 13.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.334 -0.848 . . . . 119.04000000000001 109.871 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.5 95.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.515 -0.312 . . . . 60.490000000000002 111.117 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -85.44 -30.29 23.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.473 -0.331 . . . . 258.73000000000002 111.273 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.51 154.14 37.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.397 -0.365 . . . . 339.06 110.979 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 39.0 t -104.51 148.87 25.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.219 -0.446 . . . . 42.960000000000001 110.727 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.437 ' C ' ' SG ' ' A' ' 3' ' ' CYS . 42.1 t -135.92 123.97 22.9 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.554 -0.535 . . . . 39.109999999999999 109.554 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 16' ' ' VAL . 9.4 p -143.33 127.69 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.913 0.387 . . . . 115.20999999999999 110.21 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 3' ' ' CYS . 43.1 m-20 -109.66 118.78 37.46 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.047 -0.524 . . . . 135.41999999999999 111.022 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' THR . 46.5 p -104.54 167.53 9.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.826 -0.625 . . . . 45.380000000000003 109.867 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p 179.34 117.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 121.936 0.874 . . . . 42.109999999999999 109.304 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -100.57 -71.19 0.71 Allowed 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.069 -1.423 . . . . 66.019999999999996 110.815 -179.308 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 23' ' ' ASP . 20.4 pt-20 -95.67 -177.57 4.1 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.608 -0.723 . . . . 451.81 111.782 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.05 -10.42 57.43 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.115 -0.948 . . . . 104.66 111.098 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 65.3 t0 -60.38 -43.71 96.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.842 0.353 . . . . 328.18000000000001 110.975 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -159.39 168.99 24.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.12 -0.491 . . . . 243.28999999999999 110.963 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -118.9 146.14 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.919 -0.582 . . . . 58.390000000000001 110.852 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' THR . 51.5 m -121.72 138.13 54.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.504 -0.771 . . . . 44.390000000000001 111.251 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -150.5 158.09 43.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.264 -0.425 . . . . 767.09000000000003 110.492 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.8 m -142.31 153.76 44.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 146.31999999999999 111.078 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 14' ' ' CYS . 1.8 t -167.05 121.06 1.01 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.8 -0.636 . . . . 15.640000000000001 109.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -83.95 155.09 23.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.014 0.435 . . . . 422.56 111.38 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.4 143.52 45.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.727 -0.67 . . . . 462.10000000000002 110.067 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 96.1 m -78.53 124.29 28.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 111.17 110.729 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ASN . 34.0 p -152.91 89.03 1.35 Allowed 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.451 0.643 . . . . 121.65000000000001 110.518 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 -38.84 0.76 Allowed Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.899 -1.046 . . . . 82.170000000000002 111.222 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' THR . 82.7 m-20 -135.72 141.2 44.86 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.875 0.369 . . . . 220.46000000000001 110.365 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -90.03 146.5 24.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 149.47999999999999 110.573 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.8 p -132.77 -156.21 0.73 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.511 -0.552 . . . . 169.86000000000001 109.511 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -148.29 153.33 38.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.6 -0.727 . . . . 537.64999999999998 110.655 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.9 p -65.45 149.86 96.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.586 -0.524 . . . . 32.920000000000002 109.586 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.44 131.03 15.71 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.014 1.809 . . . . 87.700000000000003 112.121 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.83 -40.17 97.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.173 -0.771 . . . . 244.37 111.173 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.1 mt -109.3 149.02 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.929 0.395 . . . . 681.24000000000001 110.584 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.1 p -69.8 150.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 508.5 110.076 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.84 -13.13 17.83 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.14 1.894 . . . . 999.99000000000001 111.298 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -72.52 128.4 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.7 . . . . 898.75 110.613 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.034 -0.984 . . . . 999.99000000000001 110.539 -179.957 . . . . . . . . 0 0 . 1 stop_ save_